assay_id,assay_test_type,tissue_id,tid,assay_tax_id,curated_by,src_id,assay_tissue,assay_type,cell_id,description,assay_subcellular_fraction,assay_category,bao_format,relationship_type,assay_strain,confidence_score,src_assay_id,chembl_id,variant_id
7524,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,BAO_0000218,N,,1,,CHEMBL618647,
7525,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,,BAO_0000218,N,,1,,CHEMBL618648,
7526,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,,BAO_0000218,N,,1,,CHEMBL618649,
7527,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,BAO_0000218,N,,1,,CHEMBL618650,
7528,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,,BAO_0000218,N,,1,,CHEMBL618651,
7529,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,,BAO_0000218,N,,1,,CHEMBL876497,
7530,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,BAO_0000218,N,,1,,CHEMBL618652,
7531,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,,BAO_0000218,N,,1,,CHEMBL618653,
7532,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,,BAO_0000218,N,,1,,CHEMBL618654,
7533,,,50597,10116.0,Intermediate,1,,A,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,,BAO_0000218,N,,1,,CHEMBL618655,
7534,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for solubility in water,,,BAO_0000218,N,,1,,CHEMBL618656,
7535,,,22229,,Intermediate,1,,P,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,,BAO_0000100,U,,0,,CHEMBL618657,
7536,,,50597,10116.0,Intermediate,1,,A,,Solubility was determined,,,BAO_0000218,N,,1,,CHEMBL618658,
7537,,,50597,10116.0,Intermediate,1,,A,,solubility in water (ug/mL) at 37 degree C.,,,BAO_0000218,N,,1,,CHEMBL618659,
7538,,,50597,10116.0,Intermediate,1,,A,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,,BAO_0000218,N,,1,,CHEMBL618660,
7539,,,50597,10116.0,Intermediate,1,,A,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,,BAO_0000218,N,,1,,CHEMBL618661,
7540,,,50597,10116.0,Intermediate,1,,A,,Half life in rats,,,BAO_0000218,N,,1,,CHEMBL873807,
7541,,,50597,10116.0,Intermediate,1,,A,,Half life in Dawley rat,,,BAO_0000218,N,,1,,CHEMBL618662,
7542,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period after 3 mg/kg iv administration,,,BAO_0000218,N,,1,,CHEMBL618663,
7543,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period after 3 mg/kg iv administration in rat,,,BAO_0000218,N,,1,,CHEMBL618664,
7544,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period after 3 mg/kg iv administration in the rat,,,BAO_0000218,N,,1,,CHEMBL618665,
7545,,,50597,10116.0,Intermediate,1,,A,,Half life period in female Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL876498,
7546,,,50597,10116.0,Intermediate,1,,A,,Half life period in rat,,,BAO_0000218,N,,1,,CHEMBL618666,
7547,,,50597,10116.0,Intermediate,1,,A,,Half-life in rats was determined,,,BAO_0000218,N,,1,,CHEMBL620440,
7548,,,50597,10116.0,Intermediate,1,,A,,Half-life in rats with metabolic oxidation,,,BAO_0000218,N,,1,,CHEMBL620441,
7549,,,50597,10116.0,Intermediate,1,,A,,Half-life in rats,,,BAO_0000218,N,,1,,CHEMBL620442,
7550,In vivo,,50597,10116.0,Intermediate,1,,A,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,BAO_0000218,N,,1,,CHEMBL620443,
7551,In vivo,,50597,10116.0,Intermediate,1,,A,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,BAO_0000218,N,,1,,CHEMBL620444,
7552,In vivo,,50597,10116.0,Intermediate,1,,A,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,BAO_0000218,N,,1,,CHEMBL620445,
7553,In vivo,,50597,10116.0,Intermediate,1,,A,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,BAO_0000218,N,,1,,CHEMBL620446,
7554,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biological half-life measured in plasma of rat,,,BAO_0000218,N,,1,,CHEMBL620447,
7555,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biological half-life measured in plasma of rat; 22-25,,,BAO_0000218,N,,1,,CHEMBL621129,
7556,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biological half-life measured in plasma of rat; 9-16,,,BAO_0000218,N,,1,,CHEMBL621130,
7557,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for its half life when administered intravenously in rat,,,BAO_0000218,N,,1,,CHEMBL873808,
7558,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,,BAO_0000218,N,,1,,CHEMBL876598,
7559,In vivo,,50597,10116.0,Intermediate,1,,A,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621131,
7560,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life (T1/2) after oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL621132,
7561,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of compound after iv administration of 20 mg/kg dose in rat,,,BAO_0000218,N,,1,,CHEMBL621133,
7562,In vivo,,50597,10116.0,Expert,1,,A,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621312,
7563,,,50597,10116.0,Intermediate,1,,A,,Half life of compound was determined in rat,,,BAO_0000218,N,,1,,CHEMBL621313,
7564,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Half life of compound was determined in rat blood,,,BAO_0000218,N,,1,,CHEMBL621314,
7565,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life at 1 mg/kg was determined in rat,,,BAO_0000218,N,,1,,CHEMBL621315,
7566,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life at 10 mg/kg was determined in rat,,,BAO_0000218,N,,1,,CHEMBL621316,
7567,,,50597,10116.0,Intermediate,1,,A,,Half life in rats,,,BAO_0000218,N,,1,,CHEMBL621317,
7568,,,50597,10116.0,Intermediate,1,,A,,Half life in rats in hours,,,BAO_0000218,N,,1,,CHEMBL621318,
7569,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,BAO_0000218,N,,1,,CHEMBL621319,
7570,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL621377,
7571,,,50597,10116.0,Intermediate,1,,A,,Half life was determined,,,BAO_0000218,N,,1,,CHEMBL621378,
7572,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL876599,
7573,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621379,
7574,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life in rat plasma,,,BAO_0000218,N,,1,,CHEMBL621380,
7575,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life in rat plasma; Not detected,,,BAO_0000218,N,,1,,CHEMBL621381,
7576,,,50597,10116.0,Intermediate,1,,A,,Half life in rats,,,BAO_0000218,N,,1,,CHEMBL618515,
7577,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period of compound was determined after peroral administration,,,BAO_0000218,N,,1,,CHEMBL618516,
7578,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,,BAO_0000218,N,,1,,CHEMBL618517,
7579,,,50597,10116.0,Intermediate,1,,A,,Half life period in rat,,,BAO_0000218,N,,1,,CHEMBL618518,
7580,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,BAO_0000218,N,,1,,CHEMBL618519,
7581,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,BAO_0000218,N,,1,,CHEMBL618698,
7582,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,,BAO_0000218,N,,1,,CHEMBL618862,
7583,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL618863,
7584,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,N,,1,,CHEMBL618864,
7585,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life time in rat the dose of 2 mg/kg,,,BAO_0000218,N,,1,,CHEMBL618865,
7586,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life 24 hr after 10 mg/kg iv administration in rats,,,BAO_0000218,N,,1,,CHEMBL618866,
7587,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life 24 hr after 2 mg/kg iv administration in rats,,,BAO_0000218,N,,1,,CHEMBL618867,
7588,,,50597,10116.0,Intermediate,1,,A,,Half-life consistent with the observed metabolic steady state in rats,,,BAO_0000218,N,,1,,CHEMBL875828,
7589,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,BAO_0000218,N,,1,,CHEMBL618868,
7590,,,50597,10116.0,Intermediate,1,,A,,Half-life for oxidative metabolic stability was determined using male human,,,BAO_0000218,N,,1,,CHEMBL618869,
7591,In vivo,,50597,10116.0,Intermediate,1,,A,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,,BAO_0000218,N,,1,,CHEMBL618870,
7592,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in rat plasma,,,BAO_0000218,N,,1,,CHEMBL618871,
7593,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in rat plasma was determined,,,BAO_0000218,N,,1,,CHEMBL618872,
7594,,,50597,10116.0,Intermediate,1,,A,,Half-life in rats was determined,,,BAO_0000218,N,,1,,CHEMBL873816,
7595,,,22224,,Autocuration,1,,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,,BAO_0000218,U,,0,,CHEMBL618873,
7596,,,22224,,Autocuration,1,,A,,Area under curve after oral dose of 0.1 mg//kg,,,BAO_0000019,U,,0,,CHEMBL621602,
7597,,,22224,,Autocuration,1,,A,,Area under curve after oral dose of 0.3 mg/kg,,,BAO_0000218,U,,0,,CHEMBL621603,
7598,,,22224,,Autocuration,1,,A,,Area under curve after oral dose of 1 mg/kg,,,BAO_0000218,U,,0,,CHEMBL621604,
7599,,,22224,,Autocuration,1,,A,,Area under curve after oral dose of 10 mg/kg,,,BAO_0000218,U,,0,,CHEMBL621605,
7600,,,22224,,Autocuration,1,,A,,Area under curve after oral dose of 23.4 mg/kg,,,BAO_0000218,U,,0,,CHEMBL621606,
7601,,,22224,,Autocuration,1,,A,,Area under curve after oral dose of 3 mg/kg,,,BAO_0000218,U,,0,,CHEMBL621607,
7602,,,22224,,Autocuration,1,,A,,Area under curve after oral dose of 3.87 mg/kg,,,BAO_0000218,U,,0,,CHEMBL621608,
7603,,,22224,,Autocuration,1,,A,,Area under curve was determined,,,BAO_0000019,U,,0,,CHEMBL621609,
7604,,,22224,,Autocuration,1,,A,,Area under curve at a dose of 10 mg/kg,,,BAO_0000218,U,,0,,CHEMBL621610,
7605,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined; ND=No data,,,BAO_0000218,N,,1,,CHEMBL621611,
7606,,,50597,10116.0,Intermediate,1,,A,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,N,,1,,CHEMBL621612,
7607,,,50597,10116.0,Intermediate,1,,A,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,,BAO_0000218,N,,1,,CHEMBL622308,
7608,,,50597,10116.0,Intermediate,1,,A,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,N,,1,,CHEMBL622309,
7609,,,50597,10116.0,Intermediate,1,,A,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,,BAO_0000218,N,,1,,CHEMBL622310,
7610,,,50597,10116.0,Intermediate,1,,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,,BAO_0000218,N,,1,,CHEMBL622311,
7611,,,50597,10116.0,Intermediate,1,,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,,BAO_0000218,N,,1,,CHEMBL622312,
7612,,,50597,10116.0,Intermediate,1,,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,N,,1,,CHEMBL622931,
7613,,,50597,10116.0,Intermediate,1,,A,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,,BAO_0000218,N,,1,,CHEMBL622932,
7614,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,N,,1,,CHEMBL622736,
7615,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,,BAO_0000218,N,,1,,CHEMBL622737,
7616,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,N,,1,,CHEMBL622738,
7617,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,,BAO_0000218,N,,1,,CHEMBL622739,
7618,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,,BAO_0000218,N,,1,,CHEMBL622740,
7619,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,,BAO_0000218,N,,1,,CHEMBL622741,
7620,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,,BAO_0000218,N,,1,,CHEMBL622742,
7621,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,,BAO_0000218,N,,1,,CHEMBL622743,
7622,,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,AUC in mice,,,BAO_0000218,N,,1,,CHEMBL622744,
7623,,,22224,,Autocuration,1,,A,,Area under curve was measured from the graph obtained from concentration Vs time,,,BAO_0000019,U,,0,,CHEMBL624134,
7624,,,22224,,Autocuration,1,,A,,Area under curve value of compound per hour after oral administration,,,BAO_0000019,U,,0,,CHEMBL624135,
7625,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined after oral administration in rats,,,BAO_0000218,N,,1,,CHEMBL624136,
7626,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined after oral administration in rats; No data,,,BAO_0000218,N,,1,,CHEMBL624137,
7627,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined after oral administration in rats;No data,,,BAO_0000218,N,,1,,CHEMBL624320,
7628,,,50588,9615.0,Intermediate,1,,A,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,BAO_0000218,N,,1,,CHEMBL624321,
7629,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL624322,
7630,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined for the compound after iv dose of 5.06 in rats,,,BAO_0000218,N,,1,,CHEMBL624323,
7631,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL624324,
7632,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL624325,
7633,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL624326,
7634,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL624327,
7635,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL624328,
7636,,,50588,9615.0,Intermediate,1,,A,,Area under curve was determined in Dogs after peroral administration,,,BAO_0000218,N,,1,,CHEMBL627848,
7637,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined in Rats after peroral administration,,,BAO_0000218,N,,1,,CHEMBL627849,
7638,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined in carotid blood of rat when administered intradermally,,,BAO_0000218,N,,1,,CHEMBL627850,
7639,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined in portal blood of rat when administered intradermally,,,BAO_0000218,N,,1,,CHEMBL627851,
7640,,,50594,10090.0,Intermediate,1,,A,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627852,
7641,,,50594,10090.0,Intermediate,1,,A,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627853,
7642,,,50594,10090.0,Intermediate,1,,A,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,,BAO_0000218,N,,1,,CHEMBL627854,
7643,,,50594,10090.0,Intermediate,1,,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627855,
7644,,,50594,10090.0,Intermediate,1,,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,,BAO_0000218,N,,1,,CHEMBL627856,
7645,,,50594,10090.0,Intermediate,1,,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL875339,
7646,,,50594,10090.0,Intermediate,1,,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,,BAO_0000218,N,,1,,CHEMBL627857,
7647,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL627858,
7648,,178.0,50597,10116.0,Intermediate,1,Blood,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627859,
7649,,955.0,50597,10116.0,Intermediate,1,Brain,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627860,
7650,,948.0,50597,10116.0,Intermediate,1,Heart,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627019,
7651,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627020,
7652,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627021,
7653,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627022,
7654,,,50597,10116.0,Intermediate,1,,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627023,
7655,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627024,
7656,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627025,
7657,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627026,
7658,,178.0,50597,10116.0,Intermediate,1,Blood,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627027,
7659,,955.0,50597,10116.0,Intermediate,1,Brain,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627028,
7660,,948.0,50597,10116.0,Intermediate,1,Heart,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627029,
7661,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627030,
7662,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627031,
7663,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627032,
7664,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627033,
7665,,,50597,10116.0,Intermediate,1,,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627034,
7666,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627035,
7667,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627036,
7668,,178.0,50597,10116.0,Intermediate,1,Blood,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL875340,
7669,,948.0,50597,10116.0,Intermediate,1,Heart,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627037,
7670,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627038,
7671,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627039,
7672,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL627040,
7673,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL624663,
7674,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL625963,
7675,,955.0,50597,10116.0,Intermediate,1,Brain,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL876799,
7676,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL626133,
7677,,,50597,10116.0,Intermediate,1,,A,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,,BAO_0000218,N,,1,,CHEMBL626134,
7678,,,50597,10116.0,Intermediate,1,,A,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626135,
7679,,,50597,10116.0,Intermediate,1,,A,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626136,
7680,,,50597,10116.0,Intermediate,1,,A,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,,BAO_0000218,N,,1,,CHEMBL626137,
7681,,,50597,10116.0,Intermediate,1,,A,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626138,
7682,,,50597,10116.0,Intermediate,1,,A,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626139,
7683,In vivo,,50597,10116.0,Intermediate,1,,A,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,BAO_0000218,N,,1,,CHEMBL626140,
7684,In vivo,,50597,10116.0,Intermediate,1,,A,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,BAO_0000218,N,,1,,CHEMBL626141,
7685,,,50597,10116.0,Intermediate,1,,A,,C24h in rat p.o. at 20 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL626142,
7686,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,BAO_0000218,N,,1,,CHEMBL627930,
7687,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,,BAO_0000218,N,,1,,CHEMBL627931,
7688,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,,BAO_0000218,N,,1,,CHEMBL627932,
7689,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,,BAO_0000218,N,,1,,CHEMBL627933,
7690,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,,BAO_0000218,N,,1,,CHEMBL627934,
7691,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,,BAO_0000218,N,,1,,CHEMBL627935,
7692,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL627936,
7693,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL627937,
7694,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL627938,
7695,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,N,,1,,CHEMBL627939,
7696,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL627940,
7697,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL627941,
7698,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,BAO_0000218,N,,1,,CHEMBL876800,
7699,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL627942,
7700,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL627943,
7701,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,,BAO_0000218,N,,1,,CHEMBL627944,
7702,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,N,,1,,CHEMBL627945,
7703,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,,BAO_0000218,N,,1,,CHEMBL628584,
7704,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,,BAO_0000218,N,,1,,CHEMBL628585,
7705,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,,BAO_0000218,N,,1,,CHEMBL628586,
7706,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,,BAO_0000218,N,,1,,CHEMBL628587,
7707,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,,BAO_0000218,N,,1,,CHEMBL628588,
7708,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,,BAO_0000218,N,,1,,CHEMBL628589,
7709,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,,BAO_0000218,N,,1,,CHEMBL625304,
7710,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,,BAO_0000218,N,,1,,CHEMBL625305,
7711,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,,BAO_0000218,N,,1,,CHEMBL625306,
7712,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,,BAO_0000218,N,,1,,CHEMBL625307,
7713,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,,BAO_0000218,N,,1,,CHEMBL625308,
7714,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,,BAO_0000218,N,,1,,CHEMBL627740,
7715,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,,BAO_0000218,N,,1,,CHEMBL627741,
7716,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,BAO_0000218,N,,1,,CHEMBL627742,
7717,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,N,,1,,CHEMBL627743,
7718,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,,BAO_0000218,N,,1,,CHEMBL627744,
7719,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL627745,
7720,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL627746,
7721,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL627747,
7722,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,N,,1,,CHEMBL876810,
7723,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL627748,
7724,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL627749,
7725,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,BAO_0000218,N,,1,,CHEMBL627750,
7726,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL618728,
7727,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL618729,
7728,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,,BAO_0000218,N,,1,,CHEMBL618730,
7729,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,,BAO_0000218,N,,1,,CHEMBL618731,
7730,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,,BAO_0000218,N,,1,,CHEMBL618732,
7731,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,,BAO_0000218,N,,1,,CHEMBL618733,
7732,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,,BAO_0000218,N,,1,,CHEMBL618734,
7733,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,,BAO_0000218,N,,1,,CHEMBL618735,
7734,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,,BAO_0000218,N,,1,,CHEMBL876602,
7735,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,,BAO_0000218,N,,1,,CHEMBL618736,
7736,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,,BAO_0000218,N,,1,,CHEMBL618737,
7737,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,,BAO_0000218,N,,1,,CHEMBL618738,
7738,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,,BAO_0000218,N,,1,,CHEMBL618739,
7739,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,,BAO_0000218,N,,1,,CHEMBL618740,
7740,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,BAO_0000218,N,,1,,CHEMBL618741,
7741,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,N,,1,,CHEMBL618742,
7742,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,,BAO_0000218,N,,1,,CHEMBL618743,
7743,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life from rat plasma at a single oral dose of 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL618744,
7744,,,50597,10116.0,Intermediate,1,,A,,Half-life in male rat,,,BAO_0000218,N,,1,,CHEMBL618745,
7745,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life in rat after peroral administration at 10 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL620479,
7746,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life in rat after peroral administration at 5 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL620480,
7747,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life in rat at a dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620481,
7748,,,50597,10116.0,Intermediate,1,,A,,Half-life was evaluated in rats,,,BAO_0000218,N,,1,,CHEMBL620482,
7749,,,50597,10116.0,Intermediate,1,,A,,Half-life was measured in rat,,,BAO_0000218,N,,1,,CHEMBL876603,
7750,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life period for the compound was determined in rats at 50 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL620483,
7751,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life period in rats after intravenous administration at 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620484,
7752,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life period in rat at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620485,
7753,In vivo,,50597,10116.0,Intermediate,1,,A,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL620486,
7754,In vivo,,50597,10116.0,Intermediate,1,,A,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,,BAO_0000218,N,,1,,CHEMBL620487,
7755,In vivo,,50597,10116.0,Intermediate,1,,A,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,,BAO_0000218,N,,1,,CHEMBL620488,
7756,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life time in rat the dose of 2 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620489,
7757,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,,BAO_0000218,N,,1,,CHEMBL620490,
7758,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620491,
7759,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,,BAO_0000218,N,,1,,CHEMBL876604,
7760,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral half life was determined,,,BAO_0000218,N,,1,,CHEMBL620492,
7761,In vivo,,50597,10116.0,Intermediate,1,,A,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,N,,1,,CHEMBL620493,
7762,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (t1/2) in rat,,,BAO_0000218,N,,1,,CHEMBL620494,
7763,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma elimination half-life was determined,,,BAO_0000218,N,,1,,CHEMBL620495,
7764,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,BAO_0000218,N,,1,,CHEMBL620496,
7765,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half life was observed after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL620497,
7766,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life was determined,,,BAO_0000218,N,,1,,CHEMBL620498,
7767,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life following oral administration in Fisher rats,,,BAO_0000218,N,,1,,CHEMBL620499,
7768,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life in rat,,,BAO_0000218,N,,1,,CHEMBL620500,
7769,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasmatic Half-life after intravenous administration to rat,,,BAO_0000218,N,,1,,CHEMBL873809,
7770,In vivo,,50597,10116.0,Intermediate,1,,A,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,,BAO_0000218,N,,1,,CHEMBL620501,
7771,In vivo,,50597,10116.0,Intermediate,1,,A,,Terminal half life after intravenous administration (1 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL620502,
7772,In vivo,,50597,10116.0,Intermediate,1,,A,,Terminal half life in Rat at a oral dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620503,
7773,In vivo,,50597,10116.0,Intermediate,1,,A,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,,BAO_0000218,N,,1,,CHEMBL620504,
7774,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL876605,
7775,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL620505,
7776,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,plasma half life was observed after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL873811,
7777,In vivo,,50597,10116.0,Expert,1,,A,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624016,
7778,,,50597,10116.0,Intermediate,1,,A,,Half life of compound determined in rat,,,BAO_0000218,N,,1,,CHEMBL624017,
7779,,,50597,10116.0,Intermediate,1,,A,,Mean residence time determined in rat,,,BAO_0000218,N,,1,,CHEMBL624018,
7780,,,50597,10116.0,Intermediate,1,,A,,Plasma half life determined in rat,,,BAO_0000218,N,,1,,CHEMBL624019,
7781,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,,BAO_0000218,N,,1,,CHEMBL624020,
7782,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for pharmacokinetic parameter maximum time period,,,BAO_0000218,N,,1,,CHEMBL624201,
7783,In vivo,,50597,10116.0,Intermediate,1,,A,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL872528,
7784,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL624202,
7785,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL624203,
7786,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL624350,
7787,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL621320,
7788,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,BAO_0000218,N,,1,,CHEMBL621321,
7789,,,50597,10116.0,Intermediate,1,,A,,Maximum time (Tmax) required to reach Cmax in rats,,,BAO_0000218,N,,1,,CHEMBL621322,
7790,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL621323,
7791,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum time of clearance of compound in rats after peroral administration,,,BAO_0000218,N,,1,,CHEMBL621324,
7792,,,50597,10116.0,Intermediate,1,,A,,Maximum time at the dose of 2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL621325,
7793,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL875837,
7794,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621326,
7795,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax in Guinea pig (PO dose),,,BAO_0000218,N,,1,,CHEMBL621327,
7796,In vivo,,50597,10116.0,Intermediate,1,,A,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,N,,1,,CHEMBL621328,
7797,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter (Tmax) in rat,,,BAO_0000218,N,,1,,CHEMBL621329,
7798,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter (Tmax) was estimated,,,BAO_0000218,N,,1,,CHEMBL621330,
7799,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Tmax) in rat,,,BAO_0000218,N,,1,,CHEMBL621331,
7800,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,,BAO_0000218,N,,1,,CHEMBL621332,
7801,In vivo,,50597,10116.0,Intermediate,1,,A,,T max in Rat at a oral dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621333,
7802,In vivo,,50597,10116.0,Intermediate,1,,A,,T max was determined at 10 mg/kg po dose in rats,,,BAO_0000218,N,,1,,CHEMBL621334,
7803,,,50594,10090.0,Intermediate,1,,A,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,,BAO_0000218,N,,1,,CHEMBL621335,
7804,,,50588,9615.0,Intermediate,1,,A,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,,BAO_0000218,N,,1,,CHEMBL621336,
7805,,,50597,10116.0,Intermediate,1,,A,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,,BAO_0000218,N,,1,,CHEMBL621337,
7806,,,50588,9615.0,Intermediate,1,,A,,Area under curve was measured after i.v. administration into Beagle dog.,,,BAO_0000218,N,,1,,CHEMBL621338,
7807,,,50588,9615.0,Intermediate,1,,A,,Area under curve was measured after iv administration into Beagle dog,,,BAO_0000218,N,,1,,CHEMBL875838,
7808,,,50588,9615.0,Intermediate,1,,A,,Area under curve was measured after po administration into Beagle dog,,,BAO_0000218,N,,1,,CHEMBL621339,
7809,,,50588,9615.0,Intermediate,1,,A,,Area under curve was measured after po administration into Beagle dog.,,,BAO_0000218,N,,1,,CHEMBL621340,
7810,,,22224,,Autocuration,1,,A,,Area under curve was measured at peroral dose of 3 mg/kg,,,BAO_0000218,U,,0,,CHEMBL621341,
7811,,,22224,,Autocuration,1,,A,,Area under curve was measured by using concentration Vs time,,,BAO_0000019,U,,0,,CHEMBL621342,
7812,,,22224,,Autocuration,1,,A,,Area under curve was measured by using concentration Vs time; not tested,,,BAO_0000019,U,,0,,CHEMBL621343,
7813,,,50594,10090.0,Intermediate,1,,A,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,,BAO_0000218,N,,1,,CHEMBL621344,
7814,,,50594,10090.0,Intermediate,1,,A,,Area under curve(AUC) was measured in mice after oral administration.,,,BAO_0000218,N,,1,,CHEMBL621345,
7815,,,22224,,Autocuration,1,,A,,Area under curve(AUC) value of the compound,,,BAO_0000019,U,,0,,CHEMBL621346,
7816,,,22224,,Autocuration,1,,A,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,,BAO_0000218,U,,0,,CHEMBL621347,
7817,,,50588,9615.0,Intermediate,1,,A,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,,BAO_0000218,N,,1,,CHEMBL621348,
7818,,178.0,22224,,Autocuration,1,Blood,A,,Area under curve(carotid artery) was determined by the availability in blood,,,BAO_0000019,U,,0,,CHEMBL621349,
7819,,178.0,22224,,Autocuration,1,Blood,A,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,,BAO_0000019,U,,0,,CHEMBL621350,
7820,,178.0,22224,,Autocuration,1,Blood,A,,Area under curve(carotid artery) was determined by the availability in blood; No data,,,BAO_0000019,U,,0,,CHEMBL875839,
7821,,178.0,22224,,Autocuration,1,Blood,A,,Area under curve(portal vein) was determined by the availability in blood,,,BAO_0000019,U,,0,,CHEMBL620211,
7822,,178.0,22224,,Autocuration,1,Blood,A,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,,BAO_0000019,U,,0,,CHEMBL620212,
7823,,178.0,22224,,Autocuration,1,Blood,A,,Area under curve(portal vein) was determined by the availability in blood; No data,,,BAO_0000019,U,,0,,CHEMBL620213,
7824,,1969.0,50797,9544.0,Intermediate,1,Plasma,A,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,,BAO_0000218,N,,1,,CHEMBL620214,
7825,,1969.0,50797,9544.0,Intermediate,1,Plasma,A,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,,BAO_0000218,N,,1,,CHEMBL620215,
7826,,1969.0,50797,9544.0,Intermediate,1,Plasma,A,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL620216,
7827,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,,BAO_0000218,N,,1,,CHEMBL620888,
7828,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,,BAO_0000218,N,,1,,CHEMBL620889,
7829,,1969.0,22224,,Autocuration,1,Plasma,A,,Area under plasma concentration vs time curve observed in rats for 0-3 h,,,BAO_0000019,U,,0,,CHEMBL620890,
7830,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under plasma time curve determined in male rat,,,BAO_0000218,N,,1,,CHEMBL620891,
7831,,,22224,,Autocuration,1,,A,,Area under the MAP curve measured over 5 min.,,,BAO_0000019,U,,0,,CHEMBL620892,
7832,,,50594,10090.0,Intermediate,1,,A,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,,BAO_0000218,N,,1,,CHEMBL621079,
7833,,,50594,10090.0,Intermediate,1,,A,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,,BAO_0000218,N,,1,,CHEMBL621080,
7834,,,50588,9615.0,Intermediate,1,,A,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL621081,
7835,,,100712,10026.0,Intermediate,1,,A,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL621082,
7836,,,50597,10116.0,Intermediate,1,,A,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL621083,
7837,,,50588,9615.0,Intermediate,1,,A,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,,BAO_0000218,N,,1,,CHEMBL621084,
7838,,,50588,9615.0,Intermediate,1,,A,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,,BAO_0000218,N,,1,,CHEMBL621085,
7839,,,50588,9615.0,Intermediate,1,,A,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,,BAO_0000218,N,,1,,CHEMBL621086,
7840,,,50588,9615.0,Intermediate,1,,A,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,,BAO_0000218,N,,1,,CHEMBL621087,
7841,,,50588,9615.0,Intermediate,1,,A,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,,BAO_0000218,N,,1,,CHEMBL622607,
7842,,,50588,9615.0,Intermediate,1,,A,,Serum AUC in marmosets (IV dose),,,BAO_0000218,N,,1,,CHEMBL622608,
7843,,,22224,,Autocuration,1,,A,,Area under the curve after intravenous administration at a dose of 10 umol/kg,,,BAO_0000019,U,,0,,CHEMBL624481,
7844,,,22224,,Autocuration,1,,A,,Area under the curve after intravenous administration at a dose of 2 umol/kg,,,BAO_0000019,U,,0,,CHEMBL624482,
7845,,,22224,,Autocuration,1,,A,,Area under the curve after intravenous administration at a dose of 4 umol/kg,,,BAO_0000019,U,,0,,CHEMBL624483,
7846,,,22224,,Autocuration,1,,A,,Area under the curve after intravenous administration at a dose of 40 umol/kg,,,BAO_0000019,U,,0,,CHEMBL624484,
7847,,,22224,,Autocuration,1,,A,,Area under the curve after intravenous administration at a dose of 5 umol/kg,,,BAO_0000019,U,,0,,CHEMBL624485,
7848,,,50597,10116.0,Intermediate,1,,A,,Area under the curve for fumarate salt was evaluated in F344 Rats.,,,BAO_0000218,N,,1,,CHEMBL624486,
7849,,,22224,,Autocuration,1,,A,,Area under the curve for the compound was calculated.,,,BAO_0000019,U,,0,,CHEMBL624487,
7850,,,22224,,Autocuration,1,,A,,Area under the curve in concentration/ time,,,BAO_0000019,U,,0,,CHEMBL624488,
7851,,,50597,10116.0,Intermediate,1,,A,,Area under the curve administered intraintestinal in rats.,,,BAO_0000218,N,,1,,CHEMBL624489,
7852,,,50597,10116.0,Intermediate,1,,A,,Area under the curve administered intravenously in rats.,,,BAO_0000218,N,,1,,CHEMBL625184,
7853,,,22224,,Autocuration,1,,A,,Area under the curve during intravenous administration,,,BAO_0000019,U,,0,,CHEMBL625185,
7854,,,22224,,Autocuration,1,,A,,Area under the curve during intravenous administration; Not determined,,,BAO_0000019,U,,0,,CHEMBL875954,
7855,,,22224,,Autocuration,1,,A,,Area under the curve during systemic administration,,,BAO_0000019,U,,0,,CHEMBL625186,
7856,,,22224,,Autocuration,1,,A,,Area under the curve during systemic administration; Not determined,,,BAO_0000019,U,,0,,CHEMBL625187,
7857,,,22224,,Autocuration,1,,A,,Area under the curve was calculated for the compound.,,,BAO_0000019,U,,0,,CHEMBL625188,
7858,,,50588,9615.0,Intermediate,1,,A,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL625189,
7859,,,50588,9615.0,Intermediate,1,,A,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL625190,
7860,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL621733,
7861,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL621734,
7862,,,50597,10116.0,Intermediate,1,,A,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,,BAO_0000218,N,,1,,CHEMBL621735,
7863,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Clearance of the drug was measured in the plasma of rat; No data,,,BAO_0000218,N,,1,,CHEMBL621736,
7864,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The pharmacokinetic parameter plasma clearance in vivo in rats,,,BAO_0000218,N,,1,,CHEMBL621737,
7865,,,50597,10116.0,Intermediate,1,,A,,Plasma clearance at the dose of 2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL621738,
7866,In vivo,,50597,10116.0,Intermediate,1,,A,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL622806,
7867,In vivo,,50597,10116.0,Intermediate,1,,A,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL623519,
7868,In vivo,,50597,10116.0,Intermediate,1,,A,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,BAO_0000218,N,,1,,CHEMBL623520,
7869,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,BAO_0000218,N,,1,,CHEMBL623521,
7870,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623522,
7871,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance rate in rat,,,BAO_0000218,N,,1,,CHEMBL623523,
7872,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance rate in rat,,,BAO_0000218,N,,1,,CHEMBL623690,
7873,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623691,
7874,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623692,
7875,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623693,
7876,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623694,
7877,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance of compound after iv administration of 20 mg/kg dose in rat,,,BAO_0000218,N,,1,,CHEMBL623695,
7878,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,,BAO_0000218,N,,1,,CHEMBL623696,
7879,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623697,
7880,In vivo,1969.0,22224,9544.0,Intermediate,1,Plasma,A,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,,BAO_0000218,U,,0,,CHEMBL623698,
7881,In vivo,1969.0,22224,10116.0,Intermediate,1,Plasma,A,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,,BAO_0000218,U,,0,,CHEMBL623699,
7882,In vivo,,50597,10116.0,Intermediate,1,,A,,Mean (%CV) PK parameters for CL(mL/min/kg).,,,BAO_0000218,N,,1,,CHEMBL623700,
7883,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,,BAO_0000218,N,,1,,CHEMBL623701,
7884,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,,BAO_0000218,N,,1,,CHEMBL623702,
7885,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,,BAO_0000218,N,,1,,CHEMBL623703,
7886,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat was determined,,,BAO_0000218,N,,1,,CHEMBL623704,
7887,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat after administration of 2 mg/kg iv,,,BAO_0000218,N,,1,,CHEMBL623705,
7888,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat after administration of 2 mg/kg iv,,,BAO_0000218,N,,1,,CHEMBL623706,
7889,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was determined,,,BAO_0000218,N,,1,,CHEMBL623707,
7890,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL623708,
7891,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623709,
7892,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat by iv administration,,,BAO_0000218,N,,1,,CHEMBL623710,
7893,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623711,
7894,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat p.o.,,,BAO_0000218,N,,1,,CHEMBL623712,
7895,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rats,,,BAO_0000218,N,,1,,CHEMBL623713,
7896,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was determined; ND denotes no data,,,BAO_0000218,N,,1,,CHEMBL623714,
7897,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was determined; ND denotes not determined,,,BAO_0000218,N,,1,,CHEMBL623715,
7898,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,BAO_0000218,N,,1,,CHEMBL623716,
7899,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,BAO_0000218,N,,1,,CHEMBL622980,
7900,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma administration to rats,,,BAO_0000218,N,,1,,CHEMBL622981,
7901,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance of the compound in female Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL622982,
7902,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was observed after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL622983,
7903,In vivo,,50597,10116.0,Intermediate,1,,A,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,,BAO_0000218,N,,1,,CHEMBL622984,
7904,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,,BAO_0000218,N,,1,,CHEMBL622985,
7905,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,plasma clearance was observed after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL623631,
7906,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo CL/F determined,,,BAO_0000218,N,,1,,CHEMBL623632,
7907,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,,BAO_0000218,N,,1,,CHEMBL623633,
7908,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,,BAO_0000218,N,,1,,CHEMBL623634,
7909,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was tested for the lower blood clearance in rat,,,BAO_0000218,N,,1,,CHEMBL623635,
7910,In vivo,,50597,10116.0,Intermediate,1,,A,,Evaluated for the low clearance in rat (in vivo),,,BAO_0000218,N,,1,,CHEMBL621195,
7911,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (CLb)of the compound was determined in rat,,,BAO_0000218,N,,1,,CHEMBL621196,
7912,In vivo,,50597,10116.0,Intermediate,1,,A,,Rapid clearance after intravenous administration in rat was determined,,,BAO_0000218,N,,1,,CHEMBL875287,
7913,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance measured in rat,,,BAO_0000218,N,,1,,CHEMBL621197,
7914,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was evaluated for plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL621198,
7915,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Low plasma clearance was calculated in rat,,,BAO_0000218,N,,1,,CHEMBL621199,
7916,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Clp) in rat,,,BAO_0000218,N,,1,,CHEMBL621200,
7917,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,,BAO_0000218,N,,1,,CHEMBL621201,
7918,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,,BAO_0000218,N,,1,,CHEMBL621202,
7919,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL621203,
7920,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance after IV dosing at 1 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL621204,
7921,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL621205,
7922,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL621206,
7923,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL621207,
7924,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL621208,
7925,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,N,,1,,CHEMBL621209,
7926,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL876484,
7927,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,BAO_0000218,N,,1,,CHEMBL621210,
7928,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL621211,
7929,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL621212,
7930,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,,BAO_0000218,N,,1,,CHEMBL621213,
7931,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,,BAO_0000218,N,,1,,CHEMBL621214,
7932,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,,BAO_0000218,N,,1,,CHEMBL621215,
7933,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,,BAO_0000218,N,,1,,CHEMBL621216,
7934,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,,BAO_0000218,N,,1,,CHEMBL621217,
7935,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,,BAO_0000218,N,,1,,CHEMBL621218,
7936,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,,BAO_0000218,N,,1,,CHEMBL621219,
7937,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,,BAO_0000218,N,,1,,CHEMBL621220,
7938,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,,BAO_0000218,N,,1,,CHEMBL621221,
7939,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,,BAO_0000218,N,,1,,CHEMBL621222,
7940,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,,BAO_0000218,N,,1,,CHEMBL621223,
7941,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,,BAO_0000218,N,,1,,CHEMBL876485,
7942,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,BAO_0000218,N,,1,,CHEMBL621224,
7943,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,N,,1,,CHEMBL621225,
7944,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,,BAO_0000218,N,,1,,CHEMBL621226,
7945,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL621227,
7946,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL621228,
7947,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL621229,
7948,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,N,,1,,CHEMBL621230,
7949,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,,BAO_0000218,N,,1,,CHEMBL621231,
7950,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL621232,
7951,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,BAO_0000218,N,,1,,CHEMBL621233,
7952,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL621234,
7953,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,,BAO_0000218,N,,1,,CHEMBL621235,
7954,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,BAO_0000218,N,,1,,CHEMBL621236,
7955,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,N,,1,,CHEMBL621237,
7956,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,,BAO_0000218,N,,1,,CHEMBL876486,
7957,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,,BAO_0000218,N,,1,,CHEMBL622436,
7958,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,N,,1,,CHEMBL622437,
7959,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,,BAO_0000218,N,,1,,CHEMBL622438,
7960,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,,BAO_0000218,N,,1,,CHEMBL622439,
7961,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,N,,1,,CHEMBL622440,
7962,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,,BAO_0000218,N,,1,,CHEMBL622441,
7963,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL622442,
7964,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL622443,
7965,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL622444,
7966,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL622445,
7967,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,,BAO_0000218,N,,1,,CHEMBL622446,
7968,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,,BAO_0000218,N,,1,,CHEMBL622447,
7969,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL622448,
7970,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,,BAO_0000218,N,,1,,CHEMBL622449,
7971,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,N,,1,,CHEMBL622450,
7972,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,,BAO_0000218,N,,1,,CHEMBL622451,
7973,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,,BAO_0000218,N,,1,,CHEMBL622452,
7974,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,,BAO_0000218,N,,1,,CHEMBL622453,
7975,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,,BAO_0000218,N,,1,,CHEMBL622454,
7976,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,,BAO_0000218,N,,1,,CHEMBL622455,
7977,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,,BAO_0000218,N,,1,,CHEMBL876024,
7978,In vivo,,50597,10116.0,Intermediate,1,,A,,T max was determined at 3 mg/kg po dose in rats,,,BAO_0000218,N,,1,,CHEMBL622456,
7979,In vivo,,50597,10116.0,Intermediate,1,,A,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL622457,
7980,In vivo,,50597,10116.0,Intermediate,1,,A,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL622458,
7981,,,50597,10116.0,Intermediate,1,,A,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,,BAO_0000218,N,,1,,CHEMBL622459,
7982,,,50597,10116.0,Intermediate,1,,A,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,,BAO_0000218,N,,1,,CHEMBL873343,
7983,,,50597,10116.0,Intermediate,1,,A,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,,BAO_0000218,N,,1,,CHEMBL622460,
7984,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Time for maximum plasma concentration determined in rat,,,BAO_0000218,N,,1,,CHEMBL622461,
7985,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL622462,
7986,In vivo,,50597,10116.0,Intermediate,1,,A,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL622463,
7987,In vivo,,50597,10116.0,Intermediate,1,,A,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL622464,
7988,In vivo,,50597,10116.0,Intermediate,1,,A,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622465,
7989,In vivo,,50597,10116.0,Intermediate,1,,A,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL622466,
7990,In vivo,,50597,10116.0,Intermediate,1,,A,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622467,
7991,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Time of maximum plasma concentration in rat,,,BAO_0000218,N,,1,,CHEMBL622468,
7992,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL876025,
7993,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,,BAO_0000218,N,,1,,CHEMBL622469,
7994,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,BAO_0000218,N,,1,,CHEMBL622470,
7995,In vivo,,50597,10116.0,Intermediate,1,,A,,Time required to reach maximum concentration (Cmax) after oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL622471,
7996,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Time required to reach maximum concentration in rat plasma,,,BAO_0000218,N,,1,,CHEMBL622472,
7997,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,,BAO_0000218,N,,1,,CHEMBL622473,
7998,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL624282,
7999,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624283,
8000,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624284,
8001,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,BAO_0000218,N,,1,,CHEMBL624285,
8002,In vivo,,50597,10116.0,Intermediate,1,,A,,Time to reach Cmax after oral administration to rats,,,BAO_0000218,N,,1,,CHEMBL624286,
8003,In vivo,,50597,10116.0,Intermediate,1,,A,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,,BAO_0000218,N,,1,,CHEMBL624287,
8004,,,50597,10116.0,Intermediate,1,,A,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,,BAO_0000218,N,,1,,CHEMBL624288,
8005,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,,BAO_0000218,N,,1,,CHEMBL624289,
8006,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL873344,
8007,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax after peroral administration (10 mg/kg) was determined in rat,,,BAO_0000218,N,,1,,CHEMBL619623,
8008,In vivo,,50597,10116.0,Expert,1,,A,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621399,
8009,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,,BAO_0000218,N,,1,,CHEMBL621400,
8010,In vivo,,50597,10116.0,Intermediate,1,,A,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,,BAO_0000218,N,,1,,CHEMBL621401,
8011,,,50597,10116.0,Intermediate,1,,A,,Tmax was determined,,,BAO_0000218,N,,1,,CHEMBL621402,
8012,,,50597,10116.0,Intermediate,1,,A,,Tmax was determined,,,BAO_0000218,N,,1,,CHEMBL621403,
8013,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax after oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL621121,
8014,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax after peroral administration in rats at 2.4 uM/kg,,,BAO_0000218,N,,1,,CHEMBL872525,
8015,,,50597,10116.0,Intermediate,1,,A,,Tmax in male rat,,,BAO_0000218,N,,1,,CHEMBL621122,
8016,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax in rat at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621123,
8017,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax in rat by po administration at a dose of 40 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621124,
8018,,,50597,10116.0,Intermediate,1,,A,,Tmax in rats,,,BAO_0000218,N,,1,,CHEMBL621125,
8019,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax was measured in rats after peroral administration at 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621126,
8020,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,,BAO_0000218,N,,1,,CHEMBL621127,
8021,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax value after administration of 20 mg/Kg oral dose in rat,,,BAO_0000218,N,,1,,CHEMBL621128,
8022,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax value at a dose of 10 mg/kg in male SD rats,,,BAO_0000218,N,,1,,CHEMBL618263,
8023,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax value at a dose of 100 mg/kg in male SD rats,,,BAO_0000218,N,,1,,CHEMBL618264,
8024,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax value at a dose of 50 mg/kg in male SD rats,,,BAO_0000218,N,,1,,CHEMBL618265,
8025,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,BAO_0000218,N,,1,,CHEMBL618266,
8026,In vivo,,50597,10116.0,Intermediate,1,,A,,time required to reach maximum concentration (Cmax) after oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL618267,
8027,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,,BAO_0000218,N,,1,,CHEMBL618450,
8028,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,,BAO_0000218,N,,1,,CHEMBL618451,
8029,,,50597,10116.0,Intermediate,1,,A,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,BAO_0000218,N,,1,,CHEMBL618452,
8030,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,,BAO_0000218,N,,1,,CHEMBL618453,
8031,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,,BAO_0000218,N,,1,,CHEMBL618454,
8032,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,,BAO_0000218,N,,1,,CHEMBL618455,
8033,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,,BAO_0000218,N,,1,,CHEMBL618456,
8034,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound distribution in rat tissues was determined,,,BAO_0000218,N,,1,,CHEMBL618457,
8035,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL618458,
8036,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL618459,
8037,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL876733,
8038,,,50588,9615.0,Intermediate,1,,A,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL618460,
8039,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL618461,
8040,,,22224,,Autocuration,1,,A,,Area under the curve was determined after oral administration (300 uM/Kg),,,BAO_0000019,U,,0,,CHEMBL618462,
8041,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL618463,
8042,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,,BAO_0000218,N,,1,,CHEMBL618464,
8043,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL618465,
8044,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,,BAO_0000218,N,,1,,CHEMBL618466,
8045,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL618467,
8046,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL618468,
8047,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,,BAO_0000218,N,,1,,CHEMBL618469,
8048,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL618470,
8049,,,22224,,Autocuration,1,,A,,Plasma drug AUC in rat (PO dose),,,BAO_0000218,U,,0,,CHEMBL618471,
8050,,,50594,10090.0,Intermediate,1,,A,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,,BAO_0000218,N,,1,,CHEMBL618472,
8051,,,22224,,Autocuration,1,,A,,Area under was determined at a dose of 30 mg/kg,,,BAO_0000218,U,,0,,CHEMBL618473,
8052,,,50506,9669.0,Intermediate,1,,A,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,,BAO_0000218,N,,1,,CHEMBL621699,
8053,,,50597,10116.0,Intermediate,1,,A,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,,BAO_0000218,N,,1,,CHEMBL621700,
8054,,,50597,10116.0,Intermediate,1,,A,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,,BAO_0000218,N,,1,,CHEMBL621701,
8055,,,50506,9669.0,Intermediate,1,,A,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,,BAO_0000218,N,,1,,CHEMBL621702,
8056,,,50588,9615.0,Intermediate,1,,A,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,,BAO_0000218,N,,1,,CHEMBL621703,
8057,,,50588,9615.0,Intermediate,1,,A,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,,BAO_0000218,N,,1,,CHEMBL621704,
8058,,,50597,10116.0,Intermediate,1,,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,,BAO_0000218,N,,1,,CHEMBL624259,
8059,,,50597,10116.0,Intermediate,1,,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,,BAO_0000218,N,,1,,CHEMBL624260,
8060,,,50597,10116.0,Intermediate,1,,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,,BAO_0000218,N,,1,,CHEMBL624430,
8061,,,50597,10116.0,Intermediate,1,,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,,BAO_0000218,N,,1,,CHEMBL624431,
8062,,,50597,10116.0,Intermediate,1,,A,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,,BAO_0000218,N,,1,,CHEMBL624432,
8063,,,50597,10116.0,Intermediate,1,,A,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,,BAO_0000218,N,,1,,CHEMBL624433,
8064,,,50597,10116.0,Intermediate,1,,A,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,,BAO_0000218,N,,1,,CHEMBL624434,
8065,,,50597,10116.0,Intermediate,1,,A,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,,BAO_0000218,N,,1,,CHEMBL624435,
8066,,,50594,10090.0,Intermediate,1,,A,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,,BAO_0000218,N,,1,,CHEMBL618570,
8067,,,50594,10090.0,Intermediate,1,,A,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,BAO_0000218,N,,1,,CHEMBL618571,
8068,,,50594,10090.0,Intermediate,1,,A,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,,BAO_0000218,N,,1,,CHEMBL618572,
8069,,,50594,10090.0,Intermediate,1,,A,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,BAO_0000218,N,,1,,CHEMBL618573,
8070,,,50594,10090.0,Intermediate,1,,A,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,,BAO_0000218,N,,1,,CHEMBL619267,
8071,,,50594,10090.0,Intermediate,1,,A,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,BAO_0000218,N,,1,,CHEMBL619431,
8072,,,50594,10090.0,Intermediate,1,,A,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,,BAO_0000218,N,,1,,CHEMBL619432,
8073,,,50594,10090.0,Intermediate,1,,A,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,,BAO_0000218,N,,1,,CHEMBL619433,
8074,,1969.0,22224,,Autocuration,1,Plasma,A,,AUC in mice after oral dose (50 mg/kg),,,BAO_0000218,U,,0,,CHEMBL619434,
8075,,1977.0,50594,10090.0,Intermediate,1,Serum,A,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,,BAO_0000218,N,,1,,CHEMBL619435,
8076,,1969.0,22224,,Autocuration,1,Plasma,A,,AUC (0-4 hr) ug/ml/h,,,BAO_0000019,U,,0,,CHEMBL619436,
8077,,,50597,10116.0,Intermediate,1,,A,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,,BAO_0000218,N,,1,,CHEMBL619437,
8078,,,22224,,Autocuration,1,,A,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,,BAO_0000218,U,,0,,CHEMBL619438,
8079,,,50594,10090.0,Intermediate,1,,A,,Compound was evaluated for Area under curve in mice,,,BAO_0000218,N,,1,,CHEMBL619439,
8080,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,BAO_0000218,N,,1,,CHEMBL619440,
8081,,,22224,,Autocuration,1,,F,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,BAO_0000218,U,,0,,CHEMBL619441,
8082,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,BAO_0000218,N,,1,,CHEMBL619442,
8083,,,22224,,Autocuration,1,,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,,BAO_0000019,U,,0,,CHEMBL875156,
8084,,,22224,,Autocuration,1,,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,,BAO_0000019,U,,0,,CHEMBL619443,
8085,,,22224,,Autocuration,1,,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,,BAO_0000019,U,,0,,CHEMBL619444,
8086,,,22224,,Autocuration,1,,A,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,,BAO_0000019,U,,0,,CHEMBL623464,
8087,,,50594,10090.0,Intermediate,1,,A,,Compound was evaluated for area under curve when administered through oral route in mouse,,,BAO_0000218,N,,1,,CHEMBL623465,
8088,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,,BAO_0000218,N,,1,,CHEMBL623466,
8089,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,,BAO_0000218,N,,1,,CHEMBL623467,
8090,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL623468,
8091,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,,BAO_0000218,N,,1,,CHEMBL622660,
8092,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance rate in Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL622661,
8093,In vivo,,50597,10116.0,Intermediate,1,,F,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,N,,1,,CHEMBL622662,
8094,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (total body clearance) in rat,,,BAO_0000218,N,,1,,CHEMBL622663,
8095,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,,BAO_0000218,N,,1,,CHEMBL622664,
8096,,,50597,10116.0,Intermediate,1,,A,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622665,
8097,,,50597,10116.0,Intermediate,1,,A,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622666,
8098,In vivo,,50597,10116.0,Intermediate,1,,A,,Cl in rat i.v. at 2 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL621615,
8099,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance of compound after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,N,,1,,CHEMBL621616,
8100,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance was determined,,,BAO_0000218,N,,1,,CHEMBL621617,
8101,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance by intravenous administration of 3.4 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL621618,
8102,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621619,
8103,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance rate after i.v. administration in rats,,,BAO_0000218,N,,1,,CHEMBL621620,
8104,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL621786,
8105,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,BAO_0000218,N,,1,,CHEMBL621787,
8106,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,,BAO_0000218,N,,1,,CHEMBL621788,
8107,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance (Cl) after oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL621789,
8108,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621790,
8109,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was tested for plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL621791,
8110,In vitro,,50597,10116.0,Intermediate,1,,A,,In vitro microsome metabolism clearance in rat was determined,Microsomes,,BAO_0000218,N,,1,,CHEMBL621792,
8111,In vitro,,50597,10116.0,Intermediate,1,,A,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Microsomes,,BAO_0000218,N,,1,,CHEMBL621793,
8112,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL621794,
8113,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,In vivo plasma clearance was determined,,,BAO_0000218,N,,1,,CHEMBL621795,
8114,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,,BAO_0000218,N,,1,,CHEMBL621796,
8115,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,401.0,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,,BAO_0000218,N,,1,,CHEMBL621797,
8116,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Plasma clearance) was measured in rat,,,BAO_0000218,N,,1,,CHEMBL621798,
8117,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (clearance) in rat i.v.,,,BAO_0000218,N,,1,,CHEMBL621799,
8118,In vivo,,50597,10116.0,Intermediate,1,,A,,"Plasma Clearance was evaluated in rats, iv",,,BAO_0000218,N,,1,,CHEMBL621800,
8119,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance (in vivo) in rats was determined,,,BAO_0000218,N,,1,,CHEMBL621801,
8120,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL621802,
8121,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was determined,,,BAO_0000218,N,,1,,CHEMBL618596,
8122,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL618597,
8123,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL618598,
8124,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rats,,,BAO_0000218,N,,1,,CHEMBL618599,
8125,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance rate determined in rat,,,BAO_0000218,N,,1,,CHEMBL618600,
8126,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was determined in rat,,,BAO_0000218,N,,1,,CHEMBL618601,
8127,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was determined,,,BAO_0000218,N,,1,,CHEMBL618602,
8128,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance value in rat,,,BAO_0000218,N,,1,,CHEMBL618603,
8129,Ex vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,,BAO_0000218,N,,1,,CHEMBL618604,
8130,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance in rat,,,BAO_0000218,N,,1,,CHEMBL618605,
8131,In vivo,,50597,10116.0,Intermediate,1,,A,,Total body clearance in rat i.v. at 2 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL618606,
8132,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance of compound in rats after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL618607,
8133,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance after iv administration to rats,,,BAO_0000218,N,,1,,CHEMBL618608,
8134,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL618609,
8135,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL618610,
8136,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL618611,
8137,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL618612,
8138,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL618613,
8139,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL621076,
8140,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL621077,
8141,In vivo,,50597,10116.0,Intermediate,1,,A,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,,BAO_0000218,N,,1,,CHEMBL621078,
8142,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance in rat,,,BAO_0000218,N,,1,,CHEMBL621251,
8143,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance in rat after oral administration at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621252,
8144,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance in rat.,,,BAO_0000218,N,,1,,CHEMBL621253,
8145,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance rate following an oral dose of 20 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL621254,
8146,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,,BAO_0000218,N,,1,,CHEMBL621255,
8147,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,,BAO_0000218,N,,1,,CHEMBL621256,
8148,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,,BAO_0000218,N,,1,,CHEMBL621257,
8149,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,,BAO_0000218,N,,1,,CHEMBL621258,
8150,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,,BAO_0000218,N,,1,,CHEMBL621259,
8151,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,,BAO_0000218,N,,1,,CHEMBL621260,
8152,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,,BAO_0000218,N,,1,,CHEMBL876494,
8153,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,,BAO_0000218,N,,1,,CHEMBL621261,
8154,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,,BAO_0000218,N,,1,,CHEMBL621262,
8155,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,,BAO_0000218,N,,1,,CHEMBL621263,
8156,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,N,,1,,CHEMBL621264,
8157,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL621265,
8158,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,,BAO_0000218,N,,1,,CHEMBL621266,
8159,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL621267,
8160,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL621268,
8161,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,,BAO_0000218,N,,1,,CHEMBL621269,
8162,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,,BAO_0000218,N,,1,,CHEMBL621270,
8163,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,,BAO_0000218,N,,1,,CHEMBL621271,
8164,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,,BAO_0000218,N,,1,,CHEMBL621272,
8165,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,,BAO_0000218,N,,1,,CHEMBL621273,
8166,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,,BAO_0000218,N,,1,,CHEMBL621274,
8167,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,,BAO_0000218,N,,1,,CHEMBL876495,
8168,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,,BAO_0000218,N,,1,,CHEMBL621275,
8169,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,N,,1,,CHEMBL621276,
8170,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,,BAO_0000218,N,,1,,CHEMBL621277,
8171,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,N,,1,,CHEMBL621278,
8172,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,,BAO_0000218,N,,1,,CHEMBL621279,
8173,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,,BAO_0000218,N,,1,,CHEMBL621280,
8174,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL621281,
8175,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,,BAO_0000218,N,,1,,CHEMBL621282,
8176,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,,BAO_0000218,N,,1,,CHEMBL621283,
8177,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,,BAO_0000218,N,,1,,CHEMBL621284,
8178,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,,BAO_0000218,N,,1,,CHEMBL621285,
8179,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,N,,1,,CHEMBL621286,
8180,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,,BAO_0000218,N,,1,,CHEMBL623220,
8181,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,,BAO_0000218,N,,1,,CHEMBL623221,
8182,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,,BAO_0000218,N,,1,,CHEMBL876029,
8183,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,,BAO_0000218,N,,1,,CHEMBL623222,
8184,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,,BAO_0000218,N,,1,,CHEMBL623223,
8185,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,,BAO_0000218,N,,1,,CHEMBL621445,
8186,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621446,
8187,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621447,
8188,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619681,
8189,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619682,
8190,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619683,
8191,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619684,
8192,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619685,
8193,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619686,
8194,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619687,
8195,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619688,
8196,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619689,
8197,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619690,
8198,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619691,
8199,In vivo,,50597,10116.0,Intermediate,1,,A,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL619692,
8200,,,50597,10116.0,Expert,1,,A,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL619693,
8201,In vivo,,50597,10116.0,Intermediate,1,,A,,Vc value after IV dose at a dose of 5 mg/kg in rats.,,,BAO_0000218,N,,1,,CHEMBL619694,
8202,In vivo,,50597,10116.0,Intermediate,1,,A,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,,BAO_0000218,N,,1,,CHEMBL619695,
8203,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for pharmacokinetic parameter volume of distribution,,,BAO_0000218,N,,1,,CHEMBL619696,
8204,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for volume of distribution in rat,,,BAO_0000218,N,,1,,CHEMBL619697,
8205,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume distribution was determined; steady state(ss),,,BAO_0000218,N,,1,,CHEMBL619698,
8206,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume of distribution after iv administration to rats,,,BAO_0000218,N,,1,,CHEMBL619699,
8207,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume of distribution dosing at 3 mg/kg iv,,,BAO_0000218,N,,1,,CHEMBL619700,
8208,In vivo,,50597,10116.0,Intermediate,1,,A,,The compound was evaluated for volume of distribution in rat,,,BAO_0000218,N,,1,,CHEMBL619701,
8209,In vivo,,50597,10116.0,Intermediate,1,,A,,The compound was tested for volume of distribution in rat,,,BAO_0000218,N,,1,,CHEMBL619702,
8210,In vivo,,50597,10116.0,Intermediate,1,,A,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,,BAO_0000218,N,,1,,CHEMBL620335,
8211,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution (VD) after oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL620336,
8212,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620337,
8213,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution in rat,,,BAO_0000218,N,,1,,CHEMBL620520,
8214,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution in rat,,,BAO_0000218,N,,1,,CHEMBL620521,
8215,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution in rat after peroral administration at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL875825,
8216,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution in rat after peroral administration at 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620522,
8217,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620523,
8218,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in rat.,,,BAO_0000218,N,,1,,CHEMBL620524,
8219,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in rat,,,BAO_0000218,N,,1,,CHEMBL620525,
8220,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in rat,,,BAO_0000218,N,,1,,CHEMBL620526,
8221,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in rat by iv administration,,,BAO_0000218,N,,1,,CHEMBL620527,
8222,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in rats,,,BAO_0000218,N,,1,,CHEMBL620528,
8223,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,,BAO_0000218,N,,1,,CHEMBL620529,
8224,,,50597,10116.0,Intermediate,1,,A,,Volume distribution at the dose of 2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL620530,
8225,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume of distribution was determined,,,BAO_0000218,N,,1,,CHEMBL620531,
8226,In vivo,,22224,9544.0,Intermediate,1,,A,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,,BAO_0000218,U,,0,,CHEMBL620532,
8227,In vivo,,22224,10116.0,Intermediate,1,,A,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,,BAO_0000218,U,,0,,CHEMBL620533,
8228,In vivo,,22224,10116.0,Intermediate,1,,A,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,,BAO_0000218,U,,0,,CHEMBL620534,
8229,In vivo,,50597,10116.0,Intermediate,1,,A,,Mean (%CV) PK parameters for Vdss(mL/kg).,,,BAO_0000218,N,,1,,CHEMBL620535,
8230,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,,BAO_0000218,N,,1,,CHEMBL875826,
8231,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,,BAO_0000218,N,,1,,CHEMBL620536,
8232,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL620537,
8233,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,,BAO_0000218,N,,1,,CHEMBL618526,
8234,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,,BAO_0000218,N,,1,,CHEMBL618527,
8235,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Vdss) in rat,,,BAO_0000218,N,,1,,CHEMBL618528,
8236,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (vdss) was measured in rat,,,BAO_0000218,N,,1,,CHEMBL618529,
8237,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL618530,
8238,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in rat,,,BAO_0000218,N,,1,,CHEMBL618531,
8239,In vivo,,50597,10116.0,Intermediate,1,,A,,The pharmacokinetic parameter volume of distribution in vivo in rats,,,BAO_0000218,N,,1,,CHEMBL618532,
8240,In vivo,,50597,10116.0,Intermediate,1,,F,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,N,,1,,CHEMBL618533,
8241,In vivo,,50597,10116.0,Intermediate,1,,A,,Vdss in rat i.v. at 2 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL618534,
8242,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution after intravenous administration (1 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL618535,
8243,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL618536,
8244,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL618537,
8245,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution at a dose of 10 uM/kg in rat was determined,,,BAO_0000218,N,,1,,CHEMBL618538,
8246,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,BAO_0000218,N,,1,,CHEMBL618539,
8247,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution was calculated in rat,,,BAO_0000218,N,,1,,CHEMBL618540,
8248,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution was determined,,,BAO_0000218,N,,1,,CHEMBL618541,
8249,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution after intravenous administration was evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL618542,
8250,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,BAO_0000218,N,,1,,CHEMBL622544,
8251,In vivo,,50597,10116.0,Intermediate,1,,A,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,,BAO_0000218,N,,1,,CHEMBL622545,
8252,In vivo,,50597,10116.0,Intermediate,1,,A,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,BAO_0000218,N,,1,,CHEMBL622546,
8253,In vivo,,50597,10116.0,Intermediate,1,,A,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,,BAO_0000218,N,,1,,CHEMBL622547,
8254,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in steady state was determined in rat,,,BAO_0000218,N,,1,,CHEMBL622548,
8255,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622549,
8256,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,BAO_0000218,N,,1,,CHEMBL622550,
8257,,,50594,10090.0,Intermediate,1,,A,,Compound was evaluated for area under curve when administered through oral route to mouse,,,BAO_0000218,N,,1,,CHEMBL622551,
8258,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,,BAO_0000218,N,,1,,CHEMBL622552,
8259,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,,BAO_0000218,N,,1,,CHEMBL622553,
8260,In vivo,,22224,,Autocuration,1,,F,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,,BAO_0000218,U,,0,,CHEMBL622554,
8261,,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL622555,
8262,,,50594,10090.0,Intermediate,1,,A,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,,BAO_0000218,N,,1,,CHEMBL622556,
8263,,,50594,10090.0,Intermediate,1,,A,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,,BAO_0000218,N,,1,,CHEMBL622557,
8264,,178.0,50594,10090.0,Intermediate,1,Blood,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,,BAO_0000218,N,,1,,CHEMBL622558,
8265,,178.0,50594,10090.0,Intermediate,1,Blood,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,,BAO_0000218,N,,1,,CHEMBL622559,
8266,,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,,BAO_0000218,N,,1,,CHEMBL622560,
8267,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,BAO_0000218,N,,1,,CHEMBL622561,
8268,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,,BAO_0000218,N,,1,,CHEMBL622562,
8269,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,BAO_0000218,N,,1,,CHEMBL622563,
8270,,,22224,,Autocuration,1,,A,,Concentration of compound in Central nervous system,,,BAO_0000019,U,,0,,CHEMBL622564,
8271,,,22224,,Autocuration,1,,A,,Concentration of compound in Central nervous system; Not detectable,,,BAO_0000019,U,,0,,CHEMBL622565,
8272,,,50594,10090.0,Intermediate,1,,A,,"Concentration of diester in the blood, following oral administration in mice",,,BAO_0000218,N,,1,,CHEMBL622566,
8273,,,50594,10090.0,Intermediate,1,,A,,"Concentration of monoester in the blood, following oral administration in mice",,,BAO_0000218,N,,1,,CHEMBL624515,
8274,,,50594,10090.0,Intermediate,1,,A,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,,BAO_0000218,N,,1,,CHEMBL624516,
8275,,,22224,,Autocuration,1,,A,,Evaluated for Pharmacokinetic property: Area under the curve,,,BAO_0000019,U,,0,,CHEMBL624517,
8276,,,50594,10090.0,Intermediate,1,,A,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,,BAO_0000218,N,,1,,CHEMBL624518,
8277,,,100710,9541.0,Intermediate,1,,A,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,,BAO_0000218,N,,1,,CHEMBL624519,
8278,,,100710,9541.0,Intermediate,1,,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,,BAO_0000218,N,,1,,CHEMBL624520,
8279,,,100710,9541.0,Intermediate,1,,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,,BAO_0000218,N,,1,,CHEMBL624521,
8280,,,100710,9541.0,Intermediate,1,,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,,BAO_0000218,N,,1,,CHEMBL624522,
8281,,,100710,9541.0,Intermediate,1,,A,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,N,,1,,CHEMBL624523,
8282,,,100710,9541.0,Intermediate,1,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,BAO_0000218,N,,1,,CHEMBL624409,
8283,,,100710,9541.0,Intermediate,1,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,,BAO_0000218,N,,1,,CHEMBL624410,
8284,,,100710,9541.0,Intermediate,1,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,BAO_0000218,N,,1,,CHEMBL624411,
8285,,,100710,9541.0,Intermediate,1,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,,BAO_0000218,N,,1,,CHEMBL623531,
8286,,,100710,9541.0,Intermediate,1,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,,BAO_0000218,N,,1,,CHEMBL623532,
8287,,,100710,9541.0,Intermediate,1,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,,BAO_0000218,N,,1,,CHEMBL623533,
8288,,,100710,9541.0,Intermediate,1,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,,BAO_0000218,N,,1,,CHEMBL623534,
8289,,,50594,10090.0,Intermediate,1,,A,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,N,,1,,CHEMBL623535,
8290,,,50594,10090.0,Intermediate,1,,A,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,N,,1,,CHEMBL623536,
8291,,,50594,10090.0,Intermediate,1,,A,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,N,,1,,CHEMBL623537,
8292,,,50594,10090.0,Intermediate,1,,A,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,N,,1,,CHEMBL623538,
8293,,,50594,10090.0,Intermediate,1,,A,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,,BAO_0000218,N,,1,,CHEMBL623539,
8294,,,50594,10090.0,Intermediate,1,,A,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,,BAO_0000218,N,,1,,CHEMBL623540,
8295,,,50594,10090.0,Intermediate,1,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,,BAO_0000218,N,,1,,CHEMBL623541,
8296,,,50594,10090.0,Intermediate,1,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,,BAO_0000218,N,,1,,CHEMBL623542,
8297,,,50594,10090.0,Intermediate,1,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,,BAO_0000218,N,,1,,CHEMBL623543,
8298,,,50594,10090.0,Intermediate,1,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,,BAO_0000218,N,,1,,CHEMBL623544,
8299,,,50594,10090.0,Intermediate,1,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,,BAO_0000218,N,,1,,CHEMBL623545,
8300,,,50594,10090.0,Intermediate,1,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,,BAO_0000218,N,,1,,CHEMBL623546,
8301,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL623547,
8302,In vivo,,50597,10116.0,Intermediate,1,,A,,High i.v. clearance in Dawley rats,,,BAO_0000218,N,,1,,CHEMBL623548,
8303,In vitro,2107.0,50597,10116.0,Intermediate,1,Liver,A,,In vitro clearance in rat liver microsomes,Microsomes,,BAO_0000218,N,,1,,CHEMBL623549,
8304,In vitro,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Intrinsic clearance in rat liver microsomes was determined,Microsomes,,BAO_0000218,N,,1,,CHEMBL623550,
8305,In vitro,2107.0,50597,10116.0,Intermediate,1,Liver,A,401.0,Intrinsic clearance in rat hepatocytes was determined,,,BAO_0000218,N,,1,,CHEMBL875276,
8306,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma Clearance was determined,,,BAO_0000218,N,,1,,CHEMBL621872,
8307,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,,BAO_0000218,N,,1,,CHEMBL621873,
8308,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat.,,,BAO_0000218,N,,1,,CHEMBL621874,
8309,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rats,,,BAO_0000218,N,,1,,CHEMBL621875,
8310,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,,BAO_0000218,N,,1,,CHEMBL621876,
8311,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,,BAO_0000218,N,,1,,CHEMBL621877,
8312,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was measured in rat,,,BAO_0000218,N,,1,,CHEMBL621878,
8313,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621879,
8314,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,,BAO_0000218,N,,1,,CHEMBL621880,
8315,In vivo,,50597,10116.0,Intermediate,1,,A,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621881,
8316,In vivo,,50597,10116.0,Intermediate,1,,A,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,BAO_0000218,N,,1,,CHEMBL621882,
8317,In vivo,,50597,10116.0,Intermediate,1,,A,,Total clearance at 1 mg/kg was determined in rat,,,BAO_0000218,N,,1,,CHEMBL875283,
8318,In vivo,,50597,10116.0,Intermediate,1,,A,,Total clearance at 10 mg/kg was determined in rat,,,BAO_0000218,N,,1,,CHEMBL621883,
8319,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance in rat,,,BAO_0000218,N,,1,,CHEMBL621884,
8320,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance rate determined in rats,,,BAO_0000218,N,,1,,CHEMBL621885,
8321,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance of compound in rat was evaluated,,,BAO_0000218,N,,1,,CHEMBL621886,
8322,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL621887,
8323,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (blood clearance) in rat,,,BAO_0000218,N,,1,,CHEMBL621888,
8324,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL621889,
8325,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rats,,,BAO_0000218,N,,1,,CHEMBL621890,
8326,In vitro,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Microsomes,,BAO_0000218,N,,1,,CHEMBL621891,
8327,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance in Dawley rat,,,BAO_0000218,N,,1,,CHEMBL621892,
8328,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance rat,,,BAO_0000218,N,,1,,CHEMBL621893,
8329,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,,BAO_0000218,N,,1,,CHEMBL621894,
8330,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance rat; Not determined,,,BAO_0000218,N,,1,,CHEMBL621895,
8331,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,,BAO_0000218,N,,1,,CHEMBL875284,
8332,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,BAO_0000218,N,,1,,CHEMBL618699,
8333,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,BAO_0000218,N,,1,,CHEMBL618700,
8334,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL618701,
8335,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,,BAO_0000218,N,,1,,CHEMBL876600,
8336,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance of compound in rat after 1 mg/kg i.v. administration,,,BAO_0000218,N,,1,,CHEMBL618702,
8337,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for Hepatic clearance in rat,,,BAO_0000218,N,,1,,CHEMBL618703,
8338,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo clearance after 5 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL618704,
8339,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was tested for plasma clearance in rats,,,BAO_0000218,N,,1,,CHEMBL618705,
8340,In vivo,,50597,10116.0,Intermediate,1,,A,,Hepatic clearance after intravenous administration was evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL618706,
8341,In vivo,,50597,10116.0,Intermediate,1,,A,,Lower clearance in rat (i.v.) at 0.5 mpk,,,BAO_0000218,N,,1,,CHEMBL618707,
8342,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Pharmacokinetic parameter expressed as plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL618708,
8343,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Clp) in rat,,,BAO_0000218,N,,1,,CHEMBL618709,
8344,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL618710,
8345,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance (Clp) in rat,,,BAO_0000218,N,,1,,CHEMBL618711,
8346,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL618712,
8347,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,,BAO_0000218,N,,1,,CHEMBL618713,
8348,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL618714,
8349,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,BAO_0000218,N,,1,,CHEMBL618715,
8350,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat was determined,,,BAO_0000218,N,,1,,CHEMBL618716,
8351,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance measured in rat,,,BAO_0000218,N,,1,,CHEMBL876601,
8352,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was calculated in rat,,,BAO_0000218,N,,1,,CHEMBL618717,
8353,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL618718,
8354,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL618719,
8355,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL618720,
8356,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL618721,
8357,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rats,,,BAO_0000218,N,,1,,CHEMBL621477,
8358,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL621478,
8359,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL621479,
8360,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was evaluated in rat; Not tested,,,BAO_0000218,N,,1,,CHEMBL621480,
8361,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance rate was determined for the compound in rat,,,BAO_0000218,N,,1,,CHEMBL621481,
8362,In vivo,,50597,10116.0,Intermediate,1,,A,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,,BAO_0000218,N,,1,,CHEMBL621482,
8363,In vivo,,50597,10116.0,Intermediate,1,,A,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,BAO_0000218,N,,1,,CHEMBL621483,
8364,In vivo,,50597,10116.0,Intermediate,1,,A,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,,BAO_0000218,N,,1,,CHEMBL621484,
8365,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621485,
8366,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621486,
8367,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621487,
8368,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621488,
8369,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621489,
8370,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621490,
8371,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621491,
8372,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621492,
8373,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621493,
8374,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621494,
8375,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621495,
8376,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621496,
8377,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621497,
8378,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621498,
8379,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL621499,
8380,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL618634,
8381,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL618635,
8382,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL618636,
8383,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619737,
8384,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL619738,
8385,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL624329,
8386,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL624330,
8387,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL624331,
8388,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL624332,
8389,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL624333,
8390,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL624334,
8391,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL624335,
8392,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620016,
8393,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620169,
8394,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620170,
8395,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620171,
8396,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620172,
8397,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620173,
8398,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620174,
8399,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620175,
8400,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620176,
8401,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620177,
8402,,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620178,
8403,,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620179,
8404,,,50597,10116.0,Intermediate,1,,A,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620180,
8405,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,,BAO_0000218,N,,1,,CHEMBL620181,
8406,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution of compound in rats after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL620182,
8407,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in rat,,,BAO_0000218,N,,1,,CHEMBL620183,
8408,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,,BAO_0000218,N,,1,,CHEMBL620184,
8409,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,BAO_0000218,N,,1,,CHEMBL620185,
8410,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,BAO_0000218,N,,1,,CHEMBL620186,
8411,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was determined in Dawley rat,,,BAO_0000218,N,,1,,CHEMBL620187,
8412,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL620188,
8413,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was reported in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL620189,
8414,In vivo,,50597,10116.0,Intermediate,1,,A,,Volumes of distribution in rat after peroral administration,,,BAO_0000218,N,,1,,CHEMBL620190,
8415,In vivo,,50597,10116.0,Intermediate,1,,A,,Volumes of distribution in rat after po administration,,,BAO_0000218,N,,1,,CHEMBL620191,
8416,In vivo,,50597,10116.0,Intermediate,1,,A,,Volumes of distribution in rat after po administration; Not determined,,,BAO_0000218,N,,1,,CHEMBL620192,
8417,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Volume) in rat i.v.,,,BAO_0000218,N,,1,,CHEMBL620193,
8418,In vivo,,50597,10116.0,Intermediate,1,,A,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,,BAO_0000218,N,,1,,CHEMBL620194,
8419,In vivo,,50597,10116.0,Intermediate,1,,A,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,,BAO_0000218,N,,1,,CHEMBL876730,
8420,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution in rat after oral administration at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620195,
8421,In vivo,,50597,10116.0,Intermediate,1,,A,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL620196,
8422,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620197,
8423,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,,BAO_0000218,N,,1,,CHEMBL620198,
8424,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in rats,,,BAO_0000218,N,,1,,CHEMBL620199,
8425,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,,BAO_0000218,N,,1,,CHEMBL620200,
8426,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,,BAO_0000218,N,,1,,CHEMBL620201,
8427,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL620202,
8428,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL620203,
8429,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,,BAO_0000218,N,,1,,CHEMBL620204,
8430,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL620205,
8431,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter (Vss) in rat,,,BAO_0000218,N,,1,,CHEMBL624664,
8432,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Volume) in rat i.v.,,,BAO_0000218,N,,1,,CHEMBL624665,
8433,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Vss) in rat,,,BAO_0000218,N,,1,,CHEMBL624666,
8434,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,,BAO_0000218,N,,1,,CHEMBL624667,
8435,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL624668,
8436,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL624669,
8437,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL624670,
8438,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL624671,
8439,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume distribution in rat,,,BAO_0000218,N,,1,,CHEMBL624672,
8440,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,,BAO_0000218,N,,1,,CHEMBL624673,
8441,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady state volume of distribution determined in rat,,,BAO_0000218,N,,1,,CHEMBL624674,
8442,In vivo,,50597,10116.0,Intermediate,1,,A,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,BAO_0000218,N,,1,,CHEMBL624675,
8443,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,,BAO_0000218,N,,1,,CHEMBL621728,
8444,,,50597,10116.0,Intermediate,1,,A,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,,BAO_0000218,N,,1,,CHEMBL621729,
8445,,,50597,10116.0,Intermediate,1,,A,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,,BAO_0000218,N,,1,,CHEMBL621730,
8446,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution in rat after administration of 2 mg/kg iv,,,BAO_0000218,N,,1,,CHEMBL621731,
8447,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution in rat after administration of 2 mg/kg iv,,,BAO_0000218,N,,1,,CHEMBL621732,
8448,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume in steady state distribution value was determined,,,BAO_0000218,N,,1,,CHEMBL621908,
8449,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume in steady state distribution value was determined; ND denotes no data,,,BAO_0000218,N,,1,,CHEMBL875347,
8450,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume in steady state distribution value was determined; ND denotes not determined,,,BAO_0000218,N,,1,,CHEMBL621909,
8451,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,BAO_0000218,N,,1,,CHEMBL621910,
8452,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution at steady state was evaluated in rats,,,BAO_0000218,N,,1,,CHEMBL621911,
8453,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution at steady state was observed after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL621912,
8454,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in steady state was determined in rat,,,BAO_0000218,N,,1,,CHEMBL621913,
8455,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in steady state was determined in rat,,,BAO_0000218,N,,1,,CHEMBL621914,
8456,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL621915,
8457,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,,BAO_0000218,N,,1,,CHEMBL621916,
8458,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,,BAO_0000218,N,,1,,CHEMBL621917,
8459,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,,BAO_0000218,N,,1,,CHEMBL621918,
8460,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Biodistribution of compound (oxidized form) in spleen tissue,,,BAO_0000218,N,,1,,CHEMBL621919,
8461,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,,BAO_0000218,N,,1,,CHEMBL621920,
8462,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,,BAO_0000218,N,,1,,CHEMBL621921,
8463,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,N,,1,,CHEMBL622401,
8464,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,,BAO_0000218,N,,1,,CHEMBL875348,
8465,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,,BAO_0000218,N,,1,,CHEMBL622402,
8466,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,,BAO_0000218,N,,1,,CHEMBL622403,
8467,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,N,,1,,CHEMBL622404,
8468,In vivo,955.0,50594,10090.0,Intermediate,1,Brain,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,,BAO_0000218,N,,1,,CHEMBL622405,
8469,In vivo,955.0,50594,10090.0,Intermediate,1,Brain,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,,BAO_0000218,N,,1,,CHEMBL622406,
8470,In vivo,955.0,50594,10090.0,Intermediate,1,Brain,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,N,,1,,CHEMBL622407,
8471,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,,BAO_0000218,N,,1,,CHEMBL622408,
8472,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,,BAO_0000218,N,,1,,CHEMBL622409,
8473,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,N,,1,,CHEMBL622410,
8474,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,,BAO_0000218,N,,1,,CHEMBL622411,
8475,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,,BAO_0000218,N,,1,,CHEMBL627864,
8476,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,N,,1,,CHEMBL627865,
8477,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,,BAO_0000218,N,,1,,CHEMBL627866,
8478,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,N,,1,,CHEMBL627751,
8479,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,,BAO_0000218,N,,1,,CHEMBL627752,
8480,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,,BAO_0000218,N,,1,,CHEMBL627753,
8481,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,,BAO_0000218,N,,1,,CHEMBL627754,
8482,,,50594,10090.0,Intermediate,1,,A,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,,BAO_0000218,N,,1,,CHEMBL627755,
8483,In vivo,955.0,50594,10090.0,Intermediate,1,Brain,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627756,
8484,In vivo,955.0,50594,10090.0,Intermediate,1,Brain,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627757,
8485,In vivo,955.0,50594,10090.0,Intermediate,1,Brain,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627758,
8486,In vivo,955.0,50594,10090.0,Intermediate,1,Brain,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627759,
8487,In vivo,955.0,50594,10090.0,Intermediate,1,Brain,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627760,
8488,In vivo,955.0,50594,10090.0,Intermediate,1,Brain,A,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627761,
8489,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL876811,
8490,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627762,
8491,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627763,
8492,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627764,
8493,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627765,
8494,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627766,
8495,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627767,
8496,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627768,
8497,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL628422,
8498,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL628423,
8499,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,,BAO_0000218,N,,1,,CHEMBL628424,
8500,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,,BAO_0000218,N,,1,,CHEMBL628425,
8501,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,,BAO_0000218,N,,1,,CHEMBL628426,
8502,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,BAO_0000218,N,,1,,CHEMBL628427,
8503,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,BAO_0000218,N,,1,,CHEMBL626938,
8504,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL626939,
8505,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL626940,
8506,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL626941,
8507,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was reported in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL626942,
8508,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance after intravenous administration (1 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL876812,
8509,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance of compound in rats was evaluated,,,BAO_0000218,N,,1,,CHEMBL626943,
8510,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,,BAO_0000218,N,,1,,CHEMBL626944,
8511,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,,BAO_0000218,N,,1,,CHEMBL626945,
8512,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,BAO_0000218,N,,1,,CHEMBL626946,
8513,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance rate in Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL626856,
8514,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,,BAO_0000218,N,,1,,CHEMBL626857,
8515,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The compound was evaluated for plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL626858,
8516,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Total plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL627018,
8517,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,,BAO_0000218,N,,1,,CHEMBL625331,
8518,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,,BAO_0000218,N,,1,,CHEMBL625332,
8519,In vivo,,50597,10116.0,Intermediate,1,,A,,C max was determined at 10 mg/kg po dose in rats,,,BAO_0000218,N,,1,,CHEMBL877590,
8520,In vivo,,50597,10116.0,Intermediate,1,,A,,C max was determined at 3 mg/kg po dose in rats,,,BAO_0000218,N,,1,,CHEMBL625333,
8521,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL625334,
8522,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after single intravenous bolus of 1 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL625335,
8523,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax of compound at 5 mg/kg after po administration was determined in rat,,,BAO_0000218,N,,1,,CHEMBL625336,
8524,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax 24 hr after 10 mg/kg oral administration in rats,,,BAO_0000218,N,,1,,CHEMBL625337,
8525,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax 24 hr after 2 mg/kg oral administration in rats,,,BAO_0000218,N,,1,,CHEMBL625338,
8526,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,,BAO_0000218,N,,1,,CHEMBL625339,
8527,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat after administration of 2 mg/kg iv,,,BAO_0000218,N,,1,,CHEMBL625340,
8528,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat after administration of 2 mg/kg iv,,,BAO_0000218,N,,1,,CHEMBL625341,
8529,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622687,
8530,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,,BAO_0000218,N,,1,,CHEMBL622688,
8531,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,,BAO_0000218,N,,1,,CHEMBL622689,
8532,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,,BAO_0000218,N,,1,,CHEMBL620295,
8533,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after 10 mg/kg oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL620296,
8534,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,,BAO_0000218,N,,1,,CHEMBL620297,
8535,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after IV dosing at 1 mg/kg in rat; no data,,,BAO_0000218,N,,1,,CHEMBL620298,
8536,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after oral administration at 20 mpk in rats,,,BAO_0000218,N,,1,,CHEMBL620299,
8537,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after oral administration at 20 mpk in rats; Not performed.,,,BAO_0000218,N,,1,,CHEMBL620300,
8538,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after oral administration at 20 mpk in rats d; Not performed.,,,BAO_0000218,N,,1,,CHEMBL620301,
8539,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL620302,
8540,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after oral administration at a dose of 2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL620303,
8541,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after oral administration at a dose of 4 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL620304,
8542,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rats after 20 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL620305,
8543,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after peroral administration in rats at 2.4 uM/kg,,,BAO_0000218,N,,1,,CHEMBL620306,
8544,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax at the dose of 2 mg/Kg administered perorally in rats,,,BAO_0000218,N,,1,,CHEMBL620307,
8545,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax at the dose of 5 mg/Kg administered perorally in rats,,,BAO_0000218,N,,1,,CHEMBL620308,
8546,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax by administering at 20 mg/kg p.o. in rats,,,BAO_0000218,N,,1,,CHEMBL620309,
8547,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in male rat,,,BAO_0000218,N,,1,,CHEMBL620310,
8548,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat,,,BAO_0000218,N,,1,,CHEMBL620311,
8549,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat,,,BAO_0000218,N,,1,,CHEMBL620312,
8550,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat,,,BAO_0000218,N,,1,,CHEMBL620313,
8551,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620314,
8552,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat at the dose of 1 mg/kg i.v.,,,BAO_0000218,N,,1,,CHEMBL620315,
8553,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat by po administration at a dose of 40 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620316,
8554,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat p.o. at 20 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL620317,
8555,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rats,,,BAO_0000218,N,,1,,CHEMBL620318,
8556,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rats,,,BAO_0000218,N,,1,,CHEMBL620319,
8557,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax was evaluated after 20 uM/kg of peroral administration,,,BAO_0000218,N,,1,,CHEMBL620320,
8558,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax was measured in rats after peroral administration at 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620321,
8559,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,,BAO_0000218,N,,1,,CHEMBL620322,
8560,,,50597,10116.0,Intermediate,1,,A,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620323,
8561,,1870.0,50597,10116.0,Intermediate,1,Frontal cortex,A,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620324,
8562,,1870.0,50597,10116.0,Intermediate,1,Frontal cortex,A,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620325,
8563,,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620326,
8564,,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620327,
8565,,,50597,10116.0,Intermediate,1,,A,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620328,
8566,,,50597,10116.0,Intermediate,1,,A,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620329,
8567,,1891.0,50597,10116.0,Intermediate,1,Midbrain,A,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620330,
8568,,1891.0,50597,10116.0,Intermediate,1,Midbrain,A,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL875286,
8569,,,50597,10116.0,Intermediate,1,,A,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620331,
8570,,,50597,10116.0,Intermediate,1,,A,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620332,
8571,,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620333,
8572,,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,,BAO_0000218,N,,1,,CHEMBL620334,
8573,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL621015,
8574,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL621016,
8575,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL621191,
8576,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL621192,
8577,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL621193,
8578,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL621194,
8579,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL624204,
8580,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL624205,
8581,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL624206,
8582,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL624207,
8583,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL624208,
8584,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL624209,
8585,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL624210,
8586,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL624211,
8587,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL624212,
8588,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL624213,
8589,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL876611,
8590,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL624214,
8591,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL624215,
8592,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL624216,
8593,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL624217,
8594,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL624218,
8595,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL624219,
8596,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL624220,
8597,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL624221,
8598,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL624222,
8599,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL624223,
8600,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL624224,
8601,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL624225,
8602,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,N,,1,,CHEMBL622420,
8603,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of steady state distribution after i.v. administration in rats,,,BAO_0000218,N,,1,,CHEMBL622421,
8604,In vivo,,50597,10116.0,Intermediate,1,,A,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,,BAO_0000218,N,,1,,CHEMBL622422,
8605,In vivo,,50597,10116.0,Intermediate,1,,A,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622423,
8606,In vivo,,50597,10116.0,Intermediate,1,,A,,Vss was determined,,,BAO_0000218,N,,1,,CHEMBL622424,
8607,In vivo,,50597,10116.0,Intermediate,1,,A,,Vss in rat,,,BAO_0000218,N,,1,,CHEMBL622425,
8608,In vivo,,50597,10116.0,Intermediate,1,,A,,Vss was evaluated after 10 uM/kg of intra arterial administration,,,BAO_0000218,N,,1,,CHEMBL876612,
8609,In vivo,,50597,10116.0,Intermediate,1,,A,,volume of distribution at steady state was observed after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL622426,
8610,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622427,
8611,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic (PK) parameter Vz in rat,,,BAO_0000218,N,,1,,CHEMBL622428,
8612,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume distribution in rats,,,BAO_0000218,N,,1,,CHEMBL622429,
8613,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in rat; No data,,,BAO_0000218,N,,1,,CHEMBL622430,
8614,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL622431,
8615,,2116.0,50597,10116.0,Intermediate,1,Ileum,A,,% absorption predicted from in vitro rat ileum transport studies,,,BAO_0000218,N,,1,,CHEMBL622432,
8616,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL622433,
8617,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL622434,
8618,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL622435,
8619,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL618748,
8620,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL618749,
8621,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL618750,
8622,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL618751,
8623,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL618752,
8624,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL618753,
8625,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,,BAO_0000218,N,,1,,CHEMBL618754,
8626,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL618755,
8627,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL618756,
8628,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL618757,
8629,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL618758,
8630,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 30 mg/kg),,,BAO_0000218,N,,1,,CHEMBL621088,
8631,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (cLogP) in rat,,,BAO_0000218,N,,1,,CHEMBL621089,
8632,,178.0,50597,10116.0,Intermediate,1,Blood,F,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,,BAO_0000218,N,,1,,CHEMBL621090,
8633,,178.0,50597,10116.0,Intermediate,1,Blood,F,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,,BAO_0000218,N,,1,,CHEMBL621091,
8634,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance in rat.,,,BAO_0000218,N,,1,,CHEMBL876731,
8635,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for its clearance when administered intravenously in rat,,,BAO_0000218,N,,1,,CHEMBL621092,
8636,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621093,
8637,,,50597,10116.0,Intermediate,1,,A,,Blood: Brain distribution ratio is determined in rat,,,BAO_0000218,N,,1,,CHEMBL621094,
8638,,,50597,10116.0,Intermediate,1,,A,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,,BAO_0000218,N,,1,,CHEMBL621095,
8639,,,50597,10116.0,Intermediate,1,,A,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,,BAO_0000218,N,,1,,CHEMBL621096,
8640,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL621097,
8641,,,50597,10116.0,Intermediate,1,,F,,Percent dose excreted in 0-48 hours administered ip to male rat,,,BAO_0000218,N,,1,,CHEMBL621098,
8642,,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL621099,
8643,,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL621100,
8644,,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL621101,
8645,,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL621102,
8646,,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL876732,
8647,,,50597,10116.0,Intermediate,1,,A,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL621103,
8648,,,50597,10116.0,Intermediate,1,,A,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL621104,
8649,,,50597,10116.0,Intermediate,1,,A,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL621105,
8650,,,50597,10116.0,Intermediate,1,,A,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL621106,
8651,,,50597,10116.0,Intermediate,1,,A,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL621107,
8652,,,50597,10116.0,Intermediate,1,,A,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL621108,
8653,,,50597,10116.0,Intermediate,1,,A,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL621109,
8654,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL621110,
8655,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL621111,
8656,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL622541,
8657,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL622542,
8658,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL622543,
8659,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624412,
8660,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624413,
8661,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624414,
8662,In vivo,2048.0,50594,10090.0,Intermediate,1,Lung,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624415,
8663,In vivo,2048.0,50594,10090.0,Intermediate,1,Lung,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624416,
8664,In vivo,2048.0,50594,10090.0,Intermediate,1,Lung,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624417,
8665,In vivo,2048.0,50594,10090.0,Intermediate,1,Lung,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624418,
8666,In vivo,2048.0,50594,10090.0,Intermediate,1,Lung,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624419,
8667,In vivo,2048.0,50594,10090.0,Intermediate,1,Lung,A,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624420,
8668,In vivo,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624421,
8669,In vivo,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624422,
8670,In vivo,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL624423,
8671,In vivo,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL625123,
8672,In vivo,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL625124,
8673,In vivo,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL625125,
8674,In vivo,14.0,50594,10090.0,Intermediate,1,Zone of skin,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL625126,
8675,In vivo,14.0,50594,10090.0,Intermediate,1,Zone of skin,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626947,
8676,In vivo,14.0,50594,10090.0,Intermediate,1,Zone of skin,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626948,
8677,In vivo,14.0,50594,10090.0,Intermediate,1,Zone of skin,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626949,
8678,In vivo,14.0,50594,10090.0,Intermediate,1,Zone of skin,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626950,
8679,In vivo,14.0,50594,10090.0,Intermediate,1,Zone of skin,A,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626951,
8680,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626952,
8681,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626953,
8682,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626954,
8683,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626955,
8684,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626956,
8685,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626957,
8686,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626958,
8687,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626959,
8688,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626960,
8689,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL626961,
8690,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627589,
8691,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,,BAO_0000218,N,,1,,CHEMBL627590,
8692,,,50594,10090.0,Intermediate,1,,A,,Time taken for EC90 was determined when tested in mouse,,,BAO_0000218,N,,1,,CHEMBL627591,
8693,,,50594,10090.0,Intermediate,1,,A,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627592,
8694,In vivo,,50594,10090.0,Intermediate,1,,A,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,,BAO_0000218,N,,1,,CHEMBL627593,
8695,,,50594,10090.0,Intermediate,1,,A,,Half life in mice,,,BAO_0000218,N,,1,,CHEMBL627594,
8696,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life period in mouse after 10 mg/Kg dose,,,BAO_0000218,N,,1,,CHEMBL876813,
8697,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life period in mouse after 10 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL627595,
8698,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,,BAO_0000218,N,,1,,CHEMBL627596,
8699,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value at 5 mg/kg po was determined in rat,,,BAO_0000218,N,,1,,CHEMBL627597,
8700,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL627598,
8701,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,,BAO_0000218,N,,1,,CHEMBL627599,
8702,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value after administration of 20 mg/Kg oral dose in rat,,,BAO_0000218,N,,1,,CHEMBL627600,
8703,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value at 1 mg/kg po in rat,,,BAO_0000218,N,,1,,CHEMBL627601,
8704,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value at 5 mg/kg po in rat,,,BAO_0000218,N,,1,,CHEMBL627776,
8705,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value at a dose of 10 mg/kg in male SD rats,,,BAO_0000218,N,,1,,CHEMBL627777,
8706,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value at a dose of 100 mg/kg in male SD rats,,,BAO_0000218,N,,1,,CHEMBL627778,
8707,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value at a dose of 50 mg/kg in male SD rats,,,BAO_0000218,N,,1,,CHEMBL627779,
8708,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value in rats at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL876814,
8709,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value was evaluated in rats at a dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627780,
8710,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value was determined after peroral administration of 20 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627781,
8711,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,,BAO_0000218,N,,1,,CHEMBL627782,
8712,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,,BAO_0000218,N,,1,,CHEMBL627783,
8713,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,,BAO_0000218,N,,1,,CHEMBL627784,
8714,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,,BAO_0000218,N,,1,,CHEMBL627785,
8715,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627786,
8716,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,,BAO_0000218,N,,1,,CHEMBL627787,
8717,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,,BAO_0000218,N,,1,,CHEMBL627788,
8718,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,,BAO_0000218,N,,1,,CHEMBL626579,
8719,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,,BAO_0000218,N,,1,,CHEMBL626580,
8720,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL876815,
8721,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,,BAO_0000218,N,,1,,CHEMBL626581,
8722,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,,BAO_0000218,N,,1,,CHEMBL626582,
8723,In vivo,,50597,10116.0,Intermediate,1,,A,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626583,
8724,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL626205,
8725,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL626206,
8726,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL626207,
8727,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623882,
8728,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,,BAO_0000218,N,,1,,CHEMBL623883,
8729,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL623884,
8730,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,,BAO_0000218,N,,1,,CHEMBL623885,
8731,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623886,
8732,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximal concentration in rat was determined,,,BAO_0000218,N,,1,,CHEMBL623887,
8733,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximal concentration after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL623888,
8734,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623889,
8735,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623890,
8736,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Cmax in rat plasma after oral dose (50 mg/Kg),,,BAO_0000218,N,,1,,CHEMBL623891,
8737,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximal plasma concentration was determined.,,,BAO_0000218,N,,1,,CHEMBL623892,
8738,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximal plasma drug concentration was determined,,,BAO_0000218,N,,1,,CHEMBL623893,
8739,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximal concentration in rats after peroral administration,,,BAO_0000218,N,,1,,CHEMBL877616,
8740,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration in rat after 2 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL623894,
8741,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,,BAO_0000218,N,,1,,CHEMBL623895,
8742,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration of compound in rat was evaluated.,,,BAO_0000218,N,,1,,CHEMBL623896,
8743,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL623897,
8744,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL623898,
8745,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,,BAO_0000218,N,,1,,CHEMBL623899,
8746,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL623900,
8747,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,,BAO_0000218,N,,1,,CHEMBL623901,
8748,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration was evaluated in rats,,,BAO_0000218,N,,1,,CHEMBL623902,
8749,In vivo,1359.0,50597,10116.0,Intermediate,1,Cerebrospinal fluid,A,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,,BAO_0000218,N,,1,,CHEMBL623903,
8750,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,,BAO_0000218,N,,1,,CHEMBL623904,
8751,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,,BAO_0000218,N,,1,,CHEMBL877617,
8752,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL623905,
8753,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL623906,
8754,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,BAO_0000218,N,,1,,CHEMBL623907,
8755,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL623908,
8756,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL623909,
8757,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL623910,
8758,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL623911,
8759,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL623912,
8760,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL624616,
8761,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL624617,
8762,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL624618,
8763,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL624619,
8764,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL624794,
8765,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL624795,
8766,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL623921,
8767,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL623922,
8768,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL623923,
8769,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL623924,
8770,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL623925,
8771,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL623926,
8772,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL623927,
8773,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL623928,
8774,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL623929,
8775,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL623930,
8776,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL623931,
8777,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622165,
8778,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL621249,
8779,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL621250,
8780,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL621448,
8781,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL621449,
8782,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL621450,
8783,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL621451,
8784,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL621452,
8785,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL621453,
8786,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL621454,
8787,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL621455,
8788,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL621456,
8789,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL625145,
8790,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL875847,
8791,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL625146,
8792,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL625147,
8793,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL625148,
8794,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL625149,
8795,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL625150,
8796,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL625151,
8797,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL625152,
8798,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL625153,
8799,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL625154,
8800,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL625155,
8801,,,50597,10116.0,Intermediate,1,,A,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL625156,
8802,,,50597,10116.0,Intermediate,1,,A,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624354,
8803,,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624355,
8804,,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624356,
8805,,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624357,
8806,,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624358,
8807,,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624359,
8808,,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624360,
8809,,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL624361,
8810,,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624362,
8811,,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624363,
8812,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624364,
8813,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624365,
8814,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624366,
8815,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624367,
8816,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624368,
8817,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL624369,
8818,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL624370,
8819,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL625069,
8820,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL625070,
8821,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL626051,
8822,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL626052,
8823,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL626053,
8824,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL626054,
8825,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL626055,
8826,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL626056,
8827,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL626057,
8828,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL625193,
8829,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL625194,
8830,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL625195,
8831,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL625196,
8832,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL625197,
8833,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL625198,
8834,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL627929,
8835,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL627074,
8836,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL627075,
8837,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL627076,
8838,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL627077,
8839,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL627078,
8840,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL627079,
8841,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,,BAO_0000218,N,,1,,CHEMBL873824,
8842,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Half life in mouse plasma was determined at dose 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627080,
8843,,,50594,10090.0,Intermediate,1,,A,,Half life was determined,,,BAO_0000218,N,,1,,CHEMBL627081,
8844,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,,BAO_0000218,N,,1,,CHEMBL627082,
8845,In vivo,,50594,10090.0,Intermediate,1,,A,,Half-life in male mice after 1 mg/kg intravenous dose,,,BAO_0000218,N,,1,,CHEMBL627083,
8847,,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Half life in mice plasma,,,BAO_0000218,N,,1,,CHEMBL627085,
8848,,,50594,10090.0,Intermediate,1,,A,,Half life in mouse,,,BAO_0000218,N,,1,,CHEMBL627086,
8849,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Half life in mouse plasma at dose 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627087,
8850,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,,BAO_0000218,N,,1,,CHEMBL627088,
8851,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,,BAO_0000218,N,,1,,CHEMBL627089,
8852,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,,BAO_0000218,N,,1,,CHEMBL627090,
8853,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,,BAO_0000218,N,,1,,CHEMBL627091,
8854,In vivo,,50594,10090.0,Intermediate,1,,A,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,,BAO_0000218,N,,1,,CHEMBL627092,
8855,In vivo,,50594,10090.0,Intermediate,1,,A,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,,BAO_0000218,N,,1,,CHEMBL876785,
8856,In vivo,,50594,10090.0,Intermediate,1,,A,,Half-life by iv administration in mouse,,,BAO_0000218,N,,1,,CHEMBL627093,
8857,In vivo,,50594,10090.0,Intermediate,1,,A,,Half-life by oral administration in mouse,,,BAO_0000218,N,,1,,CHEMBL627094,
8858,,,50594,10090.0,Intermediate,1,,A,,Half-life in mice,,,BAO_0000218,N,,1,,CHEMBL627095,
8859,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Half-life using mouse brain homogenate,,,BAO_0000218,N,,1,,CHEMBL627096,
8860,,,50594,10090.0,Intermediate,1,,A,,Half-life was measured in mice,,,BAO_0000218,N,,1,,CHEMBL627097,
8861,In vivo,,50594,10090.0,Intermediate,1,,A,,Half-life was measured in mouse after an iv dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627098,
8862,,178.0,50594,10090.0,Intermediate,1,Blood,A,,Half-life period was determined in mouse blood,,,BAO_0000218,N,,1,,CHEMBL627099,
8863,,955.0,50594,10090.0,Intermediate,1,Brain,A,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,,BAO_0000218,N,,1,,CHEMBL627100,
8864,,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Plasma half life in mouse,,,BAO_0000218,N,,1,,CHEMBL627101,
8865,,,50594,10090.0,Intermediate,1,,A,,Stability of the peptide in the presence of mouse serum,,,BAO_0000218,N,,1,,CHEMBL627102,
8866,,,50594,10090.0,Intermediate,1,,A,,Terminal half life of compound was determined in mouse,,,BAO_0000218,N,,1,,CHEMBL627103,
8867,In vivo,,50594,10090.0,Intermediate,1,,A,,Terminal half life was evaluated in mice after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL627104,
8868,In vivo,,50594,10090.0,Intermediate,1,,A,,Terminal half life was evaluated in mice after oral administration,,,BAO_0000218,N,,1,,CHEMBL627105,
8869,,,50594,10090.0,Intermediate,1,,A,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,,BAO_0000218,N,,1,,CHEMBL876786,
8870,,,50594,10090.0,Intermediate,1,,A,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,,BAO_0000218,N,,1,,CHEMBL873825,
8871,,,50594,10090.0,Intermediate,1,,A,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,,BAO_0000218,N,,1,,CHEMBL627106,
8872,In vivo,,50594,10090.0,Intermediate,1,,A,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,,BAO_0000218,N,,1,,CHEMBL626336,
8873,In vivo,,50594,10090.0,Intermediate,1,,A,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,,BAO_0000218,N,,1,,CHEMBL877462,
8874,In vivo,,50594,10090.0,Intermediate,1,,A,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,,BAO_0000218,N,,1,,CHEMBL626337,
8875,,,50594,10090.0,Intermediate,1,,A,,Half life after intraperitoneal administration of 100 mg/kg in mice,,,BAO_0000218,N,,1,,CHEMBL626338,
8876,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,,BAO_0000218,N,,1,,CHEMBL626339,
8877,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,,BAO_0000218,N,,1,,CHEMBL626340,
8878,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,,BAO_0000218,N,,1,,CHEMBL625377,
8879,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,,BAO_0000218,N,,1,,CHEMBL625378,
8880,In vivo,,50594,10090.0,Intermediate,1,,A,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,,BAO_0000218,N,,1,,CHEMBL625379,
8881,,,22224,9823.0,Autocuration,1,,A,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,,BAO_0000251,U,,0,,CHEMBL625380,
8882,,,22224,9823.0,Autocuration,1,,A,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Microsomes,,BAO_0000251,U,,0,,CHEMBL625381,
8883,,,22224,9823.0,Autocuration,1,,A,,Stability to porcine renal DHP-I,,,BAO_0000019,U,,0,,CHEMBL625382,
8884,In vivo,,22224,9823.0,Autocuration,1,,A,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,,BAO_0000218,U,,0,,CHEMBL873828,
8885,In vivo,,22224,9823.0,Autocuration,1,,A,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,,BAO_0000218,U,,0,,CHEMBL625383,
8886,,,22224,9823.0,Autocuration,1,,A,,Half-life of the parent prodrug in porcine esterase solution,,,BAO_0000019,U,,0,,CHEMBL625384,
8887,,,22224,9823.0,Autocuration,1,,A,,"First order rate constant, k was determined in in pig liver Esterase",,,BAO_0000019,U,,0,,CHEMBL625385,
8888,,2107.0,22224,9823.0,Autocuration,1,Liver,A,,Half life of the in pig liver Esterase,,,BAO_0000221,U,,0,,CHEMBL625386,
8889,,2107.0,22224,9823.0,Autocuration,1,Liver,A,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,,BAO_0000221,U,,0,,CHEMBL623571,
8890,,2107.0,22224,9823.0,Autocuration,1,Liver,A,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,,BAO_0000221,U,,0,,CHEMBL623572,
8891,,2107.0,22224,9823.0,Autocuration,1,Liver,A,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,,BAO_0000221,U,,0,,CHEMBL623573,
8892,,2107.0,22224,9823.0,Autocuration,1,Liver,A,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,,BAO_0000221,U,,0,,CHEMBL623574,
8893,,2107.0,22224,9823.0,Autocuration,1,Liver,A,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,,BAO_0000221,U,,0,,CHEMBL623575,
8894,,2107.0,22224,9823.0,Autocuration,1,Liver,A,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,,BAO_0000221,U,,0,,CHEMBL623749,
8895,,2107.0,22224,9823.0,Autocuration,1,Liver,A,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,,BAO_0000221,U,,0,,CHEMBL623750,
8896,In vitro,2107.0,22224,9823.0,Autocuration,1,Liver,A,,Half-life in vitro in pig liver,,,BAO_0000221,U,,0,,CHEMBL623751,
8897,,2107.0,22224,9823.0,Autocuration,1,Liver,A,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,,BAO_0000221,U,,0,,CHEMBL623752,
8898,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,,BAO_0000218,N,,1,,CHEMBL623753,
8899,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,,BAO_0000218,N,,1,,CHEMBL623754,
8900,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration in rat plasma was determined,,,BAO_0000218,N,,1,,CHEMBL623755,
8901,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration in rats,,,BAO_0000218,N,,1,,CHEMBL623756,
8902,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration in rats at 1-2 hours,,,BAO_0000218,N,,1,,CHEMBL623757,
8903,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,,BAO_0000218,N,,1,,CHEMBL623758,
8904,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,,BAO_0000218,N,,1,,CHEMBL623759,
8905,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration at the dose of 2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL623760,
8906,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration was evaluated in rats,,,BAO_0000218,N,,1,,CHEMBL623761,
8907,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL623762,
8908,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL877594,
8909,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623763,
8910,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623764,
8911,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL623765,
8912,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,,BAO_0000218,N,,1,,CHEMBL623766,
8913,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,,BAO_0000218,N,,1,,CHEMBL623767,
8914,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,,BAO_0000218,N,,1,,CHEMBL623768,
8915,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623769,
8916,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623770,
8917,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623771,
8918,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623772,
8919,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623773,
8920,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623774,
8921,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL623775,
8922,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat (PO dose),,,BAO_0000218,N,,1,,CHEMBL623776,
8923,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL622191,
8924,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL622192,
8925,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration determined in rat,,,BAO_0000218,N,,1,,CHEMBL622193,
8926,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622194,
8927,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622195,
8928,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration in rat,,,BAO_0000218,N,,1,,CHEMBL622196,
8929,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,BAO_0000218,N,,1,,CHEMBL622197,
8930,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,,BAO_0000218,N,,1,,CHEMBL622198,
8931,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,,BAO_0000218,N,,1,,CHEMBL622199,
8932,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration of compound was measured in rat,,,BAO_0000218,N,,1,,CHEMBL622200,
8933,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration after 20 mg/kg oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL622201,
8934,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration after oral administration to rats,,,BAO_0000218,N,,1,,CHEMBL623990,
8935,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,N,,1,,CHEMBL623991,
8936,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,,BAO_0000218,N,,1,,CHEMBL623992,
8937,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,N,,1,,CHEMBL623993,
8938,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,,BAO_0000218,N,,1,,CHEMBL623994,
8939,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,F,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,N,,1,,CHEMBL623995,
8940,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,F,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,N,,1,,CHEMBL623996,
8941,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,F,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,N,,1,,CHEMBL623997,
8942,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration dosed orally in rats,,,BAO_0000218,N,,1,,CHEMBL623998,
8943,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration dosed orally in rats after 6 hours,,,BAO_0000218,N,,1,,CHEMBL623999,
8944,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,,BAO_0000218,N,,1,,CHEMBL624000,
8945,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL624001,
8946,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration in rat after po administration,,,BAO_0000218,N,,1,,CHEMBL624002,
8947,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL624003,
8948,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,,BAO_0000218,N,,1,,CHEMBL624004,
8949,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL624005,
8950,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL624006,
8951,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL624007,
8952,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL624008,
8953,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL624009,
8954,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL874387,
8955,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL624010,
8956,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL624011,
8957,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL624012,
8958,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL624013,
8959,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL624736,
8960,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL624737,
8961,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL624738,
8962,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL624739,
8963,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL624740,
8964,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL624896,
8965,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL624897,
8966,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL624108,
8967,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL624109,
8968,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL624110,
8969,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL624111,
8970,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL624112,
8971,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL624113,
8972,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL619709,
8973,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL619710,
8974,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL619711,
8975,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL619712,
8976,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL619713,
8977,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL619714,
8978,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL619715,
8979,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL619716,
8980,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL619717,
8981,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL619718,
8982,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL619719,
8983,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL875329,
8984,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL619720,
8985,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL619721,
8986,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL619722,
8987,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL619723,
8988,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL619724,
8989,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL619725,
8990,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL619726,
8991,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL619727,
8992,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL619728,
8993,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL619729,
8994,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL619730,
8995,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL619731,
8996,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL619732,
8997,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL619733,
8998,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL619734,
8999,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL619735,
9000,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL875330,
9001,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL628465,
9002,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL628466,
9003,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL628467,
9004,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL628468,
9005,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL628469,
9006,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL628470,
9007,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL628471,
9008,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL628472,
9009,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL625191,
9010,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL625192,
9011,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,,BAO_0000218,N,,1,,CHEMBL875337,
9012,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL626341,
9013,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL626342,
9014,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,,BAO_0000218,N,,1,,CHEMBL621943,
9015,,,50597,10116.0,Intermediate,1,,A,,Half life in rats,,,BAO_0000218,N,,1,,CHEMBL621944,
9016,,,50597,10116.0,Intermediate,1,,A,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,,BAO_0000218,N,,1,,CHEMBL621945,
9017,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,,BAO_0000218,N,,1,,CHEMBL621946,
9018,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,BAO_0000218,N,,1,,CHEMBL621947,
9019,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,,BAO_0000218,N,,1,,CHEMBL621948,
9020,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,,BAO_0000218,N,,1,,CHEMBL621949,
9021,,,50597,10116.0,Intermediate,1,,A,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,,BAO_0000218,N,,1,,CHEMBL621950,
9022,,,50597,10116.0,Intermediate,1,,A,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,,BAO_0000218,N,,1,,CHEMBL621951,
9023,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,,BAO_0000218,N,,1,,CHEMBL621952,
9024,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Stability (%) in rat liver microsomes,,,BAO_0000218,N,,1,,CHEMBL621953,
9025,,,50597,10116.0,Intermediate,1,,A,,Area under curve was calculated after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL621954,
9026,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was calculated after iv administration in rat,,,BAO_0000218,N,,1,,CHEMBL621955,
9027,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was calculated in rat after peroral administration,,,BAO_0000218,N,,1,,CHEMBL621956,
9028,,,50597,10116.0,Intermediate,1,,A,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL621957,
9029,,,50597,10116.0,Intermediate,1,,A,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL621958,
9030,,,50597,10116.0,Intermediate,1,,A,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL621959,
9031,,,50597,10116.0,Intermediate,1,,A,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,,BAO_0000218,N,,1,,CHEMBL621960,
9032,,,50597,10116.0,Intermediate,1,,A,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,,BAO_0000218,N,,1,,CHEMBL621961,
9033,,,50597,10116.0,Intermediate,1,,A,,p value of the compound,,,BAO_0000218,N,,1,,CHEMBL621962,
9034,,,50597,10116.0,Intermediate,1,,F,,p value of the compound,,,BAO_0000218,N,,1,,CHEMBL876787,
9035,,,50597,10116.0,Intermediate,1,,A,,p value of the compound,,,BAO_0000218,N,,1,,CHEMBL621963,
9036,,945.0,50597,10116.0,Intermediate,1,Stomach,A,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,N,,1,,CHEMBL622637,
9037,,945.0,50597,10116.0,Intermediate,1,Stomach,A,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,N,,1,,CHEMBL622638,
9038,,945.0,50597,10116.0,Intermediate,1,Stomach,A,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,N,,1,,CHEMBL626561,
9039,,,22224,9986.0,Autocuration,1,,F,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,,BAO_0000019,U,,0,,CHEMBL626562,
9040,,,22224,9986.0,Autocuration,1,,A,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,,BAO_0000218,U,,0,,CHEMBL626563,
9041,,,22224,9986.0,Autocuration,1,,A,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,,BAO_0000218,U,,0,,CHEMBL626564,
9042,In vivo,,22224,9986.0,Autocuration,1,,A,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,,BAO_0000218,U,,0,,CHEMBL626565,
9043,In vivo,,22224,9986.0,Autocuration,1,,A,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,,BAO_0000218,U,,0,,CHEMBL626566,
9044,In vivo,,22224,9986.0,Autocuration,1,,A,,Clearance rate in rabbits,,,BAO_0000218,U,,0,,CHEMBL626567,
9045,In vivo,,22224,9986.0,Autocuration,1,,A,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,,BAO_0000218,U,,0,,CHEMBL626568,
9046,In vivo,,22224,9986.0,Autocuration,1,,A,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626569,
9047,In vivo,,22224,9986.0,Autocuration,1,,A,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626570,
9048,In vivo,,22224,9986.0,Autocuration,1,,A,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626571,
9049,In vivo,,22224,9986.0,Autocuration,1,,A,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626572,
9050,In vivo,1969.0,22224,9986.0,Autocuration,1,Plasma,A,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,,BAO_0000218,U,,0,,CHEMBL626573,
9051,,2107.0,22224,9986.0,Autocuration,1,Liver,A,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Microsomes,,BAO_0000251,U,,0,,CHEMBL626574,
9052,,2107.0,22224,9986.0,Autocuration,1,Liver,A,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Microsomes,,BAO_0000251,U,,0,,CHEMBL626575,
9053,,,22224,9986.0,Autocuration,1,,A,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,,BAO_0000218,U,,0,,CHEMBL626576,
9054,,,22224,9986.0,Autocuration,1,,A,,Dose at which bioavailability of perorally administered compound was tested in rabbit,,,BAO_0000218,U,,0,,CHEMBL626577,
9055,In vivo,,22224,9986.0,Autocuration,1,,A,,The compound was tested for its bioavailability in rabbit (by oral dosage).,,,BAO_0000218,U,,0,,CHEMBL626578,
9056,In vivo,,22224,9986.0,Autocuration,1,,A,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,BAO_0000218,U,,0,,CHEMBL625263,
9057,In vivo,,22224,9986.0,Autocuration,1,,A,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,BAO_0000218,U,,0,,CHEMBL625264,
9058,In vivo,,22224,9986.0,Autocuration,1,,A,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,BAO_0000218,U,,0,,CHEMBL625265,
9059,,,22224,9986.0,Autocuration,1,,A,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Microsomes,,BAO_0000251,U,,0,,CHEMBL625266,
9060,,,22224,9986.0,Autocuration,1,,A,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Microsomes,,BAO_0000251,U,,0,,CHEMBL876796,
9061,In vivo,,22224,9986.0,Autocuration,1,,A,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,,BAO_0000218,U,,0,,CHEMBL625267,
9062,In vivo,1969.0,22224,9986.0,Autocuration,1,Plasma,A,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,,BAO_0000218,U,,0,,CHEMBL625268,
9063,In vivo,1969.0,22224,9986.0,Autocuration,1,Plasma,A,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,,BAO_0000218,U,,0,,CHEMBL625269,
9064,In vivo,1969.0,22224,9986.0,Autocuration,1,Plasma,A,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,,BAO_0000218,U,,0,,CHEMBL624689,
9065,In vivo,,22224,9986.0,Autocuration,1,,A,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,,BAO_0000218,U,,0,,CHEMBL624690,
9066,,1088.0,22224,9986.0,Autocuration,1,Urine,A,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,,BAO_0000218,U,,0,,CHEMBL624691,
9067,,1088.0,22224,9986.0,Autocuration,1,Urine,A,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,,BAO_0000218,U,,0,,CHEMBL624692,
9068,In vivo,,22224,9986.0,Autocuration,1,,A,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,,BAO_0000218,U,,0,,CHEMBL624693,
9069,In vivo,,22224,9986.0,Autocuration,1,,A,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,,BAO_0000218,U,,0,,CHEMBL624694,
9070,In vitro,,22224,9986.0,Autocuration,1,,A,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,,BAO_0000221,U,,0,,CHEMBL877596,
9071,,,22224,9986.0,Autocuration,1,,A,,Time within which only 10% of the drug was degraded,,,BAO_0000019,U,,0,,CHEMBL624695,
9072,,2107.0,22224,9986.0,Autocuration,1,Liver,A,,Half life period in rabbit liver homogenate,,,BAO_0000221,U,,0,,CHEMBL624696,
9073,,,22224,9986.0,Autocuration,1,,A,,Half life value in rabbits,,,BAO_0000019,U,,0,,CHEMBL624697,
9074,In vivo,178.0,22224,9986.0,Autocuration,1,Blood,A,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,,BAO_0000218,U,,0,,CHEMBL624698,
9075,In vivo,178.0,22224,9986.0,Autocuration,1,Blood,A,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,,BAO_0000218,U,,0,,CHEMBL624699,
9076,In vivo,,22224,9986.0,Autocuration,1,,A,,Half-life period in rabbits following intravenous administration at 2 mg/kg,,,BAO_0000218,U,,0,,CHEMBL624700,
9077,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC 0-8 hr value in rats at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622903,
9078,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC after administration at 2000 mg/kg/day in rats,,,BAO_0000218,N,,1,,CHEMBL622904,
9079,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,,BAO_0000218,N,,1,,CHEMBL622905,
9080,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,,BAO_0000218,N,,1,,CHEMBL622906,
9081,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,BAO_0000218,N,,1,,CHEMBL622907,
9082,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC in rat after oral administration at 10.5 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL622908,
9083,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC in rat after oral administration at 11.2 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL622909,
9084,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC in rat after oral administration at 9.7 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL622910,
9085,,955.0,50597,10116.0,Intermediate,1,Brain,A,,AUC in rat brain after oral administration at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622911,
9086,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC in rat p.o.,,,BAO_0000218,N,,1,,CHEMBL622912,
9087,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC in rat p.o. at 20 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL622913,
9088,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC in rat plasma after oral administration at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622914,
9089,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC in rats,,,BAO_0000218,N,,1,,CHEMBL622915,
9090,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC value after IV dose at a dose of 5 mg/kg in rats.,,,BAO_0000218,N,,1,,CHEMBL622916,
9091,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC value after oral dose at a dose of 10 mg/kg in rats.,,,BAO_0000218,N,,1,,CHEMBL622917,
9092,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,BAO_0000218,N,,1,,CHEMBL622918,
9093,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,,BAO_0000218,N,,1,,CHEMBL622919,
9094,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration was evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL622920,
9095,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,,BAO_0000218,N,,1,,CHEMBL622921,
9096,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,,BAO_0000218,N,,1,,CHEMBL622922,
9097,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL622923,
9098,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL877604,
9099,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622924,
9100,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622925,
9101,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,,BAO_0000218,N,,1,,CHEMBL622926,
9102,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623625,
9103,In vivo,1969.0,50597,10116.0,Expert,1,Plasma,A,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623626,
9104,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma drug concentration was determined,,,BAO_0000218,N,,1,,CHEMBL623627,
9105,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL623628,
9106,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Mean peak plasma concentration was observed after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL623629,
9107,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Mean peak plasma concentration was observed after oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL623630,
9108,In vivo,,50597,10116.0,Intermediate,1,,A,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL623804,
9109,In vivo,,50597,10116.0,Intermediate,1,,A,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL623805,
9110,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Peak oral plasma concentration was determined in rats by oral administration,,,BAO_0000218,N,,1,,CHEMBL623806,
9111,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Peak plasma concentration (Cmax) was determined,,,BAO_0000218,N,,1,,CHEMBL623807,
9112,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL623808,
9113,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Peak plasma concentration (Cmax) in rats,,,BAO_0000218,N,,1,,CHEMBL623809,
9114,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Peak plasma concentration at 1 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL623810,
9115,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Peak plasma concentration in rat,,,BAO_0000218,N,,1,,CHEMBL623811,
9116,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,N,,1,,CHEMBL623812,
9117,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL877605,
9118,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Cmax) in rat,,,BAO_0000218,N,,1,,CHEMBL623813,
9119,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,,BAO_0000218,N,,1,,CHEMBL623814,
9120,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat after 3mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL623815,
9121,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,,BAO_0000218,N,Sprague-Dawley,1,,CHEMBL623816,
9122,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rats after 20 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL623145,
9123,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Cmax in rat plasma after 30mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL623146,
9124,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma concentration after oral administration of 100 mg/kg to rats,,,BAO_0000218,N,,1,,CHEMBL623147,
9125,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL623042,
9126,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for the Cmax in rat at 10 mg/kg per orally,,,BAO_0000218,N,,1,,CHEMBL623043,
9127,In vivo,,50597,10116.0,Intermediate,1,,A,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL623044,
9128,In vivo,,50597,10116.0,Intermediate,1,,A,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL623045,
9129,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability as oral Cmax in rats at 30 mins,,,BAO_0000218,N,,1,,CHEMBL623046,
9130,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability as oral Cmax in rats at 6hr,,,BAO_0000218,N,,1,,CHEMBL623226,
9131,In vivo,,50597,10116.0,Intermediate,1,,A,,The maximum concentration of compound was measured at the dose of 100 umol/kg,,,BAO_0000218,N,,1,,CHEMBL623227,
9132,In vivo,,50597,10116.0,Intermediate,1,,A,,The maximum concentration of compound was measured at the dose of 300 umol/kg,,,BAO_0000218,N,,1,,CHEMBL623228,
9133,In vivo,,50597,10116.0,Intermediate,1,,A,,The maximum concentration of compound was measured at the dose of 30 umol/kg,,,BAO_0000218,N,,1,,CHEMBL623229,
9134,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The maximum plasma levels for the compounds were determined by LC-MS.,,,BAO_0000218,N,,1,,CHEMBL623230,
9135,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,mean peak plasma concentration was observed after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL623231,
9136,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,mean peak plasma concentration was observed after oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL623232,
9137,,,50597,10116.0,Intermediate,1,,A,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL623233,
9138,,,50597,10116.0,Intermediate,1,,A,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,,BAO_0000218,N,,1,,CHEMBL623234,
9139,,,50597,10116.0,Intermediate,1,,A,,Concentration in plasma (portal) following oral dose in rats at 1 hr,,,BAO_0000218,N,,1,,CHEMBL623235,
9140,,,50597,10116.0,Intermediate,1,,A,,Concentration in plasma (portal) following oral dose in rats at 2 hr,,,BAO_0000218,N,,1,,CHEMBL623236,
9141,,,50597,10116.0,Intermediate,1,,A,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,,BAO_0000218,N,,1,,CHEMBL623237,
9142,,,50597,10116.0,Intermediate,1,,A,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,,BAO_0000218,N,,1,,CHEMBL623238,
9143,,,50597,10116.0,Intermediate,1,,A,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,,BAO_0000218,N,,1,,CHEMBL623239,
9144,In vivo,1969.0,22224,10116.0,Intermediate,1,Plasma,A,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,,BAO_0000218,U,,0,,CHEMBL623240,
9145,,1898.0,50597,10116.0,Intermediate,1,Hypothalamus,A,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,,BAO_0000218,N,,1,,CHEMBL623241,
9146,,1898.0,50597,10116.0,Intermediate,1,Hypothalamus,A,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,,BAO_0000218,N,,1,,CHEMBL623242,
9147,,,50597,10116.0,Intermediate,1,,A,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,,BAO_0000218,N,,1,,CHEMBL874394,
9148,,,50597,10116.0,Intermediate,1,,A,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,,BAO_0000218,N,,1,,CHEMBL623243,
9149,,,50597,10116.0,Intermediate,1,,A,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623244,
9150,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL623245,
9151,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL623246,
9152,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL623247,
9153,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL623248,
9154,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL623249,
9155,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL625072,
9156,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL625073,
9157,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL625074,
9158,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL625075,
9159,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL625076,
9160,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL625077,
9161,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL625078,
9162,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL874395,
9163,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL625079,
9164,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL625080,
9165,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL625081,
9166,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL625082,
9167,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL625083,
9168,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL625084,
9169,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL625085,
9170,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL625086,
9171,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL625087,
9172,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL625088,
9173,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL622205,
9174,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL622206,
9175,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL622207,
9176,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL622366,
9177,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL622367,
9178,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL875331,
9179,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL622368,
9180,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622369,
9181,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622370,
9182,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622371,
9183,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL622372,
9184,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622373,
9185,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622374,
9186,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622375,
9187,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL622376,
9188,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622377,
9189,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622378,
9190,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622379,
9191,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL622380,
9192,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622381,
9193,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL622382,
9194,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL622383,
9195,,945.0,50597,10116.0,Intermediate,1,Stomach,A,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,N,,1,,CHEMBL875332,
9196,,945.0,50597,10116.0,Intermediate,1,Stomach,A,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,N,,1,,CHEMBL622384,
9197,,945.0,50597,10116.0,Intermediate,1,Stomach,A,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,N,,1,,CHEMBL622385,
9198,,945.0,50597,10116.0,Intermediate,1,Stomach,A,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,,BAO_0000218,N,,1,,CHEMBL622386,
9199,,,50597,10116.0,Intermediate,1,,A,,The compound was tested for the plasma binding in rat,,,BAO_0000218,N,,1,,CHEMBL622387,
9200,,,50597,10116.0,Intermediate,1,,A,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,,BAO_0000218,N,,1,,CHEMBL622388,
9201,,,50597,10116.0,Intermediate,1,,A,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,,BAO_0000218,N,,1,,CHEMBL622389,
9202,,,50597,10116.0,Intermediate,1,,A,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,,BAO_0000218,N,,1,,CHEMBL622390,
9203,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,,BAO_0000218,N,,1,,CHEMBL622391,
9204,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,,BAO_0000218,N,,1,,CHEMBL622392,
9205,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,,BAO_0000218,N,,1,,CHEMBL622393,
9206,,,50597,10116.0,Intermediate,1,,A,,Plasma level at 2 hr after administration of the compound,,,BAO_0000218,N,,1,,CHEMBL622394,
9207,,,50597,10116.0,Intermediate,1,,A,,plasma level at 2 hr after administration of the compound,,,BAO_0000218,N,,1,,CHEMBL622395,
9208,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Stability in rat serum measured as % recovery at 1 min,,,BAO_0000218,N,,1,,CHEMBL622396,
9209,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Stability in rat serum measured as % recovery at 10 min,,,BAO_0000218,N,,1,,CHEMBL624894,
9210,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Stability in rat serum measured as % recovery at 10 mins,,,BAO_0000218,N,,1,,CHEMBL624895,
9211,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Stability in rat serum measured as % recovery at 2 hr,,,BAO_0000218,N,,1,,CHEMBL624058,
9212,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Stability in rat serum measured as % recovery at 3 min,,,BAO_0000218,N,,1,,CHEMBL624059,
9213,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Stability in rat serum measured as % recovery at 3 mins,,,BAO_0000218,N,,1,,CHEMBL624060,
9214,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Stability in rat serum measured as % recovery at 5 min,,,BAO_0000218,N,,1,,CHEMBL624061,
9215,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Stability in rat serum measured as % recovery at 5 mins,,,BAO_0000218,N,,1,,CHEMBL624062,
9216,In vivo,,50597,10116.0,Intermediate,1,,A,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624063,
9217,In vivo,,50597,10116.0,Intermediate,1,,A,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624064,
9218,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,,BAO_0000218,N,,1,,CHEMBL624065,
9219,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,,BAO_0000218,N,,1,,CHEMBL624066,
9220,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life tested in mature male rat at a dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL877490,
9221,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL874442,
9222,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period after administration (30 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL626890,
9223,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period in rat after 5 mg/Kg dose,,,BAO_0000218,N,,1,,CHEMBL626891,
9224,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period in rat after 5 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL626892,
9225,,,50597,10116.0,Intermediate,1,,A,,Half life period was determined,,,BAO_0000218,N,,1,,CHEMBL626893,
9226,,,50597,10116.0,Intermediate,1,,A,,Half life period was evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL626894,
9227,,,50597,10116.0,Intermediate,1,,A,,Half life period was evaluated in rat; 0.5-1.0,,,BAO_0000218,N,,1,,CHEMBL626895,
9228,,,50597,10116.0,Intermediate,1,,A,,Half life period was evaluated in rat; 5.9-7.5,,,BAO_0000218,N,,1,,CHEMBL626896,
9229,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in rat plasma,,,BAO_0000218,N,,1,,CHEMBL626897,
9230,,,50597,10116.0,Intermediate,1,,A,,Half-life time in rat was determined,,,BAO_0000218,N,,1,,CHEMBL626898,
9231,In vivo,,50597,10116.0,Intermediate,1,,A,,Terminal half-life after iv administration to rats,,,BAO_0000218,N,,1,,CHEMBL626899,
9232,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,,BAO_0000218,N,,1,,CHEMBL626900,
9233,,,50597,10116.0,Intermediate,1,,A,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,,BAO_0000218,N,,1,,CHEMBL626901,
9234,In vivo,,50597,10116.0,Intermediate,1,,A,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,,BAO_0000218,N,,1,,CHEMBL626902,
9235,In vivo,,50597,10116.0,Intermediate,1,,A,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,,BAO_0000218,N,,1,,CHEMBL626903,
9236,In vivo,,50597,10116.0,Intermediate,1,,A,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL874443,
9237,In vivo,,50597,10116.0,Intermediate,1,,A,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL626904,
9238,,,50597,10116.0,Intermediate,1,,A,,Half life in rats,,,BAO_0000218,N,,1,,CHEMBL626905,
9239,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,,BAO_0000218,N,,1,,CHEMBL873830,
9240,In vivo,,50597,10116.0,Intermediate,1,,A,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL626906,
9241,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,BAO_0000218,N,,1,,CHEMBL631076,
9242,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biological half-life was measured in plasma of rats,,,BAO_0000218,N,,1,,CHEMBL631077,
9243,In vivo,,50597,10116.0,Intermediate,1,,A,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,BAO_0000218,N,,1,,CHEMBL631078,
9244,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,,BAO_0000218,N,,1,,CHEMBL631079,
9245,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,,BAO_0000218,N,,1,,CHEMBL631080,
9246,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,,BAO_0000218,N,,1,,CHEMBL631081,
9247,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,,BAO_0000218,N,,1,,CHEMBL631239,
9248,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was evaluated for plasma half life in rat,,,BAO_0000218,N,,1,,CHEMBL631240,
9249,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC value at a dose of 5 mg/kg (p.o.) in rats,,,BAO_0000218,N,,1,,CHEMBL631241,
9250,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC value after administration of 20 mg/Kg oral dose in rat,,,BAO_0000218,N,,1,,CHEMBL631242,
9251,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL631243,
9252,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC0-96 after administration at 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL874444,
9253,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL631244,
9254,,,50597,10116.0,Intermediate,1,,A,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,,BAO_0000218,N,,1,,CHEMBL631245,
9255,,,50597,10116.0,Intermediate,1,,A,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,,BAO_0000218,N,,1,,CHEMBL627162,
9256,,,50597,10116.0,Intermediate,1,,A,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,,BAO_0000218,N,,1,,CHEMBL627163,
9257,,,50597,10116.0,Intermediate,1,,A,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,,BAO_0000218,N,,1,,CHEMBL627164,
9258,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,,BAO_0000218,N,,1,,CHEMBL627165,
9259,,,50597,10116.0,Intermediate,1,,A,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,,BAO_0000218,N,,1,,CHEMBL627166,
9260,,,50597,10116.0,Intermediate,1,,A,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,,BAO_0000218,N,,1,,CHEMBL627167,
9261,,,50597,10116.0,Intermediate,1,,A,,Area under curve (AUC) at a dose of 30 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL627822,
9262,,,50597,10116.0,Intermediate,1,,A,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL627823,
9263,,,50597,10116.0,Intermediate,1,,A,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL627824,
9264,,,50597,10116.0,Intermediate,1,,A,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL627825,
9265,,,50597,10116.0,Intermediate,1,,A,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL627826,
9266,,,50597,10116.0,Intermediate,1,,A,,Area under curve (Pharmacokinetic property) was determined,,,BAO_0000218,N,,1,,CHEMBL627827,
9267,,,50597,10116.0,Intermediate,1,,A,,Area under curve (Pharmacokinetic property) of the compound; Not determined,,,BAO_0000218,N,,1,,CHEMBL627828,
9268,,,50597,10116.0,Intermediate,1,,A,,Area under curve after intravenous administration (1 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL627829,
9269,,,50597,10116.0,Intermediate,1,,A,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,,BAO_0000218,N,,1,,CHEMBL627830,
9270,,,50597,10116.0,Intermediate,1,,A,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,,BAO_0000218,N,,1,,CHEMBL627831,
9271,,,50597,10116.0,Intermediate,1,,A,,Area under curve in male SD rats was observed after oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL627832,
9272,,,50597,10116.0,Intermediate,1,,A,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,,BAO_0000218,N,,1,,CHEMBL627833,
9273,,,50597,10116.0,Expert,1,,A,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627834,
9274,,,50597,10116.0,Expert,1,,A,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL628004,
9275,,,50597,10116.0,Intermediate,1,,A,,Area under curve at 5 mg/kg po was determined in rat,,,BAO_0000218,N,,1,,CHEMBL628005,
9276,,,50597,10116.0,Intermediate,1,,A,,Area under curve in Rat at a oral dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL628006,
9277,,,50597,10116.0,Intermediate,1,,A,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,,BAO_0000218,N,,1,,CHEMBL628007,
9278,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined,,,BAO_0000218,N,,1,,CHEMBL625676,
9279,,,50597,10116.0,Intermediate,1,,A,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,,BAO_0000218,N,,1,,CHEMBL631309,
9280,,,50597,10116.0,Intermediate,1,,A,,Area under curve after intravenous administration at 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL631310,
9281,,,50597,10116.0,Intermediate,1,,A,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,,BAO_0000218,N,,1,,CHEMBL631311,
9282,,,50597,10116.0,Intermediate,1,,A,,Area under curve at 4 hr in rat,,,BAO_0000218,N,,1,,CHEMBL631312,
9283,,,50597,10116.0,Intermediate,1,,A,,Area under curve at a dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL631313,
9284,,,50597,10116.0,Intermediate,1,,A,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,,BAO_0000218,N,,1,,CHEMBL631314,
9285,,,50597,10116.0,Intermediate,1,,A,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,,BAO_0000218,N,,1,,CHEMBL631315,
9286,,,50597,10116.0,Intermediate,1,,A,,Area under curve for a 2-mpk po dose in SD rats,,,BAO_0000218,N,,1,,CHEMBL631316,
9287,,,50597,10116.0,Intermediate,1,,A,,Area under curve in SD rats,,,BAO_0000218,N,,1,,CHEMBL631317,
9288,,,50597,10116.0,Intermediate,1,,A,,Area under curve in rat after oral administration at 13 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL874471,
9289,,,50597,10116.0,Intermediate,1,,A,,Area under curve in rat by po administration at 0-24 hr,,,BAO_0000218,N,,1,,CHEMBL631318,
9290,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under curve in rat plasma,,,BAO_0000218,N,,1,,CHEMBL631319,
9291,,,50597,10116.0,Intermediate,1,,A,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL631320,
9292,,,50597,10116.0,Intermediate,1,,A,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL631321,
9293,,,50597,10116.0,Intermediate,1,,A,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,,BAO_0000218,N,,1,,CHEMBL631322,
9294,,,50597,10116.0,Intermediate,1,,A,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,,BAO_0000218,N,,1,,CHEMBL631323,
9295,,,50597,10116.0,Intermediate,1,,A,,Area under curve value in rat at a dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL631324,
9296,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined after oral administration in rats,,,BAO_0000218,N,,1,,CHEMBL631325,
9297,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL631326,
9298,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined after peroral administration in rat,,,BAO_0000218,N,,1,,CHEMBL631327,
9299,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined at a dose 30 mpk administered orally.,,,BAO_0000218,N,,1,,CHEMBL631328,
9300,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,N,,1,,CHEMBL631329,
9301,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627217,
9302,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined in male rat,,,BAO_0000218,N,,1,,CHEMBL626352,
9303,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined in rat after PO administration,,,BAO_0000218,N,,1,,CHEMBL626353,
9304,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined in rat after a 3 mg/kg of oral dose,,,BAO_0000218,N,,1,,CHEMBL626354,
9305,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626355,
9306,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626356,
9307,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,,BAO_0000218,N,,1,,CHEMBL626357,
9308,,,50597,10116.0,Intermediate,1,,A,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626358,
9309,,,50597,10116.0,Intermediate,1,,A,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626359,
9310,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Peak plasma concentration in rat at a dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626360,
9311,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration at 2 hr in rats was evaluated.,,,BAO_0000218,N,,1,,CHEMBL626361,
9312,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration at 2 hr in rats was evaluated; Not available,,,BAO_0000218,N,,1,,CHEMBL626362,
9313,,,50597,10116.0,Intermediate,1,,A,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626363,
9314,,,50597,10116.0,Intermediate,1,,A,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL626970,
9315,,,50597,10116.0,Intermediate,1,,A,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL626971,
9316,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL626972,
9317,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL626973,
9318,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL626974,
9319,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL874592,
9320,,,50597,10116.0,Intermediate,1,,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,,BAO_0000218,N,,1,,CHEMBL626975,
9321,,,50597,10116.0,Intermediate,1,,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,,BAO_0000218,N,,1,,CHEMBL626976,
9322,,,50597,10116.0,Intermediate,1,,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,,BAO_0000218,N,,1,,CHEMBL626977,
9323,,,50597,10116.0,Intermediate,1,,A,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,,BAO_0000218,N,,1,,CHEMBL626978,
9324,,,50597,10116.0,Intermediate,1,,A,,PK study was carried to determine the relative absorption ranking in rat.,,,BAO_0000218,N,,1,,CHEMBL626979,
9325,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626980,
9326,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,,BAO_0000218,N,,1,,CHEMBL626981,
9327,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,,BAO_0000218,N,,1,,CHEMBL626982,
9328,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,,BAO_0000218,N,,1,,CHEMBL626983,
9329,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,,BAO_0000218,N,,1,,CHEMBL622522,
9330,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622523,
9331,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,,BAO_0000218,N,,1,,CHEMBL622524,
9332,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622525,
9333,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622526,
9334,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,,BAO_0000218,N,,1,,CHEMBL619849,
9335,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,,BAO_0000218,N,,1,,CHEMBL619850,
9336,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,,BAO_0000218,N,,1,,CHEMBL623864,
9337,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,,BAO_0000218,N,,1,,CHEMBL623865,
9338,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,,BAO_0000218,N,,1,,CHEMBL623866,
9339,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,,BAO_0000218,N,,1,,CHEMBL623867,
9340,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,,BAO_0000218,N,,1,,CHEMBL877615,
9341,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,,BAO_0000218,N,,1,,CHEMBL623868,
9342,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,,BAO_0000218,N,,1,,CHEMBL623869,
9343,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,,BAO_0000218,N,,1,,CHEMBL623870,
9344,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL623871,
9345,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL623872,
9346,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL622129,
9347,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL622130,
9348,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL622131,
9349,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL622132,
9350,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL622133,
9351,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL622134,
9352,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622135,
9353,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622136,
9354,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622137,
9355,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622138,
9356,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL623017,
9357,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL623018,
9358,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL623019,
9359,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL623020,
9360,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL623021,
9361,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL623022,
9362,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL623023,
9363,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL623024,
9364,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL623025,
9365,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL620545,
9366,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL620546,
9367,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL620547,
9368,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL620548,
9369,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL620549,
9370,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL620550,
9371,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL620551,
9372,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL620552,
9373,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL620553,
9374,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL620554,
9375,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL875845,
9376,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL620555,
9377,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL620556,
9378,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL620557,
9379,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL620558,
9380,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL620559,
9381,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622939,
9382,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL622940,
9383,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622941,
9384,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622942,
9385,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622943,
9386,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL622944,
9387,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622945,
9388,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622946,
9389,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for terminal half life in rat,,,BAO_0000218,N,,1,,CHEMBL622947,
9390,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,,BAO_0000218,N,,1,,CHEMBL622948,
9391,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,,BAO_0000218,N,,1,,CHEMBL622949,
9392,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for its half life in rat,,,BAO_0000218,N,,1,,CHEMBL622950,
9393,In vivo,1969.0,22224,9544.0,Intermediate,1,Plasma,A,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,,BAO_0000218,U,,0,,CHEMBL622951,
9394,,1969.0,22224,10116.0,Intermediate,1,Plasma,A,,Compound was tested for its plasma half life in Sprague Dawley rats,,,BAO_0000366,U,,0,,CHEMBL622952,
9395,,1969.0,22224,10116.0,Intermediate,1,Plasma,A,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,,BAO_0000366,U,,0,,CHEMBL622953,
9396,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was tested for plasma half-life period in rat,,,BAO_0000218,N,,1,,CHEMBL873818,
9397,In vivo,,50597,10116.0,Intermediate,1,,A,,Elimination half life after i.v. administration of compound in rats,,,BAO_0000218,N,,1,,CHEMBL622954,
9398,In vivo,,50597,10116.0,Intermediate,1,,A,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL622955,
9399,In vivo,,50597,10116.0,Intermediate,1,,A,,Elimination half-life after IV dosing at 1 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL875229,
9400,In vivo,,50597,10116.0,Intermediate,1,,A,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL622956,
9401,In vivo,,50597,10116.0,Intermediate,1,,A,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL622957,
9402,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,,BAO_0000218,N,,1,,CHEMBL622958,
9403,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,,BAO_0000218,N,,1,,CHEMBL622959,
9404,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,,BAO_0000218,N,,1,,CHEMBL622960,
9405,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,,BAO_0000218,N,,1,,CHEMBL622961,
9406,In vivo,,50597,10116.0,Intermediate,1,,A,,Evaluated for the half life in rat (in vivo),,,BAO_0000218,N,,1,,CHEMBL622962,
9407,,,50597,10116.0,Intermediate,1,,A,,Hafl life in rat,,,BAO_0000218,N,,1,,CHEMBL622963,
9408,,,50597,10116.0,Intermediate,1,,A,,Hafl life rat,,,BAO_0000218,N,,1,,CHEMBL622964,
9409,,,50597,10116.0,Intermediate,1,,A,,Hafl life rat,,,BAO_0000218,N,,1,,CHEMBL622965,
9410,,,50597,10116.0,Intermediate,1,,A,,Hafl life rat; Not determined,,,BAO_0000218,N,,1,,CHEMBL622966,
9411,,,50597,10116.0,Intermediate,1,,A,,Hafl life rat; Not determined,,,BAO_0000218,N,,1,,CHEMBL622967,
9412,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622968,
9413,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622969,
9414,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL875327,
9415,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life in rat after 1 mg/kg i.v. administration,,,BAO_0000218,N,,1,,CHEMBL628638,
9416,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life in rat after 2 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL628639,
9417,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625840,
9418,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of 10 mg/kg oral dose determined in rats,,,BAO_0000218,N,,1,,CHEMBL625841,
9419,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625842,
9420,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625843,
9421,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625844,
9422,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL873822,
9423,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625845,
9424,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL627059,
9425,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL627060,
9426,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL627061,
9427,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of compound at 5 mg/kg after po administration was determined in rat,,,BAO_0000218,N,,1,,CHEMBL627709,
9428,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life of compound determined after intravenous administration to rat,,,BAO_0000218,N,,1,,CHEMBL627710,
9429,,,50597,10116.0,Intermediate,1,,A,,Half life of compound was determined in rat,,,BAO_0000218,N,,1,,CHEMBL627711,
9430,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,N,,1,,CHEMBL627712,
9431,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL627713,
9432,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL627714,
9433,In vivo,,22224,9541.0,Intermediate,1,,A,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,,BAO_0000218,U,,0,,CHEMBL627889,
9434,In vivo,,22224,10116.0,Intermediate,1,,A,,Half life determined in rat by intravenous administration,,,BAO_0000218,U,,0,,CHEMBL627890,
9435,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life determined in rats after iv administration,,,BAO_0000218,N,,1,,CHEMBL627891,
9436,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life in rat plasma after administration of 2 mg/kg iv,,,BAO_0000218,N,,1,,CHEMBL627892,
9437,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life in rat plasma after administration of 2 mg/kg iv,,,BAO_0000218,N,,1,,CHEMBL627893,
9438,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life in rat plasma was determined,,,BAO_0000218,N,,1,,CHEMBL627894,
9439,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life in rat plasma was determined; NA means not applicable,,,BAO_0000218,N,,1,,CHEMBL627895,
9440,,,50597,10116.0,Intermediate,1,,A,,Half life in rat was tested,,,BAO_0000218,N,,1,,CHEMBL627896,
9441,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life measured in rat plasma,,,BAO_0000218,N,,1,,CHEMBL627897,
9442,,,50597,10116.0,Intermediate,1,,A,,Half life recorded in rats,,,BAO_0000218,N,,1,,CHEMBL627898,
9443,,,50597,10116.0,Intermediate,1,,A,,Half life was calculated,,,BAO_0000218,N,,1,,CHEMBL627899,
9444,,,50597,10116.0,Intermediate,1,,A,,Half life was calculated in rat,,,BAO_0000218,N,,1,,CHEMBL873823,
9445,,,50597,10116.0,Intermediate,1,,A,,Half life was determined,,,BAO_0000218,N,,1,,CHEMBL627900,
9446,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life after 10 mg/kg oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL627901,
9447,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL627902,
9448,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life after administering orally a dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627903,
9449,,,50597,10116.0,Intermediate,1,,A,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,,BAO_0000218,N,,1,,CHEMBL627904,
9450,,,50597,10116.0,Intermediate,1,,A,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,,BAO_0000218,N,,1,,CHEMBL627905,
9451,,,50597,10116.0,Intermediate,1,,A,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627906,
9452,,,50597,10116.0,Intermediate,1,,A,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627907,
9453,,,50597,10116.0,Intermediate,1,,A,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL876783,
9454,,,50597,10116.0,Intermediate,1,,A,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,,BAO_0000218,N,,1,,CHEMBL627908,
9455,,,50597,10116.0,Intermediate,1,,A,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,,BAO_0000218,N,,1,,CHEMBL627909,
9456,,,50597,10116.0,Intermediate,1,,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,,BAO_0000218,N,,1,,CHEMBL627910,
9457,,,50597,10116.0,Intermediate,1,,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,,BAO_0000218,N,,1,,CHEMBL627911,
9458,,,50597,10116.0,Intermediate,1,,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,,BAO_0000218,N,,1,,CHEMBL627912,
9459,,,50597,10116.0,Intermediate,1,,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,,BAO_0000218,N,,1,,CHEMBL627913,
9460,,,50597,10116.0,Intermediate,1,,A,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,,BAO_0000218,N,,1,,CHEMBL627914,
9461,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,,BAO_0000218,N,,1,,CHEMBL627915,
9462,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was evaluated after 20 uM/kg of peroral administration,,,BAO_0000218,N,,1,,CHEMBL627916,
9463,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627917,
9464,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627918,
9465,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,,BAO_0000218,N,,1,,CHEMBL627919,
9466,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627920,
9467,,,50597,10116.0,Intermediate,1,,A,,Area under the curve was evaluated at an oral dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627921,
9468,,,50597,10116.0,Intermediate,1,,A,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL627922,
9469,,,50597,10116.0,Intermediate,1,,A,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL876784,
9470,,,50597,10116.0,Intermediate,1,,A,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL627923,
9471,,,50597,10116.0,Intermediate,1,,A,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL626208,
9472,,,50597,10116.0,Intermediate,1,,A,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL626209,
9473,,,50597,10116.0,Intermediate,1,,A,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL626210,
9474,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,,BAO_0000218,N,,1,,CHEMBL627994,
9475,,,50597,10116.0,Intermediate,1,,A,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627995,
9476,,,50597,10116.0,Intermediate,1,,A,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,,BAO_0000218,N,,1,,CHEMBL627996,
9477,,,50597,10116.0,Intermediate,1,,A,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,,BAO_0000218,N,,1,,CHEMBL627997,
9478,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,,BAO_0000218,N,,1,,CHEMBL627998,
9479,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,,BAO_0000218,N,,1,,CHEMBL628640,
9480,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,,BAO_0000218,N,,1,,CHEMBL628641,
9481,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,,BAO_0000218,N,,1,,CHEMBL628642,
9482,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for area under the curve expressed as (h*ug/ml),,,BAO_0000218,N,,1,,CHEMBL628643,
9483,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for area under curve in rat,,,BAO_0000218,N,,1,,CHEMBL628644,
9484,,,50597,10116.0,Intermediate,1,,A,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,,BAO_0000218,N,,1,,CHEMBL628645,
9485,,,50597,10116.0,Intermediate,1,,A,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL628646,
9486,,,50597,10116.0,Intermediate,1,,A,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,,BAO_0000218,N,,1,,CHEMBL628647,
9487,,,50597,10116.0,Intermediate,1,,A,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,,BAO_0000218,N,,1,,CHEMBL628648,
9488,,,50597,10116.0,Intermediate,1,,A,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,,BAO_0000218,N,,1,,CHEMBL625358,
9489,,,50597,10116.0,Intermediate,1,,A,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,,BAO_0000218,N,,1,,CHEMBL625359,
9490,,,50597,10116.0,Intermediate,1,,A,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,,BAO_0000218,N,,1,,CHEMBL625360,
9491,,,50597,10116.0,Intermediate,1,,A,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,,BAO_0000218,N,,1,,CHEMBL625361,
9492,,,50597,10116.0,Intermediate,1,,A,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,,BAO_0000218,N,,1,,CHEMBL625362,
9493,,,50597,10116.0,Intermediate,1,,A,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,,BAO_0000218,N,,1,,CHEMBL625363,
9494,,,50597,10116.0,Intermediate,1,,A,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,BAO_0000218,N,,1,,CHEMBL625364,
9495,,,50597,10116.0,Intermediate,1,,A,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625365,
9496,,,50597,10116.0,Intermediate,1,,A,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625366,
9497,,,50597,10116.0,Intermediate,1,,A,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625367,
9498,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,,BAO_0000218,N,,1,,CHEMBL625368,
9499,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,,BAO_0000218,N,,1,,CHEMBL625369,
9500,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,,BAO_0000218,N,,1,,CHEMBL625370,
9501,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,,BAO_0000218,N,,1,,CHEMBL625371,
9502,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,,BAO_0000218,N,,1,,CHEMBL625372,
9503,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,,BAO_0000218,N,,1,,CHEMBL625373,
9504,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,,BAO_0000218,N,,1,,CHEMBL625374,
9505,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,,BAO_0000218,N,,1,,CHEMBL877593,
9506,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,,BAO_0000218,N,,1,,CHEMBL625375,
9507,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,,BAO_0000218,N,,1,,CHEMBL625376,
9508,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,,BAO_0000218,N,,1,,CHEMBL621973,
9509,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,,BAO_0000218,N,,1,,CHEMBL621974,
9510,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,,BAO_0000218,N,,1,,CHEMBL621975,
9511,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622166,
9512,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622167,
9513,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,,BAO_0000218,N,,1,,CHEMBL622168,
9514,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622169,
9515,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622170,
9516,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622171,
9517,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622172,
9518,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622173,
9519,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622174,
9520,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622175,
9521,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622176,
9522,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622177,
9523,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622178,
9524,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622179,
9525,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622180,
9526,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622181,
9527,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL622182,
9528,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622183,
9529,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622184,
9530,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622185,
9531,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL622186,
9532,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL622187,
9533,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL625002,
9534,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL622090,
9535,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL622091,
9536,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL622092,
9537,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL622093,
9538,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL622094,
9539,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL622095,
9540,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL622264,
9541,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622265,
9542,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622266,
9543,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622267,
9544,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL622268,
9545,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622269,
9546,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL625071,
9547,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL621621,
9548,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL621622,
9549,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL621623,
9550,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL621624,
9551,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL621625,
9552,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL621626,
9553,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL621627,
9554,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL621628,
9555,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL875328,
9556,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL621629,
9557,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL621630,
9558,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL621631,
9559,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL621632,
9560,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL621633,
9561,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL621634,
9562,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL621635,
9563,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL621636,
9564,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL621637,
9565,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL621638,
9566,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL618883,
9567,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL618884,
9568,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL628627,
9569,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL628628,
9570,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL628629,
9571,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life after administering orally a dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL628630,
9572,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL628631,
9573,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life after administering intravenously a dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL628632,
9574,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life after oral dosing in rats,,,BAO_0000218,N,,1,,CHEMBL628633,
9575,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL628634,
9576,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life by intravenous administration of 3.4 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627789,
9577,,,50597,10116.0,Intermediate,1,,A,,Half life in rat,,,BAO_0000218,N,,1,,CHEMBL627790,
9578,,,50597,10116.0,Intermediate,1,,A,,Half life in rat,,,BAO_0000218,N,,1,,CHEMBL627791,
9579,,,50597,10116.0,Intermediate,1,,A,,Half life in rat,,,BAO_0000218,N,,1,,CHEMBL627792,
9580,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life in rat after intravenous administration of the compound,,,BAO_0000218,N,,1,,CHEMBL627793,
9581,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,,BAO_0000218,N,,1,,CHEMBL627794,
9582,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life in rat after po administration of the compound,,,BAO_0000218,N,,1,,CHEMBL627795,
9583,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life in rat after po administration of the compound; ND means Not determined,,,BAO_0000218,N,,1,,CHEMBL627796,
9584,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,,BAO_0000218,N,,1,,CHEMBL875335,
9585,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,,BAO_0000218,N,,1,,CHEMBL627797,
9586,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life in rat i.v.,,,BAO_0000218,N,,1,,CHEMBL627798,
9587,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life in rat i.v. at 2 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL627799,
9588,,,50597,10116.0,Intermediate,1,,A,,Half life in rats,,,BAO_0000218,N,,1,,CHEMBL627800,
9589,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life in rats after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL627801,
9590,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life in rats at the dose of 1.0 mpk by i.v. administration,,,BAO_0000218,N,,1,,CHEMBL627802,
9591,,,50597,10116.0,Expert,1,,A,,Half life in rat,,,BAO_0000218,N,,1,,CHEMBL627803,
9592,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life was evaluated after intravenous administration to rats,,,BAO_0000218,N,,1,,CHEMBL873820,
9593,,,50597,10116.0,Intermediate,1,,A,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,,BAO_0000218,N,,1,,CHEMBL627804,
9594,,,50597,10116.0,Intermediate,1,,A,,Half life was evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL627805,
9595,,,50597,10116.0,Intermediate,1,,A,,Half life was evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL627806,
9596,,,50597,10116.0,Intermediate,1,,A,,Half life was evaluated in rat; Not tested,,,BAO_0000218,N,,1,,CHEMBL627107,
9597,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,,BAO_0000218,N,,1,,CHEMBL627108,
9598,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,,BAO_0000218,N,,1,,CHEMBL627109,
9599,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,,BAO_0000218,N,,1,,CHEMBL627110,
9600,In vivo,,22224,9443.0,Intermediate,1,,A,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,,BAO_0000218,U,,0,,CHEMBL627111,
9601,In vivo,,22224,9443.0,Intermediate,1,,A,,Half life was measured in monkey at dose of 10 mg/kg by po administration,,,BAO_0000218,U,,0,,CHEMBL627112,
9602,In vivo,,22224,10116.0,Intermediate,1,,A,,Half life was measured in rat at dose of 30 mg/kg by iv administration,,,BAO_0000218,U,,0,,CHEMBL627113,
9603,In vivo,,22224,10116.0,Intermediate,1,,A,,Half life was measured in rat at dose of 30 mg/kg by po administration,,,BAO_0000218,U,,0,,CHEMBL627114,
9604,,,50597,10116.0,Intermediate,1,,A,,Half life (t1/2) was determined,,,BAO_0000218,N,,1,,CHEMBL627115,
9605,,,50597,10116.0,Intermediate,1,,A,,Half life period at a dose of 10 uM/kg in rat was determined,,,BAO_0000218,N,,1,,CHEMBL627116,
9606,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,,BAO_0000218,N,,1,,CHEMBL627117,
9607,,,50597,10116.0,Intermediate,1,,A,,Half life period was determined,,,BAO_0000218,N,,1,,CHEMBL627118,
9608,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period after intravenous administration at 20 mpk in rats,,,BAO_0000218,N,,1,,CHEMBL627119,
9609,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,,BAO_0000218,N,,1,,CHEMBL627120,
9610,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL626922,
9611,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL626923,
9612,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL626924,
9613,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life period in 80% rat plasma at 37 degree Centigrade,,,BAO_0000218,N,,1,,CHEMBL626925,
9614,,,50597,10116.0,Intermediate,1,,A,,Half life period in SD rats,,,BAO_0000218,N,,1,,CHEMBL626926,
9615,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,,BAO_0000218,N,,1,,CHEMBL626927,
9616,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,,BAO_0000218,N,,1,,CHEMBL626928,
9617,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,BAO_0000218,N,,1,,CHEMBL626929,
9618,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,BAO_0000218,N,,1,,CHEMBL626930,
9619,,,50597,10116.0,Intermediate,1,,A,,Half life period in rat,,,BAO_0000218,N,,1,,CHEMBL626931,
9620,,,50597,10116.0,Intermediate,1,,A,,Half life period in rat,,,BAO_0000218,N,,1,,CHEMBL626932,
9621,,,50597,10116.0,Intermediate,1,,A,,Half life period in rat,,,BAO_0000218,N,,1,,CHEMBL626933,
9622,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period in rat after oral administration at 10.5 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL873826,
9623,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period in rat after oral administration at 11.2 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL626934,
9624,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period in rat after oral administration at 13 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL626935,
9625,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period in rat after oral administration at 9.7 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL626936,
9626,,,50597,10116.0,Intermediate,1,,A,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL626937,
9627,,,50597,10116.0,Intermediate,1,,A,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625906,
9628,,,50597,10116.0,Intermediate,1,,A,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625907,
9629,,,50597,10116.0,Intermediate,1,,A,,PK study was carried to determine AUC (area under curve) value in rat,,,BAO_0000218,N,,1,,CHEMBL625908,
9630,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC after intravenous administration to rats,,,BAO_0000218,N,,1,,CHEMBL625909,
9631,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC after oral administration to rats,,,BAO_0000218,N,,1,,CHEMBL625910,
9632,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625911,
9633,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL625912,
9634,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL626538,
9635,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,,BAO_0000218,N,,1,,CHEMBL876794,
9636,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,,BAO_0000218,N,,1,,CHEMBL626539,
9637,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL626540,
9638,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626541,
9639,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626542,
9640,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,,BAO_0000218,N,,1,,CHEMBL626543,
9641,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,,BAO_0000218,N,,1,,CHEMBL626544,
9642,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,,BAO_0000218,N,,1,,CHEMBL626545,
9643,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,,BAO_0000218,N,,1,,CHEMBL626546,
9644,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter area under curve was reported,,,BAO_0000218,N,,1,,CHEMBL626547,
9645,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (AUC) in rat,,,BAO_0000218,N,,1,,CHEMBL626548,
9646,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,,BAO_0000218,N,,1,,CHEMBL626549,
9647,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,,BAO_0000218,N,,1,,CHEMBL626550,
9648,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,,BAO_0000218,N,,1,,CHEMBL626551,
9649,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property was determined,,,BAO_0000218,N,,1,,CHEMBL623777,
9650,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623778,
9651,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,,BAO_0000218,N,,1,,CHEMBL623779,
9652,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,,BAO_0000218,N,,1,,CHEMBL623780,
9653,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,,BAO_0000218,N,,1,,CHEMBL622015,
9654,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,,BAO_0000218,N,,1,,CHEMBL622016,
9655,,,50597,10116.0,Intermediate,1,,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,,BAO_0000218,N,,1,,CHEMBL622017,
9656,,,50597,10116.0,Intermediate,1,,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,,BAO_0000218,N,,1,,CHEMBL622018,
9657,,,50597,10116.0,Intermediate,1,,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,,BAO_0000218,N,,1,,CHEMBL622019,
9658,,,50597,10116.0,Intermediate,1,,A,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,,BAO_0000218,N,,1,,CHEMBL622020,
9659,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,,BAO_0000218,N,,1,,CHEMBL622021,
9660,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,,BAO_0000218,N,,1,,CHEMBL622022,
9661,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,,BAO_0000218,N,,1,,CHEMBL622023,
9662,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL622024,
9663,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,,BAO_0000218,N,,1,,CHEMBL622693,
9664,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,,BAO_0000218,N,,1,,CHEMBL622694,
9665,,,50597,10116.0,Intermediate,1,,A,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL622695,
9666,,,50597,10116.0,Intermediate,1,,A,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,,BAO_0000218,N,,1,,CHEMBL622696,
9667,,,50597,10116.0,Intermediate,1,,A,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,,BAO_0000218,N,,1,,CHEMBL622697,
9668,,,50597,10116.0,Intermediate,1,,A,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,,BAO_0000218,N,,1,,CHEMBL622874,
9669,,,50597,10116.0,Intermediate,1,,A,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,,BAO_0000218,N,,1,,CHEMBL622875,
9670,,,50597,10116.0,Intermediate,1,,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,BAO_0000218,N,,1,,CHEMBL622876,
9671,,,50597,10116.0,Intermediate,1,,A,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,,BAO_0000218,N,,1,,CHEMBL622877,
9672,,,50597,10116.0,Intermediate,1,,A,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL622878,
9673,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL622879,
9674,,,50597,10116.0,Intermediate,1,,A,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,,BAO_0000218,N,,1,,CHEMBL877602,
9675,,,50597,10116.0,Intermediate,1,,A,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL622880,
9676,,,50597,10116.0,Intermediate,1,,A,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL622881,
9677,,,50597,10116.0,Intermediate,1,,A,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL622882,
9678,,,50597,10116.0,Intermediate,1,,A,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL622883,
9679,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,,BAO_0000218,N,,1,,CHEMBL622884,
9680,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,,BAO_0000218,N,,1,,CHEMBL622885,
9681,,,50597,10116.0,Intermediate,1,,A,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,BAO_0000218,N,,1,,CHEMBL622886,
9682,,,50597,10116.0,Intermediate,1,,A,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL622887,
9683,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL622888,
9684,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622889,
9685,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622890,
9686,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622891,
9687,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL877603,
9688,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622892,
9689,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622893,
9690,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622894,
9691,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622895,
9692,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,,BAO_0000218,N,,1,,CHEMBL622896,
9693,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622897,
9694,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622898,
9695,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622899,
9696,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622900,
9697,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624114,
9698,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624115,
9699,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624116,
9700,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624117,
9701,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624118,
9702,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624119,
9703,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624120,
9704,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624121,
9705,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624122,
9706,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624123,
9707,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624124,
9708,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624125,
9709,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624126,
9710,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624127,
9711,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624128,
9712,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624129,
9713,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL624130,
9714,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622340,
9715,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622341,
9716,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622342,
9717,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622343,
9718,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622344,
9719,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622345,
9720,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622346,
9721,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622347,
9722,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622348,
9723,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622349,
9724,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622350,
9725,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622351,
9726,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL622352,
9727,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622353,
9728,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622354,
9729,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622355,
9730,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL622356,
9731,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,,BAO_0000218,N,,1,,CHEMBL622357,
9732,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,,BAO_0000218,N,,1,,CHEMBL622358,
9733,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,,BAO_0000218,N,,1,,CHEMBL622359,
9734,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,,BAO_0000218,N,,1,,CHEMBL874393,
9735,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL622872,
9736,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL622873,
9737,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL623047,
9738,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL623048,
9739,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL623049,
9740,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL623050,
9741,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL623051,
9742,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL623052,
9743,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL626343,
9744,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,,BAO_0000218,N,,1,,CHEMBL626344,
9745,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,,BAO_0000218,N,,1,,CHEMBL626345,
9746,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,,BAO_0000218,N,,1,,CHEMBL626346,
9747,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,,BAO_0000218,N,,1,,CHEMBL626347,
9748,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,,BAO_0000218,N,,1,,CHEMBL626348,
9749,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,,BAO_0000218,N,,1,,CHEMBL626349,
9750,,,50597,10116.0,Intermediate,1,,F,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL626350,
9751,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL626351,
9752,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL627650,
9753,,,50597,10116.0,Intermediate,1,,F,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,,BAO_0000218,N,,1,,CHEMBL627651,
9754,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,,BAO_0000218,N,,1,,CHEMBL627652,
9755,,,50597,10116.0,Intermediate,1,,A,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,,BAO_0000218,N,,1,,CHEMBL627653,
9756,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL627654,
9757,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL627835,
9758,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL627836,
9759,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL627837,
9760,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL627838,
9761,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL875338,
9762,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL627839,
9763,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL627840,
9764,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL627841,
9765,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL627842,
9766,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL627843,
9767,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL627844,
9768,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL627845,
9769,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period in rat by iv administration at a dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627846,
9770,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,,BAO_0000218,N,,1,,CHEMBL627847,
9771,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,,BAO_0000218,N,,1,,CHEMBL873821,
9772,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,BAO_0000218,N,,1,,CHEMBL626079,
9773,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,,BAO_0000218,N,,1,,CHEMBL626080,
9774,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life period was evaluated in rat plasma,,,BAO_0000218,N,,1,,CHEMBL626081,
9775,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life period was evaluated in rat plasma; Not tested,,,BAO_0000218,N,,1,,CHEMBL875344,
9776,,,50597,10116.0,Intermediate,1,,A,,Half life period was evaluated in rats,,,BAO_0000218,N,,1,,CHEMBL626082,
9777,In vivo,,50597,10116.0,Intermediate,1,,A,,"Half life period was evaluated in rats, iv",,,BAO_0000218,N,,1,,CHEMBL626250,
9778,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period after intravenous administration at 5 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL626251,
9779,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,,BAO_0000218,N,,1,,CHEMBL626252,
9780,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626253,
9781,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life stability of compound was evaluated in rat plasma,,,BAO_0000218,N,,1,,CHEMBL626254,
9782,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,,BAO_0000218,N,,1,,CHEMBL626255,
9783,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL626256,
9784,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,BAO_0000218,N,,1,,CHEMBL626257,
9785,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,,BAO_0000218,N,,1,,CHEMBL626258,
9786,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,,BAO_0000218,N,,1,,CHEMBL626259,
9787,In vivo,,50597,10116.0,Intermediate,1,,A,,Half in rat i.v.,,,BAO_0000218,N,,1,,CHEMBL626260,
9788,In vivo,,50597,10116.0,Intermediate,1,,A,,Half period in rat after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL875345,
9789,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL626261,
9790,In vitro,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Half-life measured in in vitro Cathepsin B assay in rat liver,,,BAO_0000218,N,,1,,CHEMBL626262,
9791,,,50597,10116.0,Intermediate,1,,A,,Half-life of compound was determined in rats,,,BAO_0000218,N,,1,,CHEMBL626263,
9792,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life at 10 mg/kg in rat upon intravenous administration,,,BAO_0000218,N,,1,,CHEMBL625270,
9793,,,50597,10116.0,Intermediate,1,,A,,Half-life determined in rat,,,BAO_0000218,N,,1,,CHEMBL625271,
9794,,,50597,10116.0,Intermediate,1,,A,,Half-life determined in rat,,,BAO_0000218,N,,1,,CHEMBL625272,
9795,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL625273,
9796,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,,BAO_0000218,N,,1,,CHEMBL625274,
9797,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625275,
9798,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL625276,
9799,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in rat plasma,,,BAO_0000218,N,,1,,CHEMBL625277,
9800,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in rat plasma was determined,,,BAO_0000218,N,,1,,CHEMBL625278,
9801,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in rat plasma; Not tested,,,BAO_0000218,N,,1,,CHEMBL625279,
9802,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Half-life in rat serum,,,BAO_0000218,N,,1,,CHEMBL625280,
9803,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Half-life in rat serum; na is not available,,,BAO_0000218,N,,1,,CHEMBL876797,
9804,,,50597,10116.0,Intermediate,1,,A,,Half-life was calculated in rat,,,BAO_0000218,N,,1,,CHEMBL625281,
9805,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life was calculated in rat plasma,,,BAO_0000218,N,,1,,CHEMBL873827,
9806,,,50597,10116.0,Intermediate,1,,A,,Half-life was determined,,,BAO_0000218,N,,1,,CHEMBL625282,
9807,,,50597,10116.0,Intermediate,1,,A,,Half-life was determined,,,BAO_0000218,N,,1,,CHEMBL625283,
9808,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life after administration of 20 mg/Kg oral dose in rat,,,BAO_0000218,N,,1,,CHEMBL625284,
9809,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life after administration of 3.2 mg/kg intravenously in male rat,,,BAO_0000218,N,,1,,CHEMBL625285,
9810,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life after intravenous administration in female rat,,,BAO_0000218,N,,1,,CHEMBL625286,
9811,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life after intravenous administration in male rat,,,BAO_0000218,N,,1,,CHEMBL625287,
9812,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life after intravenous dose in rat,,,BAO_0000218,N,,1,,CHEMBL625288,
9813,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Half-life in a rat liver homogenate preparation,,,BAO_0000218,N,,1,,CHEMBL625289,
9814,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in plasma of rat,,,BAO_0000218,N,,1,,CHEMBL625290,
9815,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in plasma of rat at dose of 3-10 mgkg,,,BAO_0000218,N,,1,,CHEMBL876798,
9816,,,50597,10116.0,Intermediate,1,,A,,Half-life in rat,,,BAO_0000218,N,,1,,CHEMBL625291,
9817,,,50597,10116.0,Intermediate,1,,A,,Half-life in rat,,,BAO_0000218,N,,1,,CHEMBL625292,
9818,,,50597,10116.0,Intermediate,1,,A,,Half-life in rat,,,BAO_0000218,N,,1,,CHEMBL625293,
9819,,,50597,10116.0,Intermediate,1,,A,,Half-life in rat,,,BAO_0000218,N,,1,,CHEMBL622832,
9820,,,50597,10116.0,Intermediate,1,,A,,Half-life in rat,,,BAO_0000218,N,,1,,CHEMBL622833,
9821,,,50597,10116.0,Intermediate,1,,A,,Half-life in rat,,,BAO_0000218,N,,1,,CHEMBL622834,
9822,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life in rat after oral administration at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622835,
9823,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life in rat after po administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622836,
9824,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,,BAO_0000218,N,,1,,CHEMBL622837,
9825,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life in rat at 3 mg/kg dose administered intravenously,,,BAO_0000218,N,,1,,CHEMBL622838,
9826,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Half-life in rat brain homogenate,,,BAO_0000218,N,,1,,CHEMBL622839,
9827,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in rat plasma,,,BAO_0000218,N,,1,,CHEMBL622840,
9828,,,50597,10116.0,Intermediate,1,,A,,Half-life in rats,,,BAO_0000218,N,,1,,CHEMBL622841,
9829,,,50597,10116.0,Intermediate,1,,A,,Half-life in Dawley rats,,,BAO_0000218,N,,1,,CHEMBL622842,
9830,In vitro,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in vitro in rat plasma,,,BAO_0000218,N,,1,,CHEMBL622843,
9831,In vitro,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,,BAO_0000218,N,,1,,CHEMBL622844,
9832,,,50597,10116.0,Intermediate,1,,A,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,,BAO_0000218,N,,1,,CHEMBL622845,
9833,,,50597,10116.0,Intermediate,1,,A,,The area under the curve of compound was measured at the dose of 100 umol/kg,,,BAO_0000218,N,,1,,CHEMBL622846,
9834,,,50597,10116.0,Intermediate,1,,A,,The area under the curve of compound was measured at the dose of 300 umol/kg,,,BAO_0000218,N,,1,,CHEMBL622847,
9835,,,50597,10116.0,Intermediate,1,,A,,The area under the curve of compound was measured at the dose of 30 umol/kg,,,BAO_0000218,N,,1,,CHEMBL622848,
9836,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability as oral AUC in rats,,,BAO_0000218,N,,1,,CHEMBL622849,
9837,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The plasma concentration versus time curve (AUC) was determined,,,BAO_0000218,N,,1,,CHEMBL622850,
9838,,,50597,10116.0,Intermediate,1,,A,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL876807,
9839,,,50597,10116.0,Intermediate,1,,A,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622851,
9840,,,50597,10116.0,Intermediate,1,,A,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622852,
9841,,,50597,10116.0,Intermediate,1,,A,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,,BAO_0000218,N,,1,,CHEMBL622853,
9842,,,50597,10116.0,Intermediate,1,,A,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,,BAO_0000218,N,,1,,CHEMBL622854,
9843,,,50597,10116.0,Intermediate,1,,A,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622855,
9844,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,N,,1,,CHEMBL622856,
9845,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,N,,1,,CHEMBL622857,
9846,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC in rat after po administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622858,
9847,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622859,
9848,,,50597,10116.0,Intermediate,1,,A,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,,BAO_0000218,N,,1,,CHEMBL622860,
9849,,,50597,10116.0,Intermediate,1,,A,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,,BAO_0000218,N,,1,,CHEMBL622861,
9850,,,50597,10116.0,Intermediate,1,,A,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,,BAO_0000218,N,,1,,CHEMBL622862,
9851,,,50597,10116.0,Intermediate,1,,A,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,,BAO_0000218,N,,1,,CHEMBL622863,
9852,,,50597,10116.0,Intermediate,1,,A,,Area under curve value 6 hr after po administration in rat,,,BAO_0000218,N,,1,,CHEMBL623817,
9853,,,50597,10116.0,Intermediate,1,,A,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,N,,1,,CHEMBL623818,
9854,,,50597,10116.0,Intermediate,1,,A,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,,BAO_0000218,N,,1,,CHEMBL623819,
9855,,,50597,10116.0,Intermediate,1,,A,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,N,,1,,CHEMBL623820,
9856,,,50597,10116.0,Intermediate,1,,A,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,,BAO_0000218,N,,1,,CHEMBL623821,
9857,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC normalized for dose (AUCN) in rat,,,BAO_0000218,N,,1,,CHEMBL623822,
9858,,,50597,10116.0,Intermediate,1,,A,,Area under curve in rat after p.o. administration,,,BAO_0000218,N,,1,,CHEMBL623823,
9859,,,50597,10116.0,Intermediate,1,,A,,Area under curve in rat after p.o. administration,,,BAO_0000218,N,,1,,CHEMBL623824,
9860,,,50597,10116.0,Intermediate,1,,A,,Area under curve in rat after p.o. administration; Not determined,,,BAO_0000218,N,,1,,CHEMBL623825,
9861,,,50597,10116.0,Intermediate,1,,A,,Area under curve in rat after peroral administration,,,BAO_0000218,N,,1,,CHEMBL622070,
9862,,,50597,10116.0,Intermediate,1,,A,,Area under curve (carotid artery) value of the compound,,,BAO_0000218,N,,1,,CHEMBL622071,
9863,,,50597,10116.0,Intermediate,1,,A,,Bioavailability expressed as the area under curve of rat carotid artery,,,BAO_0000218,N,,1,,CHEMBL622072,
9864,,,50597,10116.0,Intermediate,1,,A,,Area under curve in male SD rats was observed after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL622073,
9865,,,50597,10116.0,Intermediate,1,,A,,Area under curve of the compound was determined,,,BAO_0000218,N,,1,,CHEMBL622074,
9866,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,,BAO_0000218,N,,1,,CHEMBL622075,
9867,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622076,
9868,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622077,
9869,,,50597,10116.0,Intermediate,1,,A,,Area under curve (portal vein) value of the compound,,,BAO_0000218,N,,1,,CHEMBL622078,
9870,,,50597,10116.0,Intermediate,1,,A,,Bioavailability expressed as the area under curve of rat portal vein,,,BAO_0000218,N,,1,,CHEMBL622079,
9871,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Area Under plasma concentration time curve in rat upon peroral administration,,,BAO_0000218,N,,1,,CHEMBL622080,
9872,,,50597,10116.0,Intermediate,1,,A,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL877612,
9873,,,50597,10116.0,Intermediate,1,,A,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL622081,
9874,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for oral bioavailability in rats,,,BAO_0000218,N,,1,,CHEMBL622082,
9875,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for oral bioavailability in rats after iv administration,,,BAO_0000218,N,,1,,CHEMBL622083,
9876,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for oral bioavailability in rats; 30-80,,,BAO_0000218,N,,1,,CHEMBL622084,
9877,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for oral bioavailability in rats; 50-60,,,BAO_0000218,N,,1,,CHEMBL622085,
9878,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for oral bioavailability in rats; no data,,,BAO_0000218,N,,1,,CHEMBL622086,
9879,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for oral bioavailability in rats; peptide,,,BAO_0000218,N,,1,,CHEMBL622087,
9880,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,,BAO_0000218,N,,1,,CHEMBL622088,
9881,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,,BAO_0000218,N,,1,,CHEMBL622089,
9882,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,,BAO_0000218,N,,1,,CHEMBL623685,
9883,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,,BAO_0000218,N,,1,,CHEMBL623686,
9884,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL623687,
9885,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL623688,
9886,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL623689,
9887,In vivo,945.0,50597,10116.0,Intermediate,1,Stomach,A,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622485,
9888,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622486,
9889,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL877613,
9890,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622487,
9891,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622488,
9892,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622489,
9893,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,BAO_0000218,N,,1,,CHEMBL622490,
9894,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,,BAO_0000218,N,,1,,CHEMBL622491,
9895,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,,BAO_0000218,N,,1,,CHEMBL622492,
9896,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,BAO_0000218,N,,1,,CHEMBL622493,
9897,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,,BAO_0000218,N,,1,,CHEMBL622494,
9898,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,,BAO_0000218,N,,1,,CHEMBL622495,
9899,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,,BAO_0000218,N,,1,,CHEMBL622496,
9900,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,,BAO_0000218,N,,1,,CHEMBL622497,
9901,,,50597,10116.0,Intermediate,1,,A,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,,BAO_0000218,N,,1,,CHEMBL622498,
9902,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,,BAO_0000218,N,,1,,CHEMBL624918,
9903,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,,BAO_0000218,N,,1,,CHEMBL624919,
9904,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of compound in rat blood after 5 min of administration,,,BAO_0000218,N,,1,,CHEMBL624920,
9905,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of compound in rat blood after 5 min of administration.,,,BAO_0000218,N,,1,,CHEMBL624921,
9906,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of compound in rat brain after 5 min of administration,,,BAO_0000218,N,,1,,CHEMBL624922,
9907,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of compound in rat heart after 5 min of administration,,,BAO_0000218,N,,1,,CHEMBL624923,
9908,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of compound in rat heart after 5 min of administration.,,,BAO_0000218,N,,1,,CHEMBL624924,
9909,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of compound in rat kidney after 5 min of administration,,,BAO_0000218,N,,1,,CHEMBL624925,
9910,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of compound in rat kidney after 5 min of administration.,,,BAO_0000218,N,,1,,CHEMBL624926,
9911,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of compound in rat liver after 5 min of administration,,,BAO_0000218,N,,1,,CHEMBL624927,
9912,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of compound in rat liver after 5 min of administration.,,,BAO_0000218,N,,1,,CHEMBL874402,
9913,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of compound in rat lung after 5 min of administration,,,BAO_0000218,N,,1,,CHEMBL624928,
9914,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of compound in rat lung after 5 min of administration.,,,BAO_0000218,N,,1,,CHEMBL624929,
9915,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of compound in rat muscle after 5 min of administration,,,BAO_0000218,N,,1,,CHEMBL624930,
9916,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of compound in rat muscle after 5 min of administration.,,,BAO_0000218,N,,1,,CHEMBL624931,
9917,,948.0,50597,10116.0,Intermediate,1,Heart,A,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,N,,1,,CHEMBL624932,
9918,,948.0,50597,10116.0,Intermediate,1,Heart,A,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,N,,1,,CHEMBL624933,
9919,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,N,,1,,CHEMBL624934,
9920,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,N,,1,,CHEMBL624935,
9921,,,50597,10116.0,Intermediate,1,,A,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,N,,1,,CHEMBL624936,
9922,,,50597,10116.0,Intermediate,1,,A,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,N,,1,,CHEMBL624937,
9923,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,N,,1,,CHEMBL624938,
9924,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,N,,1,,CHEMBL624939,
9925,,,50597,10116.0,Intermediate,1,,A,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,N,,1,,CHEMBL624940,
9926,,,50597,10116.0,Intermediate,1,,A,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,,BAO_0000218,N,,1,,CHEMBL874403,
9927,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,,BAO_0000218,N,,1,,CHEMBL624941,
9928,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,,BAO_0000218,N,,1,,CHEMBL624942,
9929,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,,BAO_0000218,N,,1,,CHEMBL624943,
9930,In vivo,,50597,10116.0,Intermediate,1,,A,,% Bioavailability after 1 day of the drug administration in rats,,,BAO_0000218,N,,1,,CHEMBL624944,
9931,In vivo,,50597,10116.0,Intermediate,1,,A,,% Bioavailability after 4 day of the drug administration in rats,,,BAO_0000218,N,,1,,CHEMBL624945,
9932,In vivo,,50597,10116.0,Intermediate,1,,A,,Absolute bioavailability was evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL624946,
9933,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL624947,
9934,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL624948,
9935,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL624949,
9936,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL622025,
9937,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL622026,
9938,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL622027,
9939,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL622028,
9940,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL622029,
9941,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL622208,
9942,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL622209,
9943,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL622210,
9944,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL622211,
9945,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL622212,
9946,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL622213,
9947,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL874404,
9948,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL620452,
9949,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL620453,
9950,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL620454,
9951,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL624067,
9952,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL624068,
9953,,992.0,50597,10116.0,Intermediate,1,Female gonad,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL624069,
9954,,992.0,50597,10116.0,Intermediate,1,Female gonad,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL624070,
9955,,992.0,50597,10116.0,Intermediate,1,Female gonad,A,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL624071,
9956,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL624072,
9957,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL624073,
9958,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL624788,
9959,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL624789,
9960,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL624790,
9961,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL624791,
9962,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL624792,
9963,,,50597,10116.0,Intermediate,1,,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL624793,
9964,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,,BAO_0000218,N,,1,,CHEMBL877491,
9965,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,,BAO_0000218,N,,1,,CHEMBL624957,
9966,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,,BAO_0000218,N,,1,,CHEMBL624958,
9967,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,,BAO_0000218,N,,1,,CHEMBL624959,
9968,,,50597,10116.0,Intermediate,1,,A,,Dissociation constant was determined,,,BAO_0000218,N,,1,,CHEMBL624960,
9969,,,50597,10116.0,Intermediate,1,,A,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,,BAO_0000218,N,,1,,CHEMBL624961,
9970,,,50597,10116.0,Intermediate,1,,A,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL624962,
9971,,,50597,10116.0,Intermediate,1,,A,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL624963,
9972,,,50597,10116.0,Intermediate,1,,A,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,,BAO_0000218,N,,1,,CHEMBL624964,
9973,,,50597,10116.0,Intermediate,1,,A,,LogP value was evaluated in the in situ rat gut perfusion assay,,,BAO_0000218,N,,1,,CHEMBL624965,
9974,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,BAO_0000218,N,,1,,CHEMBL624966,
9975,In vivo,,50597,10116.0,Intermediate,1,,A,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,,BAO_0000218,N,,1,,CHEMBL624967,
9976,In vivo,,50597,10116.0,Intermediate,1,,A,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,N,,1,,CHEMBL624968,
9977,,,50597,10116.0,Intermediate,1,,A,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,N,,1,,CHEMBL624969,
9978,,,50597,10116.0,Expert,1,,F,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,,BAO_0000218,N,,1,,CHEMBL624970,
9979,,,50597,10116.0,Intermediate,1,,A,,Half-life was evaluated after 10 uM/kg of intra arterial administration,,,BAO_0000218,N,,1,,CHEMBL624971,
9980,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life was evaluated after 20 uM/kg of peroral administration,,,BAO_0000218,N,,1,,CHEMBL624972,
9981,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624973,
9982,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life was evaluated in plasma of rat,,,BAO_0000218,N,,1,,CHEMBL624974,
9983,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624975,
9984,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL877492,
9985,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life was measured in rat after an iv dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624976,
9986,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life period of compound in rats after peroral administration,,,BAO_0000218,N,,1,,CHEMBL624977,
9987,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life period of compound was measured in rat plasma.,,,BAO_0000218,N,,1,,CHEMBL626848,
9988,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life period of compound was measured in rat plasma; ND is not determined,,,BAO_0000218,N,,1,,CHEMBL626849,
9989,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half-life period of compound was measured in rat plasma; not determined,,,BAO_0000218,N,,1,,CHEMBL626850,
9990,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,BAO_0000218,N,,1,,CHEMBL626851,
9991,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life period in rat by iv administration,,,BAO_0000218,N,,1,,CHEMBL626852,
9992,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life period in rats following intravenous administration at 2 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626853,
9993,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,BAO_0000218,N,,1,,CHEMBL626854,
9994,,,50597,10116.0,Intermediate,1,,A,,Half-life period was determined for the compound in rat,,,BAO_0000218,N,,1,,CHEMBL627486,
9995,In vivo,,50597,10116.0,Intermediate,1,,A,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,,BAO_0000218,N,,1,,CHEMBL627487,
9996,In vivo,,50597,10116.0,Intermediate,1,,A,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,,BAO_0000218,N,,1,,CHEMBL627488,
9997,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,,BAO_0000218,N,,1,,CHEMBL627489,
9998,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL627490,
9999,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,,BAO_0000218,N,,1,,CHEMBL873829,
10000,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life was determined in rat at a dose of 1 mpk i.v.,,,BAO_0000218,N,,1,,CHEMBL627655,
10001,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,,BAO_0000218,N,,1,,CHEMBL625994,
10002,In vivo,,50597,10116.0,Intermediate,1,,A,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,,BAO_0000218,N,,1,,CHEMBL625995,
10003,,,50597,10116.0,Intermediate,1,,A,,Half-life in rat,,,BAO_0000218,N,,1,,CHEMBL625996,
10004,In vitro,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,In vitro half life in rat plasma,,,BAO_0000218,N,,1,,CHEMBL625850,
10005,In vitro,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,,BAO_0000218,N,,1,,CHEMBL625851,
10006,In vitro,,50597,10116.0,Intermediate,1,,A,,In vitro half life in rat,,,BAO_0000218,N,,1,,CHEMBL625852,
10007,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo half life period after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL625853,
10008,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,,BAO_0000218,N,,1,,CHEMBL625854,
10009,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,BAO_0000218,N,,1,,CHEMBL874450,
10010,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625855,
10011,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625856,
10012,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625857,
10013,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL873831,
10014,In vivo,,50597,10116.0,Intermediate,1,,A,,Longer half-life in rat (i.v.) at 0.5 mpk,,,BAO_0000218,N,,1,,CHEMBL625858,
10015,In vivo,,50597,10116.0,Intermediate,1,,A,,Longer half-life in rat (p.o.) at 2.0 mpk,,,BAO_0000218,N,,1,,CHEMBL625859,
10016,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (half life) in rat,,,BAO_0000218,N,,1,,CHEMBL625860,
10017,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,,BAO_0000218,N,,1,,CHEMBL625861,
10018,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,,BAO_0000218,N,,1,,CHEMBL625862,
10019,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,,BAO_0000218,N,,1,,CHEMBL625863,
10020,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,,BAO_0000218,N,,1,,CHEMBL625864,
10021,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,,BAO_0000218,N,,1,,CHEMBL625865,
10022,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic half time was determined intravenously in rats.,,,BAO_0000218,N,,1,,CHEMBL625866,
10023,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,,BAO_0000218,N,,1,,CHEMBL625867,
10024,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half life of hydrolysis of the compound,,,BAO_0000218,N,,1,,CHEMBL625868,
10025,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625869,
10026,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half life period was calculated in rat,,,BAO_0000218,N,,1,,CHEMBL874451,
10027,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life in Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL625870,
10028,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life in Sprague-Dawley rats; Not determined,,,BAO_0000218,N,,1,,CHEMBL625871,
10029,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life in rats,,,BAO_0000218,N,,1,,CHEMBL625872,
10030,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life in rats; <MQL,,,BAO_0000218,N,,1,,CHEMBL625873,
10031,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life period (0-8 h) was determined,,,BAO_0000218,N,,1,,CHEMBL625874,
10032,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625875,
10033,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL625876,
10034,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL631258,
10035,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,,BAO_0000218,N,,1,,CHEMBL631259,
10036,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,,BAO_0000218,N,,1,,CHEMBL631260,
10037,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,,BAO_0000218,N,,1,,CHEMBL631261,
10038,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,,BAO_0000218,N,,1,,CHEMBL631262,
10039,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,,BAO_0000218,N,,1,,CHEMBL631263,
10040,,,50597,10116.0,Intermediate,1,,A,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,,BAO_0000218,N,,1,,CHEMBL631264,
10041,,,50597,10116.0,Intermediate,1,,A,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,,BAO_0000218,N,,1,,CHEMBL631265,
10042,,,50597,10116.0,Intermediate,1,,A,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,,BAO_0000218,N,,1,,CHEMBL631266,
10043,,,50597,10116.0,Intermediate,1,,A,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,,BAO_0000218,N,,1,,CHEMBL631267,
10044,,,50597,10116.0,Intermediate,1,,A,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,,BAO_0000218,N,,1,,CHEMBL631268,
10045,,,50597,10116.0,Intermediate,1,,A,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,,BAO_0000218,N,,1,,CHEMBL631269,
10046,,,50597,10116.0,Intermediate,1,,A,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,,BAO_0000218,N,,1,,CHEMBL631270,
10047,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,,BAO_0000218,N,,1,,CHEMBL631271,
10048,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,,BAO_0000218,N,,1,,CHEMBL631272,
10049,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,,BAO_0000218,N,,1,,CHEMBL631273,
10050,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,,BAO_0000218,N,,1,,CHEMBL631274,
10051,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,,BAO_0000218,N,,1,,CHEMBL631275,
10052,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,,BAO_0000218,N,,1,,CHEMBL626984,
10053,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,,BAO_0000218,N,,1,,CHEMBL626985,
10054,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,,BAO_0000218,N,,1,,CHEMBL626986,
10055,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,,BAO_0000218,N,,1,,CHEMBL626987,
10056,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,,BAO_0000218,N,,1,,CHEMBL626988,
10057,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,,BAO_0000218,N,,1,,CHEMBL626989,
10058,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,,BAO_0000218,N,,1,,CHEMBL626990,
10059,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,,BAO_0000218,N,,1,,CHEMBL626991,
10060,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,,BAO_0000218,N,,1,,CHEMBL626992,
10061,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,,BAO_0000218,N,,1,,CHEMBL626993,
10062,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,,BAO_0000218,N,,1,,CHEMBL874593,
10063,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,,BAO_0000218,N,,1,,CHEMBL626994,
10064,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,,BAO_0000218,N,,1,,CHEMBL626995,
10065,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,,BAO_0000218,N,,1,,CHEMBL626190,
10066,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,,BAO_0000218,N,,1,,CHEMBL626191,
10067,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,,BAO_0000218,N,,1,,CHEMBL626364,
10068,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,,BAO_0000218,N,,1,,CHEMBL626365,
10069,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,,BAO_0000218,N,,1,,CHEMBL626366,
10070,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,,BAO_0000218,N,,1,,CHEMBL626367,
10071,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,,BAO_0000218,N,,1,,CHEMBL626368,
10072,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,,BAO_0000218,N,,1,,CHEMBL626369,
10073,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,,BAO_0000218,N,,1,,CHEMBL626370,
10074,In vivo,,50597,10116.0,Intermediate,1,,A,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,,BAO_0000218,N,,1,,CHEMBL626371,
10075,In vivo,,50597,10116.0,Intermediate,1,,A,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,,BAO_0000218,N,,1,,CHEMBL626372,
10076,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability after a dose of 10 mg/kg p.o.,,,BAO_0000218,N,,1,,CHEMBL626373,
10077,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,,BAO_0000218,N,,1,,CHEMBL626374,
10078,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,,BAO_0000218,N,,1,,CHEMBL626375,
10079,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,,BAO_0000218,N,,1,,CHEMBL626376,
10080,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat po was determined,,,BAO_0000218,N,,1,,CHEMBL626377,
10081,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability of compound at 10 mg/kg in rat after oral administration,,,BAO_0000218,N,,1,,CHEMBL626378,
10082,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL626379,
10083,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL626380,
10084,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL626381,
10085,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL626382,
10086,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (Sprague-Dawley) (female),,,BAO_0000218,N,,1,,CHEMBL626383,
10087,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL874652,
10088,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,,BAO_0000218,N,,1,,CHEMBL626384,
10089,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,,BAO_0000218,N,,1,,CHEMBL626385,
10090,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat at an oral dose of 2 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626386,
10091,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL626387,
10092,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL626388,
10093,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL626389,
10094,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL626390,
10095,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,,BAO_0000218,N,,1,,CHEMBL626391,
10096,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL626392,
10097,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL626393,
10098,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was determined in rat,,,BAO_0000218,N,,1,,CHEMBL623026,
10099,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability,,,BAO_0000218,N,,1,,CHEMBL623027,
10100,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability,,,BAO_0000218,N,,1,,CHEMBL623028,
10101,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat after 1 day dosing,,,BAO_0000218,N,,1,,CHEMBL623029,
10102,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat after 4 day dosing,,,BAO_0000218,N,,1,,CHEMBL623030,
10103,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,,BAO_0000218,N,,1,,CHEMBL623031,
10104,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,,BAO_0000218,N,,1,,CHEMBL623032,
10105,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL623033,
10106,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL623034,
10107,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,,BAO_0000218,N,,1,,CHEMBL623035,
10108,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,,BAO_0000218,N,,1,,CHEMBL623036,
10109,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL623037,
10110,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL623038,
10111,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL874385,
10112,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (Fisher) (fasted),,,BAO_0000218,N,,1,,CHEMBL623039,
10113,In vivo,,22224,9443.0,Intermediate,1,,A,,Bioavailability in monkey after po administration of 10 mg/kg dose,,,BAO_0000218,U,,0,,CHEMBL623040,
10114,In vivo,,22224,9443.0,Intermediate,1,,A,,Oral bioavailability in monkey (dose 10 mg/kg),,,BAO_0000218,U,,0,,CHEMBL623041,
10115,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623741,
10116,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623742,
10117,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623743,
10118,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623744,
10119,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 2.0 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL623745,
10120,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL623746,
10121,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 5 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL623747,
10122,In vivo,,22224,10116.0,Intermediate,1,,A,,Bioavailability in rat after po administration of 30 mg/kg dose,,,BAO_0000218,U,,0,,CHEMBL623748,
10123,In vivo,,22224,10116.0,Intermediate,1,,A,,Bioavailability in rat after po administration of 30 mg/kg dose,,,BAO_0000218,U,,0,,CHEMBL623916,
10124,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,,BAO_0000218,N,,1,,CHEMBL623917,
10125,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 2 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL623918,
10126,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL874386,
10127,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Bioavailability in rat; Only traces detected in rat plasma,,,BAO_0000218,N,,1,,CHEMBL623919,
10128,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623920,
10129,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability upon oral administration of compound,,,BAO_0000218,N,,1,,CHEMBL623148,
10130,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,,BAO_0000218,N,,1,,CHEMBL623149,
10131,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623150,
10132,In vivo,,50597,10116.0,Intermediate,1,,A,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,,BAO_0000218,N,,1,,CHEMBL623151,
10133,In vivo,,50597,10116.0,Intermediate,1,,A,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,,BAO_0000218,N,,1,,CHEMBL623152,
10134,,,50597,10116.0,Expert,1,,F,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,,BAO_0000218,N,,1,,CHEMBL623153,
10135,,,50597,10116.0,Expert,1,,F,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,,BAO_0000218,N,,1,,CHEMBL623154,
10136,,,50597,10116.0,Intermediate,1,,A,,In vitro and metabolic stability was determined,,,BAO_0000218,N,,1,,CHEMBL623155,
10137,,,50597,10116.0,Intermediate,1,,A,,In vitro metabolic stability in rat hepatocytes,,,BAO_0000218,N,,1,,CHEMBL623156,
10138,,,50597,10116.0,Intermediate,1,,A,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,,BAO_0000218,N,,1,,CHEMBL623157,
10139,In vitro,2107.0,50597,10116.0,Intermediate,1,Liver,A,401.0,Metabolic rate for compound was observed in rat hepatocytes,,,BAO_0000218,N,,1,,CHEMBL623158,
10140,,,50597,10116.0,Intermediate,1,,A,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,,BAO_0000218,N,,1,,CHEMBL623159,
10141,,,50597,10116.0,Intermediate,1,,A,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,,BAO_0000218,N,,1,,CHEMBL874390,
10142,,,50597,10116.0,Intermediate,1,,A,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,,BAO_0000218,N,,1,,CHEMBL623160,
10143,,,50597,10116.0,Intermediate,1,,A,,Metabolism of compound in rat S9 microsomes; Trace,,,BAO_0000218,N,,1,,CHEMBL623161,
10144,,,50597,10116.0,Intermediate,1,,A,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,,BAO_0000218,N,,1,,CHEMBL623162,
10145,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,,BAO_0000218,N,,1,,CHEMBL623163,
10146,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,,BAO_0000218,N,,1,,CHEMBL623164,
10147,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,,BAO_0000218,N,,1,,CHEMBL623165,
10148,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,,BAO_0000218,N,,1,,CHEMBL623166,
10149,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,,BAO_0000218,N,,1,,CHEMBL624983,
10150,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,,BAO_0000218,N,,1,,CHEMBL624984,
10151,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,,BAO_0000218,N,,1,,CHEMBL624985,
10152,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,,BAO_0000218,N,,1,,CHEMBL622970,
10153,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,,BAO_0000218,N,,1,,CHEMBL622971,
10154,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,,BAO_0000218,N,,1,,CHEMBL622972,
10155,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,,BAO_0000218,N,,1,,CHEMBL622973,
10156,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,,BAO_0000218,N,,1,,CHEMBL622974,
10157,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,,BAO_0000218,N,,1,,CHEMBL622975,
10158,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,,BAO_0000218,N,,1,,CHEMBL622976,
10159,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,,BAO_0000218,N,,1,,CHEMBL622977,
10160,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,BAO_0000218,N,,1,,CHEMBL624351,
10161,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,,BAO_0000218,N,,1,,CHEMBL624352,
10162,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,BAO_0000218,N,,1,,CHEMBL624353,
10163,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,,BAO_0000218,N,,1,,CHEMBL622397,
10164,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,,BAO_0000218,N,,1,,CHEMBL622398,
10165,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,,BAO_0000218,N,,1,,CHEMBL622399,
10166,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,,BAO_0000218,N,,1,,CHEMBL622400,
10167,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,BAO_0000218,N,,1,,CHEMBL628428,
10168,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,,BAO_0000218,N,,1,,CHEMBL628590,
10169,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,BAO_0000218,N,,1,,CHEMBL628591,
10170,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,,BAO_0000218,N,,1,,CHEMBL628592,
10171,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,BAO_0000218,N,,1,,CHEMBL628593,
10172,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,,BAO_0000218,N,,1,,CHEMBL875333,
10173,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,BAO_0000218,N,,1,,CHEMBL628594,
10174,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,,BAO_0000218,N,,1,,CHEMBL628595,
10175,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Stability in rat plasma was determined,,,BAO_0000218,N,,1,,CHEMBL628596,
10176,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Stability in rat plasma was determined; ND= no data,,,BAO_0000218,N,,1,,CHEMBL628597,
10177,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Tested for plasma half life period in rat (0-8 hr),,,BAO_0000218,N,,1,,CHEMBL628598,
10178,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Tested for plasma half life period in rat (0-8 hr); Not determined,,,BAO_0000218,N,,1,,CHEMBL628599,
10179,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,,BAO_0000218,N,,1,,CHEMBL628600,
10180,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,,BAO_0000218,N,,1,,CHEMBL628601,
10181,,,50597,10116.0,Intermediate,1,,A,,Tested for the half life in rat,,,BAO_0000218,N,,1,,CHEMBL628602,
10182,In vitro,,50597,10116.0,Intermediate,1,,A,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,,BAO_0000218,N,,1,,CHEMBL628603,
10183,In vitro,,50597,10116.0,Intermediate,1,,A,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,,BAO_0000218,N,,1,,CHEMBL628604,
10184,In vitro,,50597,10116.0,Intermediate,1,,A,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,,BAO_0000218,N,,1,,CHEMBL628605,
10185,In vitro,,50597,10116.0,Intermediate,1,,A,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,,BAO_0000218,N,,1,,CHEMBL628606,
10186,In vitro,,50597,10116.0,Intermediate,1,,A,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,,BAO_0000218,N,,1,,CHEMBL628607,
10187,,,50597,10116.0,Intermediate,1,,A,,The biological half life the compound was measured at the dose of 100 umol/kg,,,BAO_0000218,N,,1,,CHEMBL628608,
10188,,,50597,10116.0,Intermediate,1,,A,,The biological half life the compound was measured at the dose of 30 umol/kg,,,BAO_0000218,N,,1,,CHEMBL628609,
10189,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The compound was evaluated for plasma half life period in rat,,,BAO_0000218,N,,1,,CHEMBL628610,
10190,In vivo,,50597,10116.0,Intermediate,1,,A,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL873819,
10191,In vivo,,50597,10116.0,Intermediate,1,,A,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL628611,
10192,In vivo,,50597,10116.0,Intermediate,1,,A,,The pharmacokinetic parameter half-life period in vivo in rats,,,BAO_0000218,N,,1,,CHEMBL628612,
10193,In vivo,,50597,10116.0,Intermediate,1,,A,,"The pharmacokinetic property, Half-life was determined",,,BAO_0000218,N,,1,,CHEMBL628613,
10194,In vivo,,50597,10116.0,Intermediate,1,,A,,"The pharmacokinetic property, Half-life in rat in vivo",,,BAO_0000218,N,,1,,CHEMBL628614,
10195,In vivo,,50597,10116.0,Intermediate,1,,A,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,,BAO_0000218,N,,1,,CHEMBL628615,
10196,In vivo,,50597,10116.0,Intermediate,1,,A,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,,BAO_0000218,N,,1,,CHEMBL628616,
10197,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The plasma half life period in rats,,,BAO_0000218,N,,1,,CHEMBL627924,
10198,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,,BAO_0000218,N,,1,,CHEMBL627925,
10199,In vivo,,50597,10116.0,Intermediate,1,,A,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,,BAO_0000218,N,,1,,CHEMBL627926,
10200,,,50597,10116.0,Intermediate,1,,A,,t1/2 (apparent elimination)of the compound was determined,,,BAO_0000218,N,,1,,CHEMBL627927,
10201,,,50597,10116.0,Intermediate,1,,A,,t1/2 value in rat,,,BAO_0000218,N,,1,,CHEMBL627928,
10202,,,50597,10116.0,Intermediate,1,,A,,Half life in rat,,,BAO_0000218,N,,1,,CHEMBL627539,
10203,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,,BAO_0000218,N,,1,,CHEMBL876790,
10204,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,,BAO_0000218,N,,1,,CHEMBL858186,
10205,,,50597,10116.0,Intermediate,1,,A,,Half-life period in fasted rats,,,BAO_0000218,N,,1,,CHEMBL627540,
10206,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,,BAO_0000218,N,,1,,CHEMBL627541,
10207,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627715,
10208,In vivo,,50597,10116.0,Intermediate,1,,A,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627716,
10209,,,50597,10116.0,Intermediate,1,,A,,Maximum time required to achieve Cmax was determined in rat,,,BAO_0000218,N,,1,,CHEMBL627717,
10210,In vivo,,50597,10116.0,Intermediate,1,,A,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,N,,1,,CHEMBL627718,
10211,In vivo,,50597,10116.0,Intermediate,1,,A,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,,BAO_0000218,N,,1,,CHEMBL627719,
10212,In vivo,,50597,10116.0,Intermediate,1,,A,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,,BAO_0000218,N,,1,,CHEMBL627720,
10213,In vivo,,50597,10116.0,Intermediate,1,,A,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL627721,
10214,In vivo,,50597,10116.0,Intermediate,1,,A,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,,BAO_0000218,N,,1,,CHEMBL627722,
10215,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL627723,
10216,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL626058,
10217,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL626059,
10218,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL626060,
10219,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,N,,1,,CHEMBL626061,
10220,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL876791,
10221,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,,BAO_0000218,N,,1,,CHEMBL626062,
10222,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax at the dose of 2 mg/Kg administered perorally in rats,,,BAO_0000218,N,,1,,CHEMBL626063,
10223,In vivo,,50597,10116.0,Intermediate,1,,A,,Tmax at the dose of 5 mg/Kg administered perorally in rats,,,BAO_0000218,N,,1,,CHEMBL626064,
10224,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,N,,1,,CHEMBL626065,
10225,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,,BAO_0000218,N,,1,,CHEMBL626066,
10226,In vivo,,50597,10116.0,Intermediate,1,,A,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,,BAO_0000218,N,,1,,CHEMBL626067,
10227,,,50597,10116.0,Intermediate,1,,F,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,,BAO_0000218,N,,1,,CHEMBL626068,
10228,,,50597,10116.0,Intermediate,1,,F,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,,BAO_0000218,N,,1,,CHEMBL626069,
10229,,,50597,10116.0,Intermediate,1,,F,,Percent total excretion of 3-methoxyacetaminophen glucuronide,,,BAO_0000218,N,,1,,CHEMBL626070,
10230,,,50597,10116.0,Intermediate,1,,F,,Percent total excretion of N-methoxyacetaminophen glucuronide,,,BAO_0000218,N,,1,,CHEMBL626071,
10231,,,50597,10116.0,Intermediate,1,,F,,Percent total excretion of N-methoxyacetaminophen sulfate,,,BAO_0000218,N,,1,,CHEMBL626072,
10232,,,50597,10116.0,Intermediate,1,,F,,Percent total excretion of acetaminophen,,,BAO_0000218,N,,1,,CHEMBL626073,
10233,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,,BAO_0000218,N,,1,,CHEMBL626741,
10234,,,50597,10116.0,Intermediate,1,,A,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,,BAO_0000218,N,,1,,CHEMBL626742,
10235,,,50597,10116.0,Intermediate,1,,A,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,,BAO_0000218,N,,1,,CHEMBL626743,
10236,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,,BAO_0000218,N,,1,,CHEMBL876792,
10237,,,50597,10116.0,Intermediate,1,,A,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,,BAO_0000218,N,,1,,CHEMBL626744,
10238,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for antidiuretic activity in rats,,,BAO_0000218,N,,1,,CHEMBL626745,
10239,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC in rat after 3mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL626746,
10240,,,50597,10116.0,Intermediate,1,,A,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626747,
10241,,,50597,10116.0,Intermediate,1,,A,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626748,
10242,,,50597,10116.0,Intermediate,1,,A,,Bioavailability administered orally at a dose of 10 mg/kg to rats,,,BAO_0000218,N,,1,,CHEMBL626749,
10243,,,50597,10116.0,Intermediate,1,,A,,Oral Bioavailability was determined,,,BAO_0000218,N,,1,,CHEMBL626750,
10244,,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL626751,
10245,,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat; Not performed.,,,BAO_0000218,N,,1,,CHEMBL626913,
10246,,,50597,10116.0,Intermediate,1,,A,,Bioavailability,,,BAO_0000218,N,,1,,CHEMBL626914,
10247,,,50597,10116.0,Intermediate,1,,A,,Bioavailability was determined; ND denotes no data,,,BAO_0000218,N,,1,,CHEMBL626915,
10248,,,50597,10116.0,Intermediate,1,,A,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL626916,
10249,,,50597,10116.0,Intermediate,1,,A,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL626917,
10250,,,50597,10116.0,Intermediate,1,,A,,Binding towards rat plasma protein at 10 uM,,,BAO_0000218,N,,1,,CHEMBL626918,
10251,,,50597,10116.0,Intermediate,1,,A,,Binding towards rat plasma protein at 100 uM,,,BAO_0000218,N,,1,,CHEMBL626919,
10252,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 20 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL626920,
10253,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,,BAO_0000218,N,,1,,CHEMBL621976,
10254,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat after 5 mg/kg oral gavage,,,BAO_0000218,N,,1,,CHEMBL877599,
10255,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL621977,
10256,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 1 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL621978,
10257,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 3 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL621979,
10258,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL621980,
10259,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability of the compound in rats after administration of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621981,
10260,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability after administration of 10 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL621982,
10261,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability after administration of 2 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL882953,
10262,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,,BAO_0000218,N,,1,,CHEMBL621983,
10263,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in dogs was determined; high,,,BAO_0000218,N,,1,,CHEMBL621984,
10264,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in monkey after intravenous administration at 1 mpk,,,BAO_0000218,N,,1,,CHEMBL621985,
10265,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in monkey after peroral administration at 10 mpk,,,BAO_0000218,N,,1,,CHEMBL621986,
10266,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat after intravenous administration at 1 mpk,,,BAO_0000218,N,,1,,CHEMBL621987,
10267,In vivo,,50597,10116.0,Intermediate,1,,F,,Bioavailability in rat after intravenous administration at 2 mpk,,,BAO_0000218,N,,1,,CHEMBL877600,
10268,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat after peroral administration at 30 mpk,,,BAO_0000218,N,,1,,CHEMBL621988,
10269,In vivo,,50597,10116.0,Intermediate,1,,F,,Bioavailability in rat after peroral administration at at 100 mpk,,,BAO_0000218,N,,1,,CHEMBL621989,
10270,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rats was evaluated,,,BAO_0000218,N,,1,,CHEMBL621990,
10271,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,,BAO_0000218,N,,1,,CHEMBL621991,
10272,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,,BAO_0000218,N,,1,,CHEMBL621992,
10273,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,,BAO_0000218,N,,1,,CHEMBL621993,
10274,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,,BAO_0000218,N,,1,,CHEMBL621994,
10275,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL621995,
10276,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL621996,
10277,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 10 mg/kg),,,BAO_0000218,N,,1,,CHEMBL621997,
10278,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,,BAO_0000218,N,,1,,CHEMBL621998,
10279,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,,BAO_0000218,N,,1,,CHEMBL621999,
10280,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622000,
10281,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was measured in rat after oral administration; 2-4,,,BAO_0000218,N,,1,,CHEMBL622001,
10282,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was measured in rat after oral administration; 3-7,,,BAO_0000218,N,,1,,CHEMBL622002,
10283,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (intraduodenal administration),,,BAO_0000218,N,,1,,CHEMBL622003,
10284,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (intraduodenal administration),,,BAO_0000218,N,,1,,CHEMBL877601,
10285,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL624871,
10286,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622004,
10287,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL882954,
10288,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,,BAO_0000218,N,,1,,CHEMBL622005,
10289,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,,BAO_0000218,N,,1,,CHEMBL622006,
10290,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was measured in rat,,,BAO_0000218,N,,1,,CHEMBL622007,
10291,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was reported,,,BAO_0000218,N,,1,,CHEMBL622008,
10292,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL622009,
10293,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,BAO_0000218,N,,1,,CHEMBL622010,
10294,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,,BAO_0000218,N,,1,,CHEMBL622011,
10295,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,,BAO_0000218,N,,1,,CHEMBL622012,
10296,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,,BAO_0000218,N,,1,,CHEMBL622013,
10297,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL622014,
10298,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was determined at 3 mg/kg po dose in rats,,,BAO_0000218,N,,1,,CHEMBL624749,
10299,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 2 mg/kg),,,BAO_0000218,N,,1,,CHEMBL624750,
10300,In vivo,,50597,10116.0,Intermediate,1,,A,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL624751,
10301,In vivo,,50597,10116.0,Intermediate,1,,A,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,,BAO_0000218,N,,1,,CHEMBL624752,
10302,In vivo,,50597,10116.0,Intermediate,1,,A,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,,BAO_0000218,N,,1,,CHEMBL624753,
10303,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624754,
10304,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,,BAO_0000218,N,,1,,CHEMBL624755,
10305,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624756,
10306,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL624757,
10307,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,,BAO_0000218,N,,1,,CHEMBL624758,
10308,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622270,
10309,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (Sprague-Dawley),,,BAO_0000218,N,,1,,CHEMBL622271,
10310,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat at the dose of 2 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622272,
10311,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622273,
10312,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (cannulated) (dose 2 mg/kg),,,BAO_0000218,N,,1,,CHEMBL622274,
10313,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability value of compound in rats was determined after peroral administration,,,BAO_0000218,N,,1,,CHEMBL622275,
10314,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 20 mg/kg),,,BAO_0000218,N,,1,,CHEMBL622276,
10315,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622277,
10316,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 5 mg/kg),,,BAO_0000218,N,,1,,CHEMBL622278,
10317,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622279,
10318,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622280,
10319,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for oral bioavailability in rats; 15-27 %,,,BAO_0000218,N,,1,,CHEMBL624083,
10320,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,,BAO_0000218,N,,1,,CHEMBL624084,
10321,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,,BAO_0000218,N,,1,,CHEMBL624085,
10322,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was tested for bioavailability in rats,,,BAO_0000218,N,,1,,CHEMBL624086,
10323,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL624087,
10324,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL624088,
10325,In vivo,,22224,9544.0,Intermediate,1,,A,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,,BAO_0000218,U,,0,,CHEMBL624089,
10326,In vivo,,22224,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,,BAO_0000218,U,,0,,CHEMBL624090,
10327,In vivo,,50597,10116.0,Intermediate,1,,A,,Evaluated for the bioavailability in rat (in vivo),,,BAO_0000218,N,,1,,CHEMBL624091,
10328,In vivo,,50597,10116.0,Intermediate,1,,A,,F value of compound in rats was determined after peroral administration,,,BAO_0000218,N,,1,,CHEMBL624092,
10329,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL624093,
10330,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL624094,
10331,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL624095,
10332,In vivo,,50597,10116.0,Intermediate,1,,A,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL624096,
10333,In vivo,,50597,10116.0,Intermediate,1,,A,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,,BAO_0000218,N,,1,,CHEMBL624097,
10334,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum fall in carotid flow in rat,,,BAO_0000218,N,,1,,CHEMBL624098,
10335,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL874392,
10336,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 5 mg/kg),,,BAO_0000218,N,,1,,CHEMBL624099,
10337,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL624100,
10338,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,,BAO_0000218,N,,1,,CHEMBL624101,
10339,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (male Wistar),,,BAO_0000218,N,,1,,CHEMBL624102,
10340,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability after administration (30 mg/kg) in rat; good,,,BAO_0000218,N,,1,,CHEMBL624103,
10341,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability at the dose of 2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL624104,
10342,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability determined in rats,,,BAO_0000218,N,,1,,CHEMBL624105,
10343,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL624106,
10344,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose single 10 mg/kg),,,BAO_0000218,N,,1,,CHEMBL624107,
10345,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose single 10 mg/kg),,,BAO_0000218,N,,1,,CHEMBL623943,
10346,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623944,
10347,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,,BAO_0000218,N,,1,,CHEMBL623945,
10348,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,,BAO_0000218,N,,1,,CHEMBL623946,
10349,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,,BAO_0000218,N,,1,,CHEMBL623947,
10350,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,,BAO_0000218,N,,1,,CHEMBL623948,
10351,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,,BAO_0000218,N,,1,,CHEMBL623949,
10352,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,,BAO_0000218,N,,1,,CHEMBL623950,
10353,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,,BAO_0000218,N,,1,,CHEMBL874398,
10354,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,,BAO_0000218,N,,1,,CHEMBL623951,
10355,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,,BAO_0000218,N,,1,,CHEMBL623952,
10356,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,,BAO_0000218,N,,1,,CHEMBL623953,
10357,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,,BAO_0000218,N,,1,,CHEMBL623954,
10358,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,,BAO_0000218,N,,1,,CHEMBL623955,
10359,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,,BAO_0000218,N,,1,,CHEMBL623956,
10360,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,,BAO_0000218,N,,1,,CHEMBL627807,
10361,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,,BAO_0000218,N,,1,,CHEMBL627808,
10362,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,,BAO_0000218,N,,1,,CHEMBL627809,
10363,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,,BAO_0000218,N,,1,,CHEMBL627810,
10364,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,,BAO_0000218,N,,1,,CHEMBL627811,
10365,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,,BAO_0000218,N,,1,,CHEMBL627812,
10366,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,,BAO_0000218,N,,1,,CHEMBL627813,
10367,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,,BAO_0000218,N,,1,,CHEMBL627814,
10368,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,,BAO_0000218,N,,1,,CHEMBL875336,
10369,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,,BAO_0000218,N,,1,,CHEMBL627815,
10370,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,,BAO_0000218,N,,1,,CHEMBL627816,
10371,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,,BAO_0000218,N,,1,,CHEMBL627817,
10372,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,,BAO_0000218,N,,1,,CHEMBL627818,
10373,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,,BAO_0000218,N,,1,,CHEMBL627819,
10374,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,,BAO_0000218,N,,1,,CHEMBL627820,
10375,,,50597,10116.0,Intermediate,1,,A,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,,BAO_0000218,N,,1,,CHEMBL627821,
10376,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,,BAO_0000218,N,,1,,CHEMBL628464,
10377,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,,BAO_0000218,N,,1,,CHEMBL626239,
10378,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,,BAO_0000218,N,,1,,CHEMBL626240,
10379,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,,BAO_0000218,N,,1,,CHEMBL626241,
10380,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,,BAO_0000218,N,,1,,CHEMBL626242,
10381,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,,BAO_0000218,N,,1,,CHEMBL626243,
10382,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,,BAO_0000218,N,,1,,CHEMBL626244,
10383,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,,BAO_0000218,N,,1,,CHEMBL626907,
10384,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,,BAO_0000218,N,,1,,CHEMBL626908,
10385,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,,BAO_0000218,N,,1,,CHEMBL626909,
10386,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,,BAO_0000218,N,,1,,CHEMBL626910,
10387,,,50597,10116.0,Intermediate,1,,F,,Percent total excretion of acetaminophen cysteine conjugate,,,BAO_0000218,N,,1,,CHEMBL875342,
10388,,,50597,10116.0,Intermediate,1,,F,,Percent total excretion of acetaminophen glucuronide,,,BAO_0000218,N,,1,,CHEMBL626911,
10389,,,50597,10116.0,Intermediate,1,,F,,Percent total excretion of acetaminophen sulfate,,,BAO_0000218,N,,1,,CHEMBL626912,
10390,,,50597,10116.0,Intermediate,1,,F,,Percent total excretion of acetaminophen-mercapturic acid,,,BAO_0000218,N,,1,,CHEMBL627065,
10391,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,,BAO_0000218,N,,1,,CHEMBL627066,
10392,In vivo,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627067,
10393,In vivo,2385.0,22224,8656.0,Autocuration,1,Muscle tissue,A,,Biodistribution of compound in rat muscle after 5 min of administration,,,BAO_0000218,U,,0,,CHEMBL627068,
10394,In vivo,2385.0,22224,8656.0,Autocuration,1,Muscle tissue,A,,Biodistribution of compound in rat muscle after 5 min of administration.,,,BAO_0000218,U,,0,,CHEMBL627069,
10395,In vivo,,22224,9940.0,Autocuration,1,,A,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,BAO_0000218,U,,0,,CHEMBL627070,
10396,In vivo,,22224,9940.0,Autocuration,1,,A,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,BAO_0000218,U,,0,,CHEMBL627071,
10397,In vivo,,22224,9940.0,Autocuration,1,,A,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,BAO_0000218,U,,0,,CHEMBL627072,
10398,In vivo,,22224,9940.0,Autocuration,1,,A,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,BAO_0000218,U,,0,,CHEMBL627073,
10399,In vivo,,22224,9940.0,Autocuration,1,,A,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,BAO_0000218,U,,0,,CHEMBL625387,
10400,In vivo,,22224,9940.0,Autocuration,1,,A,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,BAO_0000218,U,,0,,CHEMBL625388,
10401,In vivo,1969.0,22224,9940.0,Autocuration,1,Plasma,A,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,,BAO_0000218,U,,0,,CHEMBL625389,
10402,In vivo,1969.0,22224,9940.0,Autocuration,1,Plasma,A,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,,BAO_0000218,U,,0,,CHEMBL875343,
10403,,,50497,8570.0,Intermediate,1,,A,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,,BAO_0000218,N,,1,,CHEMBL876795,
10404,,,50497,8570.0,Intermediate,1,,A,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,,BAO_0000218,N,,1,,CHEMBL626552,
10405,,,50497,8570.0,Intermediate,1,,A,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,,BAO_0000218,N,,1,,CHEMBL626553,
10406,,1969.0,22224,9606.0,Autocuration,1,Plasma,A,,The human biological plasma half life of the compound,,,BAO_0000366,U,,0,,CHEMBL626554,
10407,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL626555,
10408,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,,BAO_0000218,N,,1,,CHEMBL626556,
10409,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,,BAO_0000218,N,,1,,CHEMBL626557,
10410,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,,BAO_0000218,N,,1,,CHEMBL626558,
10411,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,,BAO_0000218,N,,1,,CHEMBL626559,
10412,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,,BAO_0000218,N,,1,,CHEMBL626560,
10413,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,,BAO_0000218,N,,1,,CHEMBL876803,
10414,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,,BAO_0000218,N,,1,,CHEMBL627964,
10415,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,,BAO_0000218,N,,1,,CHEMBL627965,
10416,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,,BAO_0000218,N,,1,,CHEMBL627966,
10417,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,,BAO_0000218,N,,1,,CHEMBL627967,
10418,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,,BAO_0000218,N,,1,,CHEMBL627968,
10419,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,,BAO_0000218,N,,1,,CHEMBL627969,
10420,,,50597,10116.0,Intermediate,1,,A,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,,BAO_0000218,N,,1,,CHEMBL627970,
10421,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,,BAO_0000218,N,,1,,CHEMBL627971,
10422,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,,BAO_0000218,N,,1,,CHEMBL627972,
10423,,,180,9606.0,Expert,1,,B,,Dissociation constant against binding to human cyclophilin A,,,BAO_0000357,D,,9,,CHEMBL856029,
10424,,,11591,9913.0,Expert,1,,B,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,,BAO_0000019,H,,8,,CHEMBL627973,
10425,,,22224,,Autocuration,1,,A,,-Log C was determined by performing the electroshock minimum test,,,BAO_0000019,U,,0,,CHEMBL627974,
10426,,,22224,,Autocuration,1,,A,,-Log C was determined by performing the foot shock test,,,BAO_0000019,U,,0,,CHEMBL627975,
10427,,,22224,,Autocuration,1,,A,,-Log C was determined by performing the incl screen test,,,BAO_0000019,U,,0,,CHEMBL627976,
10428,,,22224,,Autocuration,1,,A,,-Log C was determined by performing the maximum electroshock test,,,BAO_0000019,U,,0,,CHEMBL627977,
10429,,,22224,,Autocuration,1,,A,,-Log C was determined by performing the pentylenetetrazole test,,,BAO_0000019,U,,0,,CHEMBL627978,
10430,,,22224,,Autocuration,1,,A,,Tested for experimental arotinoid inhibitory dose,,,BAO_0000019,U,,0,,CHEMBL627979,
10431,,,22224,,Autocuration,1,,A,,Negative log transformed activity,,,BAO_0000019,U,,0,,CHEMBL876804,
10432,,,22224,,Autocuration,1,,A,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,,BAO_0000019,U,,0,,CHEMBL627980,
10433,,,50512,10141.0,Intermediate,1,,A,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,,BAO_0000218,N,,1,,CHEMBL627981,
10434,,,50512,10141.0,Intermediate,1,,A,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,,BAO_0000218,N,,1,,CHEMBL627982,
10435,,,50512,10141.0,Intermediate,1,,A,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,,BAO_0000218,N,,1,,CHEMBL627983,
10436,,2116.0,50512,10141.0,Intermediate,1,Ileum,A,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,,BAO_0000218,N,,1,,CHEMBL627984,
10437,,,22229,,Autocuration,1,,P,,Solubility in water was determined; values expressed as -log,,,BAO_0000100,U,,0,,CHEMBL627985,
10438,,,22224,,Autocuration,1,,A,,Ratio of Kcat to that of Km was determined,,,BAO_0000019,U,,0,,CHEMBL627986,
10439,,,22224,,Autocuration,1,,A,,Observed first order rate constant,,,BAO_0000019,U,,0,,CHEMBL627987,
10440,,,22224,,Autocuration,1,,A,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,,BAO_0000019,U,,0,,CHEMBL627988,
10441,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,,BAO_0000218,N,,1,,CHEMBL627989,
10442,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627990,
10443,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral Bioavailability after administration of 10 mg/kg in male rat,,,BAO_0000218,N,,1,,CHEMBL876805,
10444,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL627991,
10445,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL627992,
10446,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,,BAO_0000218,N,,1,,CHEMBL627993,
10447,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability at 1 mg/kg was determined in rat,,,BAO_0000218,N,,1,,CHEMBL622817,
10448,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability at 10 mg/kg was determined in rat,,,BAO_0000218,N,,1,,CHEMBL622818,
10449,In vivo,,50597,10116.0,Intermediate,1,,A,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,,BAO_0000218,N,,1,,CHEMBL622819,
10450,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL872267,
10451,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622820,
10452,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,,BAO_0000218,N,,1,,CHEMBL622821,
10453,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622822,
10454,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622823,
10455,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622824,
10456,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat at a dose of 3 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622825,
10457,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat after oral administration at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622901,
10458,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622902,
10459,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL621844,
10460,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in Dawley rats,,,BAO_0000218,N,,1,,CHEMBL621845,
10461,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability,,,BAO_0000218,N,,1,,CHEMBL621846,
10462,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 30 mg/kg),,,BAO_0000218,N,,1,,CHEMBL621847,
10463,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,,BAO_0000218,N,,1,,CHEMBL877609,
10464,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 3 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL621848,
10465,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,,BAO_0000218,N,,1,,CHEMBL621849,
10466,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL622030,
10467,In vivo,,50597,10116.0,Intermediate,1,,A,,Percent oral bioavailability determined in rats,,,BAO_0000218,N,,1,,CHEMBL622031,
10468,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622032,
10469,In vivo,,50597,10116.0,Intermediate,1,,A,,The compound was evaluated for bioavailability in rats; 32-51,,,BAO_0000218,N,,1,,CHEMBL622033,
10470,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 20 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL622034,
10471,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622035,
10472,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability percent in rat at the dose of 2 mg/kg,,,BAO_0000218,N,,1,,CHEMBL882966,
10473,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was evaluated after 20 uM/kg of peroral administration,,,BAO_0000218,N,,1,,CHEMBL622036,
10474,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622037,
10475,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622038,
10476,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rats,,,BAO_0000218,N,,1,,CHEMBL622039,
10477,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622040,
10478,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622041,
10479,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622042,
10480,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622043,
10481,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622044,
10482,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622045,
10483,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622046,
10484,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622047,
10485,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL877610,
10486,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622048,
10487,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622049,
10488,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622050,
10489,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622051,
10490,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622052,
10491,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622053,
10492,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622054,
10493,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622055,
10494,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rats was determined; High,,,BAO_0000218,N,,1,,CHEMBL622056,
10495,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in the rat was determined,,,BAO_0000218,N,,1,,CHEMBL622057,
10496,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,,BAO_0000218,N,,1,,CHEMBL628008,
10497,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL622058,
10498,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL622059,
10499,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL622060,
10500,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL622061,
10501,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,,BAO_0000218,N,,1,,CHEMBL622062,
10502,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,,BAO_0000218,N,,1,,CHEMBL622063,
10503,In vivo,,50597,10116.0,Expert,1,,A,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL877611,
10504,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound in Sprague Dawley rats,,,BAO_0000218,N,,1,,CHEMBL622064,
10505,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound in rat,,,BAO_0000218,N,,1,,CHEMBL622065,
10506,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 2 mg/kg),,,BAO_0000218,N,,1,,CHEMBL622066,
10507,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound in rat was determined,,,BAO_0000218,N,,1,,CHEMBL622067,
10508,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound in rats,,,BAO_0000218,N,,1,,CHEMBL622068,
10509,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound was determined in rats,,,BAO_0000218,N,,1,,CHEMBL622069,
10510,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability at a dose of 30 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL624796,
10511,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 10 mg/kg),,,BAO_0000218,N,,1,,CHEMBL624797,
10512,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 10 mg/kg),,,BAO_0000218,N,,1,,CHEMBL623053,
10513,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL623054,
10514,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in fasted rat,,,BAO_0000218,N,,1,,CHEMBL623055,
10515,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in fed rat,,,BAO_0000218,N,,1,,CHEMBL623056,
10516,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,,BAO_0000218,N,,1,,CHEMBL623057,
10517,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623058,
10518,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL623059,
10519,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat after administration of 10 mg/kg po,,,BAO_0000218,N,,1,,CHEMBL623060,
10520,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623061,
10521,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623062,
10522,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623063,
10523,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623064,
10524,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in ratrs,,,BAO_0000218,N,,1,,CHEMBL623065,
10525,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623066,
10526,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623067,
10527,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rats was determined; High,,,BAO_0000218,N,,1,,CHEMBL623068,
10528,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623069,
10529,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623070,
10530,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability was calculated in rat,,,BAO_0000218,N,,1,,CHEMBL623071,
10531,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability,,,BAO_0000218,N,,1,,CHEMBL623072,
10532,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability,,,BAO_0000218,N,,1,,CHEMBL623073,
10533,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability,,,BAO_0000218,N,,1,,CHEMBL623074,
10534,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability,,,BAO_0000218,N,,1,,CHEMBL623075,
10535,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL623076,
10536,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL623077,
10537,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley),,,BAO_0000218,N,,1,,CHEMBL623078,
10538,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL623079,
10539,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL623080,
10540,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,BAO_0000218,N,,1,,CHEMBL623081,
10541,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,,BAO_0000218,N,,1,,CHEMBL623082,
10542,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in fasted rat,,,BAO_0000218,N,,1,,CHEMBL874400,
10543,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in fed rat,,,BAO_0000218,N,,1,,CHEMBL623083,
10544,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623084,
10545,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623085,
10546,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623086,
10547,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623087,
10548,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623088,
10549,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623089,
10550,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623090,
10551,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623091,
10552,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623092,
10553,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623093,
10554,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL874401,
10555,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623094,
10556,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL623095,
10557,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat after peroral administration at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623096,
10558,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat after peroral administration at 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624913,
10559,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL624914,
10560,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624915,
10561,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat; Not measured,,,BAO_0000218,N,,1,,CHEMBL624916,
10562,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL624917,
10563,,,50597,10116.0,Intermediate,1,,A,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,,BAO_0000218,N,,1,,CHEMBL625157,
10564,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,In vitro metabolic potential in rat liver microsomes,,,BAO_0000218,N,,1,,CHEMBL625158,
10565,In vivo,,50597,10116.0,Intermediate,1,,A,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,,BAO_0000218,N,,1,,CHEMBL625159,
10566,In vivo,,50597,10116.0,Intermediate,1,,A,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,,BAO_0000218,N,,1,,CHEMBL625160,
10567,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,,BAO_0000218,N,,1,,CHEMBL625161,
10568,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL625162,
10569,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL625163,
10570,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rats at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625164,
10571,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,,BAO_0000218,N,,1,,CHEMBL625165,
10572,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL625166,
10573,,,50597,10116.0,Intermediate,1,,A,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,,BAO_0000218,N,,1,,CHEMBL625167,
10574,,,50597,10116.0,Intermediate,1,,A,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,,BAO_0000218,N,,1,,CHEMBL625168,
10575,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance of the compound,,,BAO_0000218,N,,1,,CHEMBL625169,
10576,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,,BAO_0000218,N,,1,,CHEMBL626264,
10577,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,,BAO_0000218,N,,1,,CHEMBL626265,
10578,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The compound was tested for plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL626266,
10579,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,,BAO_0000218,N,,1,,CHEMBL626267,
10580,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration upon oral administration of 1 mg/Kg in rats,,,BAO_0000218,N,,1,,CHEMBL626268,
10581,,,50597,10116.0,Intermediate,1,,A,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,,BAO_0000218,N,,1,,CHEMBL626269,
10582,,,50597,10116.0,Intermediate,1,,A,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,,BAO_0000218,N,,1,,CHEMBL626270,
10583,,,50597,10116.0,Intermediate,1,,A,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL626271,
10584,,,50597,10116.0,Intermediate,1,,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,,BAO_0000218,N,,1,,CHEMBL626272,
10585,,,50597,10116.0,Intermediate,1,,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,BAO_0000218,N,,1,,CHEMBL626273,
10586,,,50597,10116.0,Intermediate,1,,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,,BAO_0000218,N,,1,,CHEMBL875346,
10587,,,50597,10116.0,Intermediate,1,,A,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,,BAO_0000218,N,,1,,CHEMBL626274,
10588,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for protein binding in rat plasma,,,BAO_0000218,N,,1,,CHEMBL626275,
10589,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,,BAO_0000218,N,,1,,CHEMBL624646,
10590,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,,BAO_0000218,N,,1,,CHEMBL624647,
10591,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,,BAO_0000218,N,,1,,CHEMBL624648,
10592,,,50597,10116.0,Intermediate,1,,A,,Area under curve ratio was determined (po/iv) in rat,,,BAO_0000218,N,,1,,CHEMBL624649,
10593,,,50597,10116.0,Intermediate,1,,A,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL624650,
10594,,,50597,10116.0,Intermediate,1,,A,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL624651,
10595,,,50597,10116.0,Intermediate,1,,A,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL624652,
10596,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624653,
10597,,,50597,10116.0,Intermediate,1,,A,,Ratio of AUCbrain to AUCplasma,,,BAO_0000218,N,,1,,CHEMBL624654,
10598,,,50597,10116.0,Intermediate,1,,A,,Ratio of brain to plasma,,,BAO_0000218,N,,1,,CHEMBL624655,
10599,,,50597,10116.0,Intermediate,1,,A,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,,BAO_0000218,N,,1,,CHEMBL624656,
10600,,,50597,10116.0,Intermediate,1,,A,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,BAO_0000218,N,,1,,CHEMBL624657,
10601,,,50597,10116.0,Intermediate,1,,A,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,,BAO_0000218,N,,1,,CHEMBL624658,
10602,,,50597,10116.0,Intermediate,1,,A,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,,BAO_0000218,N,,1,,CHEMBL624659,
10603,,,50597,10116.0,Intermediate,1,,A,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,,BAO_0000218,N,,1,,CHEMBL624660,
10604,,,50597,10116.0,Intermediate,1,,A,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,,BAO_0000218,N,,1,,CHEMBL624661,
10605,,,50597,10116.0,Intermediate,1,,A,,Steady state brain :blood ratio was determined,,,BAO_0000218,N,,1,,CHEMBL624662,
10606,,,50597,10116.0,Intermediate,1,,A,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL625199,
10607,,,50597,10116.0,Intermediate,1,,A,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,BAO_0000218,N,,1,,CHEMBL625200,
10608,,,50597,10116.0,Intermediate,1,,A,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,,BAO_0000218,N,,1,,CHEMBL625201,
10609,,,50597,10116.0,Intermediate,1,,A,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,,BAO_0000218,N,,1,,CHEMBL625202,
10610,,,50597,10116.0,Intermediate,1,,A,,Percentage recovery after 3h incubation with rat hapatocytes was determined,,,BAO_0000218,N,,1,,CHEMBL625203,
10611,,,50597,10116.0,Intermediate,1,,A,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,,BAO_0000218,N,,1,,CHEMBL625204,
10612,,,50597,10116.0,Intermediate,1,,A,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,,BAO_0000218,N,,1,,CHEMBL625205,
10613,,,50597,10116.0,Intermediate,1,,A,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL625206,
10614,,,22224,,Autocuration,1,,A,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,,BAO_0000019,U,,0,,CHEMBL625207,
10615,,,22224,,Autocuration,1,,A,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,,BAO_0000019,U,,0,,CHEMBL625208,
10616,,,50587,9606.0,Intermediate,1,,A,495.0,In vivo absorption in Caco-2 cell line monolayers was determined,,,BAO_0000218,N,,1,,CHEMBL625209,
10617,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625210,
10618,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determine after peroral administration at 10 mpk in Rat,,,BAO_0000218,N,,1,,CHEMBL625211,
10619,,,50797,9544.0,Intermediate,1,,A,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,,BAO_0000218,N,,1,,CHEMBL625212,
10620,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determine after peroral administration at 160 mpk in Rat,,,BAO_0000218,N,,1,,CHEMBL625213,
10621,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determine after peroral administration at 20 mpk in Rat,,,BAO_0000218,N,,1,,CHEMBL625214,
10622,,,50597,10116.0,Intermediate,1,,A,,Area under curve was determine after peroral administration at 50 mpk in Rat,,,BAO_0000218,N,,1,,CHEMBL874542,
10623,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP) (AlogP),,,BAO_0000100,U,,0,,CHEMBL625215,
10624,,,22224,,Autocuration,1,,A,,Activated partial thromboplastin time measured,,,BAO_0000019,U,,0,,CHEMBL625216,
10625,,,22224,,Autocuration,1,,P,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,,BAO_0000100,U,,0,,CHEMBL625217,
10626,,,22224,,Autocuration,1,,P,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,,BAO_0000100,U,,0,,CHEMBL625218,
10627,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,,BAO_0000218,N,,1,,CHEMBL622864,
10628,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,,BAO_0000218,N,,1,,CHEMBL622865,
10629,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,,BAO_0000218,N,,1,,CHEMBL622866,
10630,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,,BAO_0000218,N,,1,,CHEMBL622867,
10631,,1969.0,50512,10141.0,Intermediate,1,Plasma,A,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,,BAO_0000218,N,,1,,CHEMBL876808,
10632,,955.0,22224,,Autocuration,1,Brain,A,,AUC in brain,,,BAO_0000019,U,,0,,CHEMBL627725,
10633,,1977.0,22224,,Autocuration,1,Serum,A,,AUC in serum,,,BAO_0000019,U,,0,,CHEMBL627726,
10634,,1969.0,22224,,Autocuration,1,Plasma,A,,AUC was determined,,,BAO_0000019,U,,0,,CHEMBL627727,
10635,,1969.0,22224,,Autocuration,1,Plasma,A,,AUC of the compound.,,,BAO_0000019,U,,0,,CHEMBL627728,
10636,,1969.0,22224,,Autocuration,1,Plasma,A,,AUC value (0-4 hr),,,BAO_0000019,U,,0,,CHEMBL627729,
10637,,1969.0,22224,,Autocuration,1,Plasma,A,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,,BAO_0000019,U,,0,,CHEMBL627730,
10638,,1969.0,22224,,Autocuration,1,Plasma,A,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,,BAO_0000019,U,,0,,CHEMBL627731,
10639,,1969.0,22224,,Autocuration,1,Plasma,A,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,,BAO_0000019,U,,0,,CHEMBL627732,
10640,,1969.0,22224,,Autocuration,1,Plasma,A,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,,BAO_0000019,U,,0,,CHEMBL627733,
10641,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC(area under curve) was determined after intravenous administration in rats,,,BAO_0000218,N,,1,,CHEMBL627734,
10642,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC(area under curve) was determined after oral administration in rats,,,BAO_0000218,N,,1,,CHEMBL627735,
10643,,1969.0,50512,10141.0,Intermediate,1,Plasma,A,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,,BAO_0000218,N,,1,,CHEMBL627736,
10644,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,,BAO_0000218,N,,1,,CHEMBL876809,
10645,,,22224,,Autocuration,1,,A,,Area Under Curve after oral dosing of 100 uM/Kg,,,BAO_0000019,U,,0,,CHEMBL627737,
10646,,,22224,,Autocuration,1,,A,,Area Under Curve after oral dosing of 30 uM/Kg,,,BAO_0000019,U,,0,,CHEMBL627738,
10647,,,22224,,Autocuration,1,,A,,Area Under Curve was measured by ploting the graph between concentration verses time,,,BAO_0000019,U,,0,,CHEMBL627739,
10648,,,50588,9615.0,Intermediate,1,,A,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,,BAO_0000218,N,,1,,CHEMBL626143,
10649,,,22224,314293.0,Autocuration,1,,A,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL626144,
10650,,,50592,9986.0,Intermediate,1,,A,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,,BAO_0000218,N,,1,,CHEMBL626145,
10651,,,50597,10116.0,Intermediate,1,,A,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,,BAO_0000218,N,,1,,CHEMBL626146,
10652,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,,BAO_0000218,N,,1,,CHEMBL626147,
10653,,,22224,,Autocuration,1,,A,,Area under curve (AUC) was determined,,,BAO_0000019,U,,0,,CHEMBL626148,
10654,,,22224,,Autocuration,1,,A,,Area under curve (AUC) following ip administration at 1 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626149,
10655,,,22224,,Autocuration,1,,A,,Area under curve (AUC) was determined; ND is Not determined,,,BAO_0000019,U,,0,,CHEMBL626150,
10656,,,50588,9615.0,Intermediate,1,,A,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL626151,
10657,,,50588,9615.0,Intermediate,1,,A,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL626152,
10658,,,50588,9615.0,Intermediate,1,,A,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL626153,
10659,,,22224,,Autocuration,1,,A,,Area under curve (AUR) was determined,,,BAO_0000019,U,,0,,CHEMBL626154,
10660,,,22224,,Autocuration,1,,A,,Area under curve at 1 uM/dg administered intravenously,,,BAO_0000019,U,,0,,CHEMBL626155,
10661,,,22224,,Autocuration,1,,A,,Area under curve at 10 uM/dg administered perorally,,,BAO_0000019,U,,0,,CHEMBL626156,
10662,,,22224,,Autocuration,1,,A,,Area under curve at 2 uM/dg administered intravenously,,,BAO_0000019,U,,0,,CHEMBL626157,
10663,,,22224,,Autocuration,1,,A,,Area under curve at 20 uM/dg administered perorally,,,BAO_0000019,U,,0,,CHEMBL626158,
10664,,,50588,9615.0,Intermediate,1,,A,,Area under curve at a peroral dose of 3 mg/kg in dog,,,BAO_0000218,N,,1,,CHEMBL626159,
10665,,,50597,10116.0,Intermediate,1,,A,,Area under curve at a peroral dose of 3 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL626160,
10666,,,50588,9615.0,Intermediate,1,,A,,Area under curve at an iv dose of 1 mg/kg in dog,,,BAO_0000218,N,,1,,CHEMBL626161,
10667,,,50597,10116.0,Intermediate,1,,A,,Area under curve at an iv dose of 1 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL626162,
10668,,,22224,,Autocuration,1,,A,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,,BAO_0000019,U,,0,,CHEMBL626163,
10669,,,22224,,Autocuration,1,,A,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,,BAO_0000019,U,,0,,CHEMBL626164,
10670,,,50594,10090.0,Intermediate,1,,A,,Area under curve measured as conc vs time after intravenous administration to mice.,,,BAO_0000218,N,,1,,CHEMBL626165,
10671,,,50594,10090.0,Intermediate,1,,A,,Area under curve measured as conc vs time after peroral administration to mice.,,,BAO_0000218,N,,1,,CHEMBL626166,
10672,,,50588,9615.0,Intermediate,1,,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,,BAO_0000218,N,,1,,CHEMBL626167,
10673,,,50588,9615.0,Intermediate,1,,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,,BAO_0000218,N,,1,,CHEMBL626168,
10674,,,50588,9615.0,Intermediate,1,,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,,BAO_0000218,N,,1,,CHEMBL877463,
10675,,,50588,9615.0,Intermediate,1,,A,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,,BAO_0000218,N,,1,,CHEMBL626169,
10676,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL626170,
10677,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL626171,
10678,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL626172,
10679,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL626173,
10680,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL626174,
10681,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL626175,
10682,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL626176,
10683,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL626177,
10684,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622499,
10685,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622500,
10686,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622501,
10687,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622502,
10688,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL622503,
10689,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL877614,
10690,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL624839,
10691,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL624840,
10692,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL624841,
10693,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL624842,
10694,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL624843,
10695,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL624844,
10696,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL624845,
10697,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,,BAO_0000218,N,,1,,CHEMBL621904,
10698,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL621905,
10699,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL874382,
10700,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL621906,
10701,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL621907,
10702,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622096,
10703,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622097,
10704,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622098,
10705,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622099,
10706,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622100,
10707,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622101,
10708,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622102,
10709,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622103,
10710,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622104,
10711,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622105,
10712,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622106,
10713,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622107,
10714,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622108,
10715,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622109,
10716,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622110,
10717,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622111,
10718,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL874383,
10719,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622112,
10720,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622113,
10721,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622114,
10722,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622115,
10723,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,,BAO_0000218,N,,1,,CHEMBL622116,
10724,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622117,
10725,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622118,
10726,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rats at 6 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622119,
10727,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 6 mg/kg),,,BAO_0000218,N,,1,,CHEMBL622120,
10728,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,,BAO_0000218,N,,1,,CHEMBL622121,
10729,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622122,
10730,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622123,
10731,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622124,
10732,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL622125,
10733,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability,,,BAO_0000218,N,,1,,CHEMBL622126,
10734,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,BAO_0000218,N,,1,,CHEMBL620455,
10735,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL620456,
10736,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL620457,
10737,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability was evaluated; Not tested,,,BAO_0000218,N,,1,,CHEMBL620458,
10738,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability,,,BAO_0000218,N,,1,,CHEMBL620459,
10739,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat by oral dosing,,,BAO_0000218,N,,1,,CHEMBL620460,
10740,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 10 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL620461,
10741,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley),,,BAO_0000218,N,,1,,CHEMBL620462,
10742,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL620463,
10743,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL620464,
10744,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,,BAO_0000218,N,,1,,CHEMBL620465,
10745,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL620466,
10746,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620467,
10747,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,,BAO_0000218,N,,1,,CHEMBL620468,
10748,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,,BAO_0000218,N,,1,,CHEMBL620469,
10749,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,,BAO_0000218,N,,1,,CHEMBL620470,
10750,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL620471,
10751,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL620472,
10752,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,,BAO_0000218,N,,1,,CHEMBL620473,
10753,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL620474,
10754,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,,BAO_0000218,N,,1,,CHEMBL620475,
10755,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL620476,
10756,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL620477,
10757,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL620478,
10758,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL618768,
10759,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL618769,
10760,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL618770,
10761,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability (dose 20 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL618771,
10762,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL618772,
10763,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat at 10 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL618773,
10764,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,,BAO_0000218,N,,1,,CHEMBL875842,
10765,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 3 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL618774,
10766,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,,BAO_0000218,N,,1,,CHEMBL618775,
10767,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 60 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL618776,
10768,In vivo,,50597,10116.0,Intermediate,1,,A,,Percent bioavailability (F) in rats after iv administration,,,BAO_0000218,N,,1,,CHEMBL618777,
10769,In vivo,,50597,10116.0,Intermediate,1,,A,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL618778,
10770,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 5 uM/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL618779,
10771,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability,,,BAO_0000218,N,,1,,CHEMBL618780,
10772,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat (dose 2 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL618781,
10773,In vivo,,50597,10116.0,Intermediate,1,,A,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,,BAO_0000218,N,,1,,CHEMBL618782,
10774,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 20 mg/kg),,,BAO_0000218,N,,1,,CHEMBL618783,
10775,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL618784,
10776,In vivo,,50597,10116.0,Intermediate,1,,A,,Percent oral bioavailability evaluated in rat,,,BAO_0000218,N,,1,,CHEMBL618785,
10777,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL618786,
10778,In vivo,,50597,10116.0,Intermediate,1,,A,,Percent oral bioavailability in rat; Not determined,,,BAO_0000218,N,,1,,CHEMBL618787,
10779,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL618788,
10780,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL618789,
10781,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,,BAO_0000218,N,,1,,CHEMBL618790,
10782,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,,BAO_0000218,N,,1,,CHEMBL618791,
10783,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,,BAO_0000218,N,,1,,CHEMBL875843,
10784,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat (dose 20 mg/kg p.o.),,,BAO_0000218,N,,1,,CHEMBL618792,
10785,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax at a dose of 30 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL623395,
10786,In vivo,,22224,314293.0,Autocuration,1,,A,,Cmax in monkeys at a dose of 1 mg/kg,,,BAO_0000218,U,,0,,CHEMBL623396,
10787,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat,,,BAO_0000218,N,,1,,CHEMBL623397,
10788,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rats at a dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL623398,
10789,In vivo,,50594,10090.0,Intermediate,1,,A,,Cmax was measured in mice after an oral dose of 50 mg/kg.,,,BAO_0000218,N,,1,,CHEMBL623399,
10790,In vivo,,22224,,Autocuration,1,,A,,"Cmax value at a dose of 12.7 uM/kg, po",,,BAO_0000218,U,,0,,CHEMBL623400,
10791,In vivo,,22224,,Autocuration,1,,A,,"Cmax value at a dose of 6.3 uM/kg, iv",,,BAO_0000218,U,,0,,CHEMBL623401,
10792,In vivo,,22224,,Autocuration,1,,A,,"Cmax value at a dose of 7.1 uM/kg, iv",,,BAO_0000218,U,,0,,CHEMBL623402,
10793,In vivo,,22224,,Autocuration,1,,A,,Cmax value of compound was determined after 1 hr,,,BAO_0000218,U,,0,,CHEMBL623403,
10794,In vivo,,22224,,Autocuration,1,,A,,Cmax value of the compound,,,BAO_0000218,U,,0,,CHEMBL623404,
10795,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value administered intraintestinal in rats.,,,BAO_0000218,N,,1,,CHEMBL625997,
10796,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value administered perorally was determined in rat; Not determined,,,BAO_0000218,N,,1,,CHEMBL625998,
10797,In vivo,,22224,,Autocuration,1,,A,,Cmax value at the dose of 2.3 mg/kg,,,BAO_0000218,U,,0,,CHEMBL625999,
10798,In vivo,,22224,,Autocuration,1,,A,,Cmax value at the dose of 5 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626000,
10799,In vivo,,22224,,Autocuration,1,,A,,Cmax value in the period of 8 hr after dosing. ,,,BAO_0000218,U,,0,,CHEMBL626001,
10800,In vivo,,22224,,Autocuration,1,,A,,Cmax value at a oral dose of 20 mg/kg; Not tested,,,BAO_0000218,U,,0,,CHEMBL626002,
10801,In vivo,,22224,,Autocuration,1,,A,,Cmax value at a oral dose of 20 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626003,
10802,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,,BAO_0000218,N,,1,,CHEMBL626004,
10803,In vivo,,50512,10141.0,Intermediate,1,,A,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,,BAO_0000218,N,,1,,CHEMBL626005,
10804,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,,BAO_0000218,N,,1,,CHEMBL626006,
10805,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,,BAO_0000218,N,,1,,CHEMBL626007,
10806,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,,BAO_0000218,N,,1,,CHEMBL626008,
10807,In vivo,2107.0,50588,9615.0,Intermediate,1,Liver,A,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,,BAO_0000218,N,,1,,CHEMBL626009,
10808,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,,BAO_0000218,N,,1,,CHEMBL626010,
10809,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,,BAO_0000218,N,,1,,CHEMBL626011,
10810,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,,BAO_0000218,N,,1,,CHEMBL626012,
10811,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,,BAO_0000218,N,,1,,CHEMBL626013,
10812,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,,BAO_0000218,N,,1,,CHEMBL626014,
10813,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,,BAO_0000218,N,,1,,CHEMBL877496,
10814,In vivo,,50588,9615.0,Intermediate,1,,F,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL626015,
10815,In vivo,,50588,9615.0,Intermediate,1,,F,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL626016,
10816,In vivo,,50588,9615.0,Intermediate,1,,F,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL626017,
10817,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Bioavailability as maximal plasma concentration in dogs,,,BAO_0000218,N,,1,,CHEMBL626018,
10818,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Bioavailability as maximal plasma concentration in dogs,,,BAO_0000218,N,,1,,CHEMBL626692,
10819,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Bioavailability as maximal plasma concentration in rats,,,BAO_0000218,N,,1,,CHEMBL626693,
10820,In vivo,1969.0,22224,10116.0,Autocuration,1,Plasma,A,,Bioavailability as maximal plasma concentration in rats,,,BAO_0000218,U,,0,,CHEMBL626694,
10821,In vivo,178.0,50588,9615.0,Intermediate,1,Blood,A,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,BAO_0000218,N,,1,,CHEMBL626695,
10822,In vivo,178.0,50588,9615.0,Intermediate,1,Blood,A,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,BAO_0000218,N,,1,,CHEMBL626696,
10823,In vivo,178.0,50588,9615.0,Intermediate,1,Blood,A,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,BAO_0000218,N,,1,,CHEMBL626697,
10824,In vivo,178.0,50588,9615.0,Intermediate,1,Blood,A,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,,BAO_0000218,N,,1,,CHEMBL626859,
10825,In vivo,178.0,50588,9615.0,Intermediate,1,Blood,A,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,BAO_0000218,N,,1,,CHEMBL626860,
10826,In vivo,178.0,50588,9615.0,Intermediate,1,Blood,A,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,,BAO_0000218,N,,1,,CHEMBL626861,
10827,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,,BAO_0000218,N,,1,,CHEMBL626296,
10828,In vivo,,22224,,Autocuration,1,,A,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626297,
10829,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,,BAO_0000218,U,,0,,CHEMBL626298,
10830,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,,BAO_0000218,N,,1,,CHEMBL626299,
10831,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,,BAO_0000218,N,,1,,CHEMBL626300,
10832,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,,BAO_0000218,N,,1,,CHEMBL626301,
10833,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,,BAO_0000218,N,,1,,CHEMBL626962,
10834,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,,BAO_0000218,N,,1,,CHEMBL626963,
10835,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,,BAO_0000218,N,,1,,CHEMBL626964,
10836,In vivo,1969.0,100710,9541.0,Intermediate,1,Plasma,A,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,,BAO_0000218,N,,1,,CHEMBL626965,
10837,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL626966,
10838,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL626967,
10839,In vivo,1969.0,100710,9541.0,Intermediate,1,Plasma,A,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,,BAO_0000218,N,,1,,CHEMBL626968,
10840,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,,BAO_0000218,N,,1,,CHEMBL626969,
10841,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,,BAO_0000218,N,,1,,CHEMBL627126,
10842,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,,BAO_0000218,N,,1,,CHEMBL631276,
10843,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,,BAO_0000218,N,,1,,CHEMBL631277,
10844,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,,BAO_0000218,N,,1,,CHEMBL631278,
10845,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,,BAO_0000218,N,,1,,CHEMBL874457,
10846,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,,BAO_0000218,N,,1,,CHEMBL631279,
10847,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,,BAO_0000218,N,,1,,CHEMBL631280,
10848,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,,BAO_0000218,N,,1,,CHEMBL631281,
10849,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,,BAO_0000218,N,,1,,CHEMBL631968,
10850,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,,BAO_0000218,N,,1,,CHEMBL631969,
10851,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,,BAO_0000218,N,,1,,CHEMBL631970,
10852,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,,BAO_0000218,N,,1,,CHEMBL631971,
10853,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,,BAO_0000218,N,,1,,CHEMBL631972,
10854,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,,BAO_0000218,N,,1,,CHEMBL630435,
10855,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,,BAO_0000218,N,,1,,CHEMBL630436,
10856,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,,BAO_0000218,N,,1,,CHEMBL630437,
10857,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,,BAO_0000218,N,,1,,CHEMBL630438,
10858,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,,BAO_0000218,N,,1,,CHEMBL630439,
10859,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,,BAO_0000218,N,,1,,CHEMBL630440,
10860,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,,BAO_0000218,N,,1,,CHEMBL630441,
10861,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,,BAO_0000218,N,,1,,CHEMBL630442,
10862,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,,BAO_0000218,N,,1,,CHEMBL625234,
10863,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,,BAO_0000218,N,,1,,CHEMBL625235,
10864,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,,BAO_0000218,N,,1,,CHEMBL625236,
10865,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,,BAO_0000218,N,,1,,CHEMBL625237,
10866,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,,BAO_0000218,N,,1,,CHEMBL626125,
10867,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,,BAO_0000218,N,,1,,CHEMBL626126,
10868,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,,BAO_0000218,N,,1,,CHEMBL626127,
10869,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,,BAO_0000218,N,,1,,CHEMBL626128,
10870,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,,BAO_0000218,N,,1,,CHEMBL626129,
10871,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,,BAO_0000218,N,,1,,CHEMBL626130,
10872,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,,BAO_0000218,N,,1,,CHEMBL626131,
10873,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,,BAO_0000218,N,,1,,CHEMBL626132,
10874,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,,BAO_0000218,N,,1,,CHEMBL626752,
10875,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,,BAO_0000218,N,,1,,CHEMBL626753,
10876,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,,BAO_0000218,N,,1,,CHEMBL626754,
10877,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,,BAO_0000218,N,,1,,CHEMBL626755,
10878,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,,BAO_0000218,N,,1,,CHEMBL626756,
10879,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,,BAO_0000218,N,,1,,CHEMBL626757,
10880,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,,BAO_0000218,N,,1,,CHEMBL626758,
10881,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,,BAO_0000218,N,,1,,CHEMBL626759,
10882,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,,BAO_0000218,N,,1,,CHEMBL626760,
10883,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL626394,
10884,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL626395,
10885,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL626396,
10886,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,N,,1,,CHEMBL626397,
10887,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,N,,1,,CHEMBL626398,
10888,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL626399,
10889,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL874653,
10890,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL626400,
10891,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL626401,
10892,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,N,,1,,CHEMBL626402,
10893,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL626403,
10894,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL626404,
10895,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL626405,
10896,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL625529,
10897,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL625530,
10898,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,N,,1,,CHEMBL625531,
10899,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL625532,
10900,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL625533,
10901,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL875474,
10902,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL625534,
10903,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL625535,
10904,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,N,,1,,CHEMBL625536,
10905,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL625537,
10906,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL625538,
10907,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL625539,
10908,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL625540,
10909,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL625541,
10910,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,N,,1,,CHEMBL625542,
10911,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL625543,
10912,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL625544,
10913,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL625545,
10914,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL625546,
10915,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL625547,
10916,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL625548,
10917,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL625549,
10918,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL625550,
10919,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL625551,
10920,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL875475,
10921,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL625552,
10922,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL625553,
10923,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,N,,1,,CHEMBL625554,
10924,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,N,,1,,CHEMBL625555,
10925,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL625556,
10926,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL624986,
10927,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL624987,
10928,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,N,,1,,CHEMBL624988,
10929,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,,BAO_0000218,N,,1,,CHEMBL624989,
10930,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,,BAO_0000218,N,,1,,CHEMBL624990,
10931,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,,BAO_0000218,N,,1,,CHEMBL874391,
10932,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,,BAO_0000218,N,,1,,CHEMBL624991,
10933,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,,BAO_0000218,N,,1,,CHEMBL624992,
10934,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,,BAO_0000218,N,,1,,CHEMBL624993,
10935,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,,BAO_0000218,N,,1,,CHEMBL624994,
10936,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,,BAO_0000218,N,,1,,CHEMBL624995,
10937,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,,BAO_0000218,N,,1,,CHEMBL624996,
10938,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,,BAO_0000218,N,,1,,CHEMBL624997,
10939,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,,BAO_0000218,N,,1,,CHEMBL624998,
10940,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,,BAO_0000218,N,,1,,CHEMBL624999,
10941,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,,BAO_0000218,N,,1,,CHEMBL882955,
10942,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,,BAO_0000218,N,,1,,CHEMBL625000,
10943,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,,BAO_0000218,N,,1,,CHEMBL625001,
10944,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,,BAO_0000218,N,,1,,CHEMBL625089,
10945,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,,BAO_0000218,N,,1,,CHEMBL625090,
10946,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,,BAO_0000218,N,,1,,CHEMBL625091,
10947,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,,BAO_0000218,N,,1,,CHEMBL625092,
10948,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,,BAO_0000218,N,,1,,CHEMBL625093,
10949,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,,BAO_0000218,N,,1,,CHEMBL625094,
10950,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,,BAO_0000218,N,,1,,CHEMBL625095,
10951,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for its bioavailability in the dogs,,,BAO_0000218,N,,1,,CHEMBL625096,
10952,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for its bioavailability in the rats,,,BAO_0000218,N,,1,,CHEMBL625097,
10953,In vivo,,22224,,Autocuration,1,,A,,Compound was evaluated for oral bioavailability,,,BAO_0000218,U,,0,,CHEMBL882956,
10954,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for percentage of Oral bioavailability in rats,,,BAO_0000218,N,,1,,CHEMBL625098,
10955,In vivo,,22224,10141.0,Autocuration,1,,A,,Bioavailability in guinea pig,,,BAO_0000218,U,,0,,CHEMBL625099,
10956,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for the oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL625100,
10957,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for the oral bioavailability in dog,,,BAO_0000218,N,,1,,CHEMBL625101,
10958,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for the oral bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL874396,
10959,In vivo,,22224,9615.0,Autocuration,1,,F,,Bioavailability in dog (dosed i.v.),,,BAO_0000218,U,,0,,CHEMBL625102,
10960,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was tested for in vivo bioavailability in dog,,,BAO_0000218,N,,1,,CHEMBL625103,
10961,In vivo,,100712,10026.0,Intermediate,1,,A,,Compound was tested for in vivo bioavailability in hamsters,,,BAO_0000218,N,,1,,CHEMBL625104,
10962,In vivo,,22224,314293.0,Autocuration,1,,A,,Compound was tested for in vivo bioavailability in monkey,,,BAO_0000218,U,,0,,CHEMBL625105,
10963,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was tested for in vivo bioavailability in rat,,,BAO_0000218,N,,1,,CHEMBL625106,
10964,In vivo,,22224,10090.0,Autocuration,1,,A,,Oral bioavailability in mouse,,,BAO_0000218,U,,0,,CHEMBL625107,
10965,In vivo,,50594,10090.0,Intermediate,1,,A,,Compound was tested for percent of oral bioavailability in mice; 56-74,,,BAO_0000218,N,,1,,CHEMBL625108,
10966,In vivo,,22224,10090.0,Autocuration,1,,A,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,,BAO_0000218,U,,0,,CHEMBL625109,
10967,In vivo,,22224,9541.0,Autocuration,1,,A,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,,BAO_0000218,U,,0,,CHEMBL625110,
10968,In vivo,,22224,9541.0,Autocuration,1,,A,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,,BAO_0000218,U,,0,,CHEMBL625111,
10969,In vivo,,50594,10090.0,Intermediate,1,,A,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,,BAO_0000218,N,,1,,CHEMBL625112,
10970,In vivo,,50594,10090.0,Intermediate,1,,A,,Oral bioavailability in nude mice,,,BAO_0000218,N,,1,,CHEMBL875334,
10971,In vivo,,22224,9443.0,Autocuration,1,,A,,Bioavailability in monkey (i.d. dosing),,,BAO_0000218,U,,0,,CHEMBL628617,
10972,In vivo,,22224,10116.0,Autocuration,1,,A,,Bioavailability in rat,,,BAO_0000218,U,,0,,CHEMBL628618,
10973,In vivo,,22224,,Autocuration,1,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,,BAO_0000218,U,,0,,CHEMBL628619,
10974,In vivo,,22224,,Autocuration,1,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,,BAO_0000218,U,,0,,CHEMBL628620,
10975,In vivo,,100710,9541.0,Intermediate,1,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,BAO_0000218,N,,1,,CHEMBL628621,
10976,In vivo,,100710,9541.0,Intermediate,1,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,BAO_0000218,N,,1,,CHEMBL628622,
10977,In vivo,,100710,9541.0,Intermediate,1,,A,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,,BAO_0000218,N,,1,,CHEMBL628623,
10978,In vivo,1969.0,100710,9541.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL628624,
10979,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL628625,
10980,In vivo,1969.0,100710,9541.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL628626,
10981,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL627041,
10982,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL627042,
10983,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL627043,
10984,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,,BAO_0000218,U,,0,,CHEMBL627044,
10985,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Cmax in mouse plasma,,,BAO_0000218,N,,1,,CHEMBL627045,
10986,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,,BAO_0000218,U,,0,,CHEMBL627046,
10987,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in rat,,,BAO_0000218,N,,1,,CHEMBL627047,
10988,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,,BAO_0000218,N,,1,,CHEMBL627048,
10989,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627049,
10990,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627050,
10991,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627051,
10992,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627052,
10993,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627053,
10994,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627054,
10995,In vivo,,50594,10090.0,Intermediate,1,,A,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627055,
10996,In vivo,,50594,10090.0,Intermediate,1,,A,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627056,
10997,In vivo,,50594,10090.0,Intermediate,1,,A,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,,BAO_0000218,N,,1,,CHEMBL627057,
10998,In vivo,,50594,10090.0,Intermediate,1,,A,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL627058,
10999,In vivo,,50594,10090.0,Intermediate,1,,A,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626211,
11000,In vivo,,22224,,Autocuration,1,,A,,Maximum Concentration of the compound.,,,BAO_0000218,U,,0,,CHEMBL626212,
11001,In vivo,,50588,9615.0,Intermediate,1,,A,,Maximum Concentration was measured after iv administration into Beagle dog,,,BAO_0000218,N,,1,,CHEMBL626213,
11002,In vivo,,50588,9615.0,Intermediate,1,,A,,Maximum Concentration was measured after iv administration into Beagle dog.,,,BAO_0000218,N,,1,,CHEMBL626214,
11003,In vivo,,50588,9615.0,Intermediate,1,,A,,Maximum Concentration was measured after po administration into Beagle dog,,,BAO_0000218,N,,1,,CHEMBL626215,
11004,In vivo,,50588,9615.0,Intermediate,1,,A,,Maximum Concentration was measured after po administration into Beagle dog.,,,BAO_0000218,N,,1,,CHEMBL626216,
11005,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,,BAO_0000218,U,,0,,CHEMBL626217,
11006,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Maximum blood level reached after an iv dose of 12.2 uM/kg,,,BAO_0000218,U,,0,,CHEMBL626218,
11007,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,,BAO_0000218,U,,0,,CHEMBL626219,
11008,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,,BAO_0000218,U,,0,,CHEMBL626220,
11009,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Maximum blood level reached after an oral dose of 5.0 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626221,
11010,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Maximum blood level reached at dose of 10.6 uM/kg orally,,,BAO_0000218,U,,0,,CHEMBL626222,
11011,In vivo,,50512,10141.0,Intermediate,1,,A,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,,BAO_0000218,N,,1,,CHEMBL626223,
11012,In vivo,,50512,10141.0,Intermediate,1,,A,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,,BAO_0000218,N,,1,,CHEMBL626224,
11013,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626225,
11014,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626226,
11015,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626227,
11016,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626228,
11017,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626229,
11018,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626921,
11019,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,,BAO_0000218,N,,1,,CHEMBL876793,
11020,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625309,
11021,In vivo,,50278,1423.0,Intermediate,1,,A,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,,BAO_0000218,N,,1,,CHEMBL625310,
11022,In vivo,,22224,314293.0,Autocuration,1,,A,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,,BAO_0000218,U,,0,,CHEMBL625311,
11023,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625312,
11024,In vivo,,22224,,Autocuration,1,,A,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,,BAO_0000218,U,,0,,CHEMBL625313,
11025,In vivo,,50594,10090.0,Intermediate,1,,A,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625314,
11026,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration in male rats after iv administration of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625315,
11027,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,,BAO_0000218,N,,1,,CHEMBL625316,
11028,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,,BAO_0000218,N,,1,,CHEMBL625317,
11029,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,,BAO_0000218,N,,1,,CHEMBL625318,
11030,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,,BAO_0000218,N,,1,,CHEMBL625319,
11031,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,,BAO_0000218,N,,1,,CHEMBL625320,
11032,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,,BAO_0000218,N,,1,,CHEMBL625321,
11033,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,,BAO_0000218,N,,1,,CHEMBL625322,
11034,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,,BAO_0000218,N,,1,,CHEMBL876801,
11035,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,,BAO_0000218,N,,1,,CHEMBL625323,
11036,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,,BAO_0000218,N,,1,,CHEMBL625324,
11037,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,,BAO_0000218,N,,1,,CHEMBL625325,
11038,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,,BAO_0000218,N,,1,,CHEMBL625326,
11039,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,,BAO_0000218,N,,1,,CHEMBL625327,
11040,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,,BAO_0000218,N,,1,,CHEMBL625328,
11041,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,,BAO_0000218,N,,1,,CHEMBL625329,
11042,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,,BAO_0000218,N,,1,,CHEMBL625330,
11043,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,,BAO_0000218,N,,1,,CHEMBL627774,
11044,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,,BAO_0000218,N,,1,,CHEMBL627775,
11045,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,,BAO_0000218,N,,1,,CHEMBL627949,
11046,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,,BAO_0000218,N,,1,,CHEMBL627950,
11047,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,,BAO_0000218,N,,1,,CHEMBL627951,
11048,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,,BAO_0000218,N,,1,,CHEMBL627952,
11049,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,,BAO_0000218,N,,1,,CHEMBL627953,
11050,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,,BAO_0000218,N,,1,,CHEMBL627954,
11051,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,,BAO_0000218,N,,1,,CHEMBL627955,
11052,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,,BAO_0000218,N,,1,,CHEMBL627956,
11053,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,,BAO_0000218,N,,1,,CHEMBL876802,
11054,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,,BAO_0000218,N,,1,,CHEMBL627957,
11055,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,,BAO_0000218,N,,1,,CHEMBL627958,
11056,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,,BAO_0000218,N,,1,,CHEMBL627959,
11057,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,,BAO_0000218,N,,1,,CHEMBL627960,
11058,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,,BAO_0000218,N,,1,,CHEMBL627961,
11059,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,,BAO_0000218,N,,1,,CHEMBL627962,
11060,,,50597,10116.0,Intermediate,1,,A,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL627963,
11061,,,50597,10116.0,Intermediate,1,,A,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL624759,
11062,,,50597,10116.0,Intermediate,1,,A,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL624760,
11063,,,50597,10116.0,Intermediate,1,,A,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL624761,
11064,,,50597,10116.0,Intermediate,1,,A,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL877607,
11065,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL624762,
11066,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL624763,
11067,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL624764,
11068,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL624765,
11069,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL624766,
11070,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL624767,
11071,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL624768,
11072,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL624769,
11073,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,N,,1,,CHEMBL624770,
11074,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,N,,1,,CHEMBL624771,
11075,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL624772,
11076,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL624773,
11077,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL624774,
11078,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL624775,
11079,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,N,,1,,CHEMBL624776,
11080,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL624777,
11081,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL624778,
11082,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL624779,
11083,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,N,,1,,CHEMBL624780,
11084,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL624781,
11085,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL877608,
11086,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL624782,
11087,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL624783,
11088,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL624784,
11089,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL624785,
11090,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL624786,
11091,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL624787,
11092,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL628676,
11093,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL621842,
11094,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL621843,
11095,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL623873,
11096,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,N,,1,,CHEMBL623874,
11097,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL623875,
11098,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL623876,
11099,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL623877,
11100,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL623878,
11101,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL623879,
11102,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL623880,
11103,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL623881,
11104,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL623957,
11105,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL623958,
11106,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL623959,
11107,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL623960,
11108,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL623961,
11109,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,N,,1,,CHEMBL623962,
11110,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,N,,1,,CHEMBL624676,
11111,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL624677,
11112,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL624678,
11113,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL624679,
11114,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,N,,1,,CHEMBL624680,
11115,In vivo,,22224,,Autocuration,1,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,,BAO_0000218,U,,0,,CHEMBL624849,
11116,In vivo,,22224,,Autocuration,1,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,,BAO_0000218,U,,0,,CHEMBL624850,
11117,In vivo,,22224,,Autocuration,1,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,,BAO_0000218,U,,0,,CHEMBL874399,
11118,In vivo,,22224,,Autocuration,1,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,,BAO_0000218,U,,0,,CHEMBL624851,
11119,In vivo,,22224,,Autocuration,1,,A,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,,BAO_0000218,U,,0,,CHEMBL624852,
11120,In vivo,,22224,10116.0,Autocuration,1,,A,,Oral bioavailability in rat (dose 10 mg/kg),,,BAO_0000218,U,,0,,CHEMBL624853,
11121,In vivo,,22224,10116.0,Autocuration,1,,A,,Oral bioavailability in rat (Sprague-Dawley),,,BAO_0000218,U,,0,,CHEMBL624854,
11122,In vivo,,22224,10116.0,Autocuration,1,,A,,Oral bioavailability in rat,,,BAO_0000218,U,,0,,CHEMBL624855,
11123,In vivo,,22224,10116.0,Autocuration,1,,A,,Oral bioavailability in rats was determined in vivo,,,BAO_0000218,U,,0,,CHEMBL624856,
11124,In vivo,,22224,9615.0,Autocuration,1,,A,,Oral bioavailability in dog,,,BAO_0000218,U,,0,,CHEMBL882957,
11125,In vivo,,22224,314293.0,Autocuration,1,,A,,Oral bioavailability of compound in monkey,,,BAO_0000218,U,,0,,CHEMBL624857,
11126,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound in rat,,,BAO_0000218,N,,1,,CHEMBL622202,
11127,In vivo,,22224,10116.0,Autocuration,1,,A,,Bioavailability in rat of PMEA prodrug,,,BAO_0000218,U,,0,,CHEMBL622203,
11128,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,,BAO_0000218,N,,1,,CHEMBL625522,
11129,In vivo,,22224,9544.0,Autocuration,1,,A,,Serum conc at 3 hours following 25 mg/kg dose,,,BAO_0000218,U,,0,,CHEMBL622868,
11130,In vivo,1088.0,22224,9544.0,Autocuration,1,Urine,A,,Urine conc 0-5 hours following 25 mg/kg dose,,,BAO_0000218,U,,0,,CHEMBL622869,
11131,In vivo,1088.0,22224,9544.0,Autocuration,1,Urine,A,,Urine conc 0-24 hours following 25 mg/kg dose,,,BAO_0000218,U,,0,,CHEMBL622870,
11132,In vivo,,22224,9534.0,Autocuration,1,,A,,Oral bioavailability in African green monkeys; 20-25,,,BAO_0000218,U,,0,,CHEMBL622871,
11133,In vivo,,100710,9541.0,Intermediate,1,,A,,Oral bioavailability in cynomolgus monkey.,,,BAO_0000218,N,,1,,CHEMBL620560,
11134,In vivo,,22224,9615.0,Autocuration,1,,A,,Oral bioavailability in dog,,,BAO_0000218,U,,0,,CHEMBL620561,
11135,In vivo,,50588,9615.0,Intermediate,1,,A,,Oral bioavailability in dog at 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL620562,
11136,In vivo,,100712,10026.0,Intermediate,1,,A,,Oral bioavailability in hamster at 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL620563,
11137,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability in rat at 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL620564,
11138,In vivo,,22224,10116.0,Autocuration,1,,A,,Oral bioavailability in rat,,,BAO_0000218,U,,0,,CHEMBL872265,
11139,In vivo,,22224,10116.0,Autocuration,1,,A,,Oral bioavailability in rat,,,BAO_0000218,U,,0,,CHEMBL620565,
11140,In vivo,,22224,9347.0,Autocuration,1,,A,,Oral bioavailability,,,BAO_0000218,U,,0,,CHEMBL620566,
11141,In vivo,,22224,,Autocuration,1,,A,,Oral bioavailability was determined; range 49-102%,,,BAO_0000218,U,,0,,CHEMBL620567,
11142,In vivo,,50588,9615.0,Intermediate,1,,A,,Oral bioavailability was determined in dogs,,,BAO_0000218,N,,1,,CHEMBL620568,
11143,In vivo,,22224,10116.0,Autocuration,1,,A,,Oral bioavailability in rat,,,BAO_0000218,U,,0,,CHEMBL620569,
11144,In vivo,,22224,9347.0,Autocuration,1,,A,,Oral bioavailability,,,BAO_0000218,U,,0,,CHEMBL620570,
11145,In vivo,,22224,,Autocuration,1,,A,,Oral bioavailability was determined; Not orally available,,,BAO_0000218,U,,0,,CHEMBL620571,
11146,In vivo,,50594,10090.0,Intermediate,1,,A,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,,BAO_0000218,N,,1,,CHEMBL620572,
11147,In vivo,,22224,10090.0,Autocuration,1,,A,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,,BAO_0000218,U,,0,,CHEMBL620573,
11148,In vivo,,22224,10090.0,Autocuration,1,,A,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,,BAO_0000218,U,,0,,CHEMBL620574,
11149,In vivo,,22224,9544.0,Autocuration,1,,A,,Oral bioavailability in Rhesus monkey,,,BAO_0000218,U,,0,,CHEMBL620575,
11150,In vivo,,22224,9615.0,Autocuration,1,,A,,Oral bioavailability in dog (female mongrel),,,BAO_0000218,U,,0,,CHEMBL620576,
11151,In vivo,,22224,,Autocuration,1,,A,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,,BAO_0000218,U,,0,,CHEMBL875846,
11152,In vivo,,22224,9615.0,Autocuration,1,,A,,Oral bioavailability in dog,,,BAO_0000218,U,,0,,CHEMBL620577,
11153,In vivo,,22224,,Autocuration,1,,A,,Percentage Bioavailability was evaluated.,,,BAO_0000218,U,,0,,CHEMBL620578,
11154,In vivo,,22224,10116.0,Autocuration,1,,A,,Bioavailability in rat administered i.d.,,,BAO_0000218,U,,0,,CHEMBL620579,
11155,In vivo,,22224,9347.0,Autocuration,1,,A,,Bioavailability,,,BAO_0000218,U,,0,,CHEMBL621248,
11156,In vivo,,22224,9615.0,Autocuration,1,,A,,Bioavailability in dog (male Beagle) i.v. administration,,,BAO_0000218,U,,0,,CHEMBL625390,
11157,In vivo,,22224,10116.0,Autocuration,1,,A,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,,BAO_0000218,U,,0,,CHEMBL625391,
11158,In vivo,,22224,9443.0,Autocuration,1,,A,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,,BAO_0000218,U,,0,,CHEMBL872266,
11159,In vivo,,22224,10116.0,Autocuration,1,,A,,Oral bioavailability in rat (Sprague-Dawley) (male),,,BAO_0000218,U,,0,,CHEMBL625392,
11160,In vivo,,50597,10116.0,Intermediate,1,,A,,The oral bioavailability was measured on rats after oral administration,,,BAO_0000218,N,,1,,CHEMBL625393,
11161,In vivo,,50597,10116.0,Intermediate,1,,A,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625394,
11162,In vivo,,50797,9544.0,Intermediate,1,,A,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625395,
11163,In vivo,,22224,10116.0,Autocuration,1,,A,,Bioavailability in rat (dose 10 mg/kg i.d.),,,BAO_0000218,U,,0,,CHEMBL625396,
11164,In vivo,,22224,9615.0,Autocuration,1,,A,,Bioavailability in dog (male Beagle) i.v. administration,,,BAO_0000218,U,,0,,CHEMBL625397,
11165,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL625398,
11166,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL625399,
11167,In vivo,2037.0,50594,10090.0,Intermediate,1,Cerebellum,A,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL626074,
11168,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL626075,
11169,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626076,
11170,In vivo,1969.0,50797,9544.0,Intermediate,1,Plasma,A,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626077,
11171,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,,BAO_0000218,N,,1,,CHEMBL626078,
11172,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,,BAO_0000218,U,,0,,CHEMBL625846,
11173,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,,BAO_0000218,U,,0,,CHEMBL625847,
11174,In vivo,,50597,10116.0,Expert,1,,A,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625848,
11175,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration of compound in plasma administered orally to rats,,,BAO_0000218,N,,1,,CHEMBL625849,
11176,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,,BAO_0000218,N,,1,,CHEMBL626023,
11177,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,,BAO_0000218,N,,1,,CHEMBL626024,
11178,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,,BAO_0000218,N,,1,,CHEMBL626025,
11179,In vivo,,22224,,Autocuration,1,,A,,Maximum concentration after 10 mg/kg by oral administration,,,BAO_0000218,U,,0,,CHEMBL626026,
11180,In vivo,,22224,,Autocuration,1,,A,,Maximum concentration at a dose of 1.5 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626027,
11181,In vivo,,22224,,Autocuration,1,,A,,Maximum concentration at a dose of 2.0 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626028,
11182,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximum concentration in dog plasma,,,BAO_0000218,N,,1,,CHEMBL626029,
11183,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,,BAO_0000218,U,,0,,CHEMBL626030,
11184,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,,BAO_0000218,U,,0,,CHEMBL626031,
11185,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,,BAO_0000218,U,,0,,CHEMBL626032,
11186,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,,BAO_0000218,U,,0,,CHEMBL626033,
11187,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,,BAO_0000218,U,,0,,CHEMBL626034,
11188,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,,BAO_0000218,N,,1,,CHEMBL626035,
11189,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum concentration in plasma at Tmax,,,BAO_0000218,U,,0,,CHEMBL626036,
11190,In vivo,1969.0,50588,9615.0,Expert,1,Plasma,A,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL626037,
11191,In vivo,1969.0,100712,10026.0,Intermediate,1,Plasma,A,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL626038,
11192,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL626039,
11193,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626040,
11194,In vivo,1969.0,50592,9986.0,Intermediate,1,Plasma,A,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626041,
11195,In vivo,,22224,,Autocuration,1,,A,,Maximum concentration was calculated,,,BAO_0000218,U,,0,,CHEMBL626042,
11196,In vivo,,22224,,Autocuration,1,,A,,Maximum concentration was calculated.,,,BAO_0000218,U,,0,,CHEMBL626043,
11197,In vivo,,22224,,Autocuration,1,,A,,Maximum concentration at a peroral dose of 10 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626044,
11198,In vivo,,22224,,Autocuration,1,,A,,Maximum concentration of the drug at 10 uM/dg administered perorally,,,BAO_0000218,U,,0,,CHEMBL626045,
11199,In vivo,,22224,,Autocuration,1,,A,,Maximum concentration of the drug at 2 uM/dg administered intravenously,,,BAO_0000218,U,,0,,CHEMBL626046,
11200,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,,BAO_0000218,N,,1,,CHEMBL626047,
11201,In vivo,1969.0,100712,10026.0,Intermediate,1,Plasma,A,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,,BAO_0000218,N,,1,,CHEMBL626048,
11202,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,,BAO_0000218,N,,1,,CHEMBL626049,
11203,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL626050,
11204,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL874541,
11205,In vivo,1969.0,100712,10026.0,Intermediate,1,Plasma,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL622826,
11206,In vivo,1969.0,100712,10026.0,Intermediate,1,Plasma,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL622827,
11207,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL622828,
11208,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,,BAO_0000218,N,,1,,CHEMBL622829,
11209,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration reached following intravenous administration in male rat,,,BAO_0000218,N,,1,,CHEMBL876806,
11210,In vivo,,50588,9615.0,Intermediate,1,,A,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,,BAO_0000218,N,,1,,CHEMBL622830,
11211,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,,BAO_0000218,N,,1,,CHEMBL622831,
11212,In vivo,,50588,9615.0,Intermediate,1,,A,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL626794,
11213,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL626795,
11214,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL626796,
11215,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL626797,
11216,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum drug concentration is determined after oral dosing in rats.,,,BAO_0000218,N,,1,,CHEMBL626798,
11217,In vivo,,50588,9615.0,Intermediate,1,,A,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,,BAO_0000218,N,,1,,CHEMBL626799,
11218,In vivo,,50588,9615.0,Intermediate,1,,A,,Maximum observed concentration in oral (5 mg/kg) fed dogs,,,BAO_0000218,N,,1,,CHEMBL626800,
11219,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration,,,BAO_0000218,U,,0,,CHEMBL626801,
11220,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,,BAO_0000218,N,,1,,CHEMBL876816,
11221,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL626802,
11222,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,,BAO_0000218,N,,1,,CHEMBL626803,
11223,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration following oral administration of 30 umol/kg,,,BAO_0000218,U,,0,,CHEMBL626804,
11224,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,,BAO_0000218,N,,1,,CHEMBL626805,
11225,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL626309,
11226,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL626310,
11227,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL626311,
11228,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL626312,
11229,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL626313,
11230,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL626314,
11231,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL626315,
11232,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL626316,
11233,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,,BAO_0000218,N,,1,,CHEMBL626317,
11234,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,N,,1,,CHEMBL626318,
11235,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,N,,1,,CHEMBL626319,
11236,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,N,,1,,CHEMBL626320,
11237,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,N,,1,,CHEMBL875053,
11238,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,N,,1,,CHEMBL626321,
11239,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,N,,1,,CHEMBL626322,
11240,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,N,,1,,CHEMBL626323,
11241,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,N,,1,,CHEMBL626324,
11242,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,N,,1,,CHEMBL626325,
11243,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,N,,1,,CHEMBL626326,
11244,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,,BAO_0000218,N,,1,,CHEMBL626327,
11245,,,50597,10116.0,Intermediate,1,,A,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,,BAO_0000218,N,,1,,CHEMBL626328,
11246,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL626329,
11247,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL626330,
11248,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL626331,
11249,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL626332,
11250,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL626333,
11251,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL626334,
11252,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL626335,
11253,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624798,
11254,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624799,
11255,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624800,
11256,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624801,
11257,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624802,
11258,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624803,
11259,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624804,
11260,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624805,
11261,,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624806,
11262,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624807,
11263,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624808,
11264,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624809,
11265,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624810,
11266,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL877618,
11267,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624811,
11268,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624812,
11269,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624813,
11270,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624814,
11271,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624815,
11272,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624816,
11273,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624817,
11274,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL624818,
11275,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL624819,
11276,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL624820,
11277,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,N,,1,,CHEMBL624821,
11278,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,N,,1,,CHEMBL624822,
11279,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL624823,
11280,,,50212,562.0,Intermediate,1,,A,,Observed diffusion coefficient in organic solvent for Escherichia coli,,,BAO_0000218,N,,1,,CHEMBL624824,
11281,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,N,,1,,CHEMBL624825,
11282,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,N,,1,,CHEMBL624826,
11283,,2081.0,50597,10116.0,Intermediate,1,Cardiac atrium,A,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,N,,1,,CHEMBL876817,
11284,,2081.0,50597,10116.0,Intermediate,1,Cardiac atrium,A,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,N,,1,,CHEMBL624827,
11285,,,50597,10116.0,Intermediate,1,,A,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,N,,1,,CHEMBL624828,
11286,,,50597,10116.0,Intermediate,1,,A,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,N,,1,,CHEMBL624829,
11287,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,N,,1,,CHEMBL624830,
11288,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,N,,1,,CHEMBL624831,
11289,,2081.0,50597,10116.0,Intermediate,1,Cardiac atrium,A,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,N,,1,,CHEMBL624832,
11290,,2081.0,50597,10116.0,Intermediate,1,Cardiac atrium,A,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,N,,1,,CHEMBL624833,
11291,,,50597,10116.0,Intermediate,1,,A,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,N,,1,,CHEMBL624834,
11292,,,50597,10116.0,Intermediate,1,,A,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,N,,1,,CHEMBL624835,
11293,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,,BAO_0000218,N,,1,,CHEMBL624836,
11294,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,,BAO_0000218,N,,1,,CHEMBL624837,
11295,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL624838,
11296,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL622188,
11297,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL622189,
11298,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,,BAO_0000218,N,,1,,CHEMBL622190,
11299,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL625170,
11300,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL625171,
11301,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL625172,
11302,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL625173,
11303,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL625174,
11304,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL625175,
11305,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,,BAO_0000218,N,,1,,CHEMBL625176,
11306,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL625177,
11307,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL625178,
11308,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,,BAO_0000218,N,,1,,CHEMBL625179,
11309,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,,BAO_0000218,N,,1,,CHEMBL625180,
11310,,,22224,,Autocuration,1,,A,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,,BAO_0000218,U,,0,,CHEMBL625181,
11311,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,,BAO_0000218,N,,1,,CHEMBL625182,
11312,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL625183,
11313,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL875848,
11314,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL622260,
11315,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL622261,
11316,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL622262,
11317,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL622263,
11318,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL622418,
11319,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL622419,
11320,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL623388,
11321,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL623389,
11322,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL623390,
11323,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL623391,
11324,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL623392,
11325,In vivo,2037.0,50594,10090.0,Intermediate,1,Cerebellum,A,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL623393,
11326,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL623394,
11327,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL618885,
11328,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL618886,
11329,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL618887,
11330,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL619535,
11331,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL619536,
11332,In vivo,2037.0,50594,10090.0,Intermediate,1,Cerebellum,A,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL619537,
11333,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL619705,
11334,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL619706,
11335,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL619707,
11336,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL619708,
11337,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL625219,
11338,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL625220,
11339,In vivo,2037.0,50594,10090.0,Intermediate,1,Cerebellum,A,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL625221,
11340,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL625222,
11341,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL625223,
11342,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL625224,
11343,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,,BAO_0000218,N,,1,,CHEMBL625225,
11344,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in Rat blood after 24 hours of iv administration,,,BAO_0000218,N,,1,,CHEMBL625226,
11345,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL625227,
11346,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in Rat blood after 30 minutes of iv administration,,,BAO_0000218,N,,1,,CHEMBL625228,
11347,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL875354,
11348,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in Rat blood after 5 minutes of iv administration,,,BAO_0000218,N,,1,,CHEMBL625229,
11349,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL625230,
11350,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in Rat heart after 24 hours of iv administration,,,BAO_0000218,N,,1,,CHEMBL625231,
11351,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL625900,
11352,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in Rat heart after 30 minutes of iv administration,,,BAO_0000218,N,,1,,CHEMBL625901,
11353,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL625902,
11354,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in Rat heart after 5 minutes of iv administration,,,BAO_0000218,N,,1,,CHEMBL625903,
11355,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL625904,
11356,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in Rat liver after 24 hours of iv administration,,,BAO_0000218,N,,1,,CHEMBL625905,
11357,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL627861,
11358,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in Rat liver after 30 minutes of iv administration,,,BAO_0000218,N,,1,,CHEMBL627862,
11359,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL627863,
11360,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in Rat liver after 30 minutes of iv administration,,,BAO_0000218,N,,1,,CHEMBL627769,
11361,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,,BAO_0000218,N,,1,,CHEMBL627770,
11362,In vivo,,100710,9541.0,Intermediate,1,,A,,Cmax in cynomolgus monkey (PO dose),,,BAO_0000218,N,,1,,CHEMBL627771,
11363,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat (PO dose),,,BAO_0000218,N,,1,,CHEMBL627772,
11364,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax in rat (PO dose),,,BAO_0000218,N,,1,,CHEMBL627773,
11365,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621922,
11366,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Cmax in rat plasma after oral dose (10 mg/kg),,,BAO_0000218,N,,1,,CHEMBL621923,
11367,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Cmax in plasma after oral dose (10 mg/kg),,,BAO_0000218,U,,0,,CHEMBL621924,
11368,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,,BAO_0000218,N,,1,,CHEMBL621925,
11369,In vivo,1969.0,22224,314293.0,Autocuration,1,Plasma,A,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL621926,
11370,In vivo,1969.0,50592,9986.0,Intermediate,1,Plasma,A,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,,BAO_0000218,N,,1,,CHEMBL621927,
11371,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,,BAO_0000218,N,,1,,CHEMBL621928,
11372,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,,BAO_0000218,N,,1,,CHEMBL621929,
11373,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,,BAO_0000218,N,,1,,CHEMBL621930,
11374,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration after oral dosing in rat,,,BAO_0000218,N,,1,,CHEMBL621931,
11375,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL621932,
11376,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL621933,
11377,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,,BAO_0000218,N,,1,,CHEMBL621934,
11378,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,,BAO_0000218,N,,1,,CHEMBL621935,
11379,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,,BAO_0000218,N,,1,,CHEMBL621936,
11380,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration was determined,,,BAO_0000218,U,,0,,CHEMBL621937,
11381,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL621938,
11382,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL621939,
11383,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL621940,
11384,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL621941,
11385,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL621942,
11386,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL626178,
11387,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL626179,
11388,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL626180,
11389,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma Cmax in rat (PO dose),,,BAO_0000218,N,,1,,CHEMBL626181,
11390,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL626182,
11391,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL626183,
11392,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL626184,
11393,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL626185,
11394,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,,BAO_0000218,N,,1,,CHEMBL626186,
11395,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,,BAO_0000218,N,,1,,CHEMBL877589,
11396,In vivo,,22224,,Autocuration,1,,A,,Maximum concentration of the drug at 1 uM/dg administered intravenously,,,BAO_0000218,U,,0,,CHEMBL626187,
11397,In vivo,,22224,,Autocuration,1,,A,,Maximum concentration of the drug at 20 uM/dg administered perorally,,,BAO_0000218,U,,0,,CHEMBL626188,
11398,In vivo,,22224,,Autocuration,1,,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,,BAO_0000218,U,,0,,CHEMBL626189,
11399,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,U,,0,,CHEMBL626855,
11400,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,U,,0,,CHEMBL623781,
11401,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,U,,0,,CHEMBL623782,
11402,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL623783,
11403,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Cmax in dog plasma after 1mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL623784,
11404,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL623785,
11405,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL623786,
11406,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral maximum concentration in rat,,,BAO_0000218,N,,1,,CHEMBL623787,
11407,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral maximum concentration in rat,,,BAO_0000218,N,,1,,CHEMBL623788,
11408,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,,BAO_0000218,N,,1,,CHEMBL623789,
11409,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Peak concentration in blood after intravenous administration to mice,,,BAO_0000218,N,,1,,CHEMBL623790,
11410,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Peak concentration in blood after peroral administration to mice,,,BAO_0000218,N,,1,,CHEMBL623791,
11411,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Peak concentration in rat plasma was determined,,,BAO_0000218,N,,1,,CHEMBL623792,
11412,In vivo,1969.0,22224,314293.0,Autocuration,1,Plasma,A,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,,BAO_0000218,U,,0,,CHEMBL623793,
11413,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,,BAO_0000218,N,,1,,CHEMBL623794,
11414,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,,BAO_0000218,N,,1,,CHEMBL623795,
11415,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623796,
11416,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623797,
11417,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623798,
11418,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623799,
11419,,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624490,
11420,,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624491,
11421,,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624492,
11422,,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624493,
11423,,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL877595,
11424,,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624494,
11425,,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624495,
11426,,160.0,50597,10116.0,Intermediate,1,Intestine,A,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624681,
11427,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624682,
11428,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624683,
11429,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624684,
11430,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624685,
11431,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624686,
11432,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624687,
11433,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624688,
11434,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL627161,
11435,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL622127,
11436,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL622128,
11437,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL874384,
11438,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624898,
11439,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624899,
11440,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624900,
11441,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624901,
11442,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624902,
11443,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624903,
11444,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624904,
11445,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624905,
11446,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624906,
11447,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624907,
11448,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624908,
11449,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624909,
11450,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624910,
11451,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624911,
11452,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL874388,
11453,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL624912,
11454,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL622930,
11455,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623121,
11456,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623122,
11457,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623123,
11458,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623124,
11459,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623125,
11460,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623126,
11461,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623127,
11462,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623128,
11463,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623129,
11464,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623130,
11465,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623131,
11466,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL623132,
11467,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL623133,
11468,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL623134,
11469,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL874389,
11470,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL623135,
11471,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL623136,
11472,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL623137,
11473,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL623138,
11474,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL623139,
11475,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL623140,
11476,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL623141,
11477,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL623142,
11478,,,50597,10116.0,Intermediate,1,,A,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL623143,
11479,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,,BAO_0000218,N,,1,,CHEMBL623144,
11480,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,,BAO_0000218,N,,1,,CHEMBL623405,
11481,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL624074,
11482,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL624075,
11483,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL624076,
11484,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL624077,
11485,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL624078,
11486,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL624079,
11487,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL624261,
11488,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL624262,
11489,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL624263,
11490,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL624264,
11491,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL624265,
11492,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL624266,
11493,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL624267,
11494,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL624268,
11495,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL875227,
11496,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL624269,
11497,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL624270,
11498,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,,BAO_0000218,N,,1,,CHEMBL624271,
11499,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL624272,
11500,,,50597,10116.0,Intermediate,1,,A,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,,BAO_0000218,N,,1,,CHEMBL624273,
11501,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624274,
11502,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624275,
11503,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624276,
11504,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624277,
11505,,,22224,,Autocuration,1,,A,,% dose converted to 2-amino-5-chlorophenyl sulfate,,,BAO_0000019,U,,0,,CHEMBL624278,
11506,,,22224,,Autocuration,1,,A,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,,BAO_0000019,U,,0,,CHEMBL624279,
11507,,1988.0,50597,10116.0,Intermediate,1,Feces,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,,BAO_0000218,N,,1,,CHEMBL624280,
11508,,1988.0,50597,10116.0,Intermediate,1,Feces,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,,BAO_0000218,N,,1,,CHEMBL624281,
11509,,1988.0,50597,10116.0,Intermediate,1,Feces,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,,BAO_0000218,N,,1,,CHEMBL622933,
11510,,1988.0,50597,10116.0,Intermediate,1,Feces,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,,BAO_0000218,N,,1,,CHEMBL622934,
11511,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL622935,
11512,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in Rat liver after 5 minutes of iv administration,,,BAO_0000218,N,,1,,CHEMBL622936,
11513,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL875228,
11514,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in Rat lung after 24 hours of iv administration,,,BAO_0000218,N,,1,,CHEMBL622937,
11515,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL622938,
11516,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in Rat lung after 30 minutes of iv administration,,,BAO_0000218,N,,1,,CHEMBL619736,
11517,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL625117,
11518,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in Rat lung after 5 minutes of iv administration,,,BAO_0000218,N,,1,,CHEMBL625118,
11519,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,,BAO_0000218,N,,1,,CHEMBL625119,
11520,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,,BAO_0000218,N,,1,,CHEMBL625120,
11521,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,,BAO_0000218,N,,1,,CHEMBL625121,
11522,In vivo,10000006.0,50597,10116.0,Intermediate,1,Thalamus,A,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,,BAO_0000218,N,,1,,CHEMBL625122,
11523,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL622204,
11524,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL877503,
11525,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL627127,
11526,In vivo,10000000.0,22224,,Autocuration,1,Hippocampus,A,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,U,,0,,CHEMBL627128,
11527,In vivo,10000000.0,22224,,Autocuration,1,Hippocampus,A,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,U,,0,,CHEMBL627129,
11528,In vivo,10000000.0,22224,,Autocuration,1,Hippocampus,A,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,U,,0,,CHEMBL627130,
11529,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL627131,
11530,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL627132,
11531,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL627133,
11532,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL627134,
11533,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL627135,
11534,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL627136,
11535,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL628435,
11536,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL628436,
11537,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL628437,
11538,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL628438,
11539,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL628439,
11540,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL628440,
11541,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL628441,
11542,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL628442,
11543,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL628443,
11544,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL628444,
11545,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL628445,
11546,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL877504,
11547,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL628446,
11548,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL626874,
11549,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL626875,
11550,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL626876,
11551,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL626877,
11552,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL626878,
11553,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL626879,
11554,In vivo,1969.0,22224,314293.0,Autocuration,1,Plasma,A,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,,BAO_0000218,U,,0,,CHEMBL626880,
11555,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,,BAO_0000218,N,,1,,CHEMBL626881,
11556,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,,BAO_0000218,N,,1,,CHEMBL626882,
11557,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Peak plasma concentration was measured in dogs,,,BAO_0000218,N,,1,,CHEMBL626883,
11558,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,N,,1,,CHEMBL626884,
11559,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626885,
11560,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626886,
11561,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626887,
11562,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,N,,1,,CHEMBL626888,
11563,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,,BAO_0000218,N,,1,,CHEMBL626889,
11564,In vivo,,22224,314293.0,Autocuration,1,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,,BAO_0000218,U,,0,,CHEMBL626761,
11565,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,,BAO_0000218,N,,1,,CHEMBL626762,
11566,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,,BAO_0000218,N,,1,,CHEMBL626763,
11567,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,,BAO_0000218,N,,1,,CHEMBL626764,
11568,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,,BAO_0000218,N,,1,,CHEMBL626765,
11569,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,,BAO_0000218,N,,1,,CHEMBL626766,
11570,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,,BAO_0000218,N,,1,,CHEMBL626767,
11571,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,,BAO_0000218,N,,1,,CHEMBL626768,
11572,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,,BAO_0000218,N,,1,,CHEMBL626769,
11573,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,,BAO_0000218,N,,1,,CHEMBL874463,
11574,In vivo,,22224,314293.0,Autocuration,1,,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,,BAO_0000218,U,,0,,CHEMBL626770,
11575,In vivo,,22224,314293.0,Autocuration,1,,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,,BAO_0000218,U,,0,,CHEMBL626771,
11576,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,,BAO_0000218,N,,1,,CHEMBL626772,
11577,In vivo,,100710,9541.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,,BAO_0000218,N,,1,,CHEMBL626773,
11578,In vivo,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,,BAO_0000218,N,,1,,CHEMBL626774,
11579,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626775,
11580,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626776,
11581,In vivo,,50597,10116.0,Intermediate,1,,A,,Maximum concentration (Cmax) in rat when administered orally,,,BAO_0000218,N,,1,,CHEMBL626777,
11582,In vivo,1969.0,22224,314293.0,Autocuration,1,Plasma,A,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,,BAO_0000218,U,,0,,CHEMBL626778,
11583,In vivo,,22224,10116.0,Autocuration,1,,A,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,,BAO_0000218,U,,0,,CHEMBL626779,
11584,In vivo,,22224,10116.0,Autocuration,1,,A,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,,BAO_0000218,U,,0,,CHEMBL626780,
11585,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,,BAO_0000218,U,,0,,CHEMBL626781,
11586,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic profile Cmax was evaluated in rats,,,BAO_0000218,N,,1,,CHEMBL632164,
11587,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,,BAO_0000218,N,,1,,CHEMBL632165,
11588,In vivo,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,,BAO_0000218,N,,1,,CHEMBL632166,
11589,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,,BAO_0000218,N,,1,,CHEMBL632167,
11590,In vivo,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,,BAO_0000218,N,,1,,CHEMBL632168,
11591,In vivo,1969.0,22224,10116.0,Autocuration,1,Plasma,A,,Cmax in rat plasma,,,BAO_0000218,U,,0,,CHEMBL632169,
11592,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Cmax in dog plasma after 30mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL632170,
11593,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Cmax in rat plasma after 30mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL632171,
11594,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma level in rats at 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL632172,
11595,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Tested for maximum plasma concentration in mice,,,BAO_0000218,N,,1,,CHEMBL632173,
11596,In vivo,,50597,10116.0,Intermediate,1,,A,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL632174,
11597,In vivo,,50597,10116.0,Intermediate,1,,A,,The Cmax values in female wistar rats.,,,BAO_0000218,N,,1,,CHEMBL632175,
11598,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL632176,
11599,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL632177,
11600,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,,BAO_0000218,N,,1,,CHEMBL632178,
11601,In vivo,,50597,10116.0,Intermediate,1,,A,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,,BAO_0000218,N,,1,,CHEMBL632179,
11602,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,,BAO_0000218,N,,1,,CHEMBL632180,
11603,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,,BAO_0000218,N,,1,,CHEMBL632181,
11604,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,,BAO_0000218,N,,1,,CHEMBL632182,
11605,In vivo,178.0,22224,10090.0,Autocuration,1,Blood,A,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,,BAO_0000218,U,,0,,CHEMBL632183,
11606,In vivo,,50588,9615.0,Intermediate,1,,A,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,,BAO_0000218,N,,1,,CHEMBL632184,
11607,In vivo,,50597,10116.0,Intermediate,1,,A,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,,BAO_0000218,N,,1,,CHEMBL874470,
11608,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL631302,
11609,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL631303,
11610,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL631304,
11611,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL631305,
11612,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL631306,
11613,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL631307,
11614,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL631308,
11615,,,50597,10116.0,Intermediate,1,,A,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625557,
11616,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625558,
11617,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625559,
11618,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625560,
11619,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625561,
11620,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625562,
11621,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL875320,
11622,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625563,
11623,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625564,
11624,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625565,
11625,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625566,
11626,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625567,
11627,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL625568,
11628,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL628217,
11629,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL628218,
11630,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL628219,
11631,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,,BAO_0000218,N,,1,,CHEMBL628220,
11632,,,22224,,Autocuration,1,,A,,Distribution in the blood after 120 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628221,
11633,,,22224,,Autocuration,1,,A,,Distribution in the blood after 15 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628222,
11634,,,22224,,Autocuration,1,,A,,Distribution in the blood after 30 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628223,
11635,,,22224,,Autocuration,1,,A,,Distribution in the blood after 5 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628224,
11636,,,22224,,Autocuration,1,,A,,Distribution in the blood after 60 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628225,
11637,,,22224,,Autocuration,1,,A,,Distribution in the blood after 90 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628226,
11638,,,22224,,Autocuration,1,,A,,Distribution in the bone after 120 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628227,
11639,,,22224,,Autocuration,1,,A,,Distribution in the bone after 15 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL875481,
11640,,,22224,,Autocuration,1,,A,,Distribution in the bone after 30 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628228,
11641,,,22224,,Autocuration,1,,A,,Distribution in the bone after 5 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628229,
11642,,,22224,,Autocuration,1,,A,,Distribution in the bone after 60 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628230,
11643,,,22224,,Autocuration,1,,A,,Distribution in the bone after 90 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628231,
11644,,,22224,,Autocuration,1,,A,,Distribution in the heart after 120 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628232,
11645,,,22224,,Autocuration,1,,A,,Distribution in the heart after 15 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628233,
11646,,,22224,,Autocuration,1,,A,,Distribution in the heart after 30 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628234,
11647,,,22224,,Autocuration,1,,A,,Distribution in the heart after 5 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628235,
11648,,,22224,,Autocuration,1,,A,,Distribution in the heart after 60 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628236,
11649,,,22224,,Autocuration,1,,A,,Distribution in the heart after 90 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628237,
11650,,,22224,,Autocuration,1,,A,,Distribution in the kidneys after 120 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628238,
11651,,,22224,,Autocuration,1,,A,,Distribution in the kidneys after 15 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628239,
11652,,,22224,,Autocuration,1,,A,,Distribution in the kidneys after 30 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628240,
11653,,,22224,,Autocuration,1,,A,,Distribution in the kidneys after 5 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628241,
11654,,,22224,,Autocuration,1,,A,,Distribution in the kidneys after 60 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628242,
11655,,,22224,,Autocuration,1,,A,,Distribution in the kidneys after 90 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL875482,
11656,,,22224,,Autocuration,1,,A,,Distribution in the liver after 120 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628243,
11657,,,22224,,Autocuration,1,,A,,Distribution in the liver after 15 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628244,
11658,,,22224,,Autocuration,1,,A,,Distribution in the liver after 30 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628245,
11659,,,22224,,Autocuration,1,,A,,Distribution in the liver after 5 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628246,
11660,,,22224,,Autocuration,1,,A,,Distribution in the liver after 60 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628247,
11661,,,22224,,Autocuration,1,,A,,Distribution in the liver after 90 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628248,
11662,,,22224,,Autocuration,1,,A,,Distribution in the lung after 120 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628249,
11663,,,50594,10090.0,Intermediate,1,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,,BAO_0000218,N,,1,,CHEMBL625452,
11664,,,50594,10090.0,Intermediate,1,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,,BAO_0000218,N,,1,,CHEMBL625453,
11665,,,50594,10090.0,Intermediate,1,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,,BAO_0000218,N,,1,,CHEMBL625454,
11666,,,50594,10090.0,Intermediate,1,,A,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,,BAO_0000218,N,,1,,CHEMBL623844,
11667,,,50597,10116.0,Intermediate,1,,A,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,,BAO_0000218,N,,1,,CHEMBL623845,
11668,,,50597,10116.0,Intermediate,1,,A,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,,BAO_0000218,N,,1,,CHEMBL623846,
11669,,,22224,,Autocuration,1,,A,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,,BAO_0000218,U,,0,,CHEMBL623847,
11670,,,100710,9541.0,Intermediate,1,,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,BAO_0000218,N,,1,,CHEMBL623848,
11671,,,100710,9541.0,Intermediate,1,,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,BAO_0000218,N,,1,,CHEMBL623849,
11672,,,100710,9541.0,Intermediate,1,,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,BAO_0000218,N,,1,,CHEMBL623850,
11673,,,100710,9541.0,Intermediate,1,,A,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,BAO_0000218,N,,1,,CHEMBL623851,
11674,,,22224,314293.0,Autocuration,1,,A,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,BAO_0000218,U,,0,,CHEMBL623852,
11675,,,50506,9669.0,Intermediate,1,,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,BAO_0000218,N,,1,,CHEMBL624551,
11676,,,50506,9669.0,Intermediate,1,,A,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,BAO_0000218,N,,1,,CHEMBL624552,
11677,,,22224,314293.0,Autocuration,1,,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,BAO_0000218,U,,0,,CHEMBL624553,
11678,,,22224,314293.0,Autocuration,1,,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,,BAO_0000218,U,,0,,CHEMBL624554,
11679,,,50597,10116.0,Intermediate,1,,A,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL624555,
11680,,,50597,10116.0,Intermediate,1,,A,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,BAO_0000218,N,,1,,CHEMBL624741,
11681,,,50588,9615.0,Intermediate,1,,A,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,,BAO_0000218,N,,1,,CHEMBL624742,
11682,,,100712,10026.0,Intermediate,1,,A,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,,BAO_0000218,N,,1,,CHEMBL624743,
11683,,,50597,10116.0,Intermediate,1,,A,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,,BAO_0000218,N,,1,,CHEMBL877606,
11684,,,22224,,Autocuration,1,,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,,BAO_0000218,U,,0,,CHEMBL624744,
11685,,178.0,22224,,Autocuration,1,Blood,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,U,,0,,CHEMBL624745,
11686,,178.0,22224,,Autocuration,1,Blood,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,U,,0,,CHEMBL624746,
11687,,178.0,22224,,Autocuration,1,Blood,A,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,,BAO_0000218,U,,0,,CHEMBL624747,
11688,,,22224,,Autocuration,1,,A,,Oral absorption expressed as Area under curve was determined,,,BAO_0000019,U,,0,,CHEMBL624748,
11689,,,50588,9615.0,Intermediate,1,,A,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,,BAO_0000218,N,,1,,CHEMBL622504,
11690,,,50588,9615.0,Intermediate,1,,A,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,,BAO_0000218,N,,1,,CHEMBL622505,
11691,,,100712,10026.0,Intermediate,1,,A,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,BAO_0000218,N,,1,,CHEMBL622506,
11692,,,100712,10026.0,Intermediate,1,,A,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,,BAO_0000218,N,,1,,CHEMBL622507,
11693,,,50597,10116.0,Intermediate,1,,A,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,,BAO_0000218,N,,1,,CHEMBL622508,
11694,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,,BAO_0000019,U,,0,,CHEMBL622509,
11695,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,N,,1,,CHEMBL622510,
11696,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,,BAO_0000218,N,,1,,CHEMBL622511,
11697,,,100710,9541.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL622512,
11698,,,100710,9541.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL622513,
11699,,,100710,9541.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL622514,
11700,,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL622515,
11701,,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL622516,
11702,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL622517,
11703,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL622518,
11704,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL622519,
11705,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL622520,
11706,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL622521,
11707,In vivo,14.0,50594,10090.0,Intermediate,1,Zone of skin,A,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL625113,
11708,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL625114,
11709,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL874397,
11710,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL625115,
11711,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL625116,
11712,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL623932,
11713,In vivo,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL623933,
11714,In vivo,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL623934,
11715,In vivo,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL623935,
11716,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,,BAO_0000218,N,,1,,CHEMBL623936,
11717,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,,BAO_0000218,N,,1,,CHEMBL623937,
11718,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,,BAO_0000218,N,,1,,CHEMBL623938,
11719,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,N,,1,,CHEMBL623939,
11720,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,BAO_0000218,N,,1,,CHEMBL623940,
11721,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,BAO_0000218,N,,1,,CHEMBL623941,
11722,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,N,,1,,CHEMBL627216,
11723,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,N,,1,,CHEMBL623942,
11724,,955.0,50594,10090.0,Intermediate,1,Brain,A,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,N,,1,,CHEMBL618793,
11725,,955.0,50594,10090.0,Intermediate,1,Brain,A,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,N,,1,,CHEMBL618794,
11726,,955.0,50594,10090.0,Intermediate,1,Brain,A,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,N,,1,,CHEMBL618795,
11727,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,N,,1,,CHEMBL618796,
11728,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,N,,1,,CHEMBL618797,
11729,,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,,BAO_0000218,N,,1,,CHEMBL618798,
11730,,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,N,,1,,CHEMBL618799,
11731,,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,BAO_0000218,N,,1,,CHEMBL618800,
11732,,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,BAO_0000218,N,,1,,CHEMBL618801,
11733,,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,N,,1,,CHEMBL618802,
11734,,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,N,,1,,CHEMBL618803,
11735,,2107.0,50594,10090.0,Intermediate,1,Liver,A,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,,BAO_0000218,N,,1,,CHEMBL618804,
11736,,2107.0,50594,10090.0,Intermediate,1,Liver,A,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,N,,1,,CHEMBL618805,
11737,,2107.0,50594,10090.0,Intermediate,1,Liver,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,BAO_0000218,N,,1,,CHEMBL618806,
11738,,2107.0,50594,10090.0,Intermediate,1,Liver,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,BAO_0000218,N,,1,,CHEMBL618807,
11739,,2107.0,50594,10090.0,Intermediate,1,Liver,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,N,,1,,CHEMBL618808,
11740,,2107.0,50594,10090.0,Intermediate,1,Liver,A,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,N,,1,,CHEMBL618809,
11741,,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,N,,1,,CHEMBL618810,
11742,,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,,BAO_0000218,N,,1,,CHEMBL618811,
11743,,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,BAO_0000218,N,,1,,CHEMBL875844,
11744,,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,N,,1,,CHEMBL618812,
11745,,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,N,,1,,CHEMBL618813,
11746,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,N,,1,,CHEMBL618814,
11747,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,N,,1,,CHEMBL618815,
11748,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,N,,1,,CHEMBL618816,
11749,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,N,,1,,CHEMBL618817,
11750,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,N,,1,,CHEMBL620544,
11751,In vivo,,50597,10116.0,Intermediate,1,,A,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,,BAO_0000218,N,,1,,CHEMBL626230,
11752,In vivo,,50597,10116.0,Intermediate,1,,A,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,,BAO_0000218,N,,1,,CHEMBL626231,
11753,In vivo,,50597,10116.0,Intermediate,1,,A,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,,BAO_0000218,N,,1,,CHEMBL626232,
11754,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,,BAO_0000218,N,,1,,CHEMBL626233,
11755,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,,BAO_0000218,N,,1,,CHEMBL626234,
11756,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,,BAO_0000218,N,,1,,CHEMBL875341,
11757,In vivo,1969.0,50587,9606.0,Intermediate,1,Plasma,A,,The maximum plasma concentration (100 mg/kg) administered orally in human,,,BAO_0000218,N,,1,,CHEMBL626235,
11758,In vivo,1969.0,22224,9481.0,Autocuration,1,Plasma,A,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,,BAO_0000218,U,,0,,CHEMBL626236,
11759,In vivo,1969.0,22224,314293.0,Autocuration,1,Plasma,A,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,,BAO_0000218,U,,0,,CHEMBL626237,
11760,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,,BAO_0000218,N,,1,,CHEMBL626238,
11761,In vivo,1969.0,50587,9606.0,Intermediate,1,Plasma,A,,The maximum plasma concentration (200 mg/kg) administered orally in human,,,BAO_0000218,N,,1,,CHEMBL622412,
11762,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,,BAO_0000218,N,,1,,CHEMBL623114,
11763,In vivo,1969.0,22224,9481.0,Autocuration,1,Plasma,A,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,,BAO_0000218,U,,0,,CHEMBL623115,
11764,In vivo,1969.0,22224,314293.0,Autocuration,1,Plasma,A,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,,BAO_0000218,U,,0,,CHEMBL623116,
11765,In vivo,1969.0,22224,9615.0,Autocuration,1,Plasma,A,,The maximum plasma concentration (30 mg/kg) administered orally in dog,,,BAO_0000218,U,,0,,CHEMBL623117,
11766,In vivo,1969.0,50587,9606.0,Intermediate,1,Plasma,A,,The maximum plasma concentration (400 mg/kg) administered orally in human,,,BAO_0000218,N,,1,,CHEMBL623118,
11767,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,,BAO_0000218,N,,1,,CHEMBL623119,
11768,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The maximum plasma concentration (50 mg/kg) administered orally in rat,,,BAO_0000218,N,,1,,CHEMBL623120,
11769,In vivo,1969.0,50587,9606.0,Intermediate,1,Plasma,A,,The maximum plasma concentration (800 mg/kg) administered orally in human,,,BAO_0000218,N,,1,,CHEMBL623286,
11770,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The maximum plasma concentration was measured on rats,,,BAO_0000218,N,,1,,CHEMBL623287,
11771,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The maximum plasma concentration was measured on rats after oral administration,,,BAO_0000218,N,,1,,CHEMBL623288,
11772,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma drug Cmax in rat (PO dose),,,BAO_0000218,N,,1,,CHEMBL623289,
11773,In vivo,,22224,,Autocuration,1,,A,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,,BAO_0000218,U,,0,,CHEMBL623290,
11774,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,maximum Plasma concentration in Dog was determined after Peroral administration,,,BAO_0000218,N,,1,,CHEMBL623291,
11775,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,maximum Plasma concentration in Rats was determined after Peroral administration,,,BAO_0000218,N,,1,,CHEMBL623292,
11776,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,,BAO_0000218,N,,1,,CHEMBL623293,
11777,In vivo,1969.0,22224,314293.0,Autocuration,1,Plasma,A,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,,BAO_0000218,U,,0,,CHEMBL623294,
11778,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL623295,
11779,In vivo,,50594,10090.0,Intermediate,1,,A,,maximum concentration was measured when administered through oral route in mice,,,BAO_0000218,N,,1,,CHEMBL623296,
11780,,,50594,10090.0,Intermediate,1,,A,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,,BAO_0000218,N,,1,,CHEMBL875349,
11781,,,22224,314293.0,Autocuration,1,,A,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,,BAO_0000019,U,,0,,CHEMBL623297,
11782,,,22224,314293.0,Autocuration,1,,A,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,,BAO_0000019,U,,0,,CHEMBL623298,
11783,,,22224,314293.0,Autocuration,1,,A,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,,BAO_0000019,U,,0,,CHEMBL623299,
11784,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter was evaluated in rats,,,BAO_0000218,N,,1,,CHEMBL623300,
11785,,,50594,10090.0,Intermediate,1,,A,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,BAO_0000218,N,,1,,CHEMBL623301,
11786,,,50594,10090.0,Intermediate,1,,A,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,,BAO_0000218,N,,1,,CHEMBL623302,
11787,,,50594,10090.0,Intermediate,1,,A,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,,BAO_0000218,N,,1,,CHEMBL623303,
11788,,,50594,10090.0,Intermediate,1,,A,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,,BAO_0000218,N,,1,,CHEMBL623304,
11789,,,50594,10090.0,Intermediate,1,,A,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,,BAO_0000218,N,,1,,CHEMBL623305,
11790,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,,BAO_0000218,N,,1,,CHEMBL623306,
11791,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,,BAO_0000218,N,,1,,CHEMBL623307,
11792,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,,BAO_0000218,N,,1,,CHEMBL623308,
11793,,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,,BAO_0000218,N,,1,,CHEMBL623309,
11794,,,50594,10090.0,Intermediate,1,,A,,Plasma Concentration after 120 min of oral administration to mice,,,BAO_0000218,N,,1,,CHEMBL623310,
11795,,,50594,10090.0,Intermediate,1,,A,,Plasma Concentration after 30 min of oral administration to mice,,,BAO_0000218,N,,1,,CHEMBL623311,
11796,,,100710,9541.0,Intermediate,1,,A,,Plasma Concentration after 60 min of oral administration to mice,,,BAO_0000218,N,,1,,CHEMBL623312,
11797,,,50594,10090.0,Intermediate,1,,A,,Plasma Concentration after 60 min of oral administration to mice; Not determined,,,BAO_0000218,N,,1,,CHEMBL875350,
11798,,,50594,10090.0,Intermediate,1,,A,,Plasma Concentration after 90 min of oral administration to mice,,,BAO_0000218,N,,1,,CHEMBL628635,
11799,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL628636,
11800,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL628637,
11801,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,,BAO_0000218,N,,1,,CHEMBL628058,
11802,,,50597,10116.0,Intermediate,1,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,,BAO_0000218,N,,1,,CHEMBL628059,
11803,,,50597,10116.0,Intermediate,1,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,,BAO_0000218,N,,1,,CHEMBL628060,
11804,,,22224,,Autocuration,1,,A,,Distribution in the lung after 15 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628061,
11805,,,22224,,Autocuration,1,,A,,Distribution in the lung after 30 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628062,
11806,,,22224,,Autocuration,1,,A,,Distribution in the lung after 5 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628063,
11807,,,22224,,Autocuration,1,,A,,Distribution in the lung after 60 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628064,
11808,,,22224,,Autocuration,1,,A,,Distribution in the lung after 90 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628065,
11809,,2385.0,22224,,Autocuration,1,Muscle tissue,A,,Distribution in the muscle after 120 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628066,
11810,,2385.0,22224,,Autocuration,1,Muscle tissue,A,,Distribution in the muscle after 15 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628067,
11811,,2385.0,50594,10090.0,Intermediate,1,Muscle tissue,A,,Distribution in the muscle after 30 min of intravenous administration,,,BAO_0000218,N,,1,,CHEMBL874646,
11812,,2385.0,22224,,Autocuration,1,Muscle tissue,A,,Distribution in the muscle after 5 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628068,
11813,,2385.0,22224,,Autocuration,1,Muscle tissue,A,,Distribution in the muscle after 60 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628069,
11814,,2385.0,22224,,Autocuration,1,Muscle tissue,A,,Distribution in the muscle after 90 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628070,
11815,,2106.0,22224,,Autocuration,1,Spleen,A,,Distribution in the spleen after 120 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628071,
11816,,2106.0,22224,,Autocuration,1,Spleen,A,,Distribution in the spleen after 15 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628072,
11817,,2106.0,22224,,Autocuration,1,Spleen,A,,Distribution in the spleen after 30 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628073,
11818,,2106.0,22224,,Autocuration,1,Spleen,A,,Distribution in the spleen after 5 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628074,
11819,,2106.0,22224,,Autocuration,1,Spleen,A,,Distribution in the spleen after 60 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628075,
11820,,2106.0,22224,,Autocuration,1,Spleen,A,,Distribution in the spleen after 90 min of intravenous administration,,,BAO_0000019,U,,0,,CHEMBL628076,
11821,,1235.0,50597,10116.0,Intermediate,1,Adrenal cortex,A,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,,BAO_0000218,N,,1,,CHEMBL628077,
11822,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,,BAO_0000218,N,,1,,CHEMBL628078,
11823,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,,BAO_0000218,N,,1,,CHEMBL628079,
11824,,992.0,50597,10116.0,Intermediate,1,Female gonad,A,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,,BAO_0000218,N,,1,,CHEMBL628080,
11825,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,,BAO_0000218,N,,1,,CHEMBL628081,
11826,,1235.0,50597,10116.0,Intermediate,1,Adrenal cortex,A,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,,BAO_0000218,N,,1,,CHEMBL628082,
11827,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,,BAO_0000218,N,,1,,CHEMBL874647,
11828,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,,BAO_0000218,N,,1,,CHEMBL626406,
11829,,992.0,50597,10116.0,Intermediate,1,Female gonad,A,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,,BAO_0000218,N,,1,,CHEMBL626407,
11830,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,,BAO_0000218,N,,1,,CHEMBL626408,
11831,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,,BAO_0000218,N,,1,,CHEMBL626409,
11832,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,,BAO_0000218,N,,1,,CHEMBL626410,
11833,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,,BAO_0000218,N,,1,,CHEMBL626411,
11834,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,,BAO_0000218,N,,1,,CHEMBL626412,
11835,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,,BAO_0000218,N,,1,,CHEMBL626413,
11836,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,,BAO_0000218,N,,1,,CHEMBL626414,
11837,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,,BAO_0000218,N,,1,,CHEMBL626415,
11838,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,,BAO_0000218,N,,1,,CHEMBL626416,
11839,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,,BAO_0000218,N,,1,,CHEMBL627062,
11840,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,,BAO_0000218,N,,1,,CHEMBL627063,
11841,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,,BAO_0000218,N,,1,,CHEMBL627064,
11842,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,,BAO_0000218,N,,1,,CHEMBL627227,
11843,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,,BAO_0000218,N,,1,,CHEMBL627228,
11844,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,,BAO_0000218,N,,1,,CHEMBL627229,
11845,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,,BAO_0000218,N,,1,,CHEMBL625792,
11846,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,,BAO_0000218,N,,1,,CHEMBL625793,
11847,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,,BAO_0000218,N,,1,,CHEMBL625794,
11848,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,,BAO_0000218,N,,1,,CHEMBL625795,
11849,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,,BAO_0000218,N,,1,,CHEMBL625796,
11850,,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625797,
11851,,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625798,
11852,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL875613,
11853,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL625799,
11854,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL625800,
11855,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL625801,
11856,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL625802,
11857,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL625803,
11858,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,,BAO_0000019,U,,0,,CHEMBL625804,
11859,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL622530,
11860,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,,BAO_0000218,N,,1,,CHEMBL622531,
11861,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,BAO_0000218,N,,1,,CHEMBL622532,
11862,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL623176,
11863,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,BAO_0000218,N,,1,,CHEMBL623177,
11864,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,BAO_0000218,N,,1,,CHEMBL623178,
11865,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,,BAO_0000218,N,,1,,CHEMBL623179,
11866,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,,BAO_0000218,N,,1,,CHEMBL623180,
11867,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL623181,
11868,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL624131,
11869,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,,BAO_0000218,N,,1,,CHEMBL624132,
11870,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL624133,
11871,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,,BAO_0000218,N,,1,,CHEMBL624846,
11872,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL624847,
11873,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL624848,
11874,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,,BAO_0000218,N,,1,,CHEMBL625012,
11875,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL625013,
11876,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,,BAO_0000218,N,,1,,CHEMBL625014,
11877,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,,BAO_0000218,N,,1,,CHEMBL625015,
11878,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL625016,
11879,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,,BAO_0000218,N,,1,,CHEMBL625017,
11880,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL625018,
11881,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL625019,
11882,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL625020,
11883,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,,BAO_0000218,N,,1,,CHEMBL625021,
11884,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,N,,1,,CHEMBL625022,
11885,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,,BAO_0000218,N,,1,,CHEMBL625023,
11886,,,100710,9541.0,Intermediate,1,,A,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,,BAO_0000218,N,,1,,CHEMBL625024,
11887,,,100710,9541.0,Intermediate,1,,A,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,,BAO_0000218,N,,1,,CHEMBL627626,
11888,,955.0,22224,,Autocuration,1,Brain,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,BAO_0000218,U,,0,,CHEMBL627627,
11889,,1977.0,22224,,Autocuration,1,Serum,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,,BAO_0000218,U,,0,,CHEMBL627628,
11890,,955.0,22224,,Autocuration,1,Brain,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,BAO_0000218,U,,0,,CHEMBL627629,
11891,,1977.0,22224,,Autocuration,1,Serum,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,,BAO_0000218,U,,0,,CHEMBL627630,
11892,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,,BAO_0000019,U,,0,,CHEMBL627631,
11893,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,,BAO_0000218,U,,0,,CHEMBL629515,
11894,,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,N,,1,,CHEMBL629516,
11895,,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,N,,1,,CHEMBL629517,
11896,,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,N,,1,,CHEMBL629518,
11897,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,,BAO_0000218,N,,1,,CHEMBL877499,
11898,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,,BAO_0000218,N,,1,,CHEMBL629519,
11899,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,,BAO_0000218,N,,1,,CHEMBL629520,
11900,,,50594,10090.0,Intermediate,1,,A,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,,BAO_0000218,N,,1,,CHEMBL629521,
11901,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,,BAO_0000218,N,,1,,CHEMBL629522,
11902,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,,BAO_0000218,N,,1,,CHEMBL629523,
11903,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,,BAO_0000218,N,,1,,CHEMBL629524,
11904,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,,BAO_0000218,N,,1,,CHEMBL629525,
11905,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,,BAO_0000218,N,,1,,CHEMBL629526,
11906,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,,BAO_0000218,N,,1,,CHEMBL629527,
11907,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,,BAO_0000218,N,,1,,CHEMBL629528,
11908,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,,BAO_0000218,N,,1,,CHEMBL629529,
11909,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,,BAO_0000218,N,,1,,CHEMBL629530,
11910,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,,BAO_0000218,N,,1,,CHEMBL629531,
11911,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,,BAO_0000218,N,,1,,CHEMBL628656,
11912,,,50594,10090.0,Intermediate,1,,A,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,,BAO_0000218,N,,1,,CHEMBL628657,
11913,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628658,
11914,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628659,
11915,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL877500,
11916,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628660,
11917,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628661,
11918,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628662,
11919,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628663,
11920,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628664,
11921,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628665,
11922,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628666,
11923,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628667,
11924,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628668,
11925,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628669,
11926,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628670,
11927,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628671,
11928,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL628672,
11929,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL630300,
11930,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629787,
11931,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629788,
11932,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629789,
11933,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629790,
11934,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629791,
11935,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629792,
11936,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629793,
11937,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629794,
11938,,,50597,10116.0,Intermediate,1,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,,BAO_0000218,N,,1,,CHEMBL874459,
11939,,,50597,10116.0,Intermediate,1,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,,BAO_0000218,N,,1,,CHEMBL629795,
11940,,,50597,10116.0,Intermediate,1,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,,BAO_0000218,N,,1,,CHEMBL629796,
11941,,,50597,10116.0,Intermediate,1,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,,BAO_0000218,N,,1,,CHEMBL629797,
11942,,,50597,10116.0,Intermediate,1,,A,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,,BAO_0000218,N,,1,,CHEMBL629798,
11943,In vivo,2369.0,50597,10116.0,Intermediate,1,Adrenal gland,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629799,
11944,In vivo,2369.0,50597,10116.0,Intermediate,1,Adrenal gland,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629800,
11945,In vivo,2369.0,50597,10116.0,Intermediate,1,Adrenal gland,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629801,
11946,In vivo,2369.0,50597,10116.0,Intermediate,1,Adrenal gland,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,,BAO_0000218,N,,1,,CHEMBL629802,
11947,In vivo,2369.0,50597,10116.0,Intermediate,1,Adrenal gland,A,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629803,
11948,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629804,
11949,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629805,
11950,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629806,
11951,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629807,
11952,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629808,
11953,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629809,
11954,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629810,
11955,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629811,
11956,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629812,
11957,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629813,
11958,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL874460,
11959,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629814,
11960,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629815,
11961,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629816,
11962,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL629817,
11963,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL626643,
11964,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL626644,
11965,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL626806,
11966,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL626807,
11967,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627261,
11968,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627262,
11969,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627263,
11970,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627264,
11971,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627265,
11972,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627266,
11973,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627267,
11974,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627268,
11975,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627269,
11976,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627270,
11977,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,,BAO_0000218,N,,1,,CHEMBL627271,
11978,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,,BAO_0000218,N,,1,,CHEMBL627946,
11979,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,,BAO_0000218,N,,1,,CHEMBL875472,
11980,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,,BAO_0000218,N,,1,,CHEMBL627947,
11981,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,,BAO_0000218,N,,1,,CHEMBL627948,
11982,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,,BAO_0000218,N,,1,,CHEMBL628113,
11983,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,,BAO_0000218,N,,1,,CHEMBL628114,
11984,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,,BAO_0000218,N,,1,,CHEMBL628115,
11985,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,,BAO_0000218,N,,1,,CHEMBL628116,
11986,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,,BAO_0000218,N,,1,,CHEMBL628117,
11987,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,,BAO_0000218,N,,1,,CHEMBL628118,
11988,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,,BAO_0000218,N,,1,,CHEMBL628119,
11989,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,,BAO_0000218,N,,1,,CHEMBL628120,
11990,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,,BAO_0000218,N,,1,,CHEMBL628121,
11991,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,,BAO_0000218,N,,1,,CHEMBL628122,
11992,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,,BAO_0000218,N,,1,,CHEMBL627297,
11993,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,,BAO_0000218,N,,1,,CHEMBL627298,
11994,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,,BAO_0000218,N,,1,,CHEMBL627299,
11995,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,,BAO_0000218,N,,1,,CHEMBL627300,
11996,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,,BAO_0000218,N,,1,,CHEMBL627301,
11997,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,,BAO_0000218,N,,1,,CHEMBL627302,
11998,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,,BAO_0000218,N,,1,,CHEMBL627303,
11999,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,,BAO_0000218,N,,1,,CHEMBL627304,
12000,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,,BAO_0000218,N,,1,,CHEMBL627305,
12001,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,,BAO_0000218,N,,1,,CHEMBL627306,
12002,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,,BAO_0000218,N,,1,,CHEMBL623982,
12003,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,,BAO_0000218,N,,1,,CHEMBL623983,
12004,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,,BAO_0000218,N,,1,,CHEMBL623984,
12005,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,,BAO_0000218,N,,1,,CHEMBL623985,
12006,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,,BAO_0000218,N,,1,,CHEMBL623986,
12007,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,,BAO_0000218,N,,1,,CHEMBL623987,
12008,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,,BAO_0000218,N,,1,,CHEMBL623988,
12009,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,,BAO_0000218,N,,1,,CHEMBL623989,
12010,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,,BAO_0000218,N,,1,,CHEMBL622215,
12011,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,,BAO_0000218,N,,1,,CHEMBL622216,
12012,,,50597,10116.0,Intermediate,1,,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,,BAO_0000218,N,,1,,CHEMBL877481,
12013,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,,BAO_0000218,U,,0,,CHEMBL622217,
12014,,,50594,10090.0,Intermediate,1,,A,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,,BAO_0000218,N,,1,,CHEMBL622218,
12015,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic profile AUC was evaluated in rats,,,BAO_0000218,N,,1,,CHEMBL622219,
12016,,,22224,,Autocuration,1,,A,,Pharmacokinetic property (Area under curve),,,BAO_0000019,U,,0,,CHEMBL622220,
12017,,,50588,9615.0,Intermediate,1,,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,,BAO_0000218,N,,1,,CHEMBL622221,
12018,,,50594,10090.0,Intermediate,1,,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,,BAO_0000218,N,,1,,CHEMBL622222,
12019,,,50588,9615.0,Intermediate,1,,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,,BAO_0000218,N,,1,,CHEMBL622223,
12020,,,50594,10090.0,Intermediate,1,,A,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,,BAO_0000218,N,,1,,CHEMBL622224,
12021,,,22224,,Autocuration,1,,A,,Plasma concentration (AUC) was determined,,,BAO_0000019,U,,0,,CHEMBL622225,
12022,,,22224,,Autocuration,1,,A,,Plasma concentration (AUC) was determined; Not detectable,,,BAO_0000019,U,,0,,CHEMBL622226,
12023,,,50512,10141.0,Intermediate,1,,A,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,,BAO_0000218,N,,1,,CHEMBL624154,
12024,,,50597,10116.0,Intermediate,1,,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624155,
12025,,,50597,10116.0,Intermediate,1,,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,,BAO_0000218,N,,1,,CHEMBL624156,
12026,,,50597,10116.0,Intermediate,1,,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624157,
12027,,,50597,10116.0,Intermediate,1,,A,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624158,
12028,,,50597,10116.0,Intermediate,1,,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,,BAO_0000218,N,,1,,CHEMBL624159,
12029,,,50597,10116.0,Intermediate,1,,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,,BAO_0000218,N,,1,,CHEMBL624160,
12030,,,50597,10116.0,Intermediate,1,,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,,BAO_0000218,N,,1,,CHEMBL624161,
12031,,,50597,10116.0,Intermediate,1,,A,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,,BAO_0000218,N,,1,,CHEMBL624162,
12032,,,50588,9615.0,Intermediate,1,,A,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,,BAO_0000218,N,,1,,CHEMBL624163,
12033,,,50597,10116.0,Intermediate,1,,A,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL624164,
12034,,,50597,10116.0,Intermediate,1,,A,,The AUC(0-infinity) values in female wistar rats.,,,BAO_0000218,N,,1,,CHEMBL624165,
12035,,,50597,10116.0,Intermediate,1,,A,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL624166,
12036,,,50597,10116.0,Intermediate,1,,A,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,,BAO_0000218,N,,1,,CHEMBL624167,
12037,,,50597,10116.0,Intermediate,1,,A,,The AUC(0-t)values in female wistar rats.,,,BAO_0000218,N,,1,,CHEMBL624168,
12038,,,50597,10116.0,Intermediate,1,,A,,The Area under the concentration time curve of compound was measured on rats,,,BAO_0000218,N,,1,,CHEMBL624169,
12039,,,50587,9606.0,Intermediate,1,,A,,The area under curve (100 mg/kg) administered orally in humans,,,BAO_0000218,N,,1,,CHEMBL624170,
12040,,,22224,9481.0,Autocuration,1,,A,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,,BAO_0000218,U,,0,,CHEMBL624171,
12041,,,22224,314293.0,Autocuration,1,,A,,The area under curve (12.5 mg/kg) administered intravenously in monkey,,,BAO_0000218,U,,0,,CHEMBL624172,
12042,,,50588,9615.0,Intermediate,1,,A,,The area under curve (15 mg/kg) administered intravenously in dog,,,BAO_0000218,N,,1,,CHEMBL624173,
12043,,,50587,9606.0,Intermediate,1,,A,,The area under curve (200 mg/kg) administered orally in humans,,,BAO_0000218,N,,1,,CHEMBL877488,
12044,,,50597,10116.0,Intermediate,1,,A,,The area under curve (25 mg/kg) administered intravenously in rat,,,BAO_0000218,N,,1,,CHEMBL624174,
12045,,,22224,9481.0,Autocuration,1,,A,,The area under curve (25 mg/kg) administered orally in marmoset,,,BAO_0000218,U,,0,,CHEMBL624175,
12046,,,22224,314293.0,Autocuration,1,,A,,The area under curve (25 mg/kg) administered orally in monkey,,,BAO_0000218,U,,0,,CHEMBL624176,
12047,,,50588,9615.0,Intermediate,1,,A,,The area under curve (30 mg/kg) administered orally in dog,,,BAO_0000218,N,,1,,CHEMBL624177,
12048,,,50587,9606.0,Intermediate,1,,A,,The area under curve (400 mg/kg) administered orally in humans,,,BAO_0000218,N,,1,,CHEMBL624178,
12049,,,50597,10116.0,Intermediate,1,,A,,The area under curve (50 mg/kg) administered orally in fasted rat,,,BAO_0000218,N,,1,,CHEMBL624179,
12050,,,50597,10116.0,Intermediate,1,,A,,The area under curve (50 mg/kg) administered orally in rat,,,BAO_0000218,N,,1,,CHEMBL627689,
12051,,,50587,9606.0,Intermediate,1,,A,,The area under curve (800 mg/kg) administered orally in humans,,,BAO_0000218,N,,1,,CHEMBL627690,
12052,,,22224,,Autocuration,1,,A,,The compound was evaluated for area under the curve,,,BAO_0000019,U,,0,,CHEMBL627691,
12053,,,22224,9481.0,Autocuration,1,,A,,The compound was evaluated for area under the curve in marmosets,,,BAO_0000019,U,,0,,CHEMBL627692,
12054,,,22224,9481.0,Autocuration,1,,A,,The compound was evaluated for area under the curve in marmosets,,,BAO_0000019,U,,0,,CHEMBL627693,
12055,,,50597,10116.0,Intermediate,1,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,BAO_0000218,N,,1,,CHEMBL627694,
12056,,,50597,10116.0,Intermediate,1,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,,BAO_0000218,N,,1,,CHEMBL627695,
12057,,,22224,,Autocuration,1,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,,BAO_0000218,U,,0,,CHEMBL627696,
12058,,,50597,10116.0,Intermediate,1,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,BAO_0000218,N,,1,,CHEMBL627697,
12059,,,50597,10116.0,Intermediate,1,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,,BAO_0000218,N,,1,,CHEMBL627698,
12060,,,50597,10116.0,Intermediate,1,,A,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,,BAO_0000218,N,,1,,CHEMBL627699,
12061,,,50597,10116.0,Intermediate,1,,A,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,,BAO_0000218,N,,1,,CHEMBL627700,
12062,,,50597,10116.0,Intermediate,1,,A,,Total drug exposure is determined after oral dosing in rats.,,,BAO_0000218,N,,1,,CHEMBL627701,
12063,,,22224,,Autocuration,1,,A,,Total drug exposure (5 mg/kg) when administered intravenously,,,BAO_0000218,U,,0,,CHEMBL627702,
12064,,,22224,,Autocuration,1,,A,,Total drug exposure (5 mg/kg) when administered orally,,,BAO_0000218,U,,0,,CHEMBL627703,
12065,,,22224,314293.0,Autocuration,1,,A,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,,BAO_0000218,U,,0,,CHEMBL626873,
12066,,,50597,10116.0,Intermediate,1,,A,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL629583,
12067,,,50588,9615.0,Intermediate,1,,A,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,,BAO_0000218,N,,1,,CHEMBL629584,
12068,,,50588,9615.0,Intermediate,1,,A,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,,BAO_0000218,N,,1,,CHEMBL629585,
12069,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629586,
12070,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629587,
12071,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629588,
12072,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629589,
12073,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629590,
12074,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629591,
12075,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629592,
12076,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629593,
12077,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629594,
12078,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL629595,
12079,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL630290,
12080,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627137,
12081,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627138,
12082,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627139,
12083,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627140,
12084,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627141,
12085,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627142,
12086,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627143,
12087,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL874449,
12088,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627144,
12089,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627145,
12090,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627146,
12091,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627147,
12092,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627148,
12093,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627149,
12094,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL632160,
12095,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL632161,
12096,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL632162,
12097,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL632163,
12098,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL874469,
12099,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627182,
12100,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627183,
12101,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627184,
12102,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627185,
12103,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627186,
12104,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627187,
12105,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627188,
12106,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627189,
12107,In vivo,,50597,10116.0,Intermediate,1,,A,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627190,
12108,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627191,
12109,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627192,
12110,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL627193,
12111,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL874590,
12112,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627194,
12113,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627195,
12114,In vivo,992.0,50597,10116.0,Intermediate,1,Female gonad,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627196,
12115,In vivo,992.0,50597,10116.0,Intermediate,1,Female gonad,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627197,
12116,In vivo,992.0,50597,10116.0,Intermediate,1,Female gonad,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627198,
12117,In vivo,992.0,50597,10116.0,Intermediate,1,Female gonad,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,,BAO_0000218,N,,1,,CHEMBL627199,
12118,In vivo,992.0,50597,10116.0,Intermediate,1,Female gonad,A,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627200,
12119,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627201,
12120,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627202,
12121,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627203,
12122,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627204,
12123,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627205,
12124,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627206,
12125,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627207,
12126,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627208,
12127,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627209,
12128,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627210,
12129,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627211,
12130,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627212,
12131,In vivo,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL627213,
12132,In vivo,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL626599,
12133,In vivo,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL626600,
12134,In vivo,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,,BAO_0000218,N,,1,,CHEMBL626601,
12135,,,22224,,Autocuration,1,,A,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,,BAO_0000019,U,,0,,CHEMBL627484,
12136,,1969.0,100710,9541.0,Intermediate,1,Plasma,A,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,,BAO_0000218,N,,1,,CHEMBL627485,
12137,,1969.0,100710,9541.0,Intermediate,1,Plasma,A,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,,BAO_0000218,N,,1,,CHEMBL628147,
12138,,1969.0,100710,9541.0,Intermediate,1,Plasma,A,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,,BAO_0000218,N,,1,,CHEMBL628148,
12139,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,,BAO_0000218,N,,1,,CHEMBL628149,
12140,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,,BAO_0000218,N,,1,,CHEMBL628150,
12141,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,,BAO_0000218,N,,1,,CHEMBL628318,
12142,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,,BAO_0000218,N,,1,,CHEMBL628319,
12143,,,50588,9615.0,Intermediate,1,,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,BAO_0000218,N,,1,,CHEMBL875609,
12144,,,22224,,Autocuration,1,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,,BAO_0000019,U,,0,,CHEMBL628320,
12145,,,22224,,Autocuration,1,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,,BAO_0000019,U,,0,,CHEMBL628321,
12146,,,22224,,Autocuration,1,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,,BAO_0000019,U,,0,,CHEMBL628322,
12147,,,22224,,Autocuration,1,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,,BAO_0000019,U,,0,,CHEMBL628323,
12148,,,22224,,Autocuration,1,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,,BAO_0000019,U,,0,,CHEMBL628324,
12149,,,22224,,Autocuration,1,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,,BAO_0000019,U,,0,,CHEMBL628325,
12150,,,22224,,Autocuration,1,,A,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,,BAO_0000019,U,,0,,CHEMBL628326,
12151,,1236.0,50588,9615.0,Intermediate,1,Adrenal medulla,A,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL628327,
12152,,1236.0,50588,9615.0,Intermediate,1,Adrenal medulla,A,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL628328,
12153,,178.0,50588,9615.0,Intermediate,1,Blood,A,,"Concentration of compound in blood of dog 1, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL628329,
12154,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,,BAO_0000218,N,,1,,CHEMBL628330,
12155,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,,BAO_0000218,N,,1,,CHEMBL628331,
12156,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,,BAO_0000218,N,,1,,CHEMBL628332,
12157,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,,BAO_0000218,N,,1,,CHEMBL628333,
12158,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,,BAO_0000218,N,,1,,CHEMBL628334,
12159,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,,BAO_0000218,N,,1,,CHEMBL628335,
12160,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,,BAO_0000218,N,,1,,CHEMBL628336,
12161,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,,BAO_0000218,N,,1,,CHEMBL628337,
12162,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,,BAO_0000218,N,,1,,CHEMBL628338,
12163,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,,BAO_0000218,N,,1,,CHEMBL875610,
12164,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,,BAO_0000218,N,,1,,CHEMBL628339,
12165,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,,BAO_0000218,N,,1,,CHEMBL628340,
12166,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,,BAO_0000218,N,,1,,CHEMBL628341,
12167,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,,BAO_0000218,N,,1,,CHEMBL622214,
12168,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,,BAO_0000218,N,,1,,CHEMBL623167,
12169,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,,BAO_0000218,N,,1,,CHEMBL623168,
12170,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,,BAO_0000218,N,,1,,CHEMBL623169,
12171,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,,BAO_0000218,N,,1,,CHEMBL623170,
12172,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,,BAO_0000218,N,,1,,CHEMBL627224,
12173,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,,BAO_0000218,N,,1,,CHEMBL875634,
12174,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,,BAO_0000218,N,,1,,CHEMBL627225,
12175,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,,BAO_0000218,N,,1,,CHEMBL627226,
12176,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,,BAO_0000218,N,,1,,CHEMBL626083,
12177,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,,BAO_0000218,N,,1,,CHEMBL626084,
12178,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,,BAO_0000218,N,,1,,CHEMBL626085,
12179,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,,BAO_0000218,N,,1,,CHEMBL626086,
12180,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,,BAO_0000218,N,,1,,CHEMBL626087,
12181,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,,BAO_0000218,N,,1,,CHEMBL626088,
12182,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,,BAO_0000218,N,,1,,CHEMBL626089,
12183,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,,BAO_0000218,N,,1,,CHEMBL626090,
12184,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,,BAO_0000218,N,,1,,CHEMBL626091,
12185,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,,BAO_0000218,N,,1,,CHEMBL626092,
12186,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,,BAO_0000218,N,,1,,CHEMBL626093,
12187,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,,BAO_0000218,N,,1,,CHEMBL626094,
12188,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,,BAO_0000218,N,,1,,CHEMBL626095,
12189,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,,BAO_0000218,N,,1,,CHEMBL626096,
12190,,,22224,314293.0,Autocuration,1,,A,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,,BAO_0000218,U,,0,,CHEMBL626097,
12191,,,50597,10116.0,Intermediate,1,,A,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL626098,
12192,,1969.0,22224,,Autocuration,1,Plasma,A,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,,BAO_0000218,U,,0,,CHEMBL626099,
12193,,1969.0,22224,,Autocuration,1,Plasma,A,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,,BAO_0000218,U,,0,,CHEMBL626100,
12194,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,AUC 0-inf in dog,,,BAO_0000218,N,,1,,CHEMBL626101,
12195,,1969.0,50512,10141.0,Intermediate,1,Plasma,A,,AUC 0-inf in guinea pig,,,BAO_0000218,N,,1,,CHEMBL626102,
12196,,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,AUC 0-t in dog,,,BAO_0000218,N,,1,,CHEMBL626103,
12197,,1969.0,50512,10141.0,Intermediate,1,Plasma,A,,AUC 0-t in guinea pig,,,BAO_0000218,N,,1,,CHEMBL628391,
12198,,,50597,10116.0,Intermediate,1,,A,,The compound was tested for brain to plasma partition in rat,,,BAO_0000218,N,,1,,CHEMBL628392,
12199,,,50597,10116.0,Intermediate,1,,A,,The compound was tested for brain to plasma partition in rat.,,,BAO_0000218,N,,1,,CHEMBL628393,
12200,,178.0,22224,,Autocuration,1,Blood,A,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,,BAO_0000019,U,,0,,CHEMBL628394,
12201,,,50588,9615.0,Intermediate,1,,A,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,,BAO_0000218,N,,1,,CHEMBL628395,
12202,,,22224,314293.0,Autocuration,1,,A,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,,BAO_0000218,U,,0,,CHEMBL628396,
12203,,,50592,9986.0,Intermediate,1,,A,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,,BAO_0000218,N,,1,,CHEMBL628397,
12204,,,50597,10116.0,Intermediate,1,,A,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,,BAO_0000218,N,,1,,CHEMBL628398,
12205,,,50797,9544.0,Intermediate,1,,A,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,,BAO_0000218,N,,1,,CHEMBL628399,
12206,,,50588,9615.0,Intermediate,1,,A,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL628400,
12207,,,50597,10116.0,Intermediate,1,,A,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL874907,
12208,,,22224,,Autocuration,1,,A,,Area under curve of the compound was determined,,,BAO_0000019,U,,0,,CHEMBL628401,
12209,,1969.0,22224,314293.0,Autocuration,1,Plasma,A,,AUC in monkeys at a dose of 1 mg/kg,,,BAO_0000218,U,,0,,CHEMBL628402,
12210,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,AUC in rats at a dose of 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL628403,
12211,,,22224,,Autocuration,1,,A,,Compound was evaluated for the overall absorbance loss at pH of 2,,,BAO_0000019,U,,0,,CHEMBL628404,
12212,,,22224,,Autocuration,1,,A,,Compound was evaluated for the overall absorbance loss at pH of 4,,,BAO_0000019,U,,0,,CHEMBL628405,
12213,,,22224,,Autocuration,1,,A,,Compound was evaluated for the overall absorbance loss at pH of 7,,,BAO_0000019,U,,0,,CHEMBL628406,
12214,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for its absorption in the rats,,,BAO_0000218,N,,1,,CHEMBL628407,
12215,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,,BAO_0000218,N,,1,,CHEMBL628408,
12216,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,,BAO_0000218,N,,1,,CHEMBL629171,
12217,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,,BAO_0000218,N,,1,,CHEMBL629172,
12218,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,,BAO_0000218,N,,1,,CHEMBL629173,
12219,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum,,,BAO_0000218,N,,1,,CHEMBL629174,
12220,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 10-17,,,BAO_0000218,N,,1,,CHEMBL629175,
12221,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 10-18,,,BAO_0000218,N,,1,,CHEMBL629176,
12222,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 10-19,,,BAO_0000218,N,,1,,CHEMBL629177,
12223,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 12-15,,,BAO_0000218,N,,1,,CHEMBL629178,
12224,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 13-19,,,BAO_0000218,N,,1,,CHEMBL631869,
12225,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 14-17,,,BAO_0000218,N,,1,,CHEMBL631870,
12226,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 15-18,,,BAO_0000218,N,,1,,CHEMBL631871,
12227,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 2-5,,,BAO_0000218,N,,1,,CHEMBL631872,
12228,,2116.0,22224,,Autocuration,1,Ileum,A,,In vitro percent permeability into rat ileum; Range is 23-42,,,BAO_0000221,U,,0,,CHEMBL875775,
12229,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 28-36,,,BAO_0000218,N,,1,,CHEMBL631873,
12230,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 29-35,,,BAO_0000218,N,,1,,CHEMBL631874,
12231,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 46-66,,,BAO_0000218,N,,1,,CHEMBL631875,
12232,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 50-68,,,BAO_0000218,N,,1,,CHEMBL631876,
12233,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; Range is 78-81,,,BAO_0000218,N,,1,,CHEMBL631877,
12234,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,,BAO_0000218,N,,1,,CHEMBL631878,
12235,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; nd indicates not detected,,,BAO_0000218,N,,1,,CHEMBL631879,
12236,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; nt indicates not detected,,,BAO_0000218,N,,1,,CHEMBL631880,
12237,,,50597,10116.0,Intermediate,1,,A,,In vitro percent permeability into rat ileum; nt indicates not tested,,,BAO_0000218,N,,1,,CHEMBL631881,
12238,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for oral absorption in bile-duct cannulated rats,,,BAO_0000218,N,,1,,CHEMBL631882,
12239,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for oral absorption in bile-duct cannulated rats.,,,BAO_0000218,N,,1,,CHEMBL630749,
12240,,,50587,9606.0,Intermediate,1,,A,,Oral absorption using Caco-2 cell monolayers.,,,BAO_0000218,N,,1,,CHEMBL630750,
12241,,,50587,9606.0,Intermediate,1,,A,,Percent of the drug absorbed after administration to humans was determined,,,BAO_0000218,N,,1,,CHEMBL630253,
12242,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,,BAO_0000218,N,,1,,CHEMBL630254,
12243,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,,BAO_0000218,N,,1,,CHEMBL630255,
12244,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,,BAO_0000218,N,,1,,CHEMBL630256,
12245,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL875781,
12246,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL630257,
12247,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,,BAO_0000218,N,,1,,CHEMBL630258,
12248,,,50597,10116.0,Intermediate,1,,A,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,,BAO_0000218,N,,1,,CHEMBL630259,
12249,,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,,BAO_0000218,N,,1,,CHEMBL630260,
12250,,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,,BAO_0000218,N,,1,,CHEMBL630261,
12251,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,,BAO_0000218,N,,1,,CHEMBL630262,
12252,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,,BAO_0000218,N,,1,,CHEMBL630263,
12253,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,,BAO_0000218,N,,1,,CHEMBL630264,
12254,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,,BAO_0000218,N,,1,,CHEMBL630265,
12255,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,,BAO_0000218,N,,1,,CHEMBL630266,
12256,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,,BAO_0000218,N,,1,,CHEMBL630267,
12257,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,,BAO_0000218,N,,1,,CHEMBL630268,
12258,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,,BAO_0000218,N,,1,,CHEMBL630269,
12259,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,,BAO_0000218,N,,1,,CHEMBL630270,
12260,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,,BAO_0000218,N,,1,,CHEMBL630141,
12261,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,,BAO_0000218,N,,1,,CHEMBL630142,
12262,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,,BAO_0000218,N,,1,,CHEMBL630143,
12263,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,,BAO_0000218,N,,1,,CHEMBL630144,
12264,,2367.0,50597,10116.0,Intermediate,1,Prostate gland,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,,BAO_0000218,N,,1,,CHEMBL630145,
12265,,2367.0,50597,10116.0,Intermediate,1,Prostate gland,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,,BAO_0000218,N,,1,,CHEMBL630146,
12266,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,,BAO_0000218,N,,1,,CHEMBL630147,
12267,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,,BAO_0000218,N,,1,,CHEMBL630148,
12268,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,,BAO_0000218,N,,1,,CHEMBL630149,
12269,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,,BAO_0000218,N,,1,,CHEMBL630150,
12270,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,,BAO_0000218,N,,1,,CHEMBL630151,
12271,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,,BAO_0000218,N,,1,,CHEMBL632031,
12272,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,,BAO_0000218,N,,1,,CHEMBL632032,
12273,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,,BAO_0000218,N,,1,,CHEMBL632033,
12274,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,,BAO_0000218,N,,1,,CHEMBL632034,
12275,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,,BAO_0000218,N,,1,,CHEMBL632035,
12276,,,50597,10116.0,Intermediate,1,,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,,BAO_0000218,N,,1,,CHEMBL632036,
12277,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,,BAO_0000218,N,,1,,CHEMBL632037,
12278,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,,BAO_0000218,N,,1,,CHEMBL632038,
12279,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,,BAO_0000218,N,,1,,CHEMBL632039,
12280,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,,BAO_0000218,N,,1,,CHEMBL632040,
12281,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,,BAO_0000218,N,,1,,CHEMBL632041,
12282,,178.0,50588,9615.0,Intermediate,1,Blood,A,,"Concentration of compound in blood of dog 2, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL632042,
12283,,,50588,9615.0,Intermediate,1,,A,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL632043,
12284,,,50588,9615.0,Intermediate,1,,A,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL632044,
12285,,2107.0,50588,9615.0,Intermediate,1,Liver,A,,"Concentration of compound in liver of dog 1, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL632045,
12286,,2107.0,50588,9615.0,Intermediate,1,Liver,A,,"Concentration of compound in liver of dog 2, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL632046,
12287,,2048.0,50588,9615.0,Intermediate,1,Lung,A,,"Concentration of compound in lung of dog 1, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL632047,
12288,,2048.0,50588,9615.0,Intermediate,1,Lung,A,,"Concentration of compound in lung of dog 2, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL632048,
12289,,2385.0,50588,9615.0,Intermediate,1,Muscle tissue,A,,"Concentration of compound in muscle of dog 1, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL632049,
12290,,2385.0,50588,9615.0,Intermediate,1,Muscle tissue,A,,"Concentration of compound in muscle of dog 2, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL876418,
12291,,2106.0,50588,9615.0,Intermediate,1,Spleen,A,,"Concentration of compound in spleen of dog 1,after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL632050,
12292,,2106.0,50588,9615.0,Intermediate,1,Spleen,A,,"Concentration of compound in spleen of dog 2, after administering intravenously",,,BAO_0000218,N,,1,,CHEMBL632051,
12293,,,22224,,Autocuration,1,,F,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,,BAO_0000218,U,,0,,CHEMBL632052,
12294,,,22224,,Autocuration,1,,F,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,,BAO_0000218,U,,0,,CHEMBL632053,
12295,,,22224,,Autocuration,1,,A,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,BAO_0000218,U,,0,,CHEMBL632054,
12296,,,22224,,Autocuration,1,,F,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,,BAO_0000218,U,,0,,CHEMBL632055,
12297,,,22224,,Autocuration,1,,F,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,,BAO_0000218,U,,0,,CHEMBL631181,
12298,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,,BAO_0000218,U,,0,,CHEMBL631182,
12299,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,BAO_0000218,U,,0,,CHEMBL631183,
12300,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,U,,0,,CHEMBL631184,
12301,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,U,,0,,CHEMBL629774,
12302,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,U,,0,,CHEMBL629775,
12303,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,U,,0,,CHEMBL876549,
12304,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,U,,0,,CHEMBL628172,
12305,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,U,,0,,CHEMBL628173,
12306,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,,BAO_0000218,U,,0,,CHEMBL628174,
12307,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,,BAO_0000218,U,,0,,CHEMBL628175,
12308,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,U,,0,,CHEMBL628176,
12309,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,U,,0,,CHEMBL628177,
12310,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,U,,0,,CHEMBL628178,
12311,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,U,,0,,CHEMBL628179,
12312,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,BAO_0000218,U,,0,,CHEMBL628180,
12313,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,,BAO_0000218,U,,0,,CHEMBL628181,
12314,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,U,,0,,CHEMBL628182,
12315,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,U,,0,,CHEMBL628183,
12316,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,,BAO_0000218,U,,0,,CHEMBL628184,
12317,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,U,,0,,CHEMBL628185,
12318,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,U,,0,,CHEMBL875617,
12319,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,BAO_0000218,U,,0,,CHEMBL628186,
12320,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,U,,0,,CHEMBL628187,
12321,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,U,,0,,CHEMBL628188,
12322,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,U,,0,,CHEMBL628189,
12323,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,,BAO_0000218,U,,0,,CHEMBL628190,
12324,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,U,,0,,CHEMBL628191,
12325,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,,BAO_0000218,U,,0,,CHEMBL626513,
12326,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,,BAO_0000218,N,,1,,CHEMBL626514,
12327,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,,BAO_0000218,N,,1,,CHEMBL626515,
12328,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,,BAO_0000218,N,,1,,CHEMBL626516,
12329,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,,BAO_0000218,N,,1,,CHEMBL626517,
12330,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,,BAO_0000218,N,,1,,CHEMBL626518,
12331,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,,BAO_0000218,N,,1,,CHEMBL626519,
12332,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,,BAO_0000218,N,,1,,CHEMBL626520,
12333,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,,BAO_0000218,N,,1,,CHEMBL626521,
12334,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,,BAO_0000218,N,,1,,CHEMBL626522,
12335,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,,BAO_0000218,N,,1,,CHEMBL626523,
12336,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,,BAO_0000218,N,,1,,CHEMBL626524,
12337,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,,BAO_0000218,N,,1,,CHEMBL626688,
12338,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,,BAO_0000218,N,,1,,CHEMBL626689,
12339,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,,BAO_0000218,N,,1,,CHEMBL626690,
12340,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,,BAO_0000218,N,,1,,CHEMBL626691,
12341,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,,BAO_0000218,N,,1,,CHEMBL627319,
12342,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,,BAO_0000218,N,,1,,CHEMBL624052,
12343,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,,BAO_0000218,N,,1,,CHEMBL624053,
12344,,,50597,10116.0,Intermediate,1,,A,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,N,,1,,CHEMBL624054,
12345,,,50597,10116.0,Intermediate,1,,A,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,N,,1,,CHEMBL624055,
12346,,,50597,10116.0,Intermediate,1,,A,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,N,,1,,CHEMBL624056,
12347,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,N,,1,,CHEMBL624057,
12348,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,N,,1,,CHEMBL622281,
12349,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,N,,1,,CHEMBL622282,
12350,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,N,,1,,CHEMBL622283,
12351,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,N,,1,,CHEMBL622284,
12352,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,N,,1,,CHEMBL622285,
12353,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,,BAO_0000218,N,,1,,CHEMBL622286,
12354,,,22224,,Autocuration,1,,P,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,,BAO_0000100,U,,0,,CHEMBL622287,
12355,,,50594,10090.0,Intermediate,1,,A,,Partition coefficient (logD7.4),,,BAO_0000218,N,,1,,CHEMBL622288,
12356,,,50594,10090.0,Intermediate,1,,A,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,BAO_0000218,N,,1,,CHEMBL622289,
12357,,955.0,50594,10090.0,Intermediate,1,Brain,A,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,,BAO_0000218,N,,1,,CHEMBL622290,
12358,,,50594,10090.0,Intermediate,1,,A,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,BAO_0000218,N,,1,,CHEMBL622291,
12359,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,,BAO_0000218,N,,1,,CHEMBL622292,
12360,,,50594,10090.0,Intermediate,1,,A,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,,BAO_0000218,N,,1,,CHEMBL622293,
12361,,955.0,50594,10090.0,Intermediate,1,Brain,A,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,,BAO_0000218,N,,1,,CHEMBL622294,
12362,,,50594,10090.0,Intermediate,1,,A,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,,BAO_0000218,N,,1,,CHEMBL622295,
12363,,955.0,50597,10116.0,Intermediate,1,Brain,A,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,,BAO_0000218,N,,1,,CHEMBL622296,
12364,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,,BAO_0000218,N,,1,,CHEMBL874409,
12365,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,,BAO_0000218,N,,1,,CHEMBL622297,
12366,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,,BAO_0000218,N,,1,,CHEMBL622298,
12367,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,,BAO_0000218,N,,1,,CHEMBL622299,
12368,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,,BAO_0000218,N,,1,,CHEMBL622300,
12369,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,,BAO_0000218,N,,1,,CHEMBL622301,
12370,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,,BAO_0000218,N,,1,,CHEMBL622302,
12371,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,,BAO_0000218,N,,1,,CHEMBL622303,
12372,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,,BAO_0000218,N,,1,,CHEMBL622304,
12373,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,,BAO_0000218,N,,1,,CHEMBL622305,
12374,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,,BAO_0000218,N,,1,,CHEMBL622306,
12375,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,,BAO_0000218,N,,1,,CHEMBL626864,
12376,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,,BAO_0000218,N,,1,,CHEMBL626865,
12377,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,,BAO_0000218,N,,1,,CHEMBL626866,
12378,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,,BAO_0000218,N,,1,,CHEMBL626867,
12379,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,,BAO_0000218,N,,1,,CHEMBL626868,
12380,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,,BAO_0000218,N,,1,,CHEMBL626869,
12381,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,,BAO_0000218,N,,1,,CHEMBL626870,
12382,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,,BAO_0000218,N,,1,,CHEMBL626871,
12383,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,,BAO_0000218,N,,1,,CHEMBL626872,
12384,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,,BAO_0000218,N,,1,,CHEMBL632185,
12385,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,,BAO_0000218,N,,1,,CHEMBL632186,
12386,,,22224,,Autocuration,1,,A,,Amount of acetic acid produced by the compound,,,BAO_0000019,U,,0,,CHEMBL629310,
12387,,,22224,,Autocuration,1,,A,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,,BAO_0000019,U,,0,,CHEMBL629311,
12388,,,50597,10116.0,Intermediate,1,,A,,Log of (Cbrain/Cblood) in rats,,,BAO_0000218,N,,1,,CHEMBL629312,
12389,,,22224,,Autocuration,1,,A,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,BAO_0000221,U,,0,,CHEMBL629313,
12390,,,22224,,Autocuration,1,,A,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,BAO_0000221,U,,0,,CHEMBL629314,
12391,,,22224,,Autocuration,1,,A,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,BAO_0000221,U,,0,,CHEMBL629315,
12392,,,22224,,Autocuration,1,,B,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,,BAO_0000219,U,,0,,CHEMBL629316,
12393,,,22224,,Autocuration,1,,A,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,BAO_0000221,U,,0,,CHEMBL629317,
12394,,,22224,,Autocuration,1,,A,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,,BAO_0000019,U,,0,,CHEMBL629318,
12395,,,22224,,Autocuration,1,,A,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,,BAO_0000019,U,,0,,CHEMBL877497,
12396,,,22224,,Autocuration,1,,A,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,,BAO_0000019,U,,0,,CHEMBL629319,
12397,,,22224,,Autocuration,1,,A,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,,BAO_0000019,U,,0,,CHEMBL629320,
12398,,,22224,,Autocuration,1,,A,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,,BAO_0000019,U,,0,,CHEMBL629496,
12399,,,22224,,Autocuration,1,,A,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,,BAO_0000019,U,,0,,CHEMBL629497,
12400,,,22224,,Autocuration,1,,A,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,,BAO_0000019,U,,0,,CHEMBL629498,
12401,,,22224,,Autocuration,1,,A,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,,BAO_0000019,U,,0,,CHEMBL629499,
12402,,,22224,,Autocuration,1,,A,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,,BAO_0000019,U,,0,,CHEMBL629500,
12403,,,22224,,Autocuration,1,,A,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,,BAO_0000019,U,,0,,CHEMBL629501,
12404,,,22224,,Autocuration,1,,A,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,,BAO_0000019,U,,0,,CHEMBL629502,
12405,In vivo,,22224,,Autocuration,1,,F,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,,BAO_0000218,U,,0,,CHEMBL629503,
12406,,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL629504,
12407,,,22224,,Autocuration,1,,A,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,,BAO_0000019,U,,0,,CHEMBL629505,
12408,,,22224,,Autocuration,1,,A,,Compound was evaluated for total body clearance,,,BAO_0000019,U,,0,,CHEMBL629506,
12409,,,22224,,Autocuration,1,,A,,Compound was evaluated for volume of distribution at steady state,,,BAO_0000019,U,,0,,CHEMBL629507,
12410,,,22224,,Autocuration,1,,A,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,,BAO_0000019,U,,0,,CHEMBL877498,
12411,,,22224,,Autocuration,1,,A,,Percentage of the diamine which is monoprotonated at pH 7.4,,,BAO_0000019,U,,0,,CHEMBL629508,
12412,,,22224,,Autocuration,1,,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,,BAO_0000019,U,,0,,CHEMBL629509,
12413,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,,BAO_0000218,N,,1,,CHEMBL629510,
12414,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,BAO_0000218,N,,1,,CHEMBL629511,
12415,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,BAO_0000218,N,,1,,CHEMBL629512,
12416,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,BAO_0000218,N,,1,,CHEMBL629513,
12417,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,,BAO_0000218,N,,1,,CHEMBL629514,
12418,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,BAO_0000218,N,,1,,CHEMBL628447,
12419,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,,BAO_0000218,N,,1,,CHEMBL628448,
12420,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,,BAO_0000218,N,,1,,CHEMBL628449,
12421,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,,BAO_0000218,N,,1,,CHEMBL631119,
12422,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,,BAO_0000218,N,,1,,CHEMBL631120,
12423,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,,BAO_0000218,N,,1,,CHEMBL631121,
12424,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,,BAO_0000218,N,,1,,CHEMBL874458,
12425,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,BAO_0000218,N,,1,,CHEMBL631122,
12426,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,BAO_0000218,N,,1,,CHEMBL631123,
12427,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,BAO_0000218,N,,1,,CHEMBL631124,
12428,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,BAO_0000218,N,,1,,CHEMBL631125,
12429,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,BAO_0000218,N,,1,,CHEMBL631290,
12430,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,BAO_0000218,N,,1,,CHEMBL631291,
12431,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,BAO_0000218,N,,1,,CHEMBL631292,
12432,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,,BAO_0000218,N,,1,,CHEMBL631293,
12433,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,,BAO_0000218,N,,1,,CHEMBL631294,
12434,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,,BAO_0000218,N,,1,,CHEMBL631295,
12435,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,,BAO_0000218,N,,1,,CHEMBL631296,
12436,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,,BAO_0000218,N,,1,,CHEMBL631297,
12437,,,22224,,Autocuration,1,,A,,Maximum biodistribution (Bmax) was determined.,,,BAO_0000218,U,,0,,CHEMBL631298,
12438,,,50594,10090.0,Intermediate,1,,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,,BAO_0000218,N,,1,,CHEMBL631299,
12439,,,50594,10090.0,Intermediate,1,,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,,BAO_0000218,N,,1,,CHEMBL631300,
12440,,,50594,10090.0,Intermediate,1,,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,,BAO_0000218,N,,1,,CHEMBL631301,
12441,,,50594,10090.0,Intermediate,1,,A,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,,BAO_0000218,N,,1,,CHEMBL630291,
12442,,,22224,,Autocuration,1,,A,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,,BAO_0000218,U,,0,,CHEMBL630292,
12443,,,22224,,Autocuration,1,,A,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,,BAO_0000218,U,,0,,CHEMBL630293,
12444,,,22224,,Autocuration,1,,A,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,,BAO_0000218,U,,0,,CHEMBL630294,
12445,,,22224,,Autocuration,1,,A,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,,BAO_0000218,U,,0,,CHEMBL630295,
12446,,,22224,,Autocuration,1,,A,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,,BAO_0000218,U,,0,,CHEMBL630296,
12447,,,22224,,Autocuration,1,,A,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,,BAO_0000218,U,,0,,CHEMBL626782,
12448,,,22224,,Autocuration,1,,A,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,,BAO_0000218,U,,0,,CHEMBL626783,
12449,,,22224,,Autocuration,1,,A,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,,BAO_0000218,U,,0,,CHEMBL626784,
12450,,,22224,,Autocuration,1,,A,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,,BAO_0000218,U,,0,,CHEMBL626785,
12451,,,22224,,Autocuration,1,,A,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,,BAO_0000218,U,,0,,CHEMBL626786,
12452,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,U,,0,,CHEMBL626787,
12453,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,,BAO_0000218,U,,0,,CHEMBL626788,
12454,,,22224,,Autocuration,1,,A,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,U,,0,,CHEMBL625927,
12455,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL625928,
12456,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,N,,1,,CHEMBL625929,
12457,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,,BAO_0000218,N,,1,,CHEMBL625930,
12458,,178.0,50597,10116.0,Intermediate,1,Blood,A,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,,BAO_0000218,N,,1,,CHEMBL625931,
12459,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,,BAO_0000218,N,,1,,CHEMBL627230,
12460,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627231,
12461,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,N,,1,,CHEMBL627232,
12462,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,,BAO_0000218,N,,1,,CHEMBL627233,
12463,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL875470,
12464,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627234,
12465,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627235,
12466,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627236,
12467,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627237,
12468,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627238,
12469,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627239,
12470,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627240,
12471,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627241,
12472,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627242,
12473,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,,BAO_0000218,N,,1,,CHEMBL627243,
12474,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,N,,1,,CHEMBL627244,
12475,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627245,
12476,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627246,
12477,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627247,
12478,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627248,
12479,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627249,
12480,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL625569,
12481,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL625570,
12482,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL625571,
12483,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,N,,1,,CHEMBL625572,
12484,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,N,,1,,CHEMBL625573,
12485,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625574,
12486,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,,BAO_0000218,N,,1,,CHEMBL626245,
12487,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL626246,
12488,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,U,,0,,CHEMBL626247,
12489,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,U,,0,,CHEMBL626248,
12490,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,BAO_0000218,U,,0,,CHEMBL626249,
12491,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,U,,0,,CHEMBL626420,
12492,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,BAO_0000218,U,,0,,CHEMBL626421,
12493,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,U,,0,,CHEMBL626422,
12494,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,U,,0,,CHEMBL626423,
12495,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,U,,0,,CHEMBL626424,
12496,,,50588,9615.0,Intermediate,1,,A,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,,BAO_0000218,N,,1,,CHEMBL626425,
12497,,,50597,10116.0,Intermediate,1,,A,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,,BAO_0000218,N,,1,,CHEMBL875476,
12498,,,100710,9541.0,Intermediate,1,,A,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,,BAO_0000218,N,,1,,CHEMBL626426,
12499,,,22224,,Autocuration,1,,P,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,,BAO_0000100,U,,0,,CHEMBL626427,
12500,,,22224,,Autocuration,1,,P,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,,BAO_0000100,U,,0,,CHEMBL626428,
12501,,,22224,,Autocuration,1,,A,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,,BAO_0000019,U,,0,,CHEMBL626429,
12502,,1088.0,22224,,Autocuration,1,Urine,A,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,,BAO_0000019,U,,0,,CHEMBL625025,
12503,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL625026,
12504,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL625027,
12505,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL874410,
12506,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL625028,
12507,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL625029,
12508,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL625030,
12509,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL625031,
12510,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL625032,
12511,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL625033,
12512,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL625034,
12513,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624872,
12514,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624873,
12515,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624874,
12516,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624875,
12517,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624876,
12518,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624877,
12519,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624878,
12520,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624879,
12521,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624880,
12522,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624881,
12523,,948.0,50597,10116.0,Intermediate,1,Heart,A,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,,BAO_0000218,N,,1,,CHEMBL624882,
12524,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624883,
12525,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624884,
12526,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624885,
12527,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624886,
12528,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624887,
12529,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624888,
12530,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624889,
12531,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624890,
12532,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL621964,
12533,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL621965,
12534,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL621966,
12535,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL621967,
12536,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL622164,
12537,,,22224,,Autocuration,1,,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,,BAO_0000019,U,,0,,CHEMBL623097,
12538,,,22224,,Autocuration,1,,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,,BAO_0000019,U,,0,,CHEMBL623098,
12539,,,22224,,Autocuration,1,,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,,BAO_0000019,U,,0,,CHEMBL623099,
12540,,,22224,,Autocuration,1,,A,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,,BAO_0000019,U,,0,,CHEMBL623100,
12541,,,50597,10116.0,Intermediate,1,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,,BAO_0000218,N,,1,,CHEMBL628673,
12542,,,50597,10116.0,Intermediate,1,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,,BAO_0000218,N,,1,,CHEMBL628674,
12543,,,50597,10116.0,Intermediate,1,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,,BAO_0000218,N,,1,,CHEMBL628675,
12544,,,50597,10116.0,Intermediate,1,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,,BAO_0000218,N,,1,,CHEMBL627644,
12545,,,50597,10116.0,Intermediate,1,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,,BAO_0000218,N,,1,,CHEMBL627645,
12546,,,50597,10116.0,Intermediate,1,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,,BAO_0000218,N,,1,,CHEMBL627646,
12547,,,50597,10116.0,Intermediate,1,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,,BAO_0000218,N,,1,,CHEMBL627647,
12548,,,50597,10116.0,Intermediate,1,,A,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,,BAO_0000218,N,,1,,CHEMBL627648,
12549,,,50597,10116.0,Intermediate,1,,A,,Free level in rat plasma,,,BAO_0000218,N,,1,,CHEMBL627649,
12550,,,22224,,Autocuration,1,,A,,Level reaching in blood plasma of rat or human was determined,,,BAO_0000019,U,,0,,CHEMBL628313,
12551,,,50597,10116.0,Intermediate,1,,A,,Log (Cbrain/Cblood) in rats,,,BAO_0000218,N,,1,,CHEMBL628314,
12552,,,22224,,Autocuration,1,,A,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,,BAO_0000019,U,,0,,CHEMBL628315,
12553,,,22224,,Autocuration,1,,A,,Mean percentage of compound transport through membrane; expressed as membrane transport,,,BAO_0000019,U,,0,,CHEMBL628316,
12554,,,22224,,Autocuration,1,,A,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,,BAO_0000218,U,,0,,CHEMBL628317,
12555,,,22224,,Autocuration,1,,A,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,,BAO_0000019,U,,0,,CHEMBL628473,
12556,,,22224,,Autocuration,1,,A,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,,BAO_0000019,U,,0,,CHEMBL628474,
12557,,,22224,,Autocuration,1,,A,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,,BAO_0000019,U,,0,,CHEMBL628475,
12558,,,22224,,Autocuration,1,,A,,Net water uptake by a carrier mediated transport (%cm) mechanism,,,BAO_0000019,U,,0,,CHEMBL628476,
12559,,,22224,314293.0,Autocuration,1,,A,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,,BAO_0000218,U,,0,,CHEMBL628477,
12560,,,50506,9669.0,Intermediate,1,,A,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,,BAO_0000218,N,,1,,CHEMBL628478,
12561,,,50506,9669.0,Intermediate,1,,A,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,,BAO_0000218,N,,1,,CHEMBL628479,
12562,,,22224,314293.0,Autocuration,1,,A,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,,BAO_0000218,U,,0,,CHEMBL628480,
12563,,,22224,314293.0,Autocuration,1,,A,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,,BAO_0000218,U,,0,,CHEMBL628481,
12564,,,50597,10116.0,Intermediate,1,,A,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL628482,
12565,,,50597,10116.0,Intermediate,1,,A,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,BAO_0000218,N,,1,,CHEMBL628483,
12566,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,,BAO_0000218,N,,1,,CHEMBL628484,
12567,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,BAO_0000218,N,,1,,CHEMBL628485,
12568,,1969.0,100710,9541.0,Intermediate,1,Plasma,A,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,,BAO_0000218,N,,1,,CHEMBL628486,
12569,,1969.0,50587,9606.0,Intermediate,1,Plasma,A,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,,BAO_0000218,N,,1,,CHEMBL628487,
12570,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,,BAO_0000218,N,,1,,CHEMBL628488,
12571,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,BAO_0000218,N,,1,,CHEMBL628489,
12572,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,,BAO_0000218,N,,1,,CHEMBL628490,
12573,,,100710,9541.0,Intermediate,1,,A,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,BAO_0000218,N,,1,,CHEMBL628491,
12574,,,100710,9541.0,Intermediate,1,,A,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,,BAO_0000218,N,,1,,CHEMBL877507,
12575,,,22224,,Autocuration,1,,A,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,,BAO_0000218,U,,0,,CHEMBL628492,
12576,,,22224,314293.0,Autocuration,1,,A,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,,BAO_0000019,U,,0,,CHEMBL628493,
12577,,,22224,314293.0,Autocuration,1,,A,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,,BAO_0000019,U,,0,,CHEMBL628494,
12578,,,22224,314293.0,Autocuration,1,,A,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,,BAO_0000019,U,,0,,CHEMBL628495,
12579,,,50587,9606.0,Intermediate,1,,A,,Permeability in Caco-2 assay at 10E-6,,,BAO_0000218,N,,1,,CHEMBL628496,
12580,,955.0,22224,,Autocuration,1,Brain,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,,BAO_0000218,U,,0,,CHEMBL628497,
12581,,955.0,22224,,Autocuration,1,Brain,A,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,,BAO_0000218,U,,0,,CHEMBL628498,
12582,,,22224,,Autocuration,1,,A,,Plasma protein binding was determined,,,BAO_0000019,U,,0,,CHEMBL628499,
12583,,,22224,,Autocuration,1,,A,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,,BAO_0000218,U,,0,,CHEMBL627656,
12584,,,22224,,Autocuration,1,,A,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,,BAO_0000218,U,,0,,CHEMBL627657,
12585,,,22224,,Autocuration,1,,A,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,,BAO_0000218,U,,0,,CHEMBL626808,
12586,,,22224,,Autocuration,1,,A,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,,BAO_0000218,U,,0,,CHEMBL626809,
12587,,,22224,,Autocuration,1,,A,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,,BAO_0000218,U,,0,,CHEMBL626810,
12588,,,22224,,Autocuration,1,,A,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,,BAO_0000218,U,,0,,CHEMBL626811,
12589,,,22224,,Autocuration,1,,A,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,,BAO_0000218,U,,0,,CHEMBL874465,
12590,,,22224,,Autocuration,1,,A,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,,BAO_0000218,U,,0,,CHEMBL626812,
12591,,,22224,,Autocuration,1,,A,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,,BAO_0000218,U,,0,,CHEMBL626813,
12592,,,22224,,Autocuration,1,,A,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,,BAO_0000218,U,,0,,CHEMBL626814,
12593,,,22224,,Autocuration,1,,A,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,,BAO_0000019,U,,0,,CHEMBL626815,
12594,,,22224,,Autocuration,1,,A,,Partition coefficient (logP),,,BAO_0000019,U,,0,,CHEMBL628566,
12595,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,BAO_0000100,U,,0,,CHEMBL628567,
12596,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL628568,
12597,In vivo,,50588,9615.0,Intermediate,1,,A,,C max in dog,,,BAO_0000218,N,,1,,CHEMBL628569,
12598,In vivo,,50512,10141.0,Intermediate,1,,A,,C max in guinea pig,,,BAO_0000218,N,,1,,CHEMBL628570,
12599,In vivo,,22224,,Autocuration,1,,A,,C max value was evaluated,,,BAO_0000218,U,,0,,CHEMBL628571,
12600,In vivo,,22224,,Autocuration,1,,A,,Cmax value after oral dose of 0.1 mg//kg,,,BAO_0000218,U,,0,,CHEMBL628572,
12601,In vivo,,22224,,Autocuration,1,,A,,Cmax value after oral dose of 0.3 mg/kg,,,BAO_0000218,U,,0,,CHEMBL628573,
12602,In vivo,,22224,,Autocuration,1,,A,,Cmax value after oral dose of 1 mg/kg,,,BAO_0000218,U,,0,,CHEMBL628574,
12603,In vivo,,22224,,Autocuration,1,,A,,Cmax value after oral dose of 10 mg/kg,,,BAO_0000218,U,,0,,CHEMBL628575,
12604,In vivo,,22224,,Autocuration,1,,A,,Cmax value after oral dose of 23.4 mg/kg,,,BAO_0000218,U,,0,,CHEMBL628576,
12605,In vivo,,22224,,Autocuration,1,,A,,Cmax value after oral dose of 3 mg/kg,,,BAO_0000218,U,,0,,CHEMBL628577,
12606,In vivo,,22224,,Autocuration,1,,A,,Cmax value after oral dose of 3.87 mg/kg,,,BAO_0000218,U,,0,,CHEMBL628578,
12607,In vivo,,50588,9615.0,Intermediate,1,,A,,Cmax value in female Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL874466,
12608,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax value in male rats,,,BAO_0000218,N,,1,,CHEMBL628579,
12609,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Cmax value in rat plasma when administered 20 mg/kg perorally,,,BAO_0000218,N,,1,,CHEMBL628580,
12610,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,BAO_0000218,N,,1,,CHEMBL628581,
12611,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,BAO_0000218,N,,1,,CHEMBL628582,
12612,,,50588,9615.0,Intermediate,1,,A,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,,BAO_0000218,N,,1,,CHEMBL628583,
12613,,,22224,314293.0,Autocuration,1,,A,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,,BAO_0000218,U,,0,,CHEMBL625782,
12614,,,50592,9986.0,Intermediate,1,,A,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,,BAO_0000218,N,,1,,CHEMBL625783,
12615,,,50597,10116.0,Intermediate,1,,A,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,,BAO_0000218,N,,1,,CHEMBL625784,
12616,,1969.0,50797,9544.0,Intermediate,1,Plasma,A,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,,BAO_0000218,N,,1,,CHEMBL625785,
12617,,,50597,10116.0,Intermediate,1,,A,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625786,
12618,,,22224,,Autocuration,1,,A,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,,BAO_0000019,U,,0,,CHEMBL874467,
12619,,,50588,9615.0,Intermediate,1,,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,,BAO_0000218,N,,1,,CHEMBL625787,
12620,,,50677,12721.0,Intermediate,1,,A,,cytotoxicity against HIV protease enzyme.,,,BAO_0000218,N,,1,,CHEMBL625964,
12621,,,50594,10090.0,Intermediate,1,,A,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,,BAO_0000218,N,,1,,CHEMBL625965,
12622,,,50594,10090.0,Intermediate,1,,A,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,,BAO_0000218,N,,1,,CHEMBL625966,
12623,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,The plasma clearance in dog.,,,BAO_0000218,N,,1,,CHEMBL625967,
12624,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The plasma clearance in rat.,,,BAO_0000218,N,,1,,CHEMBL625968,
12625,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Clearance from plasma in male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL625969,
12626,In vivo,1969.0,100710,9541.0,Intermediate,1,Plasma,A,,Clearance from plasma in male cynomolgus monkeys,,,BAO_0000218,N,,1,,CHEMBL625970,
12627,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,,BAO_0000218,N,,1,,CHEMBL625971,
12628,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Clearance of compound in dog plasma,,,BAO_0000218,N,,1,,CHEMBL625972,
12629,In vivo,1969.0,50587,9606.0,Intermediate,1,Plasma,A,,Clearance of compound in human plasma,,,BAO_0000218,N,,1,,CHEMBL625973,
12630,In vivo,,50588,9615.0,Intermediate,1,,A,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,,BAO_0000218,N,,1,,CHEMBL625974,
12631,In vivo,,50588,9615.0,Intermediate,1,,A,,Clearance of compound when administered intravenously as an individual dose to a single dog.,,,BAO_0000218,N,,1,,CHEMBL625975,
12632,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,"Clearance (10 mg/kg, intravenously) in dog plasma",,,BAO_0000218,N,,1,,CHEMBL625976,
12633,In vivo,,50588,9615.0,Intermediate,1,,A,,Clearance value in dog,,,BAO_0000218,N,,1,,CHEMBL625977,
12634,In vivo,,50512,10141.0,Intermediate,1,,A,,Clearance value in guinea pig,,,BAO_0000218,N,,1,,CHEMBL625978,
12635,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance values in rats after iv administration.,,,BAO_0000218,N,,1,,CHEMBL874468,
12636,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,,BAO_0000218,U,,0,,CHEMBL625421,
12637,In vivo,,50592,9986.0,Intermediate,1,,A,,In vivo clearance (5 mg/kg) was determined in rabbits,,,BAO_0000218,N,,1,,CHEMBL625422,
12638,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma Clearance rate was determined for the compound in rats,,,BAO_0000218,N,,1,,CHEMBL625423,
12639,In vivo,,22224,9520.0,Autocuration,1,,A,,Plasma Clearance rate was determined for the compound in squirrel monkeys,,,BAO_0000218,U,,0,,CHEMBL625424,
12640,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL625425,
12641,In vivo,,22224,,Autocuration,1,,A,,Plasma clearance of the compound,,,BAO_0000218,U,,0,,CHEMBL625426,
12642,In vivo,,50512,10141.0,Intermediate,1,,A,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,,BAO_0000218,N,,1,,CHEMBL625427,
12643,In vivo,,50512,10141.0,Intermediate,1,,A,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,,BAO_0000218,N,,1,,CHEMBL625428,
12644,In vivo,,22224,,Autocuration,1,,A,,Plasma clearance was determined,,,BAO_0000218,U,,0,,CHEMBL625429,
12645,In vivo,,50588,9615.0,Intermediate,1,,A,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,,BAO_0000218,N,,1,,CHEMBL625430,
12646,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance rate was determined for the compound in rats,,,BAO_0000218,N,,1,,CHEMBL625431,
12647,In vivo,,22224,9520.0,Autocuration,1,,A,,Plasma clearance rate was determined for the compound in squirrel monkeys,,,BAO_0000218,U,,0,,CHEMBL627307,
12648,In vivo,,22224,,Autocuration,1,,A,,Slow clearance (CL) was determined,,,BAO_0000218,U,,0,,CHEMBL627308,
12649,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,U,,0,,CHEMBL627309,
12650,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,,BAO_0000218,U,,0,,CHEMBL627310,
12651,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,BAO_0000218,U,,0,,CHEMBL627311,
12652,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,U,,0,,CHEMBL627312,
12653,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,BAO_0000218,U,,0,,CHEMBL627313,
12654,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,U,,0,,CHEMBL627314,
12655,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,U,,0,,CHEMBL627315,
12656,,,22224,,Autocuration,1,,A,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,U,,0,,CHEMBL627316,
12657,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,,BAO_0000218,U,,0,,CHEMBL627317,
12658,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,U,,0,,CHEMBL627318,
12659,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,,BAO_0000218,U,,0,,CHEMBL627999,
12660,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,,BAO_0000218,U,,0,,CHEMBL628000,
12661,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,,BAO_0000218,U,,0,,CHEMBL628001,
12662,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,U,,0,,CHEMBL628002,
12663,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,U,,0,,CHEMBL625610,
12664,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,U,,0,,CHEMBL625611,
12665,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,,BAO_0000218,U,,0,,CHEMBL625612,
12666,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,,BAO_0000218,U,,0,,CHEMBL625613,
12667,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,,BAO_0000218,U,,0,,CHEMBL875479,
12668,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,,BAO_0000218,U,,0,,CHEMBL625614,
12669,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,,BAO_0000218,U,,0,,CHEMBL625615,
12670,,,22224,,Autocuration,1,,A,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,,BAO_0000218,U,,0,,CHEMBL626302,
12671,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL626303,
12672,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,,BAO_0000218,N,,1,,CHEMBL627420,
12673,,,50597,10116.0,Intermediate,1,,A,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,,BAO_0000218,N,,1,,CHEMBL627421,
12674,,,50597,10116.0,Intermediate,1,,A,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,,BAO_0000218,N,,1,,CHEMBL625695,
12675,,,50597,10116.0,Intermediate,1,,A,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,,BAO_0000218,N,,1,,CHEMBL625696,
12676,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Distribution of compound in mice brain was measured after 1 hr,,,BAO_0000218,N,,1,,CHEMBL875606,
12677,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Distribution of compound in mice brain was measured after 24 hr r,,,BAO_0000218,N,,1,,CHEMBL625697,
12678,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Distribution of compound in mice brain was measured after 2 hr,,,BAO_0000218,N,,1,,CHEMBL625698,
12679,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Distribution of compound in mice brain was measured after 3 hr,,,BAO_0000218,N,,1,,CHEMBL625699,
12680,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Distribution of compound in mice brain was measured after 6 hr,,,BAO_0000218,N,,1,,CHEMBL625700,
12681,,,50594,10090.0,Intermediate,1,,A,,Distribution of compound in mice liver was measured after 1 hr,,,BAO_0000218,N,,1,,CHEMBL625701,
12682,,,50594,10090.0,Intermediate,1,,A,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,,BAO_0000218,N,,1,,CHEMBL625702,
12683,,,50594,10090.0,Intermediate,1,,A,,Distribution of compound in mice liver was measured after 2 hr,,,BAO_0000218,N,,1,,CHEMBL625703,
12684,,,50594,10090.0,Intermediate,1,,A,,Distribution of compound in mice liver was measured after 3 hr,,,BAO_0000218,N,,1,,CHEMBL625704,
12685,,,50594,10090.0,Intermediate,1,,A,,Distribution of compound in mice liver was measured after 6 hr,,,BAO_0000218,N,,1,,CHEMBL625705,
12686,,1236.0,50588,9615.0,Intermediate,1,Adrenal medulla,A,,Distribution in dog adrenal medulla 30 min after administration.,,,BAO_0000218,N,,1,,CHEMBL625706,
12687,,1236.0,50588,9615.0,Intermediate,1,Adrenal medulla,A,,Distribution in dog adrenal medulla 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL625707,
12688,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog Ovary 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL625708,
12689,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog Ovary 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL625709,
12690,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog adipose 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624180,
12691,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog adipose 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624181,
12692,,1235.0,50588,9615.0,Intermediate,1,Adrenal cortex,A,,Distribution in female dog adrenal cortex 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624182,
12693,,1235.0,50588,9615.0,Intermediate,1,Adrenal cortex,A,,Distribution in female dog adrenal cortex 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624183,
12694,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624184,
12695,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL877489,
12696,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624185,
12697,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624186,
12698,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624187,
12699,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624188,
12700,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624189,
12701,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624190,
12702,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624191,
12703,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624192,
12704,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624193,
12705,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624194,
12706,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624891,
12707,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL624892,
12708,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL624893,
12709,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL627632,
12710,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL627633,
12711,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL627634,
12712,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL627635,
12713,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL627636,
12714,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL626816,
12715,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626817,
12716,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL626818,
12717,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626819,
12718,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL626820,
12719,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626821,
12720,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626822,
12721,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626823,
12722,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL626824,
12723,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626825,
12724,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL626826,
12725,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626827,
12726,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL626828,
12727,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626829,
12728,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626830,
12729,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL627150,
12730,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL627151,
12731,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,,BAO_0000218,N,,1,,CHEMBL627152,
12732,,,50597,10116.0,Intermediate,1,,A,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL627153,
12733,,,22224,,Autocuration,1,,A,,Rate of acetate production by the compound was determined,,,BAO_0000019,U,,0,,CHEMBL627154,
12734,,,22224,,Autocuration,1,,A,,Rate of acetate production by the compound was determined; Not determined,,,BAO_0000019,U,,0,,CHEMBL627155,
12735,,,22224,,Autocuration,1,,A,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,,BAO_0000019,U,,0,,CHEMBL627156,
12736,,,22224,,Autocuration,1,,A,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,,BAO_0000019,U,,0,,CHEMBL627157,
12737,,,50592,9986.0,Intermediate,1,,A,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,,BAO_0000218,N,,1,,CHEMBL627158,
12738,,1969.0,50592,9986.0,Intermediate,1,Plasma,A,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,,BAO_0000218,N,,1,,CHEMBL627159,
12739,,,50594,10090.0,Intermediate,1,,A,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,,BAO_0000218,N,,1,,CHEMBL627160,
12740,,,50597,10116.0,Intermediate,1,,A,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,,BAO_0000218,N,,1,,CHEMBL628540,
12741,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,,BAO_0000218,N,,1,,CHEMBL628541,
12742,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,,BAO_0000218,N,,1,,CHEMBL628542,
12743,,,22229,,Autocuration,1,,P,,Solubility after at a pH 1.2,,,BAO_0000100,U,,0,,CHEMBL628543,
12744,,,22229,,Autocuration,1,,P,,Solubility after at pH 1.2,,,BAO_0000100,U,,0,,CHEMBL628544,
12745,,,22229,,Autocuration,1,,P,,Solubility after injection of water,,,BAO_0000100,U,,0,,CHEMBL628545,
12746,,,22224,,Autocuration,1,,A,,Statistical significance of IC 50 values; Expressed as R value,,,BAO_0000019,U,,0,,CHEMBL628546,
12747,,,22224,,Autocuration,1,,A,,Systemic availability with respect to methyldopa was determined,,,BAO_0000019,U,,0,,CHEMBL874455,
12748,,,50597,10116.0,Intermediate,1,,A,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,,BAO_0000218,N,,1,,CHEMBL628547,
12749,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,,BAO_0000218,N,,1,,CHEMBL628548,
12750,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,,BAO_0000218,N,,1,,CHEMBL628549,
12751,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,,BAO_0000218,N,,1,,CHEMBL628550,
12752,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,,BAO_0000218,N,,1,,CHEMBL628551,
12753,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,,BAO_0000218,N,,1,,CHEMBL628552,
12754,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,,BAO_0000218,N,,1,,CHEMBL628553,
12755,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,,BAO_0000218,N,,1,,CHEMBL628554,
12756,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,,BAO_0000218,N,,1,,CHEMBL628555,
12757,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,,BAO_0000218,N,,1,,CHEMBL628556,
12758,,2113.0,50592,9986.0,Intermediate,1,Kidney,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,,BAO_0000218,N,,1,,CHEMBL628557,
12759,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,,BAO_0000218,N,,1,,CHEMBL628558,
12760,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,,BAO_0000218,N,,1,,CHEMBL628559,
12761,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,,BAO_0000218,N,,1,,CHEMBL628560,
12762,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,,BAO_0000218,N,,1,,CHEMBL874456,
12763,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,,BAO_0000218,N,,1,,CHEMBL628561,
12764,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,,BAO_0000218,N,,1,,CHEMBL628562,
12765,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,,BAO_0000218,N,,1,,CHEMBL628563,
12766,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,,BAO_0000218,N,,1,,CHEMBL628564,
12767,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,,BAO_0000218,N,,1,,CHEMBL628565,
12768,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,,BAO_0000218,N,,1,,CHEMBL631248,
12769,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,,BAO_0000218,N,,1,,CHEMBL631249,
12770,,2113.0,50592,9986.0,Intermediate,1,Kidney,A,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,,BAO_0000218,N,,1,,CHEMBL627214,
12771,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,,BAO_0000218,N,,1,,CHEMBL874591,
12772,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,,BAO_0000218,N,,1,,CHEMBL627215,
12773,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,,BAO_0000218,N,,1,,CHEMBL625471,
12774,,,50592,9986.0,Intermediate,1,,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,,BAO_0000218,N,,1,,CHEMBL625472,
12775,,,50592,9986.0,Intermediate,1,,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,,BAO_0000218,N,,1,,CHEMBL625473,
12776,In vivo,,50588,9615.0,Intermediate,1,,A,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,,BAO_0000218,N,,1,,CHEMBL625474,
12777,In vivo,,50588,9615.0,Intermediate,1,,A,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,,BAO_0000218,N,,1,,CHEMBL625475,
12778,In vivo,,50597,10116.0,Intermediate,1,,A,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,,BAO_0000218,N,,1,,CHEMBL625476,
12779,In vivo,,50597,10116.0,Intermediate,1,,A,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,,BAO_0000218,N,,1,,CHEMBL625477,
12780,In vivo,,50597,10116.0,Intermediate,1,,A,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,,BAO_0000218,N,,1,,CHEMBL625478,
12781,In vitro,,50597,10116.0,Intermediate,1,esophageal tunica muscularis mucosae,A,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,,BAO_0000218,N,,1,,CHEMBL625479,
12782,In vitro,,50597,10116.0,Intermediate,1,esophageal tunica muscularis mucosae,A,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,,BAO_0000218,N,,1,,CHEMBL625480,
12783,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,,BAO_0000218,N,,1,,CHEMBL625481,
12784,In vivo,,50597,10116.0,Intermediate,1,,A,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL625482,
12785,In vivo,,50597,10116.0,Intermediate,1,,A,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL625483,
12786,In vivo,,50597,10116.0,Intermediate,1,,A,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL625484,
12787,In vivo,,50597,10116.0,Intermediate,1,,A,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL625485,
12788,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL625486,
12789,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL625487,
12790,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL625488,
12791,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL625489,
12792,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL625490,
12793,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,,BAO_0000218,N,,1,,CHEMBL625491,
12794,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,,BAO_0000218,N,,1,,CHEMBL625492,
12795,In vivo,1969.0,50587,9606.0,Intermediate,1,Plasma,A,,plasma clearance in human,,,BAO_0000218,N,,1,,CHEMBL625493,
12796,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625494,
12797,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625495,
12798,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625496,
12799,,,22229,,Autocuration,1,,P,,1-Octanol/water partition coefficient measured at 7.4,,,BAO_0000100,U,,0,,CHEMBL625497,
12800,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625498,
12801,,,22224,,Autocuration,1,,A,,Partition coefficient (logP),,,BAO_0000019,U,,0,,CHEMBL625499,
12802,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625500,
12803,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625501,
12804,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625502,
12805,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP) (relative to BAY K 8644),,,BAO_0000100,U,,0,,CHEMBL625503,
12806,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625504,
12807,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625505,
12808,,,22229,,Autocuration,1,,P,,Calculated partition coefficient of the compound,,,BAO_0000100,U,,0,,CHEMBL625506,
12809,,,22224,,Autocuration,1,,A,,Partition coefficient (logP),,,BAO_0000019,U,,0,,CHEMBL625507,
12810,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625508,
12811,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625509,
12812,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625510,
12813,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL883125,
12814,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625511,
12815,,,22224,,Autocuration,1,,A,,Partition coefficient of the compound,,,BAO_0000019,U,,0,,CHEMBL874650,
12816,,,22224,,Autocuration,1,,A,,Partition coefficient of the compound,,,BAO_0000019,U,,0,,CHEMBL625512,
12817,,,22224,,Autocuration,1,,A,,Partition coefficient of compound was determined,,,BAO_0000019,U,,0,,CHEMBL625513,
12818,,,22224,,Autocuration,1,,A,,Partition coefficient was determined,,,BAO_0000019,U,,0,,CHEMBL625514,
12819,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625515,
12820,,,22229,,Autocuration,1,,P,,partition coefficient of compound was determined,,,BAO_0000100,U,,0,,CHEMBL625516,
12821,In vivo,,50588,9615.0,Intermediate,1,,A,,The total body administered intravenously in dog,,,BAO_0000218,N,,1,,CHEMBL625517,
12822,In vivo,,50597,10116.0,Intermediate,1,,A,,The total body administered intravenously in rats,,,BAO_0000218,N,,1,,CHEMBL625518,
12823,,,50594,10090.0,Intermediate,1,,A,,Time taken for the administration to female NIH mice weighing 25-30 g.,,,BAO_0000218,N,,1,,CHEMBL625519,
12824,,,22224,,Autocuration,1,,A,,Time taken for the administration,,,BAO_0000019,U,,0,,CHEMBL625520,
12825,In vivo,,50588,9615.0,Intermediate,1,,A,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,,BAO_0000218,N,,1,,CHEMBL874651,
12826,In vivo,,22224,314293.0,Autocuration,1,,A,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,,BAO_0000218,U,,0,,CHEMBL625521,
12827,In vivo,,50592,9986.0,Intermediate,1,,A,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,,BAO_0000218,N,,1,,CHEMBL623171,
12828,In vivo,,50597,10116.0,Intermediate,1,,A,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,,BAO_0000218,N,,1,,CHEMBL623853,
12829,,,22224,,Autocuration,1,,A,,Plasma clearance for the compound was determined.,,,BAO_0000019,U,,0,,CHEMBL623854,
12830,,,22224,,Autocuration,1,,P,,CLog P value of the compound,,,BAO_0000100,U,,0,,CHEMBL874405,
12831,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL623855,
12832,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL623856,
12833,,,22224,,Autocuration,1,,P,,ClogP value of the compound; nd ='no data',,,BAO_0000100,U,,0,,CHEMBL623857,
12834,,,22224,,Autocuration,1,,P,,ClogP value of the compound; nd ='not determined',,,BAO_0000100,U,,0,,CHEMBL623858,
12835,,,22224,,Autocuration,1,,P,,CLog P was determined,,,BAO_0000100,U,,0,,CHEMBL623859,
12836,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL839829,
12837,,,22224,,Autocuration,1,,A,,CLogP was calculated,,,BAO_0000019,U,,0,,CHEMBL623860,
12838,,,22224,,Autocuration,1,,A,,CLogP value was determined,,,BAO_0000019,U,,0,,CHEMBL623861,
12839,,,22224,,Autocuration,1,,A,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,,BAO_0000019,U,,0,,CHEMBL623862,
12840,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL874406,
12841,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL623863,
12842,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624021,
12843,,1236.0,50588,9615.0,Intermediate,1,Adrenal medulla,A,,Distribution in female dog adrenal medulla 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624022,
12844,,1236.0,50588,9615.0,Intermediate,1,Adrenal medulla,A,,Distribution in female dog adrenal medulla 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624023,
12845,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog bile 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624024,
12846,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog bile 72 hr after administration.,,,BAO_0000218,N,,1,,CHEMBL624025,
12847,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog blood 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624026,
12848,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog blood 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624027,
12849,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog heart 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624028,
12850,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog heart 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624029,
12851,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog kidney 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624030,
12852,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog kidney 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624031,
12853,,160.0,50588,9615.0,Intermediate,1,Intestine,A,,Distribution in female dog large intestine 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624032,
12854,,160.0,50588,9615.0,Intermediate,1,Intestine,A,,Distribution in female dog large intestine 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL874407,
12855,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog liver 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624033,
12856,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog liver 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624034,
12857,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog lung 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624035,
12858,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog lung 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624036,
12859,,2385.0,50588,9615.0,Intermediate,1,Muscle tissue,A,,Distribution in female dog muscle 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624037,
12860,,2385.0,50588,9615.0,Intermediate,1,Muscle tissue,A,,Distribution in female dog muscle 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624038,
12861,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog pancreas 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624039,
12862,,,50588,9615.0,Intermediate,1,,A,,Distribution in female dog pancreas 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624040,
12863,,160.0,50588,9615.0,Intermediate,1,Intestine,A,,Distribution in female dog small intestine 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624041,
12864,,160.0,50588,9615.0,Intermediate,1,Intestine,A,,Distribution in female dog small intestine 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624042,
12865,,2106.0,50588,9615.0,Intermediate,1,Spleen,A,,Distribution in female dog spleen 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624043,
12866,,2106.0,50588,9615.0,Intermediate,1,Spleen,A,,Distribution in female dog spleen 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624044,
12867,,945.0,50588,9615.0,Intermediate,1,Stomach,A,,Distribution in female dog stomach 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624045,
12868,,945.0,50588,9615.0,Intermediate,1,Stomach,A,,Distribution in female dog stomach 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624046,
12869,,2046.0,50588,9615.0,Intermediate,1,Thyroid gland,A,,Distribution in female dog thyroid 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624047,
12870,,2046.0,50588,9615.0,Intermediate,1,Thyroid gland,A,,Distribution in female dog thyroid 72 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL624048,
12871,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Distribution in female dog urine 24 hours after administration.,,,BAO_0000218,N,,1,,CHEMBL874408,
12872,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Distribution in female dog urine 72 hr after administration.,,,BAO_0000218,N,,1,,CHEMBL624049,
12873,,1969.0,22224,,Autocuration,1,Plasma,A,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,,BAO_0000218,U,,0,,CHEMBL624050,
12874,,,22224,,Autocuration,1,,A,,Plasma concentration at 7 hr after intravenous dosing,,,BAO_0000019,U,,0,,CHEMBL624051,
12875,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,,BAO_0000218,N,,1,,CHEMBL623278,
12876,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,,BAO_0000218,N,,1,,CHEMBL623279,
12877,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,,BAO_0000218,N,,1,,CHEMBL623280,
12878,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,,BAO_0000218,N,,1,,CHEMBL623963,
12879,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,,BAO_0000218,N,,1,,CHEMBL623964,
12880,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,,BAO_0000218,N,,1,,CHEMBL623965,
12881,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,,BAO_0000218,N,,1,,CHEMBL623966,
12882,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,,BAO_0000218,N,,1,,CHEMBL874415,
12883,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,,BAO_0000218,N,,1,,CHEMBL623967,
12884,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,,BAO_0000218,N,,1,,CHEMBL623968,
12885,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,,BAO_0000218,N,,1,,CHEMBL623969,
12886,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,,BAO_0000218,N,,1,,CHEMBL628409,
12887,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,,BAO_0000218,N,,1,,CHEMBL628410,
12888,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,,BAO_0000218,N,,1,,CHEMBL628411,
12889,,,50597,10116.0,Intermediate,1,,A,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,,BAO_0000218,N,,1,,CHEMBL628412,
12890,,,22224,,Autocuration,1,,A,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,,BAO_0000019,U,,0,,CHEMBL628413,
12891,,1969.0,22224,,Autocuration,1,Plasma,A,,The concentration in plasmat; Not determined,,,BAO_0000019,U,,0,,CHEMBL628414,
12892,,,50597,10116.0,Intermediate,1,,A,,Tissue level at 10 mg/kg/po in wistar rats in blood,,,BAO_0000218,N,,1,,CHEMBL628415,
12893,,,50597,10116.0,Intermediate,1,,A,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,,BAO_0000218,N,,1,,CHEMBL628416,
12894,,,50597,10116.0,Intermediate,1,,A,,Tissue level at 10 mg/kg/po in wistar rats in heart,,,BAO_0000218,N,,1,,CHEMBL628417,
12895,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Tissue level at 10 mg/kg/po in wistar rats in liver,,,BAO_0000218,N,,1,,CHEMBL874908,
12896,,,50597,10116.0,Intermediate,1,,A,,Tissue level at 10 mg/kg/po in wistar rats in plasma,,,BAO_0000218,N,,1,,CHEMBL628418,
12897,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,,BAO_0000218,N,,1,,CHEMBL628419,
12898,,,50597,10116.0,Intermediate,1,,A,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,,BAO_0000218,N,,1,,CHEMBL628420,
12899,,,22224,,Autocuration,1,,A,,Water solubility at 37 degree C.,,,BAO_0000019,U,,0,,CHEMBL628421,
12900,,,22229,,Autocuration,1,,P,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,BAO_0000100,U,,0,,CHEMBL626726,
12901,,,22229,,Autocuration,1,,P,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,BAO_0000100,U,,0,,CHEMBL626727,
12902,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626728,
12903,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626729,
12904,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626730,
12905,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626731,
12906,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626732,
12907,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626733,
12908,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626734,
12909,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626735,
12910,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL874909,
12911,,948.0,50597,10116.0,Intermediate,1,Heart,A,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626736,
12912,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL626737,
12913,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL630999,
12914,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631000,
12915,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631001,
12916,,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631002,
12917,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631003,
12918,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631004,
12919,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631005,
12920,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631006,
12921,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631007,
12922,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631008,
12923,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631009,
12924,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631010,
12925,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631011,
12926,,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL631012,
12927,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL630271,
12928,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL630272,
12929,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL630273,
12930,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL630274,
12931,,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL630275,
12932,,,50597,10116.0,Intermediate,1,,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL875782,
12933,,,50597,10116.0,Intermediate,1,,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL630276,
12934,,,50597,10116.0,Intermediate,1,,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL630277,
12935,,,50597,10116.0,Intermediate,1,,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL630278,
12936,,,50597,10116.0,Intermediate,1,,A,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,,BAO_0000218,N,,1,,CHEMBL630279,
12937,,,22224,,Autocuration,1,,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,,BAO_0000019,U,,0,,CHEMBL630280,
12938,,,22224,,Autocuration,1,,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,BAO_0000019,U,,0,,CHEMBL630281,
12939,,,50592,9986.0,Intermediate,1,,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,,BAO_0000218,N,,1,,CHEMBL630282,
12940,,,50592,9986.0,Intermediate,1,,A,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,,BAO_0000218,N,,1,,CHEMBL630283,
12941,,,22224,,Autocuration,1,,A,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,,BAO_0000019,U,,0,,CHEMBL630284,
12942,,,22224,,Autocuration,1,,A,,Alkylating activity was determined,,,BAO_0000019,U,,0,,CHEMBL630285,
12943,,,22224,,Autocuration,1,,A,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),Microsomes,,BAO_0000251,U,,0,,CHEMBL630286,
12944,,,50592,9986.0,Intermediate,1,,A,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,,BAO_0000218,N,,1,,CHEMBL630069,
12945,,,50592,9986.0,Intermediate,1,,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,,BAO_0000218,N,,1,,CHEMBL630070,
12946,,,50592,9986.0,Intermediate,1,,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,,BAO_0000218,N,,1,,CHEMBL630071,
12947,,,50592,9986.0,Intermediate,1,,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,,BAO_0000218,N,,1,,CHEMBL630072,
12948,,,50592,9986.0,Intermediate,1,,A,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,,BAO_0000218,N,,1,,CHEMBL875110,
12949,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for antidiuretic activity in rats,,,BAO_0000218,N,,1,,CHEMBL630073,
12950,,,22224,,Autocuration,1,,A,,Compound was tested for inactivation kinetic values,,,BAO_0000019,U,,0,,CHEMBL630074,
12951,In vivo,,22224,,Autocuration,1,,A,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,,BAO_0000218,U,,0,,CHEMBL630075,
12952,,,22224,,Autocuration,1,,A,,Dissociation rate calculated from the first-order equation using the t1/2 value,,,BAO_0000019,U,,0,,CHEMBL630076,
12953,,,22229,,Autocuration,1,,P,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,,BAO_0000100,U,,0,,CHEMBL630077,
12954,,,22229,,Autocuration,1,,P,,Aqueous solubility was measured,,,BAO_0000100,U,,0,,CHEMBL630078,
12955,,,22229,,Autocuration,1,,P,,Aqueous solubility was measured at a pH 4,,,BAO_0000100,U,,0,,CHEMBL630079,
12956,,,22229,,Autocuration,1,,P,,Aqueous solubility (pH 7),,,BAO_0000100,U,,0,,CHEMBL630080,
12957,,,22229,,Autocuration,1,,P,,Aqueous solubility was measured at a pH 9,,,BAO_0000100,U,,0,,CHEMBL630081,
12958,,,22224,,Autocuration,1,,A,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,,BAO_0000019,U,,0,,CHEMBL630082,
12959,,,22224,,Autocuration,1,,A,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,BAO_0000019,U,,0,,CHEMBL630083,
12960,,,22224,,Autocuration,1,,A,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,,BAO_0000019,U,,0,,CHEMBL630084,
12961,,,22229,,Autocuration,1,,P,,Aqueous solubility of the compound,,,BAO_0000100,U,,0,,CHEMBL629198,
12962,,,22229,,Autocuration,1,,P,,Aqueous solubility at 37 degree Celsius at pH 7.38,,,BAO_0000100,U,,0,,CHEMBL629199,
12963,,,22229,,Autocuration,1,,P,,Aqueous solubility in pH 7.4 phosphate buffer,,,BAO_0000100,U,,0,,CHEMBL629200,
12964,,,50588,9615.0,Intermediate,1,,A,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,,BAO_0000218,N,,1,,CHEMBL629201,
12965,,,50588,9615.0,Intermediate,1,,A,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,,BAO_0000218,N,,1,,CHEMBL629202,
12966,,,50587,9606.0,Intermediate,1,,A,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000218,N,,1,,CHEMBL875111,
12967,,,50587,9606.0,Intermediate,1,,A,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000218,N,,1,,CHEMBL629203,
12968,,,50587,9606.0,Intermediate,1,,A,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000218,N,,1,,CHEMBL629204,
12969,,,50587,9606.0,Intermediate,1,,A,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000218,N,,1,,CHEMBL629205,
12970,,,50587,9606.0,Intermediate,1,,A,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000218,N,,1,,CHEMBL629206,
12971,,,22224,,Autocuration,1,,A,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,,BAO_0000019,U,,0,,CHEMBL631185,
12972,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for the average bile flow rat in rats,,,BAO_0000218,N,,1,,CHEMBL631186,
12973,,,50592,9986.0,Intermediate,1,,A,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,BAO_0000218,N,,1,,CHEMBL631187,
12974,,,50592,9986.0,Intermediate,1,,A,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,,BAO_0000218,N,,1,,CHEMBL631188,
12975,,,22224,,Autocuration,1,,A,,Average half life period was determined,,,BAO_0000019,U,,0,,CHEMBL876419,
12976,,,22224,,Autocuration,1,,A,,Average half life period was determined,,,BAO_0000019,U,,0,,CHEMBL631189,
12977,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,BAO_0000218,N,,1,,CHEMBL631190,
12978,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,,BAO_0000218,N,,1,,CHEMBL631191,
12979,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,,BAO_0000218,N,,1,,CHEMBL631192,
12980,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,,BAO_0000218,N,,1,,CHEMBL632400,
12981,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,BAO_0000218,N,,1,,CHEMBL630564,
12982,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,,BAO_0000218,N,,1,,CHEMBL630565,
12983,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,,BAO_0000218,N,,1,,CHEMBL630566,
12984,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,,BAO_0000218,N,,1,,CHEMBL631229,
12985,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,,BAO_0000218,N,,1,,CHEMBL631230,
12986,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL876428,
12987,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL631231,
12988,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP) (MacLogP),,,BAO_0000100,U,,0,,CHEMBL631232,
12989,,,22224,,Autocuration,1,,A,,Hydrophilicity was determined,,,BAO_0000019,U,,0,,CHEMBL631233,
12990,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL631234,
12991,,,22224,,Autocuration,1,,A,,Increased absorption was determined,,,BAO_0000019,U,,0,,CHEMBL883126,
12992,,,22224,,Autocuration,1,,P,,Lipophilicity value was evaluated,,,BAO_0000100,U,,0,,CHEMBL631235,
12993,,,22224,,Autocuration,1,,P,,Log P value of the compound.,,,BAO_0000100,U,,0,,CHEMBL631236,
12994,,,22224,,Autocuration,1,,A,,Partition coefficient of compound was determined,,,BAO_0000019,U,,0,,CHEMBL631237,
12995,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL631238,
12996,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL876429,
12997,,,22224,,Autocuration,1,,A,,Partition coefficient was measured by medchem software; Not calculated,,,BAO_0000019,U,,0,,CHEMBL631414,
12998,,,22224,,Autocuration,1,,P,,Partition coefficient was measured by octanol-water using standard shake-flask method,,,BAO_0000100,U,,0,,CHEMBL631415,
12999,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL631416,
13000,,,22224,,Autocuration,1,,A,,Partition coefficient (logP),,,BAO_0000019,U,,0,,CHEMBL631417,
13001,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL631418,
13002,,,22229,,Autocuration,1,,P,,The Octanol/Water partition coefficient CLogP,,,BAO_0000100,U,,0,,CHEMBL631419,
13003,,,22224,,Autocuration,1,,A,,The pharmacokinetic parameter C Log p was reported,,,BAO_0000019,U,,0,,CHEMBL631420,
13004,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL631421,
13005,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL631422,
13006,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL631423,
13007,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL876430,
13008,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL631424,
13009,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Compound was administered intravenously in dog to evaluate plasma clearance values,,,BAO_0000218,N,,1,,CHEMBL631425,
13010,In vivo,1969.0,22224,314293.0,Autocuration,1,Plasma,A,,Compound was administered intravenously in monkey to evaluate plasma clearance values,,,BAO_0000218,U,,0,,CHEMBL631426,
13011,In vivo,1969.0,50594,10090.0,Intermediate,1,Plasma,A,,Compound was administered intravenously in mouse to evaluate plasma clearance values,,,BAO_0000218,N,,1,,CHEMBL631427,
13012,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL631428,
13013,In vitro,2107.0,50797,9544.0,Intermediate,1,Liver,A,,Intrinsic clearance in Rhesus liver microsome,Microsomes,,BAO_0000218,N,,1,,CHEMBL631429,
13014,In vitro,2107.0,50588,9615.0,Intermediate,1,Liver,A,,Intrinsic clearance in dog liver microsome,Microsomes,,BAO_0000218,N,,1,,CHEMBL631430,
13015,In vitro,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Intrinsic clearance in rat liver microsome,Microsomes,,BAO_0000218,N,,1,,CHEMBL631431,
13016,In vivo,1969.0,50797,9544.0,Intermediate,1,Plasma,A,,Low plasma clearance was calculated in rhesus monkey,,,BAO_0000218,N,,1,,CHEMBL631432,
13017,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,,BAO_0000218,N,,1,,CHEMBL631433,
13018,In vivo,,22224,,Autocuration,1,,A,,Plasma clearance after intravenous dose of 0.3 mg/kg,,,BAO_0000218,U,,0,,CHEMBL631434,
13019,In vivo,,22224,,Autocuration,1,,A,,Plasma clearance after intravenous dose of 1 mg/kg,,,BAO_0000218,U,,0,,CHEMBL631435,
13020,In vivo,,22224,,Autocuration,1,,A,,Plasma clearance after intravenous dose of 3 mg/kg,,,BAO_0000218,U,,0,,CHEMBL631436,
13021,In vivo,,22224,,Autocuration,1,,A,,Plasma clearance after intravenous dose of 3.87 mg/kg,,,BAO_0000218,U,,0,,CHEMBL631437,
13022,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance after peroral administration at 10 mpk in Rat,,,BAO_0000218,N,,1,,CHEMBL631438,
13023,In vivo,,50797,9544.0,Intermediate,1,,A,,Plasma clearance after peroral administration at 10 mpk in Rhesus,,,BAO_0000218,N,,1,,CHEMBL876431,
13024,In vivo,,50588,9615.0,Intermediate,1,,A,,Plasma clearance after peroral administration at 10 mpk in dog,,,BAO_0000218,N,,1,,CHEMBL631439,
13025,In vivo,,50597,10116.0,Intermediate,1,,A,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,,BAO_0000218,N,,1,,CHEMBL631440,
13026,,,22224,,Autocuration,1,,A,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,,BAO_0000019,U,,0,,CHEMBL631441,
13027,,,22224,,Autocuration,1,,A,,Critical Micellar concentration was determined,,,BAO_0000019,U,,0,,CHEMBL631442,
13028,,,22224,,Autocuration,1,,A,,Critical Micellar concentration of the compound. was determined,,,BAO_0000019,U,,0,,CHEMBL626525,
13029,,,22224,,Autocuration,1,,A,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,,BAO_0000019,U,,0,,CHEMBL627168,
13030,,,22224,,Autocuration,1,,A,,Critical micellar concentration was measured in water by the dye solubilization method,,,BAO_0000019,U,,0,,CHEMBL875618,
13031,,,22224,,Autocuration,1,,B,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,,BAO_0000019,U,,0,,CHEMBL626612,
13032,,,22224,,Autocuration,1,,A,,CMR value (relative to BAY K 8644),,,BAO_0000019,U,,0,,CHEMBL626613,
13033,,,22224,,Autocuration,1,,A,,Carbamoylating activity was determined,,,BAO_0000019,U,,0,,CHEMBL626614,
13034,,,22224,314293.0,Autocuration,1,,A,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,,BAO_0000218,U,,0,,CHEMBL626615,
13035,,,22224,,Autocuration,1,,A,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,,BAO_0000019,U,,0,,CHEMBL626616,
13036,,,22224,,Autocuration,1,,A,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,,BAO_0000019,U,,0,,CHEMBL626617,
13037,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,,BAO_0000218,N,,1,,CHEMBL626618,
13038,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,,BAO_0000218,N,,1,,CHEMBL626619,
13039,In vivo,,50588,9615.0,Intermediate,1,,A,,"Clearance rate at 0.46 mg/kg, iv, in dogs",,,BAO_0000218,N,,1,,CHEMBL626620,
13040,In vivo,,50597,10116.0,Intermediate,1,,A,,"Clearance rate at 5.5 mg/kg, iv, in rat",,,BAO_0000218,N,,1,,CHEMBL626621,
13041,In vivo,,100710,9541.0,Intermediate,1,,A,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL626622,
13042,In vivo,,100710,9541.0,Intermediate,1,,A,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL626623,
13043,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL626624,
13044,In vivo,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL626625,
13045,Ex vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,,BAO_0000218,N,,1,,CHEMBL626626,
13046,In vivo,,22224,,Autocuration,1,,A,,Tested for the total clearance of the compound,,,BAO_0000218,U,,0,,CHEMBL626627,
13047,In vivo,,50588,9615.0,Intermediate,1,,A,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL626628,
13048,In vivo,,22224,,Autocuration,1,,A,,Total body clearance was determined,,,BAO_0000218,U,,0,,CHEMBL626629,
13049,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,BAO_0000218,N,,1,,CHEMBL626630,
13050,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,BAO_0000218,N,,1,,CHEMBL626631,
13051,,,22229,,Autocuration,1,,P,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,BAO_0000100,U,,0,,CHEMBL626632,
13052,,,22229,,Autocuration,1,,P,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,BAO_0000100,U,,0,,CHEMBL626633,
13053,,,22229,,Autocuration,1,,P,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,,BAO_0000100,U,,0,,CHEMBL626634,
13054,,,22229,,Autocuration,1,,P,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,,BAO_0000100,U,,0,,CHEMBL626635,
13055,,,22229,,Autocuration,1,,P,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,,BAO_0000100,U,,0,,CHEMBL626636,
13056,,,22229,,Autocuration,1,,P,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,,BAO_0000100,U,,0,,CHEMBL626637,
13057,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,,BAO_0000218,N,,1,,CHEMBL626638,
13058,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,,BAO_0000218,N,,1,,CHEMBL626639,
13059,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,,BAO_0000218,N,,1,,CHEMBL626640,
13060,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,,BAO_0000218,N,,1,,CHEMBL626641,
13061,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,,BAO_0000218,N,,1,,CHEMBL627272,
13062,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,,BAO_0000218,N,,1,,CHEMBL627273,
13063,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,,BAO_0000218,N,,1,,CHEMBL627441,
13064,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,,BAO_0000218,N,,1,,CHEMBL628355,
13065,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,,BAO_0000218,N,,1,,CHEMBL628356,
13066,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,,BAO_0000218,N,,1,,CHEMBL628357,
13067,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,,BAO_0000218,N,,1,,CHEMBL628358,
13068,,,50339,4754.0,Intermediate,1,,A,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,,BAO_0000218,N,,1,,CHEMBL622307,
13069,,,22224,,Autocuration,1,,A,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,,BAO_0000019,U,,0,,CHEMBL622527,
13070,,,22224,,Autocuration,1,,A,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,,BAO_0000019,U,,0,,CHEMBL622528,
13071,,,22224,,Autocuration,1,,A,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,,BAO_0000019,U,,0,,CHEMBL622529,
13072,,,22224,,Autocuration,1,,A,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,,BAO_0000019,U,,0,,CHEMBL622992,
13073,,,22224,,Autocuration,1,,A,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,,BAO_0000019,U,,0,,CHEMBL622993,
13074,,,22224,,Autocuration,1,,A,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,,BAO_0000019,U,,0,,CHEMBL622994,
13075,,,50597,10116.0,Intermediate,1,,A,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,,BAO_0000218,N,,1,,CHEMBL622995,
13076,,,50597,10116.0,Intermediate,1,,A,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,,BAO_0000218,N,,1,,CHEMBL622996,
13077,,,50597,10116.0,Intermediate,1,,A,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,,BAO_0000218,N,,1,,CHEMBL622997,
13078,,,50597,10116.0,Intermediate,1,,A,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,,BAO_0000218,N,,1,,CHEMBL622998,
13079,,,22224,,Autocuration,1,,A,,Cp max following ip administration at 1 mg/kg,,,BAO_0000218,U,,0,,CHEMBL622999,
13080,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum concentration in plasma was reported at 0.5 hour,,,BAO_0000218,U,,0,,CHEMBL623000,
13081,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,Maximum concentration in plasma was reported at 2 hour,,,BAO_0000218,U,,0,,CHEMBL623001,
13082,,,50594,10090.0,Intermediate,1,,A,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,,BAO_0000218,N,,1,,CHEMBL623002,
13083,,,22229,,Autocuration,1,,P,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,,BAO_0000100,U,,0,,CHEMBL623003,
13084,,,22224,,Autocuration,1,,A,,Steady state concentration was evaluated,,,BAO_0000019,U,,0,,CHEMBL623004,
13085,,,22224,,Autocuration,1,,A,,Partition coefficient (logP),,,BAO_0000019,U,,0,,CHEMBL623005,
13086,,,22224,,Autocuration,1,,A,,Partition coefficient (logD7.4),,,BAO_0000019,U,,0,,CHEMBL623006,
13087,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623007,
13088,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623008,
13089,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL876654,
13090,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623009,
13091,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623010,
13092,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623011,
13093,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623012,
13094,,,22224,,Autocuration,1,,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,BAO_0000019,U,,0,,CHEMBL623013,
13095,,,22224,,Autocuration,1,,A,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,BAO_0000019,U,,0,,CHEMBL623014,
13096,,1088.0,22224,,Autocuration,1,Urine,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,,BAO_0000019,U,,0,,CHEMBL623015,
13097,,1088.0,22224,,Autocuration,1,Urine,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,,BAO_0000019,U,,0,,CHEMBL623016,
13098,,1088.0,22224,,Autocuration,1,Urine,A,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,,BAO_0000019,U,,0,,CHEMBL624858,
13099,,,50597,10116.0,Intermediate,1,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,,BAO_0000218,N,,1,,CHEMBL624859,
13100,,,50597,10116.0,Intermediate,1,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL624860,
13101,,,50597,10116.0,Intermediate,1,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,BAO_0000218,N,,1,,CHEMBL624861,
13102,,,50597,10116.0,Intermediate,1,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,,BAO_0000218,N,,1,,CHEMBL624862,
13103,,,50597,10116.0,Intermediate,1,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,,BAO_0000218,N,,1,,CHEMBL624863,
13104,,,50597,10116.0,Intermediate,1,,A,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,,BAO_0000218,N,,1,,CHEMBL876655,
13105,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,BAO_0000218,N,,1,,CHEMBL624864,
13106,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,BAO_0000218,N,,1,,CHEMBL624865,
13107,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,BAO_0000218,N,,1,,CHEMBL624866,
13108,,,50588,9615.0,Expert,1,,F,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL624867,
13109,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,BAO_0000218,N,,1,,CHEMBL624868,
13110,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,,BAO_0000218,N,,1,,CHEMBL628450,
13111,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,BAO_0000218,N,,1,,CHEMBL628451,
13112,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,BAO_0000218,N,,1,,CHEMBL628452,
13113,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,BAO_0000218,N,,1,,CHEMBL628453,
13114,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL628454,
13115,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,,BAO_0000218,N,,1,,CHEMBL628455,
13116,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,,BAO_0000218,N,,1,,CHEMBL628456,
13117,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,,BAO_0000218,N,,1,,CHEMBL628457,
13118,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,,BAO_0000218,N,,1,,CHEMBL877505,
13119,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,,BAO_0000218,N,,1,,CHEMBL628458,
13120,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,,BAO_0000218,N,,1,,CHEMBL628459,
13121,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,,BAO_0000218,N,,1,,CHEMBL628460,
13122,,,50588,9615.0,Intermediate,1,,A,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,,BAO_0000218,N,,1,,CHEMBL628461,
13123,,,22224,,Autocuration,1,,B,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,,BAO_0000218,U,,0,,CHEMBL628462,
13124,,,50588,9615.0,Intermediate,1,,A,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,BAO_0000218,N,,1,,CHEMBL628463,
13125,,,50597,10116.0,Expert,1,,F,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,,BAO_0000218,N,,1,,CHEMBL625666,
13126,,,22224,,Autocuration,1,,B,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,BAO_0000218,U,,0,,CHEMBL625667,
13127,,,50597,10116.0,Expert,1,,A,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,BAO_0000218,N,,1,,CHEMBL625668,
13128,,,50597,10116.0,Intermediate,1,,A,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,,BAO_0000218,N,,1,,CHEMBL625669,
13129,,,22224,,Autocuration,1,,A,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,,BAO_0000019,U,,0,,CHEMBL625670,
13130,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,,BAO_0000218,N,,1,,CHEMBL625671,
13131,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,,BAO_0000218,N,,1,,CHEMBL625672,
13132,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,,BAO_0000218,N,,1,,CHEMBL625673,
13133,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,,BAO_0000218,N,,1,,CHEMBL625674,
13134,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,,BAO_0000218,N,,1,,CHEMBL625675,
13135,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,BAO_0000218,N,,1,,CHEMBL627637,
13136,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,,BAO_0000218,N,,1,,CHEMBL627638,
13137,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,,BAO_0000218,N,,1,,CHEMBL627639,
13138,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,,BAO_0000218,N,,1,,CHEMBL627640,
13139,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,,BAO_0000218,N,,1,,CHEMBL627641,
13140,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,BAO_0000218,N,,1,,CHEMBL627642,
13141,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,,BAO_0000218,N,,1,,CHEMBL877506,
13142,,,50594,10090.0,Intermediate,1,,A,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,,BAO_0000218,N,,1,,CHEMBL627275,
13143,,,50506,9669.0,Intermediate,1,,A,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,,BAO_0000218,N,,1,,CHEMBL627643,
13144,,,50506,9669.0,Intermediate,1,,A,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,BAO_0000218,N,,1,,CHEMBL631246,
13145,,,50506,9669.0,Intermediate,1,,A,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,,BAO_0000218,N,,1,,CHEMBL631247,
13146,,,50506,9669.0,Intermediate,1,,A,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,BAO_0000218,N,,1,,CHEMBL629532,
13147,,,50506,9669.0,Intermediate,1,,A,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,,BAO_0000218,N,,1,,CHEMBL629533,
13148,,,50506,9669.0,Intermediate,1,,A,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,,BAO_0000218,N,,1,,CHEMBL629534,
13149,,,50506,9669.0,Intermediate,1,,A,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,,BAO_0000218,N,,1,,CHEMBL629535,
13150,,,22224,,Autocuration,1,,A,,Pharmacokinetic parameter :drug bound to plasma was reported,,,BAO_0000019,U,,0,,CHEMBL625932,
13151,,,22224,,Autocuration,1,,A,,compound was evaluated for drug bound in plasma,,,BAO_0000019,U,,0,,CHEMBL625933,
13152,,,50597,10116.0,Intermediate,1,,A,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,,BAO_0000218,N,,1,,CHEMBL625934,
13153,,,22224,9347.0,Autocuration,1,,A,,Bioavailability,,,BAO_0000218,U,,0,,CHEMBL625935,
13154,,,50597,10116.0,Intermediate,1,,A,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,,BAO_0000218,N,,1,,CHEMBL625936,
13155,,,50597,10116.0,Intermediate,1,,A,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,,BAO_0000218,N,,1,,CHEMBL625937,
13156,,,50588,9615.0,Intermediate,1,,A,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,,BAO_0000218,N,,1,,CHEMBL625938,
13157,,1970.0,50597,10116.0,Intermediate,1,Bile,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,,BAO_0000218,N,,1,,CHEMBL625939,
13158,,1970.0,50597,10116.0,Intermediate,1,Bile,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,,BAO_0000218,N,,1,,CHEMBL625940,
13159,,1970.0,50597,10116.0,Intermediate,1,Bile,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,,BAO_0000218,N,,1,,CHEMBL874464,
13160,,1970.0,50597,10116.0,Intermediate,1,Bile,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,,BAO_0000218,N,,1,,CHEMBL625941,
13161,,1970.0,50597,10116.0,Intermediate,1,Bile,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,,BAO_0000218,N,,1,,CHEMBL625942,
13162,,1970.0,50597,10116.0,Intermediate,1,Bile,A,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,,BAO_0000218,N,,1,,CHEMBL625943,
13163,,1977.0,50587,9606.0,Intermediate,1,Serum,A,,In vitro protein binding in human serum at 5 ug/ml,,,BAO_0000218,N,,1,,CHEMBL625944,
13164,,,22224,,Autocuration,1,,A,,Serum protein binding ability was measured,,,BAO_0000019,U,,0,,CHEMBL625945,
13165,,,22224,,Autocuration,1,,A,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,,BAO_0000019,U,,0,,CHEMBL625946,
13166,In vivo,,22224,9615.0,Autocuration,1,,A,,Oral bioavailability in dog,,,BAO_0000218,U,,0,,CHEMBL625947,
13167,In vivo,,50597,10116.0,Intermediate,1,,A,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,BAO_0000218,N,,1,,CHEMBL625948,
13168,In vivo,,22224,,Autocuration,1,,A,,Absolute oral bioavailability at an iv dose of 14 mg/kg,,,BAO_0000218,U,,0,,CHEMBL625949,
13169,In vivo,,22224,,Autocuration,1,,A,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,,BAO_0000218,U,,0,,CHEMBL625950,
13170,In vivo,,22224,9347.0,Autocuration,1,,A,,Oral bioavailability (dose 15 mg/kg i.v.),,,BAO_0000218,U,,0,,CHEMBL625951,
13171,In vivo,,22224,,Autocuration,1,,A,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,,BAO_0000218,U,,0,,CHEMBL625952,
13172,In vivo,,22224,,Autocuration,1,,A,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,,BAO_0000218,U,,0,,CHEMBL625953,
13173,In vivo,,22224,,Autocuration,1,,A,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,,BAO_0000218,U,,0,,CHEMBL625954,
13174,In vivo,,22224,,Autocuration,1,,A,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,,BAO_0000218,U,,0,,CHEMBL882959,
13175,In vivo,,50588,9615.0,Intermediate,1,,A,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,,BAO_0000218,N,,1,,CHEMBL625955,
13176,In vivo,,22224,9669.0,Autocuration,1,,A,,Bioavailability in ferret,,,BAO_0000218,U,,0,,CHEMBL625956,
13177,In vivo,,100710,9541.0,Intermediate,1,,A,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,,BAO_0000218,N,,1,,CHEMBL625957,
13178,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,BAO_0000218,N,,1,,CHEMBL625958,
13179,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,BAO_0000218,N,,1,,CHEMBL625959,
13180,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,BAO_0000218,N,,1,,CHEMBL626642,
13181,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,BAO_0000218,N,,1,,CHEMBL631330,
13182,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,BAO_0000218,N,,1,,CHEMBL631331,
13183,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,BAO_0000218,N,,1,,CHEMBL631332,
13184,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,BAO_0000218,N,,1,,CHEMBL631333,
13185,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,BAO_0000218,N,,1,,CHEMBL632018,
13186,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,BAO_0000218,N,,1,,CHEMBL632019,
13187,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,BAO_0000218,N,,1,,CHEMBL632020,
13188,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,BAO_0000218,N,,1,,CHEMBL632021,
13189,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,BAO_0000218,N,,1,,CHEMBL632022,
13190,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,BAO_0000218,N,,1,,CHEMBL632023,
13191,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,BAO_0000218,N,,1,,CHEMBL632024,
13192,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,BAO_0000218,N,,1,,CHEMBL874472,
13193,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,BAO_0000218,N,,1,,CHEMBL632025,
13194,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,BAO_0000218,N,,1,,CHEMBL632026,
13195,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,BAO_0000218,N,,1,,CHEMBL632027,
13196,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,BAO_0000218,N,,1,,CHEMBL632028,
13197,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,BAO_0000218,N,,1,,CHEMBL626430,
13198,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,BAO_0000218,N,,1,,CHEMBL626431,
13199,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,BAO_0000218,N,,1,,CHEMBL626432,
13200,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,BAO_0000218,N,,1,,CHEMBL626433,
13201,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,BAO_0000218,N,,1,,CHEMBL626434,
13202,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627280,
13203,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627281,
13204,,,50597,10116.0,Intermediate,1,,A,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627282,
13205,,,22224,,Autocuration,1,,A,,Total body clearance was measured at given dose,,,BAO_0000019,U,,0,,CHEMBL627283,
13206,,,22224,,Autocuration,1,,A,,Total body clearance was measured at given dose.,,,BAO_0000218,U,,0,,CHEMBL627284,
13207,,,50597,10116.0,Intermediate,1,,A,,Metabolic clearance from the body in rat,,,BAO_0000218,N,,1,,CHEMBL627285,
13208,In vivo,,22224,,Autocuration,1,,A,,Renal clearance from the body,,,BAO_0000218,U,,0,,CHEMBL627286,
13209,In vivo,,50597,10116.0,Intermediate,1,,A,,Renal clearance from the body in rat,,,BAO_0000218,N,,1,,CHEMBL875477,
13210,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL627287,
13211,In vivo,,50588,9615.0,Intermediate,1,,A,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,,BAO_0000218,N,,1,,CHEMBL627288,
13212,,,50597,10116.0,Intermediate,1,,A,,Total clearance from the body in rat,,,BAO_0000218,N,,1,,CHEMBL627289,
13213,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Clearance into cortex from rat plasma or PBS,,,BAO_0000218,N,,1,,CHEMBL627290,
13214,In vivo,,22224,,Autocuration,1,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,,BAO_0000218,U,,0,,CHEMBL627291,
13215,In vivo,,22224,,Autocuration,1,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,,BAO_0000218,U,,0,,CHEMBL627292,
13216,In vivo,,22224,,Autocuration,1,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,,BAO_0000218,U,,0,,CHEMBL627293,
13217,In vivo,,22224,,Autocuration,1,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,,BAO_0000218,U,,0,,CHEMBL627294,
13218,In vivo,,22224,,Autocuration,1,,A,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,,BAO_0000218,U,,0,,CHEMBL875478,
13219,In vivo,,22224,,Autocuration,1,,A,,Clearance was determined,,,BAO_0000218,U,,0,,CHEMBL627295,
13220,In vivo,,50594,10090.0,Intermediate,1,,A,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,,BAO_0000218,N,,1,,CHEMBL627296,
13221,In vivo,,50592,9986.0,Intermediate,1,,A,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,,BAO_0000218,N,,1,,CHEMBL626119,
13222,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,,BAO_0000218,N,,1,,CHEMBL626120,
13223,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance in rat after iv dose (100 ug/kg),,,BAO_0000218,N,,1,,CHEMBL626121,
13224,In vivo,,22224,10141.0,Autocuration,1,,A,,Clearance in guinea pig,,,BAO_0000218,U,,0,,CHEMBL626122,
13225,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for clearance in rat,,,BAO_0000218,N,,1,,CHEMBL626123,
13226,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for the clearance in dog,,,BAO_0000218,N,,1,,CHEMBL623456,
13227,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for the clearance in rat,,,BAO_0000218,N,,1,,CHEMBL623457,
13228,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was tested in vivo for clearance after iv administration in the rat,,,BAO_0000218,N,,1,,CHEMBL623458,
13229,In vivo,,22224,,Autocuration,1,,A,,IV clearance determined at an iv dose of 14 mg/kg,,,BAO_0000218,U,,0,,CHEMBL623459,
13230,In vivo,,22224,,Autocuration,1,,A,,IV clearance determined at an iv dose of 15.2 mg/kg,,,BAO_0000218,U,,0,,CHEMBL875484,
13231,In vivo,,22224,,Autocuration,1,,A,,IV clearance determined at an iv dose of 15 mg/kg,,,BAO_0000218,U,,0,,CHEMBL623460,
13232,In vivo,,22224,,Autocuration,1,,A,,IV clearance determined at an peroral dose of 30 mg/kg.,,,BAO_0000218,U,,0,,CHEMBL623461,
13233,In vivo,,22224,,Autocuration,1,,A,,IV clearance determined at an peroral dose of 30.2 mg/kg.,,,BAO_0000218,U,,0,,CHEMBL623462,
13234,In vivo,,22224,,Autocuration,1,,A,,IV clearance determined at an peroral dose of 30.3 mg/kg.,,,BAO_0000218,U,,0,,CHEMBL627386,
13235,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627387,
13236,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627388,
13237,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627389,
13238,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627390,
13239,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627391,
13240,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627392,
13241,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627393,
13242,In vivo,3126.0,50597,10116.0,Intermediate,1,Trachea,A,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627394,
13243,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627395,
13244,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL875485,
13245,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627396,
13246,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627397,
13247,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627398,
13248,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627399,
13249,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627400,
13250,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627401,
13251,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627402,
13252,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627403,
13253,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL627404,
13254,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623101,
13255,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL877480,
13256,In vivo,3126.0,50597,10116.0,Intermediate,1,Trachea,A,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623102,
13257,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623103,
13258,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623104,
13259,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623105,
13260,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623106,
13261,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623107,
13262,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623108,
13263,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623109,
13264,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623110,
13265,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL623111,
13266,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL625060,
13267,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL625061,
13268,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL625062,
13269,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL625063,
13270,In vivo,3126.0,50597,10116.0,Intermediate,1,Trachea,A,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL625064,
13271,In vivo,10000001.0,50597,10116.0,Intermediate,1,Bone,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL625065,
13272,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL625066,
13273,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL625067,
13274,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL625068,
13275,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL622159,
13276,In vivo,160.0,50597,10116.0,Intermediate,1,Intestine,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL622160,
13277,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL622161,
13278,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL622162,
13279,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL622163,
13280,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL622313,
13281,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL622314,
13282,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL622315,
13283,In vivo,3126.0,50597,10116.0,Intermediate,1,Trachea,A,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,,BAO_0000218,N,,1,,CHEMBL622316,
13284,,,50212,562.0,Intermediate,1,,A,,Normal diffusion coefficient in water for Escherichia coli,,,BAO_0000218,N,,1,,CHEMBL877486,
13285,,,22224,,Autocuration,1,,A,,Average max percent decrease in RVR (renal vascular resistance) was determined,,,BAO_0000019,U,,0,,CHEMBL622317,
13286,,,22224,,Autocuration,1,,A,,Average max percent decrease in RVR (renal vascular resistance) was determined.,,,BAO_0000019,U,,0,,CHEMBL622318,
13287,,,22224,,Autocuration,1,,A,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,,BAO_0000019,U,,0,,CHEMBL622319,
13288,,,22224,,Autocuration,1,,A,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,,BAO_0000019,U,,0,,CHEMBL622320,
13289,,,22224,,Autocuration,1,,A,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,,BAO_0000019,U,,0,,CHEMBL622321,
13290,,,22224,,Autocuration,1,,A,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,,BAO_0000019,U,,0,,CHEMBL622322,
13291,,,22224,,Autocuration,1,,A,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,,BAO_0000019,U,,0,,CHEMBL622323,
13292,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,,BAO_0000218,N,,1,,CHEMBL622324,
13293,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL622325,
13294,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL622326,
13295,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL877487,
13296,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL622327,
13297,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL622328,
13298,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL622329,
13299,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL622330,
13300,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL622331,
13301,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL622332,
13302,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL622333,
13303,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL627658,
13304,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL630428,
13305,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL630429,
13306,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL630430,
13307,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL630431,
13308,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL630432,
13309,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL630433,
13310,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL630434,
13311,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629372,
13312,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629553,
13313,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629554,
13314,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL874447,
13315,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629555,
13316,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629556,
13317,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629557,
13318,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629558,
13319,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629559,
13320,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629560,
13321,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629561,
13322,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629562,
13323,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629563,
13324,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629564,
13325,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629565,
13326,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629566,
13327,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629567,
13328,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629568,
13329,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629569,
13330,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629570,
13331,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL629571,
13332,In vivo,,22224,10116.0,Autocuration,1,,A,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,BAO_0000218,U,,0,,CHEMBL629572,
13333,In vivo,,22224,10116.0,Autocuration,1,,A,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,,BAO_0000218,U,,0,,CHEMBL629573,
13334,In vivo,,22224,9347.0,Autocuration,1,,A,,Bioavailability (dose 20 mg/kg),,,BAO_0000218,U,,0,,CHEMBL629574,
13335,In vivo,,22224,9615.0,Autocuration,1,,A,,Bioavailability in dog,,,BAO_0000218,U,,0,,CHEMBL629575,
13336,In vivo,,22224,10116.0,Autocuration,1,,A,,Bioavailability in rat (Sprague-Dawley) (male),,,BAO_0000218,U,,0,,CHEMBL874448,
13337,In vivo,,22224,9443.0,Autocuration,1,,A,,Bioavailability in monkey (dose 10 mg/kg i.d.),,,BAO_0000218,U,,0,,CHEMBL629576,
13338,In vivo,,22224,10116.0,Autocuration,1,,A,,Bioavailability in rat,,,BAO_0000218,U,,0,,CHEMBL629577,
13339,In vivo,,22224,10116.0,Autocuration,1,,A,,Bioavailability in rat,,,BAO_0000218,U,,0,,CHEMBL629578,
13340,In vivo,,22224,9615.0,Autocuration,1,,A,,Bioavailability in dog (dose 3.0 mg/kg p.o.),,,BAO_0000218,U,,0,,CHEMBL629579,
13341,In vivo,,22224,9615.0,Autocuration,1,,A,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,,BAO_0000218,U,,0,,CHEMBL882958,
13342,In vivo,,50505,9598.0,Intermediate,1,,A,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,,BAO_0000218,N,,1,,CHEMBL629580,
13343,In vivo,,22224,9347.0,Autocuration,1,,A,,Bioavailability,,,BAO_0000218,U,,0,,CHEMBL629581,
13344,In vivo,,22224,9520.0,Autocuration,1,,A,,Bioavailability in squirrel monkey,,,BAO_0000218,U,,0,,CHEMBL629582,
13345,In vivo,,50588,9615.0,Intermediate,1,,A,,Bioavailability was evaluated in dog,,,BAO_0000218,N,,1,,CHEMBL628522,
13346,In vivo,,100712,10026.0,Intermediate,1,,A,,Bioavailability was evaluated in hamster,,,BAO_0000218,N,,1,,CHEMBL625432,
13347,In vivo,,22224,10116.0,Autocuration,1,,A,,Bioavailability in rat,,,BAO_0000218,U,,0,,CHEMBL625433,
13348,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625434,
13349,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,,BAO_0000218,N,,1,,CHEMBL625435,
13350,In vivo,,22224,10116.0,Autocuration,1,,A,,Bioavailability in rat (dose 10 mg/kg p.o.),,,BAO_0000218,U,,0,,CHEMBL625436,
13351,In vivo,,100710,9541.0,Intermediate,1,,A,,Bioavailability was measured in cynomolgus monkeys.,,,BAO_0000218,N,,1,,CHEMBL874588,
13352,In vivo,,50594,10090.0,Intermediate,1,,A,,Bioavailability was measured in nude mice.,,,BAO_0000218,N,,1,,CHEMBL625437,
13353,In vivo,,22224,9669.0,Autocuration,1,,A,,Bioavailability in ferret (dose 10 mg/kg i.d.),,,BAO_0000218,U,,0,,CHEMBL625438,
13354,In vivo,,22224,314293.0,Autocuration,1,,A,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,,BAO_0000218,U,,0,,CHEMBL625439,
13355,In vivo,,22224,314293.0,Autocuration,1,,A,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,,BAO_0000218,U,,0,,CHEMBL625440,
13356,In vivo,,22224,314293.0,Autocuration,1,,A,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,,BAO_0000218,U,,0,,CHEMBL625441,
13357,In vivo,,22224,10116.0,Autocuration,1,,A,,Bioavailability in rat (dose 10 mg/kg i.d.),,,BAO_0000218,U,,0,,CHEMBL625442,
13358,In vivo,,50597,10116.0,Intermediate,1,,A,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,,BAO_0000218,N,,1,,CHEMBL625443,
13359,In vivo,,22224,,Autocuration,1,,A,,Bioavailability was determined; extremely poor,,,BAO_0000218,U,,0,,CHEMBL625444,
13360,In vivo,,50594,10090.0,Intermediate,1,,A,,% bioavailability in mice after oral administration of prodrug,,,BAO_0000218,N,,1,,CHEMBL625445,
13361,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,,BAO_0000218,N,,1,,CHEMBL625446,
13362,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,,BAO_0000218,N,,1,,CHEMBL882960,
13363,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,,BAO_0000218,N,,1,,CHEMBL625447,
13364,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,,BAO_0000218,N,,1,,CHEMBL625448,
13365,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,,BAO_0000218,N,,1,,CHEMBL625449,
13366,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,,BAO_0000218,N,,1,,CHEMBL874589,
13367,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,,BAO_0000218,N,,1,,CHEMBL625450,
13368,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,,BAO_0000218,N,,1,,CHEMBL625451,
13369,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,,BAO_0000218,N,,1,,CHEMBL626584,
13370,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,,BAO_0000218,N,,1,,CHEMBL626585,
13371,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,,BAO_0000218,N,,1,,CHEMBL626586,
13372,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,,BAO_0000218,N,,1,,CHEMBL626587,
13373,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,,BAO_0000218,N,,1,,CHEMBL626588,
13374,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,,BAO_0000218,N,,1,,CHEMBL626589,
13375,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,,BAO_0000218,N,,1,,CHEMBL626590,
13376,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,,BAO_0000218,N,,1,,CHEMBL626591,
13377,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,,BAO_0000218,N,,1,,CHEMBL627181,
13378,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,,BAO_0000218,N,,1,,CHEMBL628083,
13379,In vivo,,22224,,Autocuration,1,,A,,IV clearance determined at an peroral dose of 15 mg/kg.,,,BAO_0000218,U,,0,,CHEMBL628084,
13380,In vivo,,50064,102285.0,Expert,1,,F,,Mouse oral clearance was measured against Hymenolepiasis nana.,,,BAO_0000218,N,,1,,CHEMBL628085,
13381,In vivo,,50545,6339.0,Expert,1,,F,,Mouse oral clearance was measured against Nematospiroides dubius,,,BAO_0000218,N,,1,,CHEMBL628086,
13382,In vivo,,22224,,Autocuration,1,,F,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,,BAO_0000218,U,,0,,CHEMBL628087,
13383,In vivo,,50594,10090.0,Intermediate,1,,A,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,BAO_0000218,N,,1,,CHEMBL628088,
13384,In vivo,,22224,,Autocuration,1,,B,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,,BAO_0000218,U,,0,,CHEMBL628089,
13385,In vivo,,22224,,Autocuration,1,,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,U,,0,,CHEMBL628090,
13386,In vivo,,22224,,Autocuration,1,,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,U,,0,,CHEMBL628091,
13387,In vivo,,22224,,Autocuration,1,,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,U,,0,,CHEMBL628092,
13388,In vivo,,22224,,Autocuration,1,,A,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,U,,0,,CHEMBL628093,
13389,In vivo,,22224,,Autocuration,1,,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,U,,0,,CHEMBL875607,
13390,In vivo,,22224,,Autocuration,1,,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,U,,0,,CHEMBL625710,
13391,In vivo,,22224,,Autocuration,1,,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,U,,0,,CHEMBL625711,
13392,In vivo,,22224,,Autocuration,1,,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,U,,0,,CHEMBL625712,
13393,In vivo,,22224,,Autocuration,1,,A,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,,BAO_0000218,U,,0,,CHEMBL625713,
13394,In vivo,,50588,9615.0,Intermediate,1,,A,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625714,
13395,In vivo,,50797,9544.0,Intermediate,1,,A,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,,BAO_0000218,N,,1,,CHEMBL625715,
13396,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL625716,
13397,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,,BAO_0000218,N,,1,,CHEMBL625717,
13398,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance was determined for the compound in rats,,,BAO_0000218,N,,1,,CHEMBL625718,
13399,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,,BAO_0000218,N,,1,,CHEMBL625719,
13400,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,,BAO_0000218,N,,1,,CHEMBL625720,
13401,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,,BAO_0000218,N,,1,,CHEMBL625721,
13402,In vivo,,50597,10116.0,Intermediate,1,,A,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,,BAO_0000218,N,,1,,CHEMBL625722,
13403,In vivo,,50597,10116.0,Intermediate,1,,A,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,,BAO_0000218,N,,1,,CHEMBL625723,
13404,In vivo,,50545,6339.0,Intermediate,1,,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,,BAO_0000218,N,,1,,CHEMBL625724,
13405,In vivo,,50545,6339.0,Intermediate,1,,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,,BAO_0000218,N,,1,,CHEMBL625725,
13406,In vivo,,50545,6339.0,Intermediate,1,,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,,BAO_0000218,N,,1,,CHEMBL625726,
13407,In vivo,,50545,6339.0,Intermediate,1,,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,,BAO_0000218,N,,1,,CHEMBL875608,
13408,In vivo,,50545,6339.0,Intermediate,1,,A,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,,BAO_0000218,N,,1,,CHEMBL625727,
13409,In vivo,1088.0,22224,10116.0,Autocuration,1,Urine,A,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,,BAO_0000218,U,,0,,CHEMBL625728,
13410,In vivo,,22224,10116.0,Autocuration,1,,A,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,,BAO_0000218,U,,0,,CHEMBL625729,
13411,In vivo,,22224,10116.0,Autocuration,1,,A,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,,BAO_0000218,U,,0,,CHEMBL625730,
13412,In vivo,1088.0,22224,10116.0,Autocuration,1,Urine,A,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,,BAO_0000218,U,,0,,CHEMBL625731,
13413,In vivo,1088.0,22224,10116.0,Autocuration,1,Urine,A,,Urinary clearance was determined in rat at 25 mg/kg os dosage,,,BAO_0000218,U,,0,,CHEMBL626417,
13414,In vivo,1088.0,50587,9606.0,Intermediate,1,Urine,A,,Urinary clearance was determined at 100 mg/kg oral dosage in human,,,BAO_0000218,N,,1,,CHEMBL626418,
13415,In vivo,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,,BAO_0000218,N,,1,,CHEMBL626419,
13416,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL626592,
13417,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,,BAO_0000218,N,,1,,CHEMBL626593,
13418,In vivo,,50597,10116.0,Intermediate,1,,A,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,,BAO_0000218,N,,1,,CHEMBL626594,
13419,In vivo,,50588,9615.0,Intermediate,1,,A,,Clearance rate in dogs,,,BAO_0000218,N,,1,,CHEMBL625035,
13420,In vitro,,22224,,Autocuration,1,,A,,Compound was measured for intrinsic clearance,,,BAO_0000019,U,,0,,CHEMBL625036,
13421,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625037,
13422,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625038,
13423,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625039,
13424,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625040,
13425,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625041,
13426,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625042,
13427,,,22224,,Autocuration,1,,A,,Partition coefficient of the compound,,,BAO_0000019,U,,0,,CHEMBL874411,
13428,,,22224,,Autocuration,1,,A,,Permeability,,,BAO_0000019,U,,0,,CHEMBL625043,
13429,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625044,
13430,,,22224,,Autocuration,1,,A,,Partition coefficient (logD),,,BAO_0000019,U,,0,,CHEMBL625045,
13431,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,BAO_0000100,U,,0,,CHEMBL625046,
13432,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,,BAO_0000100,U,,0,,CHEMBL625047,
13433,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625048,
13434,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625049,
13435,,,22229,,Autocuration,1,,P,,Calculated logarithm of partition coefficient (P) was determined,,,BAO_0000100,U,,0,,CHEMBL625050,
13436,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625051,
13437,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL874412,
13438,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625052,
13439,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL625053,
13440,,,22224,,Autocuration,1,,A,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,,BAO_0000019,U,,0,,CHEMBL623250,
13441,,,22224,,Autocuration,1,,A,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,,BAO_0000019,U,,0,,CHEMBL623251,
13442,,,22224,,Autocuration,1,,A,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,,BAO_0000019,U,,0,,CHEMBL623252,
13443,,,22224,,Autocuration,1,,A,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,,BAO_0000019,U,,0,,CHEMBL623253,
13444,,,22224,,Autocuration,1,,A,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,,BAO_0000019,U,,0,,CHEMBL623254,
13445,,,22224,,Autocuration,1,,A,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,,BAO_0000019,U,,0,,CHEMBL623255,
13446,,,22224,,Autocuration,1,,A,,Percent degradation of compound at a pH of 1 over a 18 hr period,,,BAO_0000019,U,,0,,CHEMBL626831,
13447,,,22224,,Autocuration,1,,A,,Percent degradation of compound at pH of 1 over an 18 hr period,,,BAO_0000019,U,,0,,CHEMBL877494,
13448,,,22224,,Autocuration,1,,A,,Delta Logarithm of Partition Coefficient value was determined.,,,BAO_0000019,U,,0,,CHEMBL626832,
13449,,,22224,,Autocuration,1,,A,,Delta logPoct-cyc,,,BAO_0000019,U,,0,,CHEMBL626833,
13450,,,22224,,Autocuration,1,,P,,Lipophilicity estimated on reversed phase TLC,,,BAO_0000100,U,,0,,CHEMBL626834,
13451,,,22224,,Autocuration,1,,A,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,,BAO_0000019,U,,0,,CHEMBL626835,
13452,,,22224,,Autocuration,1,,A,,Delta logPoct-cyc,,,BAO_0000019,U,,0,,CHEMBL626836,
13453,,,22229,,Autocuration,1,,P,,Change in logarithm of partition coefficient of the compound,,,BAO_0000100,U,,0,,CHEMBL626837,
13454,,,22224,,Autocuration,1,,A,,Delta logD (pH 6.5),,,BAO_0000019,U,,0,,CHEMBL626838,
13455,,,22224,,Autocuration,1,,P,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,,BAO_0000100,U,,0,,CHEMBL626839,
13456,,,22224,,Autocuration,1,,A,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,,BAO_0000019,U,,0,,CHEMBL626840,
13457,,,22224,,Autocuration,1,,A,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,,BAO_0000019,U,,0,,CHEMBL626841,
13458,,,22224,,Autocuration,1,,A,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,,BAO_0000219,U,,0,,CHEMBL626842,
13459,,,22224,,Autocuration,1,,A,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,,BAO_0000219,U,,0,,CHEMBL626843,
13460,,,50597,10116.0,Intermediate,1,,A,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,,BAO_0000218,N,,1,,CHEMBL626844,
13461,,,50597,10116.0,Intermediate,1,,A,,Amount of deuterium retained was reported after normal workup in rats,,,BAO_0000218,N,,1,,CHEMBL877495,
13462,,,50597,10116.0,Intermediate,1,,A,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,,BAO_0000218,N,,1,,CHEMBL626845,
13463,,,50597,10116.0,Intermediate,1,,A,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,,BAO_0000218,N,,1,,CHEMBL626846,
13464,,,50597,10116.0,Intermediate,1,,A,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,BAO_0000218,N,,1,,CHEMBL626847,
13465,,,50597,10116.0,Intermediate,1,,A,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,,BAO_0000218,N,,1,,CHEMBL628677,
13466,,,50597,10116.0,Intermediate,1,,A,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,,BAO_0000218,N,,1,,CHEMBL628678,
13467,,,22224,,Autocuration,1,,A,,Compound was subjected to electrochemical oxidation,,,BAO_0000019,U,,0,,CHEMBL628679,
13468,,,22224,,Autocuration,1,,A,,Compound was subjected to photochemical oxidation,,,BAO_0000019,U,,0,,CHEMBL628680,
13469,,,22224,,Autocuration,1,,A,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,,BAO_0000019,U,,0,,CHEMBL628681,
13470,,,22224,,Autocuration,1,,A,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,,BAO_0000019,U,,0,,CHEMBL628682,
13471,,,22224,,Autocuration,1,,A,,Oxidation of compound by methemoglobin in presence of hydroperoxide,,,BAO_0000019,U,,0,,CHEMBL628683,
13472,,,50597,10116.0,Intermediate,1,,A,,Percent diffusion through fuzzy rat skin after 48 h of incubation,,,BAO_0000218,N,,1,,CHEMBL628684,
13473,,,22229,,Autocuration,1,,P,,Dissociation constant (pKa),,,BAO_0000100,U,,0,,CHEMBL877501,
13474,,,22224,,Autocuration,1,,P,,Dissociation constant value of the compound; ND means not determined.,,,BAO_0000100,U,,0,,CHEMBL628685,
13475,,178.0,50597,10116.0,Intermediate,1,Blood,A,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,,BAO_0000218,N,,1,,CHEMBL628686,
13476,,178.0,50597,10116.0,Intermediate,1,Blood,A,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,BAO_0000218,N,,1,,CHEMBL628687,
13477,,,50597,10116.0,Intermediate,1,,A,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,,BAO_0000218,N,,1,,CHEMBL628688,
13478,,,50597,10116.0,Intermediate,1,,A,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,BAO_0000218,N,,1,,CHEMBL628689,
13479,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,,BAO_0000218,N,,1,,CHEMBL628690,
13480,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,,BAO_0000218,N,,1,,CHEMBL629363,
13481,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,,BAO_0000218,N,,1,,CHEMBL629364,
13482,,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,BAO_0000218,N,,1,,CHEMBL629365,
13483,,,50597,10116.0,Intermediate,1,,A,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,,BAO_0000218,N,,1,,CHEMBL629366,
13484,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,,BAO_0000218,N,,1,,CHEMBL629367,
13485,,1988.0,50597,10116.0,Intermediate,1,Feces,A,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,,BAO_0000218,N,,1,,CHEMBL629368,
13486,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,,BAO_0000218,N,,1,,CHEMBL877502,
13487,,2037.0,50594,10090.0,Intermediate,1,Cerebellum,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,,BAO_0000218,N,,1,,CHEMBL629369,
13488,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,,BAO_0000218,N,,1,,CHEMBL629370,
13489,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL629371,
13490,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL626276,
13491,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL626277,
13492,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL631250,
13493,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL631251,
13494,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL631252,
13495,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL631253,
13496,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL631254,
13497,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL631255,
13498,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL631256,
13499,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL631257,
13500,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628009,
13501,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628010,
13502,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628011,
13503,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628012,
13504,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628013,
13505,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628014,
13506,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628015,
13507,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628016,
13508,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL874461,
13509,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628017,
13510,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628018,
13511,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628019,
13512,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628020,
13513,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628021,
13514,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628022,
13515,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628023,
13516,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL628024,
13517,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL628025,
13518,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL628026,
13519,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL628027,
13520,,1088.0,22224,314293.0,Autocuration,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,,BAO_0000218,U,,0,,CHEMBL628028,
13521,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628029,
13522,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628030,
13523,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628031,
13524,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628032,
13525,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628033,
13526,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628034,
13527,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628035,
13528,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL628036,
13529,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL874462,
13530,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,,BAO_0000218,N,,1,,CHEMBL628037,
13531,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,,BAO_0000218,N,,1,,CHEMBL628123,
13532,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,,BAO_0000218,N,,1,,CHEMBL628124,
13533,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,,BAO_0000218,N,,1,,CHEMBL628125,
13534,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,,BAO_0000218,N,,1,,CHEMBL628126,
13535,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,,BAO_0000218,N,,1,,CHEMBL628127,
13536,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,,BAO_0000218,N,,1,,CHEMBL628128,
13537,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,,BAO_0000218,N,,1,,CHEMBL628129,
13538,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,,BAO_0000218,N,,1,,CHEMBL628130,
13539,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,,BAO_0000218,N,,1,,CHEMBL628131,
13540,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,,BAO_0000218,N,,1,,CHEMBL628132,
13541,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,,BAO_0000218,N,,1,,CHEMBL628133,
13542,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,,BAO_0000218,N,,1,,CHEMBL628134,
13543,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,,BAO_0000218,N,,1,,CHEMBL628135,
13544,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,,BAO_0000218,N,,1,,CHEMBL628136,
13545,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,,BAO_0000218,N,,1,,CHEMBL628137,
13546,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,,BAO_0000218,N,,1,,CHEMBL628138,
13547,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,,BAO_0000218,N,,1,,CHEMBL628139,
13548,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,,BAO_0000218,N,,1,,CHEMBL628140,
13549,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,,BAO_0000218,N,,1,,CHEMBL628141,
13550,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,,BAO_0000218,N,,1,,CHEMBL628142,
13551,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,,BAO_0000218,N,,1,,CHEMBL628143,
13552,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,,BAO_0000218,N,,1,,CHEMBL628144,
13553,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,,BAO_0000218,N,,1,,CHEMBL628145,
13554,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,,BAO_0000218,N,,1,,CHEMBL628146,
13555,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,,BAO_0000218,N,,1,,CHEMBL625355,
13556,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,,BAO_0000218,N,,1,,CHEMBL625356,
13557,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,,BAO_0000218,N,,1,,CHEMBL625357,
13558,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,,BAO_0000218,N,,1,,CHEMBL625527,
13559,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,,BAO_0000218,N,,1,,CHEMBL875473,
13560,In vivo,,50588,9615.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,,BAO_0000218,N,,1,,CHEMBL625528,
13561,In vivo,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,,BAO_0000218,N,,1,,CHEMBL626304,
13562,In vivo,1637.0,50588,9615.0,Intermediate,1,Artery,A,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,,BAO_0000218,N,,1,,CHEMBL624138,
13563,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624139,
13564,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624140,
13565,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624141,
13566,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624142,
13567,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624143,
13568,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624144,
13569,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624145,
13570,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624146,
13571,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624147,
13572,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP) (MacLogP),,,BAO_0000100,U,,0,,CHEMBL883123,
13573,,,22224,,Autocuration,1,,A,,Partition coefficient (logP),,,BAO_0000019,U,,0,,CHEMBL624148,
13574,,,22224,,Autocuration,1,,A,,Kinetic parameter was determined,,,BAO_0000019,U,,0,,CHEMBL874416,
13575,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624149,
13576,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL624150,
13577,,,22224,,Autocuration,1,,P,,Lipophilicity was determined,,,BAO_0000100,U,,0,,CHEMBL624151,
13578,,,22224,,Autocuration,1,,P,,Lipophilicity was determined,,,BAO_0000100,U,,0,,CHEMBL624152,
13579,,,22224,,Autocuration,1,,P,,Lipophilicity was determined,,,BAO_0000100,U,,0,,CHEMBL622139,
13580,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL622140,
13581,,,22224,,Autocuration,1,,P,,Lipophilicity was determined,,,BAO_0000100,U,,0,,CHEMBL622141,
13582,,,22224,,Autocuration,1,,P,,Lipophilicity in octanol-water,,,BAO_0000100,U,,0,,CHEMBL622142,
13583,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL622143,
13584,,,22229,,Autocuration,1,,P,,Octanol-water partition coefficient was determined,,,BAO_0000100,U,,0,,CHEMBL622144,
13585,,,22224,,Autocuration,1,,A,,Partition coefficient (logP),,,BAO_0000019,U,,0,,CHEMBL877473,
13586,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL622145,
13587,,,22224,,Autocuration,1,,A,,Partition coefficient was determined; ND means not determined,,,BAO_0000019,U,,0,,CHEMBL622146,
13588,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP),,,BAO_0000100,U,,0,,CHEMBL622147,
13589,,,22224,,Autocuration,1,,A,,Partition coefficient of the compound,,,BAO_0000019,U,,0,,CHEMBL622148,
13590,,,22224,,Autocuration,1,,A,,Permeability was determined,,,BAO_0000019,U,,0,,CHEMBL883124,
13591,,,22229,,Autocuration,1,,P,,The compound was evaluated for the partition coefficient,,,BAO_0000100,U,,0,,CHEMBL622149,
13592,,,22224,,Autocuration,1,,A,,Partition coefficient (logP),,,BAO_0000019,U,,0,,CHEMBL622150,
13593,,,22224,,Autocuration,1,,P,,The lipophilicity was reported,,,BAO_0000100,U,,0,,CHEMBL622151,
13594,,,22229,,Autocuration,1,,P,,logarithm of the octanol-water partition coefficient for the compound,,,BAO_0000100,U,,0,,CHEMBL622152,
13595,,,22224,,Autocuration,1,,A,,Clogp value was determined,,,BAO_0000019,U,,0,,CHEMBL622153,
13596,In vivo,,22224,,Autocuration,1,,A,,Clp at a dose of 1.5 mg/kg,,,BAO_0000218,U,,0,,CHEMBL877474,
13597,In vivo,,22224,,Autocuration,1,,A,,Clp at a dose of 2.0 mg/kg,,,BAO_0000218,U,,0,,CHEMBL622154,
13598,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,"Clp, plasma clearance at a dose of 10 mg/kg",,,BAO_0000218,U,,0,,CHEMBL622155,
13599,In vivo,1969.0,22224,,Autocuration,1,Plasma,A,,"Clp, plasma clearance at a dose of 50 mg/kg",,,BAO_0000218,U,,0,,CHEMBL622156,
13600,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was tested for plasma clearance in rat,,,BAO_0000218,N,,1,,CHEMBL622157,
13601,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Compound was tested for plasma clearance in rat; Not determined,,,BAO_0000218,N,,1,,CHEMBL622158,
13602,In vivo,,50597,10116.0,Intermediate,1,,A,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622807,
13603,In vivo,,50797,9544.0,Intermediate,1,,A,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,,BAO_0000218,N,,1,,CHEMBL622808,
13604,In vivo,,22224,,Autocuration,1,,A,,Plasma clearance by iv administration at a dose 0.003 ug/mL,,,BAO_0000218,U,,0,,CHEMBL622809,
13605,In vivo,,22224,,Autocuration,1,,A,,Plasma clearance determined,,,BAO_0000218,U,,0,,CHEMBL622810,
13606,In vivo,,100712,10026.0,Intermediate,1,,A,,Plasma clearance after iv administration at 3 mg/kg in hamster,,,BAO_0000218,N,,1,,CHEMBL876653,
13607,In vivo,,100712,10026.0,Intermediate,1,,A,,Plasma clearance after iv administration at 4 mg/kg in hamster,,,BAO_0000218,N,,1,,CHEMBL622811,
13608,In vivo,,50597,10116.0,Intermediate,1,,A,,Rate of clearance in rat was determined,,,BAO_0000218,N,,1,,CHEMBL622986,
13609,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL622987,
13610,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL622988,
13611,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL622989,
13612,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,,BAO_0000218,N,,1,,CHEMBL622990,
13613,In vivo,1969.0,22224,314293.0,Autocuration,1,Plasma,A,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,,BAO_0000218,U,,0,,CHEMBL622991,
13614,In vivo,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,,BAO_0000218,N,,1,,CHEMBL622227,
13615,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,,BAO_0000218,N,,1,,CHEMBL622228,
13616,In vivo,,50597,10116.0,Intermediate,1,,A,,Clpl value in rat,,,BAO_0000218,N,,1,,CHEMBL622229,
13617,In vivo,,50512,10141.0,Intermediate,1,,A,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,,BAO_0000218,N,,1,,CHEMBL622230,
13618,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,,BAO_0000218,N,,1,,CHEMBL622231,
13619,In vivo,,100710,9541.0,Intermediate,1,,A,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,,BAO_0000218,N,,1,,CHEMBL622232,
13620,In vivo,,22224,,Autocuration,1,,A,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,,BAO_0000218,U,,0,,CHEMBL622233,
13621,In vivo,,22224,,Autocuration,1,,A,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,,BAO_0000218,U,,0,,CHEMBL622234,
13622,In vivo,,22224,,Autocuration,1,,A,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,,BAO_0000218,U,,0,,CHEMBL622235,
13623,In vivo,,22224,,Autocuration,1,,A,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,,BAO_0000218,U,,0,,CHEMBL622236,
13624,In vivo,,22224,,Autocuration,1,,A,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,,BAO_0000218,U,,0,,CHEMBL622237,
13625,In vivo,,22224,,Autocuration,1,,A,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,,BAO_0000218,U,,0,,CHEMBL877482,
13626,In vivo,,22224,,Autocuration,1,,A,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,,BAO_0000218,U,,0,,CHEMBL622238,
13627,In vivo,,22224,,Autocuration,1,,A,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,,BAO_0000218,U,,0,,CHEMBL622239,
13628,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Cmax was calculated as maximum concentration reached in the blood,,,BAO_0000218,U,,0,,CHEMBL622240,
13629,In vivo,178.0,22224,,Autocuration,1,Blood,A,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,,BAO_0000218,U,,0,,CHEMBL622241,
13630,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax was determine after peroral administration at 10 mpk in Rat,,,BAO_0000218,N,,1,,CHEMBL631013,
13631,In vivo,,50797,9544.0,Intermediate,1,,A,,Cmax was determine after peroral administration at 10 mpk in Rhesus,,,BAO_0000218,N,,1,,CHEMBL631014,
13632,In vivo,,50588,9615.0,Intermediate,1,,A,,Cmax was determine after peroral administration at 10 mpk in dog,,,BAO_0000218,N,,1,,CHEMBL631015,
13633,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax was determine after peroral administration at 160 mpk in Rat,,,BAO_0000218,N,,1,,CHEMBL631016,
13634,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax was determine after peroral administration at 20 mpk in Rat,,,BAO_0000218,N,,1,,CHEMBL631017,
13635,In vivo,,50597,10116.0,Intermediate,1,,A,,Cmax was determine after peroral administration at 50 mpk in Rat,,,BAO_0000218,N,,1,,CHEMBL631018,
13636,In vivo,,22224,,Autocuration,1,,A,,Cmax was determined,,,BAO_0000218,U,,0,,CHEMBL631019,
13637,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,,BAO_0000218,N,,1,,CHEMBL875761,
13638,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,,BAO_0000218,N,,1,,CHEMBL631020,
13639,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,,BAO_0000218,N,,1,,CHEMBL631669,
13640,,955.0,50594,10090.0,Intermediate,1,Brain,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,,BAO_0000218,N,,1,,CHEMBL631670,
13641,,2435.0,50594,10090.0,Intermediate,1,Striatum,A,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,,BAO_0000218,N,,1,,CHEMBL631671,
13642,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,,BAO_0000218,N,,1,,CHEMBL631672,
13643,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,,BAO_0000218,N,,1,,CHEMBL631673,
13644,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,,BAO_0000218,N,,1,,CHEMBL631856,
13645,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,,BAO_0000218,N,,1,,CHEMBL631857,
13646,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,,BAO_0000218,N,,1,,CHEMBL631858,
13647,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,,BAO_0000218,N,,1,,CHEMBL631859,
13648,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,,BAO_0000218,N,,1,,CHEMBL631860,
13649,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,,BAO_0000218,N,,1,,CHEMBL631861,
13650,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,,BAO_0000218,N,,1,,CHEMBL631862,
13651,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,,BAO_0000218,N,,1,,CHEMBL631863,
13652,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,,BAO_0000218,N,,1,,CHEMBL631864,
13653,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,,BAO_0000218,N,,1,,CHEMBL631865,
13654,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,,BAO_0000218,N,,1,,CHEMBL631866,
13655,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,,BAO_0000218,N,,1,,CHEMBL629360,
13656,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,,BAO_0000218,N,,1,,CHEMBL629361,
13657,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,,BAO_0000218,N,,1,,CHEMBL629362,
13658,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,,BAO_0000218,N,,1,,CHEMBL630740,
13659,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,,BAO_0000218,N,,1,,CHEMBL630741,
13660,,178.0,50597,10116.0,Intermediate,1,Blood,A,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,,BAO_0000218,N,,1,,CHEMBL630742,
13661,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,,BAO_0000218,N,,1,,CHEMBL630743,
13662,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,,BAO_0000218,N,,1,,CHEMBL630744,
13663,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,,BAO_0000218,N,,1,,CHEMBL630745,
13664,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,,BAO_0000218,N,,1,,CHEMBL630746,
13665,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,,BAO_0000218,N,,1,,CHEMBL630747,
13666,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,,BAO_0000218,N,,1,,CHEMBL630748,
13667,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,,BAO_0000218,N,,1,,CHEMBL632056,
13668,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,,BAO_0000218,N,,1,,CHEMBL632057,
13669,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,,BAO_0000218,N,,1,,CHEMBL632058,
13670,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,,BAO_0000218,N,,1,,CHEMBL632059,
13671,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,,BAO_0000218,N,,1,,CHEMBL632060,
13672,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,,BAO_0000218,N,,1,,CHEMBL632061,
13673,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,,BAO_0000218,N,,1,,CHEMBL629207,
13674,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,,BAO_0000218,N,,1,,CHEMBL629208,
13675,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,,BAO_0000218,N,,1,,CHEMBL629209,
13676,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,,BAO_0000218,N,,1,,CHEMBL629210,
13677,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,,BAO_0000218,N,,1,,CHEMBL629211,
13678,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,,BAO_0000218,N,,1,,CHEMBL629212,
13679,,,50597,10116.0,Intermediate,1,,A,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,,BAO_0000218,N,,1,,CHEMBL629213,
13680,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629214,
13681,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL629215,
13682,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,,BAO_0000218,N,,1,,CHEMBL635154,
13683,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL629216,
13684,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL629217,
13685,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL629218,
13686,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL629219,
13687,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,N,,1,,CHEMBL629220,
13688,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL629221,
13689,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL631127,
13690,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL631128,
13691,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL631129,
13692,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL631130,
13693,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,N,,1,,CHEMBL631131,
13694,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL631132,
13695,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL631133,
13696,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL631134,
13697,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL875120,
13698,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL631135,
13699,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,N,,1,,CHEMBL631136,
13700,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL631137,
13701,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL631138,
13702,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL631139,
13703,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL631140,
13704,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,,BAO_0000218,N,,1,,CHEMBL631141,
13705,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,,BAO_0000218,N,,1,,CHEMBL631142,
13706,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,,BAO_0000218,N,,1,,CHEMBL631143,
13707,,,50597,10116.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,,BAO_0000218,N,,1,,CHEMBL631144,
13708,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL631145,
13709,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL631146,
13710,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL631147,
13711,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL631148,
13712,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL631149,
13713,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL631150,
13714,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL631151,
13715,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL631152,
13716,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL631443,
13717,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL631444,
13718,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,N,,1,,CHEMBL631445,
13719,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,,BAO_0000218,N,,1,,CHEMBL631446,
13720,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL631447,
13721,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,,BAO_0000218,N,,1,,CHEMBL631448,
13722,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,,BAO_0000218,N,,1,,CHEMBL631449,
13723,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,,BAO_0000218,N,,1,,CHEMBL631450,
13724,,,50588,9615.0,Intermediate,1,,A,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,,BAO_0000218,N,,1,,CHEMBL629724,
13725,In vivo,14.0,50594,10090.0,Intermediate,1,Zone of skin,A,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL629725,
13726,In vivo,14.0,50594,10090.0,Intermediate,1,Zone of skin,A,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL629726,
13727,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL629727,
13728,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL630404,
13729,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL630405,
13730,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL630406,
13731,In vivo,945.0,50594,10090.0,Intermediate,1,Stomach,A,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL630407,
13732,In vivo,945.0,50594,10090.0,Intermediate,1,Stomach,A,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL630573,
13733,In vivo,945.0,50594,10090.0,Intermediate,1,Stomach,A,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL630574,
13734,In vivo,945.0,50594,10090.0,Intermediate,1,Stomach,A,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL630575,
13735,In vivo,,50594,10090.0,Intermediate,1,,A,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL630576,
13736,In vivo,,50594,10090.0,Intermediate,1,,A,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL630577,
13737,In vivo,,50594,10090.0,Intermediate,1,,A,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL630578,
13738,In vivo,,50594,10090.0,Intermediate,1,,A,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,,BAO_0000218,N,,1,,CHEMBL630579,
13739,,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,,BAO_0000218,N,,1,,CHEMBL630580,
13740,,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,,BAO_0000218,N,,1,,CHEMBL630581,
13741,,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,,BAO_0000218,N,,1,,CHEMBL630582,
13742,,,50594,10090.0,Intermediate,1,,A,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,,BAO_0000218,N,,1,,CHEMBL630583,
13743,,,50594,10090.0,Intermediate,1,,A,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,,BAO_0000218,N,,1,,CHEMBL630584,
13744,,,50594,10090.0,Intermediate,1,,A,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,,BAO_0000218,N,,1,,CHEMBL630585,
13745,,,50594,10090.0,Intermediate,1,,A,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,,BAO_0000218,N,,1,,CHEMBL630586,
13746,,,50594,10090.0,Intermediate,1,,A,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,,BAO_0000218,N,,1,,CHEMBL630587,
13747,,,50594,10090.0,Intermediate,1,,A,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,,BAO_0000218,N,,1,,CHEMBL630588,
13748,,,50594,10090.0,Intermediate,1,,A,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,,BAO_0000218,N,,1,,CHEMBL630589,
13749,,,50594,10090.0,Intermediate,1,,A,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,,BAO_0000218,N,,1,,CHEMBL630590,
13750,,1988.0,22224,,Autocuration,1,Feces,A,,Removal of 238-Plutonium(IV) in feces at 24 h,,,BAO_0000019,U,,0,,CHEMBL630591,
13751,,1988.0,22224,,Autocuration,1,Feces,A,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,,BAO_0000019,U,,0,,CHEMBL630592,
13752,,,22224,,Autocuration,1,,A,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,,BAO_0000019,U,,0,,CHEMBL630593,
13753,,,22224,,Autocuration,1,,A,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,,BAO_0000019,U,,0,,CHEMBL630594,
13754,,1088.0,22224,,Autocuration,1,Urine,A,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,,BAO_0000019,U,,0,,CHEMBL630595,
13755,,1088.0,22224,,Autocuration,1,Urine,A,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,,BAO_0000019,U,,0,,CHEMBL630596,
13756,,1088.0,22224,,Autocuration,1,Urine,A,,Removal of 238-Plutonium(IV) in urine after 0-24 h,,,BAO_0000019,U,,0,,CHEMBL630597,
13757,,1088.0,22224,,Autocuration,1,Urine,A,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,,BAO_0000019,U,,0,,CHEMBL630598,
13758,,1088.0,22224,,Autocuration,1,Urine,A,,Removal of 238-Plutonium(IV) in urine after 0-4 h,,,BAO_0000019,U,,0,,CHEMBL630599,
13759,,1088.0,22224,,Autocuration,1,Urine,A,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,,BAO_0000019,U,,0,,CHEMBL630600,
13760,,1088.0,22224,,Autocuration,1,Urine,A,,Removal of 238-Plutonium(IV) in urine after 4-24 h,,,BAO_0000019,U,,0,,CHEMBL630601,
13761,,1088.0,22224,,Autocuration,1,Urine,A,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,,BAO_0000019,U,,0,,CHEMBL630602,
13762,,1088.0,22224,,Autocuration,1,Urine,A,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,,BAO_0000019,U,,0,,CHEMBL630603,
13763,,1088.0,22224,,Autocuration,1,Urine,A,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,,BAO_0000019,U,,0,,CHEMBL630604,
13764,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL624869,
13765,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL624870,
13766,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL623189,
13767,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL623190,
13768,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL623191,
13769,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL623192,
13770,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL623193,
13771,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL623194,
13772,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL623195,
13773,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL623196,
13774,,,50597,10116.0,Intermediate,1,,A,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,,BAO_0000218,N,,1,,CHEMBL623197,
13775,,,50597,10116.0,Intermediate,1,,A,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,BAO_0000218,N,,1,,CHEMBL623198,
13776,,,50597,10116.0,Intermediate,1,,A,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,,BAO_0000218,N,,1,,CHEMBL623199,
13777,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,,BAO_0000218,N,,1,,CHEMBL623200,
13778,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,,BAO_0000218,N,,1,,CHEMBL623201,
13779,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,,BAO_0000218,N,,1,,CHEMBL623202,
13780,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,,BAO_0000218,N,,1,,CHEMBL623203,
13781,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,,BAO_0000218,N,,1,,CHEMBL623204,
13782,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,,BAO_0000218,N,,1,,CHEMBL623205,
13783,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,,BAO_0000218,N,,1,,CHEMBL623206,
13784,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,,BAO_0000218,N,,1,,CHEMBL623207,
13785,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,,BAO_0000218,N,,1,,CHEMBL623208,
13786,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,BAO_0000218,N,,1,,CHEMBL623209,
13787,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,,BAO_0000218,N,,1,,CHEMBL623210,
13788,,,50597,10116.0,Intermediate,1,,A,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,,BAO_0000218,N,,1,,CHEMBL623211,
13789,,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,,BAO_0000218,N,,1,,CHEMBL623212,
13790,,,22224,,Autocuration,1,,A,,Tested in vitro for intrinsic activity relative to quinpirole,,,BAO_0000019,U,,0,,CHEMBL623213,
13791,,,22224,,Autocuration,1,,A,,"Relative ion enhancement, determined in pulsed ultrafiltration",,,BAO_0000019,U,,0,,CHEMBL623214,
13792,,,22224,,Autocuration,1,,A,,% ionization at the pH 7.4 at 37 degree Centigrade,,,BAO_0000019,U,,0,,CHEMBL623215,
13793,,,22224,,Autocuration,1,,A,,Percentage ionization was measured,,,BAO_0000019,U,,0,,CHEMBL623216,
13794,,,50591,9913.0,Intermediate,1,,A,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,,BAO_0000218,N,,1,,CHEMBL623217,
13795,,,22224,,Autocuration,1,,A,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,,BAO_0000019,U,,0,,CHEMBL623218,
13796,,,22224,,Autocuration,1,,A,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,,BAO_0000019,U,,0,,CHEMBL623913,
13797,,,22224,,Autocuration,1,,A,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,,BAO_0000019,U,,0,,CHEMBL623914,
13798,,,22229,,Autocuration,1,,P,,Compound was evaluated for the partition coefficient in octanol/water,,,BAO_0000100,U,,0,,CHEMBL623915,
13799,,,22229,,Autocuration,1,,P,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,,BAO_0000100,U,,0,,CHEMBL624080,
13800,,,22224,,Autocuration,1,,A,,Equilibrium constant measured by the pulse radiolysis at pH 7,,,BAO_0000019,U,,0,,CHEMBL624081,
13801,,,50587,9606.0,Intermediate,1,,A,,In vitro hydrolytic rate constant determined in human blood,,,BAO_0000218,N,,1,,CHEMBL624082,
13802,,,50587,9606.0,Intermediate,1,,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,,BAO_0000218,N,,1,,CHEMBL625054,
13803,,,22224,,Autocuration,1,,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,,BAO_0000019,U,,0,,CHEMBL877485,
13804,,,50594,10090.0,Intermediate,1,,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,,BAO_0000218,N,,1,,CHEMBL625055,
13805,,,50594,10090.0,Intermediate,1,,A,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,,BAO_0000218,N,,1,,CHEMBL625056,
13806,,,50587,9606.0,Intermediate,1,,A,,In vitro oxidation of compound in presence of human plasma,,,BAO_0000218,N,,1,,CHEMBL625057,
13807,,,22224,,Autocuration,1,,A,,In vitro oxidation of compound in presence of hydrogen peroxide,,,BAO_0000019,U,,0,,CHEMBL625058,
13808,,,50594,10090.0,Intermediate,1,,A,,In vitro oxidation of compound in presence of mouse brain homogenate,,,BAO_0000218,N,,1,,CHEMBL625059,
13809,,,50594,10090.0,Intermediate,1,,A,,In vitro oxidation of compound in presence of mouse liver homogenate,,,BAO_0000218,N,,1,,CHEMBL629536,
13810,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629537,
13811,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629538,
13812,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629539,
13813,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,BAO_0000218,N,,1,,CHEMBL874445,
13814,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629540,
13815,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629541,
13816,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629542,
13817,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,BAO_0000218,N,,1,,CHEMBL630243,
13818,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,BAO_0000218,N,,1,,CHEMBL630244,
13819,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,BAO_0000218,N,,1,,CHEMBL630245,
13820,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,BAO_0000218,N,,1,,CHEMBL630246,
13821,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,BAO_0000218,N,,1,,CHEMBL630247,
13822,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,BAO_0000218,N,,1,,CHEMBL630248,
13823,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630249,
13824,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630250,
13825,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630251,
13826,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood at 3 hr after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630252,
13827,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood at 60 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630408,
13828,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630409,
13829,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL874446,
13830,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630410,
13831,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630411,
13832,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630412,
13833,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630413,
13834,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution in rat cerebellum at 3 hr after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630414,
13835,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630415,
13836,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat cortex at 120 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630416,
13837,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat cortex at 1440 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630417,
13838,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat cortex at 15 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630418,
13839,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat cortex at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630419,
13840,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat cortex at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630420,
13841,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat cortex at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630421,
13842,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat cortex at 3 hr after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630422,
13843,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat cortex at 60 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630423,
13844,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart at 120 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630424,
13845,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart at 15 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630425,
13846,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL629462,
13847,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630426,
13848,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630427,
13849,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart at 3 hr after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625877,
13850,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart at 60 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625878,
13851,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625879,
13852,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625880,
13853,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625881,
13854,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625882,
13855,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625883,
13856,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney at 120 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625884,
13857,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney at 1440 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625885,
13858,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney at 15 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628649,
13859,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628650,
13860,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628651,
13861,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628652,
13862,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney at 60 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628653,
13863,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver at 120 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628654,
13864,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver at 1440 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628655,
13865,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver at 15 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625238,
13866,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625239,
13867,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625240,
13868,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625241,
13869,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver at 60 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625242,
13870,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in rat lung at 120 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL874587,
13871,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in rat lung at 1440 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625405,
13872,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in rat lung at 15 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625406,
13873,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in rat lung at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625407,
13874,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in rat lung at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625408,
13875,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in rat lung at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL625409,
13876,,1515.0,50597,10116.0,Intermediate,1,Thoracic aorta,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,,BAO_0000218,N,,1,,CHEMBL625410,
13877,,1515.0,50597,10116.0,Intermediate,1,Thoracic aorta,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,,BAO_0000218,N,,1,,CHEMBL625411,
13878,,1515.0,50597,10116.0,Intermediate,1,Thoracic aorta,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,,BAO_0000218,N,,1,,CHEMBL625412,
13879,,1515.0,50597,10116.0,Intermediate,1,Thoracic aorta,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,,BAO_0000218,N,,1,,CHEMBL625413,
13880,,1515.0,50597,10116.0,Intermediate,1,Thoracic aorta,A,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,,BAO_0000218,N,,1,,CHEMBL625414,
13881,,1515.0,50597,10116.0,Intermediate,1,Thoracic aorta,A,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,,BAO_0000218,N,,1,,CHEMBL625415,
13882,,1515.0,50597,10116.0,Intermediate,1,Thoracic aorta,A,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,,BAO_0000218,N,,1,,CHEMBL625416,
13883,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,,BAO_0000218,N,,1,,CHEMBL625417,
13884,,1988.0,50597,10116.0,Intermediate,1,Feces,A,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,,BAO_0000218,N,,1,,CHEMBL625418,
13885,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,,BAO_0000218,N,,1,,CHEMBL625419,
13886,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,,BAO_0000218,N,,1,,CHEMBL625420,
13887,,,50597,10116.0,Intermediate,1,,A,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,,BAO_0000218,N,,1,,CHEMBL626996,
13888,,1988.0,50597,10116.0,Intermediate,1,Feces,A,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,,BAO_0000218,N,,1,,CHEMBL626997,
13889,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,,BAO_0000218,N,,1,,CHEMBL626998,
13890,,,50597,10116.0,Intermediate,1,,A,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,,BAO_0000218,N,,1,,CHEMBL626999,
13891,,,50594,10090.0,Intermediate,1,,A,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,,BAO_0000218,N,,1,,CHEMBL627000,
13892,,,50594,10090.0,Intermediate,1,,A,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,,BAO_0000218,N,,1,,CHEMBL627001,
13893,,,50594,10090.0,Intermediate,1,,A,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,,BAO_0000218,N,,1,,CHEMBL627002,
13894,,,50594,10090.0,Intermediate,1,,A,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,,BAO_0000218,N,,1,,CHEMBL627003,
13895,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,,BAO_0000218,N,,1,,CHEMBL627004,
13896,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,,BAO_0000218,N,,1,,CHEMBL627005,
13897,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,,BAO_0000218,N,,1,,CHEMBL874594,
13898,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,,BAO_0000218,N,,1,,CHEMBL627006,
13899,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,,BAO_0000218,N,,1,,CHEMBL627007,
13900,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,,BAO_0000218,N,,1,,CHEMBL627884,
13901,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,,BAO_0000218,N,,1,,CHEMBL627885,
13902,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,,BAO_0000218,N,,1,,CHEMBL627886,
13903,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,,BAO_0000218,N,,1,,CHEMBL627887,
13904,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,,BAO_0000218,N,,1,,CHEMBL627888,
13905,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,,BAO_0000218,N,,1,,CHEMBL628057,
13906,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,,BAO_0000218,N,,1,,CHEMBL627405,
13907,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627406,
13908,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627407,
13909,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627408,
13910,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627409,
13911,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL875486,
13912,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627410,
13913,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627411,
13914,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627412,
13915,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627413,
13916,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627414,
13917,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627415,
13918,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627416,
13919,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627417,
13920,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627418,
13921,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627419,
13922,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627320,
13923,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627321,
13924,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL627322,
13925,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL627323,
13926,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL627491,
13927,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL627492,
13928,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL627493,
13929,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL627494,
13930,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL627495,
13931,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL627496,
13932,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL627497,
13933,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL627498,
13934,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL627499,
13935,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL627500,
13936,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL627501,
13937,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL625616,
13938,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL625617,
13939,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL625618,
13940,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL625619,
13941,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL625620,
13942,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL625621,
13943,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL625622,
13944,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL625788,
13945,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL625789,
13946,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL625790,
13947,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL625791,
13948,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL622334,
13949,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL622335,
13950,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL622336,
13951,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL622337,
13952,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL622338,
13953,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL622339,
13954,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL624153,
13955,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL628430,
13956,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL628431,
13957,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL628432,
13958,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL628433,
13959,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,N,,1,,CHEMBL628434,
13960,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,N,,1,,CHEMBL626789,
13961,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,,BAO_0000218,N,,1,,CHEMBL626790,
13962,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,N,,1,,CHEMBL626791,
13963,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,N,,1,,CHEMBL626792,
13964,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,N,,1,,CHEMBL626793,
13965,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627436,
13966,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627437,
13967,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627438,
13968,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627439,
13969,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627440,
13970,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627602,
13971,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627603,
13972,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627604,
13973,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627605,
13974,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627606,
13975,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627607,
13976,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627608,
13977,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627609,
13978,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627610,
13979,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627611,
13980,,,50597,10116.0,Intermediate,1,,A,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,BAO_0000218,N,,1,,CHEMBL627612,
13981,,,22229,,Autocuration,1,,P,,Octanol:water partition coefficient is evaluated,,,BAO_0000100,U,,0,,CHEMBL627613,
13982,,,22224,,Autocuration,1,,P,,Partition coefficient in 1-octanol/water system,,,BAO_0000100,U,,0,,CHEMBL627614,
13983,,,22224,,Autocuration,1,,P,,Partition coefficient in 1-octanol/water system measured using radio active compounds,,,BAO_0000100,U,,0,,CHEMBL627615,
13984,,,22224,,Autocuration,1,,P,,Partition coefficient in octanol/water system was determined,,,BAO_0000100,U,,0,,CHEMBL627616,
13985,,,22224,,Autocuration,1,,P,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,,BAO_0000100,U,,0,,CHEMBL627617,
13986,,,22224,,Autocuration,1,,A,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,,BAO_0000019,U,,0,,CHEMBL627618,
13987,,,22224,,Autocuration,1,,A,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,,BAO_0000019,U,,0,,CHEMBL627619,
13988,,,22224,,Autocuration,1,,A,,Pseudo-first-order rate constant of the compound,,,BAO_0000019,U,,0,,CHEMBL627620,
13989,,,22224,,Autocuration,1,,A,,Pseudo-first-order rate constant with 1-min time point,,,BAO_0000019,U,,0,,CHEMBL627621,
13990,,,22224,,Autocuration,1,,A,,Pseudo-first-order rate constant without 1-min time point,,,BAO_0000019,U,,0,,CHEMBL627622,
13991,,,22224,,Autocuration,1,,A,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,,BAO_0000019,U,,0,,CHEMBL627623,
13992,,,22224,,Autocuration,1,,A,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,,BAO_0000019,U,,0,,CHEMBL627624,
13993,,,22224,,Autocuration,1,,A,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,,BAO_0000019,U,,0,,CHEMBL627625,
13994,,,22224,,Autocuration,1,,A,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,,BAO_0000019,U,,0,,CHEMBL628523,
13995,,,22224,,Autocuration,1,,A,,The alkaline hydrolysis second order rate constant(K OH) of the compound,,,BAO_0000019,U,,0,,CHEMBL628524,
13996,,,22224,,Autocuration,1,,A,,The efflux rate constant of the compound,,,BAO_0000019,U,,0,,CHEMBL628525,
13997,,,22224,,Autocuration,1,,A,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,BAO_0000019,U,,0,,CHEMBL625732,
13998,,,22224,,Autocuration,1,,A,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,BAO_0000019,U,,0,,CHEMBL625733,
13999,,,22224,,Autocuration,1,,F,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,,BAO_0000019,U,,0,,CHEMBL625734,
14000,,,22224,,Autocuration,1,,A,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,,BAO_0000019,U,,0,,CHEMBL625913,
14001,,,22224,,Autocuration,1,,A,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,,BAO_0000019,U,,0,,CHEMBL625914,
14002,,,22224,,Autocuration,1,,A,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,,BAO_0000019,U,,0,,CHEMBL625915,
14003,,,22224,,Autocuration,1,,A,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,,BAO_0000019,U,,0,,CHEMBL625916,
14004,,,22224,,Autocuration,1,,A,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,,BAO_0000019,U,,0,,CHEMBL625917,
14005,,,22224,,Autocuration,1,,A,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL625918,
14006,,,22224,,Autocuration,1,,A,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL625919,
14007,,,22224,,Autocuration,1,,A,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL625920,
14008,,,22224,,Autocuration,1,,A,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL874453,
14009,,,22224,,Autocuration,1,,A,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL625921,
14010,,,22224,,Autocuration,1,,A,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,,BAO_0000019,U,,0,,CHEMBL625922,
14011,,,22224,,Autocuration,1,,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL625923,
14012,,,22224,,Autocuration,1,,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL625924,
14013,,,22224,,Autocuration,1,,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL625925,
14014,,,22224,,Autocuration,1,,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL625926,
14015,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in rat lung at 60 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL627704,
14016,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL627705,
14017,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL627706,
14018,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL627707,
14019,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL627708,
14020,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628361,
14021,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628362,
14022,In vivo,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Biodistribution in rat striatum at 120 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628363,
14023,In vivo,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Biodistribution in rat striatum at 1440 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628364,
14024,In vivo,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Biodistribution in rat striatum at 15 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628365,
14025,In vivo,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Biodistribution in rat striatum at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL874454,
14026,In vivo,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Biodistribution in rat striatum at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628531,
14027,In vivo,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Biodistribution in rat striatum at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628532,
14028,In vivo,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Biodistribution in rat striatum at 3 hr after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628533,
14029,In vivo,2435.0,50597,10116.0,Intermediate,1,Striatum,A,,Biodistribution in rat striatum at 60 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628534,
14030,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in rat thyroid at 120 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628535,
14031,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628536,
14032,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in rat thyroid at 15 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628537,
14033,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in rat thyroid at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628538,
14034,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in rat thyroid at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628539,
14035,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in rat thyroid at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630297,
14036,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in rat thyroid at 60 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630298,
14037,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL630299,
14038,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628094,
14039,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628095,
14040,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL874648,
14041,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628096,
14042,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628097,
14043,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,,BAO_0000218,N,,1,,CHEMBL628098,
14044,,,22224,,Autocuration,1,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,,BAO_0000019,U,,0,,CHEMBL628099,
14045,,,22224,,Autocuration,1,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,BAO_0000019,U,,0,,CHEMBL628100,
14046,,,22224,,Autocuration,1,,A,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,,BAO_0000019,U,,0,,CHEMBL628101,
14047,,,22224,,Autocuration,1,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,,BAO_0000019,U,,0,,CHEMBL628102,
14048,,,22224,,Autocuration,1,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,,BAO_0000019,U,,0,,CHEMBL628103,
14049,,,22224,,Autocuration,1,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,,BAO_0000019,U,,0,,CHEMBL628104,
14050,,,22224,,Autocuration,1,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,,BAO_0000019,U,,0,,CHEMBL628105,
14051,,,22224,,Autocuration,1,,A,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,,BAO_0000019,U,,0,,CHEMBL628106,
14052,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,BAO_0000218,N,,1,,CHEMBL628107,
14053,,1088.0,22224,,Autocuration,1,Urine,F,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,,BAO_0000218,U,,0,,CHEMBL628108,
14054,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,BAO_0000218,N,,1,,CHEMBL628109,
14055,,1088.0,22224,,Autocuration,1,Urine,F,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,,BAO_0000218,U,,0,,CHEMBL625299,
14056,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,,BAO_0000218,N,,1,,CHEMBL625300,
14057,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,,BAO_0000218,N,,1,,CHEMBL625301,
14058,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,,BAO_0000218,N,,1,,CHEMBL625302,
14059,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,,BAO_0000218,N,,1,,CHEMBL874649,
14060,,,50597,10116.0,Intermediate,1,,A,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,,BAO_0000218,N,,1,,CHEMBL625303,
14061,,,50597,10116.0,Intermediate,1,,A,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,,BAO_0000218,N,,1,,CHEMBL625463,
14062,,2107.0,50587,9606.0,Intermediate,1,Liver,A,,In vitro metabolism in human liver microsomes,,,BAO_0000218,N,,1,,CHEMBL625464,
14063,,,50587,9606.0,Intermediate,1,,A,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,,BAO_0000218,N,,1,,CHEMBL625465,
14064,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625466,
14065,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625467,
14066,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625468,
14067,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625469,
14068,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625470,
14069,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL632418,
14070,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627250,
14071,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627251,
14072,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627252,
14073,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627253,
14074,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627254,
14075,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL875471,
14076,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627255,
14077,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627256,
14078,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627257,
14079,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627258,
14080,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627259,
14081,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627260,
14082,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623256,
14083,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL874413,
14084,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623257,
14085,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623258,
14086,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623259,
14087,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623260,
14088,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623261,
14089,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623262,
14090,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623263,
14091,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623264,
14092,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623265,
14093,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623266,
14094,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623267,
14095,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623268,
14096,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623269,
14097,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623270,
14098,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623271,
14099,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623272,
14100,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623273,
14101,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623274,
14102,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL874414,
14103,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623275,
14104,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL629150,
14105,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623276,
14106,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623277,
14107,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623112,
14108,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623113,
14109,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623800,
14110,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623801,
14111,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,,BAO_0000218,N,,1,,CHEMBL623802,
14112,In vivo,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL623803,
14113,In vivo,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL623970,
14114,In vivo,995.0,50597,10116.0,Intermediate,1,Uterus,A,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL623971,
14115,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL623972,
14116,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL623973,
14117,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL623974,
14118,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL623975,
14119,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL623976,
14120,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL623977,
14121,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL623978,
14122,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL623979,
14123,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL623980,
14124,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL623981,
14125,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL626278,
14126,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,,BAO_0000218,N,,1,,CHEMBL626279,
14127,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in mice bladder plus excreted urine was determined,,,BAO_0000218,N,,1,,CHEMBL626280,
14128,,,50594,10090.0,Intermediate,1,,A,,"Percentage biodistribution in mouse blood, 10 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626281,
14129,,,50594,10090.0,Intermediate,1,,A,,"Percentage biodistribution in mouse blood, 30 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626282,
14130,,,50594,10090.0,Intermediate,1,,A,,"Percentage biodistribution in mouse blood, 5 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626283,
14131,,,50594,10090.0,Intermediate,1,,A,,"Percentage biodistribution in mouse blood, 60 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626284,
14132,,955.0,50594,10090.0,Intermediate,1,Brain,A,,"Percentage biodistribution in mouse brain, 10 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626285,
14133,,955.0,50594,10090.0,Intermediate,1,Brain,A,,"Percentage biodistribution in mouse brain, 30 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626286,
14134,,955.0,50594,10090.0,Intermediate,1,Brain,A,,"Percentage biodistribution in mouse brain, 5 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626287,
14135,,955.0,50594,10090.0,Intermediate,1,Brain,A,,"Percentage biodistribution in mouse brain, 60 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626288,
14136,,,50594,10090.0,Intermediate,1,,A,,"Percentage biodistribution in mouse heart, 10 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626289,
14137,,,50594,10090.0,Intermediate,1,,A,,"Percentage biodistribution in mouse heart, 30 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626290,
14138,,,50594,10090.0,Intermediate,1,,A,,"Percentage biodistribution in mouse heart, 5 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626291,
14139,,,50594,10090.0,Intermediate,1,,A,,"Percentage biodistribution in mouse heart, 60 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL839888,
14140,,160.0,50594,10090.0,Intermediate,1,Intestine,A,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626292,
14141,,160.0,50594,10090.0,Intermediate,1,Intestine,A,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626293,
14142,,160.0,50594,10090.0,Intermediate,1,Intestine,A,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626294,
14143,,160.0,50594,10090.0,Intermediate,1,Intestine,A,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL626295,
14144,,2107.0,50594,10090.0,Intermediate,1,Liver,A,,"Percentage biodistribution in mouse liver, 10 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL627659,
14145,,2107.0,50594,10090.0,Intermediate,1,Liver,A,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,,BAO_0000218,N,,1,,CHEMBL627660,
14146,,2107.0,50594,10090.0,Intermediate,1,Liver,A,,"Percentage biodistribution in mouse liver, 5 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL627661,
14147,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution in mice liver at 60 minutes of post injection,,,BAO_0000218,N,,1,,CHEMBL627662,
14148,In vivo,2048.0,50594,10090.0,Intermediate,1,Lung,A,,Biodistribution in mice lungs at 10 min of post injection,,,BAO_0000218,N,,1,,CHEMBL627663,
14149,,,50594,10090.0,Intermediate,1,,A,,"Percentage biodistribution in mouse lung, 30 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL627664,
14150,,,50594,10090.0,Intermediate,1,,A,,"Percentage biodistribution in mousee lung, 5 minutes post injection",,,BAO_0000218,N,,1,,CHEMBL627665,
14151,In vivo,2048.0,50594,10090.0,Intermediate,1,Lung,A,,Biodistribution in mice lungs at 60 min of post injection,,,BAO_0000218,N,,1,,CHEMBL627666,
14152,,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Percentage biodistribution in mouse spleen,,,BAO_0000218,N,,1,,CHEMBL627667,
14153,,945.0,50594,10090.0,Intermediate,1,Stomach,A,,Percentage biodistribution in mouse stomach,,,BAO_0000218,N,,1,,CHEMBL627668,
14154,,1088.0,50594,10090.0,Intermediate,1,Urine,A,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,,BAO_0000218,N,,1,,CHEMBL627669,
14155,In vivo,1255.0,22224,,Autocuration,1,Urinary bladder,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,,BAO_0000218,U,,0,,CHEMBL627670,
14156,In vivo,178.0,22224,,Autocuration,1,Blood,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,,BAO_0000218,U,,0,,CHEMBL627671,
14157,In vivo,1474.0,22224,,Autocuration,1,Bone element,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,,BAO_0000218,U,,0,,CHEMBL627672,
14158,In vivo,,22224,,Autocuration,1,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,,BAO_0000218,U,,0,,CHEMBL627673,
14159,In vivo,2113.0,22224,,Autocuration,1,Kidney,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,,BAO_0000218,U,,0,,CHEMBL627674,
14160,In vivo,2107.0,22224,,Autocuration,1,Liver,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,,BAO_0000218,U,,0,,CHEMBL627675,
14161,In vivo,2048.0,22224,,Autocuration,1,Lung,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,,BAO_0000218,U,,0,,CHEMBL627676,
14162,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,,BAO_0000218,U,,0,,CHEMBL627677,
14163,,,22224,,Autocuration,1,,A,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL627678,
14164,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Affinity for protein binding expressed as association constant in fresh rat serum,,,BAO_0000218,N,,1,,CHEMBL627679,
14165,,,22224,,Autocuration,1,,A,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,BAO_0000019,U,,0,,CHEMBL627680,
14166,,,22224,,Autocuration,1,,A,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,BAO_0000019,U,,0,,CHEMBL627681,
14167,,,22224,,Autocuration,1,,A,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,,BAO_0000019,U,,0,,CHEMBL627682,
14168,,,22224,,Autocuration,1,,A,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,,BAO_0000019,U,,0,,CHEMBL627683,
14169,,,22224,,Autocuration,1,,A,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,,BAO_0000019,U,,0,,CHEMBL627684,
14170,,,22224,,Autocuration,1,,A,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,BAO_0000019,U,,0,,CHEMBL874441,
14171,,,22224,,Autocuration,1,,A,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,,BAO_0000019,U,,0,,CHEMBL627685,
14172,,,22224,,Autocuration,1,,A,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,,BAO_0000019,U,,0,,CHEMBL627686,
14173,,,22224,,Autocuration,1,,A,,Apparent rate constant Koff for inactivation of dTMP synthase.,,,BAO_0000019,U,,0,,CHEMBL627687,
14174,,,22224,,Autocuration,1,,A,,The irreversible inhibitor activity by second order rate equation.,,,BAO_0000019,U,,0,,CHEMBL627688,
14175,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL628038,
14176,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,,BAO_0000218,N,,1,,CHEMBL628039,
14177,,,50597,10116.0,Intermediate,1,,A,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,,BAO_0000218,N,,1,,CHEMBL628040,
14178,,,22224,,Autocuration,1,,A,,Dissociation rate calculated from the first-order equation using t1/2 value,,,BAO_0000019,U,,0,,CHEMBL628041,
14179,,,22224,,Autocuration,1,,A,,The compound was tested for Binding constant against DNA,,,BAO_0000019,U,,0,,CHEMBL630226,
14180,,,22224,,Autocuration,1,,A,,First order rate constant for cyclization of the compound,,,BAO_0000019,U,,0,,CHEMBL628042,
14181,,,22224,,Autocuration,1,,A,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,BAO_0000019,U,,0,,CHEMBL625232,
14182,,,22224,,Autocuration,1,,A,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,BAO_0000019,U,,0,,CHEMBL625233,
14183,,,22224,,Autocuration,1,,A,,Hydrolysis rate constant was determined,,,BAO_0000019,U,,0,,CHEMBL625979,
14184,,,22224,,Autocuration,1,,A,,Observed first order rate constant,,,BAO_0000019,U,,0,,CHEMBL625980,
14185,,,22224,,Autocuration,1,,A,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,BAO_0000019,U,,0,,CHEMBL625981,
14186,,,22224,,Autocuration,1,,A,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,BAO_0000019,U,,0,,CHEMBL625982,
14187,,,22224,,Autocuration,1,,A,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,,BAO_0000019,U,,0,,CHEMBL625983,
14188,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL625984,
14189,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL625985,
14190,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL625986,
14191,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL625987,
14192,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL625988,
14193,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL625989,
14194,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL625990,
14195,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL625991,
14196,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL625992,
14197,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL625993,
14198,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL631973,
14199,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL632143,
14200,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL632144,
14201,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL632145,
14202,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL632146,
14203,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL632147,
14204,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL632148,
14205,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL632149,
14206,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL632150,
14207,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL632151,
14208,,,50587,9606.0,Intermediate,1,,A,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,,BAO_0000218,N,,1,,CHEMBL632152,
14209,,,50587,9606.0,Intermediate,1,,A,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,BAO_0000218,N,,1,,CHEMBL632153,
14210,,,50587,9606.0,Intermediate,1,,A,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,,BAO_0000218,N,,1,,CHEMBL632154,
14211,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,,BAO_0000218,N,,1,,CHEMBL632155,
14212,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,,BAO_0000218,N,,1,,CHEMBL632156,
14213,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,,BAO_0000218,N,,1,,CHEMBL632157,
14214,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,,BAO_0000218,N,,1,,CHEMBL632158,
14215,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,,BAO_0000218,N,,1,,CHEMBL632159,
14216,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,,BAO_0000218,N,,1,,CHEMBL626305,
14217,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,,BAO_0000218,N,,1,,CHEMBL626306,
14218,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,,BAO_0000218,N,,1,,CHEMBL626307,
14219,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,,BAO_0000218,N,,1,,CHEMBL626308,
14220,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,,BAO_0000218,N,,1,,CHEMBL626479,
14221,,,50602,10298.0,Intermediate,1,,A,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,,BAO_0000218,N,,1,,CHEMBL626480,
14222,,,22229,,Autocuration,1,,P,,Calculated partition coefficient (clogP) (MlogP),,,BAO_0000100,U,,0,,CHEMBL626481,
14223,,,22224,,Autocuration,1,,A,,Equipotent potent ratio relative to carbachol (nicotinic activity),,,BAO_0000019,U,,0,,CHEMBL626482,
14224,,,50588,9615.0,Intermediate,1,,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,,BAO_0000218,N,,1,,CHEMBL626483,
14225,,,50588,9615.0,Intermediate,1,,A,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,,BAO_0000218,N,,1,,CHEMBL626484,
14226,,,22229,,Autocuration,1,,P,,Solubility at pH 7.4 in micro g/mL;NA denotes available,,,BAO_0000100,U,,0,,CHEMBL626485,
14227,,,22229,,Autocuration,1,,P,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,,BAO_0000100,U,,0,,CHEMBL626486,
14228,,,22229,,Autocuration,1,,P,,Solubility at pH 7.4 in ug/mL;NA denotes not available,,,BAO_0000100,U,,0,,CHEMBL626487,
14229,In vivo,1969.0,50588,9615.0,Intermediate,1,Plasma,A,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,,BAO_0000218,N,,1,,CHEMBL626488,
14230,,1977.0,50597,10116.0,Intermediate,1,Serum,A,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,,BAO_0000218,N,,1,,CHEMBL626489,
14231,,,22224,,Autocuration,1,,A,,Area under the MAP curve measured over 5 min; ND means Not determined,,,BAO_0000019,U,,0,,CHEMBL626490,
14232,,,22224,,Autocuration,1,,P,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,,BAO_0000100,U,,0,,CHEMBL626491,
14233,,,22229,,Autocuration,1,,P,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,,BAO_0000100,U,,0,,CHEMBL626492,
14234,,,22224,,Autocuration,1,,A,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,,BAO_0000019,U,,0,,CHEMBL626493,
14235,In vivo,,50597,10116.0,Intermediate,1,,A,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,,BAO_0000218,N,,1,,CHEMBL626494,
14236,In vivo,,22224,,Autocuration,1,,A,,Half life after oral tested,,,BAO_0000218,U,,0,,CHEMBL626495,
14237,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,Half life was determined in plasma of rat; NT indicates not tested,,,BAO_0000218,N,,1,,CHEMBL626496,
14238,In vivo,,50597,10116.0,Intermediate,1,,A,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,,BAO_0000218,N,,1,,CHEMBL626497,
14239,In vivo,,22224,,Autocuration,1,,A,,Oral bioavailability after oral tested,,,BAO_0000218,U,,0,,CHEMBL626498,
14240,,,50597,10116.0,Intermediate,1,,A,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,,BAO_0000218,N,,1,,CHEMBL626499,
14241,,,50597,10116.0,Intermediate,1,,A,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,,BAO_0000218,N,,1,,CHEMBL626500,
14242,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,half life was determined in plasma of rat; NT indicates not tested,,,BAO_0000218,N,,1,,CHEMBL626501,
14243,,1969.0,50597,10116.0,Intermediate,1,Plasma,A,,half life was determined in plasma of rat; NT means not tested,,,BAO_0000218,N,,1,,CHEMBL626502,
14244,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,,BAO_0000218,N,,1,,CHEMBL626503,
14245,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,,BAO_0000218,N,,1,,CHEMBL626504,
14246,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,,BAO_0000218,N,,1,,CHEMBL626505,
14247,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,,BAO_0000218,N,,1,,CHEMBL626506,
14248,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,,BAO_0000218,N,,1,,CHEMBL626507,
14249,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,,BAO_0000218,N,,1,,CHEMBL626508,
14250,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,,BAO_0000218,N,,1,,CHEMBL626509,
14251,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,,BAO_0000218,N,,1,,CHEMBL875480,
14252,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,,BAO_0000218,N,,1,,CHEMBL626510,
14253,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,,BAO_0000218,N,,1,,CHEMBL626511,
14254,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,,BAO_0000218,N,,1,,CHEMBL626512,
14255,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,,BAO_0000218,N,,1,,CHEMBL628208,
14256,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,,BAO_0000218,N,,1,,CHEMBL628209,
14257,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,,BAO_0000218,N,,1,,CHEMBL628210,
14258,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,,BAO_0000218,N,,1,,CHEMBL628211,
14259,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,,BAO_0000218,N,,1,,CHEMBL628212,
14260,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,,BAO_0000218,N,,1,,CHEMBL628213,
14261,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628214,
14262,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628215,
14263,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628216,
14264,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626595,
14265,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626596,
14266,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626597,
14267,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626598,
14268,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622242,
14269,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622243,
14270,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622244,
14271,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622245,
14272,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622246,
14273,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622247,
14274,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622248,
14275,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL877483,
14276,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622249,
14277,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622250,
14278,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622251,
14279,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622252,
14280,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622253,
14281,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622254,
14282,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622255,
14283,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622256,
14284,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622257,
14285,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622258,
14286,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622259,
14287,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622927,
14288,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622928,
14289,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL622929,
14290,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623182,
14291,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623183,
14292,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623184,
14293,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623185,
14294,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL877484,
14295,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627274,
14296,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623186,
14297,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623187,
14298,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL623188,
14299,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628055,
14300,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628056,
14301,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628200,
14302,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628201,
14303,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628202,
14304,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628203,
14305,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628204,
14306,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628205,
14307,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628206,
14308,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,,BAO_0000218,U,,0,,CHEMBL628207,
14309,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,,BAO_0000218,U,,0,,CHEMBL627220,
14310,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,,BAO_0000218,U,,0,,CHEMBL627221,
14311,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,,BAO_0000218,U,,0,,CHEMBL627222,
14312,In vivo,,22224,,Autocuration,1,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,,BAO_0000218,U,,0,,CHEMBL627223,
14313,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,,BAO_0000218,U,,0,,CHEMBL632062,
14314,In vivo,2106.0,22224,,Autocuration,1,Spleen,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,,BAO_0000218,U,,0,,CHEMBL632063,
14315,In vivo,1255.0,22224,,Autocuration,1,Urinary bladder,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,,BAO_0000218,U,,0,,CHEMBL632064,
14316,In vivo,178.0,22224,,Autocuration,1,Blood,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,,BAO_0000218,U,,0,,CHEMBL632065,
14317,In vivo,1474.0,22224,,Autocuration,1,Bone element,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,,BAO_0000218,U,,0,,CHEMBL632066,
14318,In vivo,,22224,,Autocuration,1,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,,BAO_0000218,U,,0,,CHEMBL632067,
14319,In vivo,2113.0,22224,,Autocuration,1,Kidney,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,,BAO_0000218,U,,0,,CHEMBL629188,
14320,In vivo,2107.0,22224,,Autocuration,1,Liver,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,,BAO_0000218,U,,0,,CHEMBL629189,
14321,In vivo,2048.0,22224,,Autocuration,1,Lung,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,,BAO_0000218,U,,0,,CHEMBL629190,
14322,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,,BAO_0000218,U,,0,,CHEMBL629191,
14323,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,,BAO_0000218,U,,0,,CHEMBL629192,
14324,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,,BAO_0000218,U,,0,,CHEMBL629193,
14325,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,,BAO_0000218,U,,0,,CHEMBL629194,
14326,In vivo,,22224,,Autocuration,1,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,,BAO_0000218,U,,0,,CHEMBL629195,
14327,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,,BAO_0000218,U,,0,,CHEMBL629373,
14328,In vivo,2106.0,22224,,Autocuration,1,Spleen,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,,BAO_0000218,U,,0,,CHEMBL629374,
14329,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,,BAO_0000218,U,,0,,CHEMBL629375,
14330,In vivo,1255.0,22224,,Autocuration,1,Urinary bladder,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,,BAO_0000218,U,,0,,CHEMBL629376,
14331,In vivo,178.0,22224,,Autocuration,1,Blood,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,,BAO_0000218,U,,0,,CHEMBL629377,
14332,In vivo,1474.0,22224,,Autocuration,1,Bone element,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,,BAO_0000218,U,,0,,CHEMBL629378,
14333,In vivo,,22224,,Autocuration,1,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,,BAO_0000218,U,,0,,CHEMBL629379,
14334,In vivo,2113.0,22224,,Autocuration,1,Kidney,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,,BAO_0000218,U,,0,,CHEMBL629151,
14335,In vivo,2107.0,22224,,Autocuration,1,Liver,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,,BAO_0000218,U,,0,,CHEMBL629152,
14336,In vivo,2048.0,22224,,Autocuration,1,Lung,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,,BAO_0000218,U,,0,,CHEMBL629153,
14337,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,,BAO_0000218,U,,0,,CHEMBL629154,
14338,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,,BAO_0000218,U,,0,,CHEMBL629155,
14339,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,,BAO_0000218,U,,0,,CHEMBL629156,
14340,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,,BAO_0000218,U,,0,,CHEMBL629157,
14341,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,,BAO_0000218,U,,0,,CHEMBL629158,
14342,In vivo,,22224,,Autocuration,1,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,,BAO_0000218,U,,0,,CHEMBL629159,
14343,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,,BAO_0000218,U,,0,,CHEMBL629160,
14344,In vivo,2106.0,22224,,Autocuration,1,Spleen,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,,BAO_0000218,U,,0,,CHEMBL629161,
14345,In vivo,1255.0,22224,,Autocuration,1,Urinary bladder,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,,BAO_0000218,U,,0,,CHEMBL629162,
14346,In vivo,178.0,22224,,Autocuration,1,Blood,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,,BAO_0000218,U,,0,,CHEMBL629163,
14347,In vivo,1474.0,22224,,Autocuration,1,Bone element,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,,BAO_0000218,U,,0,,CHEMBL629164,
14348,In vivo,,22224,,Autocuration,1,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,,BAO_0000218,U,,0,,CHEMBL629165,
14349,In vivo,2107.0,22224,,Autocuration,1,Liver,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,,BAO_0000218,U,,0,,CHEMBL629166,
14350,In vivo,2048.0,22224,,Autocuration,1,Lung,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,,BAO_0000218,U,,0,,CHEMBL629167,
14351,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,,BAO_0000218,U,,0,,CHEMBL629168,
14352,,,22224,,Autocuration,1,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,,BAO_0000019,U,,0,,CHEMBL629169,
14353,,,22224,,Autocuration,1,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,,BAO_0000019,U,,0,,CHEMBL629170,
14354,,,22224,,Autocuration,1,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,,BAO_0000019,U,,0,,CHEMBL631153,
14355,,,22224,,Autocuration,1,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,,BAO_0000019,U,,0,,CHEMBL875121,
14356,,,22224,,Autocuration,1,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,,BAO_0000019,U,,0,,CHEMBL631154,
14357,,,22224,,Autocuration,1,,A,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,,BAO_0000019,U,,0,,CHEMBL631155,
14358,,,22224,,Autocuration,1,,A,,Hydrolysis rate constant was determined,,,BAO_0000019,U,,0,,CHEMBL631156,
14359,,,22224,,Autocuration,1,,A,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,,BAO_0000019,U,,0,,CHEMBL631157,
14360,,,22224,,Autocuration,1,,A,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,BAO_0000019,U,,0,,CHEMBL631158,
14361,,,22224,,Autocuration,1,,A,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,BAO_0000019,U,,0,,CHEMBL631159,
14362,,,22224,,Autocuration,1,,A,,Observed second order rate constant,,,BAO_0000019,U,,0,,CHEMBL631160,
14363,,,22224,,Autocuration,1,,A,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,,BAO_0000019,U,,0,,CHEMBL631161,
14364,,,22224,,Autocuration,1,,A,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,,BAO_0000019,U,,0,,CHEMBL631162,
14365,,,22224,,Autocuration,1,,A,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,,BAO_0000019,U,,0,,CHEMBL630313,
14366,,,22224,,Autocuration,1,,A,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,,BAO_0000019,U,,0,,CHEMBL630314,
14367,,,22224,,Autocuration,1,,A,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,,BAO_0000019,U,,0,,CHEMBL630315,
14368,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL630316,
14369,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL630986,
14370,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL630987,
14371,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL630988,
14372,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL630989,
14373,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL630990,
14374,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL630991,
14375,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL630992,
14376,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL630993,
14377,,,22224,,Autocuration,1,,A,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,,BAO_0000019,U,,0,,CHEMBL630994,
14378,,,50597,10116.0,Intermediate,1,,A,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,,BAO_0000218,N,,1,,CHEMBL630995,
14379,,,22224,,Autocuration,1,,A,,Association constant for compound at 31 degree C was determined,,,BAO_0000019,U,,0,,CHEMBL629252,
14380,,,22224,,Autocuration,1,,A,,Calculated antagonist equilibrium dissociation constant of the compound,,,BAO_0000019,U,,0,,CHEMBL629253,
14381,,,22224,,Autocuration,1,,A,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,,BAO_0000019,U,,0,,CHEMBL629944,
14382,,3126.0,50512,10141.0,Intermediate,1,Trachea,A,,Dissociation constants vs LTE4 on guinea pig trachea,,,BAO_0000218,N,,1,,CHEMBL629945,
14383,,,22224,,Autocuration,1,,A,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,,BAO_0000019,U,,0,,CHEMBL629946,
14384,,,22224,,Autocuration,1,,A,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,,BAO_0000019,U,,0,,CHEMBL629947,
14385,,,22224,,Autocuration,1,,A,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,,BAO_0000019,U,,0,,CHEMBL629948,
14386,,,22224,,Autocuration,1,,A,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,,BAO_0000019,U,,0,,CHEMBL856024,
14387,,,22224,,Autocuration,1,,A,,Affinity constant KD value was derived from TMP,,,BAO_0000019,U,,0,,CHEMBL629949,
14388,,,22224,,Autocuration,1,,A,,Apparent dissociation (binding) rate constant was evaluated,,,BAO_0000019,U,,0,,CHEMBL629950,
14389,,,22224,,Autocuration,1,,P,,Dissociation constant (KD) of the compound,,,BAO_0000100,U,,0,,CHEMBL630127,
14390,,,22224,,Autocuration,1,,P,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,,BAO_0000100,U,,0,,CHEMBL630128,
14391,,,22224,,Autocuration,1,,P,,Dissociation constant from ESR titration experiments,,,BAO_0000100,U,,0,,CHEMBL630129,
14392,,,22224,,Autocuration,1,,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,,BAO_0000019,U,,0,,CHEMBL630130,
14393,,,22224,,Autocuration,1,,P,,Dissociation constant was evaluated.,,,BAO_0000100,U,,0,,CHEMBL875234,
14394,,,22224,,Autocuration,1,,P,,Dissociation constant was reported,,,BAO_0000100,U,,0,,CHEMBL630131,
14395,,,50597,10116.0,Intermediate,1,,A,,Dissociation constant was determined in rat pituitary cells.,,,BAO_0000218,N,,1,,CHEMBL630132,
14396,,,22224,,Autocuration,1,,A,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,,BAO_0000019,U,,0,,CHEMBL630133,
14397,,,22224,,Autocuration,1,,A,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,,BAO_0000019,U,,0,,CHEMBL630134,
14398,,,22224,,Autocuration,1,,A,,Equilibrium dissociation constant of the compound,,,BAO_0000019,U,,0,,CHEMBL630135,
14399,,,22224,,Autocuration,1,,A,,Equilibrium dissociation constant was determined,,,BAO_0000019,U,,0,,CHEMBL630136,
14400,,,22224,,Autocuration,1,,A,,Kinetic constant KD was evaluated,,,BAO_0000019,U,,0,,CHEMBL630137,
14401,,,22224,,Autocuration,1,,A,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,,BAO_0000019,U,,0,,CHEMBL630138,
14402,,,22224,,Autocuration,1,,A,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,,BAO_0000019,U,,0,,CHEMBL630139,
14403,,,22224,,Autocuration,1,,A,,Rate constant for hydrolysis in aqueous acetone.,,,BAO_0000019,U,,0,,CHEMBL630140,
14404,,,22224,,Autocuration,1,,A,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,,BAO_0000019,U,,0,,CHEMBL875235,
14405,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,,BAO_0000218,N,,1,,CHEMBL876439,
14406,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,,BAO_0000218,N,,1,,CHEMBL630605,
14407,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,,BAO_0000218,N,,1,,CHEMBL630606,
14408,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,,BAO_0000218,N,,1,,CHEMBL630607,
14409,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,,BAO_0000218,N,,1,,CHEMBL630608,
14410,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,,BAO_0000218,N,,1,,CHEMBL630609,
14411,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,,BAO_0000218,N,,1,,CHEMBL630610,
14412,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,,BAO_0000218,N,,1,,CHEMBL630611,
14413,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,,BAO_0000218,N,,1,,CHEMBL629552,
14414,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629733,
14415,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629734,
14416,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629735,
14417,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629736,
14418,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629737,
14419,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629738,
14420,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629739,
14421,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,,BAO_0000218,N,,1,,CHEMBL629740,
14422,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629741,
14423,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629742,
14424,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629743,
14425,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629744,
14426,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629745,
14427,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629746,
14428,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629747,
14429,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629748,
14430,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629749,
14431,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629750,
14432,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629751,
14433,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629752,
14434,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629753,
14435,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629754,
14436,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629755,
14437,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629756,
14438,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629757,
14439,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629758,
14440,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629759,
14441,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,,BAO_0000218,N,,1,,CHEMBL629760,
14442,,,50597,10116.0,Intermediate,1,,A,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,,BAO_0000218,N,,1,,CHEMBL876443,
14443,,,50588,9615.0,Intermediate,1,,A,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,,BAO_0000218,N,,1,,CHEMBL629761,
14444,,,50588,9615.0,Intermediate,1,,A,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,,BAO_0000218,N,,1,,CHEMBL629762,
14445,,,50594,10090.0,Intermediate,1,,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL629763,
14446,,,50594,10090.0,Intermediate,1,,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL629764,
14447,,,50594,10090.0,Intermediate,1,,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL629765,
14448,,,50594,10090.0,Intermediate,1,,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL629766,
14449,,,50594,10090.0,Intermediate,1,,A,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL629767,
14450,,,50588,9615.0,Intermediate,1,,A,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,,BAO_0000218,N,,1,,CHEMBL629768,
14451,,,50594,10090.0,Intermediate,1,,A,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL629769,
14452,,,50588,9615.0,Intermediate,1,,A,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,,BAO_0000218,N,,1,,CHEMBL629770,
14453,,,50588,9615.0,Intermediate,1,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL629771,
14454,,,50594,10090.0,Intermediate,1,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL629772,
14455,,,50594,10090.0,Intermediate,1,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL629773,
14456,,,50594,10090.0,Intermediate,1,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL625455,
14457,,,50594,10090.0,Intermediate,1,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL625456,
14458,,,50594,10090.0,Intermediate,1,,A,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,,BAO_0000218,N,,1,,CHEMBL625457,
14459,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625458,
14460,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625459,
14461,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL875483,
14462,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL634779,
14463,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625460,
14464,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626117,
14465,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626118,
14466,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628342,
14467,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628343,
14468,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628344,
14469,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628345,
14470,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628346,
14471,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628347,
14472,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628348,
14473,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628349,
14474,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL875611,
14475,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628350,
14476,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628351,
14477,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628352,
14478,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628353,
14479,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628354,
14480,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626667,
14481,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626668,
14482,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626669,
14483,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626670,
14484,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626671,
14485,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626672,
14486,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626673,
14487,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626674,
14488,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626675,
14489,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626676,
14490,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626677,
14491,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626678,
14492,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626679,
14493,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL875612,
14494,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626680,
14495,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626681,
14496,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626682,
14497,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626683,
14498,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626684,
14499,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626685,
14500,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626686,
14501,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626687,
14502,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL624978,
14503,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL624979,
14504,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL624980,
14505,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL624981,
14506,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL624982,
14507,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,,BAO_0000218,U,,0,,CHEMBL627564,
14508,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,,BAO_0000218,U,,0,,CHEMBL627565,
14509,In vivo,,22224,,Autocuration,1,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,,BAO_0000218,U,,0,,CHEMBL627566,
14510,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,,BAO_0000218,U,,0,,CHEMBL627567,
14511,In vivo,2106.0,22224,,Autocuration,1,Spleen,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,,BAO_0000218,U,,0,,CHEMBL627568,
14512,In vivo,2113.0,22224,,Autocuration,1,Kidney,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,,BAO_0000218,U,,0,,CHEMBL627569,
14513,In vivo,1255.0,22224,,Autocuration,1,Urinary bladder,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,,BAO_0000218,U,,0,,CHEMBL627570,
14514,In vivo,178.0,22224,,Autocuration,1,Blood,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,,BAO_0000218,U,,0,,CHEMBL627571,
14515,In vivo,1474.0,22224,,Autocuration,1,Bone element,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,,BAO_0000218,U,,0,,CHEMBL627572,
14516,In vivo,,22224,,Autocuration,1,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,,BAO_0000218,U,,0,,CHEMBL627573,
14517,In vivo,2113.0,22224,,Autocuration,1,Kidney,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,,BAO_0000218,U,,0,,CHEMBL627574,
14518,In vivo,2107.0,22224,,Autocuration,1,Liver,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,,BAO_0000218,U,,0,,CHEMBL627575,
14519,In vivo,2048.0,22224,,Autocuration,1,Lung,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,,BAO_0000218,U,,0,,CHEMBL627576,
14520,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,,BAO_0000218,U,,0,,CHEMBL627577,
14521,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,,BAO_0000218,U,,0,,CHEMBL627578,
14522,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,,BAO_0000218,U,,0,,CHEMBL627579,
14523,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,,BAO_0000218,U,,0,,CHEMBL627580,
14524,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,,BAO_0000218,U,,0,,CHEMBL627581,
14525,In vivo,,22224,,Autocuration,1,,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,,BAO_0000218,U,,0,,CHEMBL627582,
14526,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,,BAO_0000218,U,,0,,CHEMBL627583,
14527,In vivo,2106.0,22224,,Autocuration,1,Spleen,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,,BAO_0000218,U,,0,,CHEMBL627584,
14528,In vivo,2367.0,22224,,Autocuration,1,Prostate gland,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,,BAO_0000218,U,,0,,CHEMBL627585,
14529,In vivo,2385.0,22224,,Autocuration,1,Muscle tissue,A,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,,BAO_0000218,U,,0,,CHEMBL627586,
14530,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL627587,
14531,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL627588,
14532,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL628250,
14533,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL628251,
14534,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL628252,
14535,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL628253,
14536,In vivo,1898.0,50597,10116.0,Intermediate,1,Hypothalamus,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL628254,
14537,In vivo,1898.0,50597,10116.0,Intermediate,1,Hypothalamus,A,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL877493,
14538,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL628255,
14539,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL628256,
14540,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL628257,
14541,In vivo,1898.0,50597,10116.0,Intermediate,1,Hypothalamus,A,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL628258,
14542,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL628259,
14543,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL628429,
14544,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,,BAO_0000218,N,,1,,CHEMBL626862,
14545,In vivo,1898.0,50597,10116.0,Intermediate,1,Hypothalamus,A,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,,BAO_0000218,N,,1,,CHEMBL626863,
14546,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,,BAO_0000218,N,,1,,CHEMBL625886,
14547,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,,BAO_0000218,N,,1,,CHEMBL625887,
14548,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,,BAO_0000218,N,,1,,CHEMBL625888,
14549,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,,BAO_0000218,N,,1,,CHEMBL625889,
14550,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,,BAO_0000218,N,,1,,CHEMBL625890,
14551,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,,BAO_0000218,N,,1,,CHEMBL625891,
14552,In vivo,1898.0,50597,10116.0,Intermediate,1,Hypothalamus,A,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,,BAO_0000218,N,,1,,CHEMBL625892,
14553,In vivo,1898.0,50597,10116.0,Intermediate,1,Hypothalamus,A,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,,BAO_0000218,N,,1,,CHEMBL625893,
14554,In vivo,2037.0,50597,10116.0,Intermediate,1,Cerebellum,A,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,,BAO_0000218,N,,1,,CHEMBL625894,
14555,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,,BAO_0000218,N,,1,,CHEMBL625895,
14556,,,22224,,Autocuration,1,,A,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,BAO_0000019,U,,0,,CHEMBL625896,
14557,,,22224,,Autocuration,1,,A,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,,BAO_0000019,U,,0,,CHEMBL625897,
14558,,,22224,,Autocuration,1,,A,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,BAO_0000019,U,,0,,CHEMBL625898,
14559,,,22224,,Autocuration,1,,A,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,,BAO_0000019,U,,0,,CHEMBL625899,
14560,,,22224,,Autocuration,1,,A,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,BAO_0000019,U,,0,,CHEMBL626124,
14561,,,50212,562.0,Intermediate,1,,A,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,,BAO_0000218,N,,1,,CHEMBL628500,
14562,,,50597,10116.0,Intermediate,1,,A,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,,BAO_0000218,N,,1,,CHEMBL857856,
14563,,,50597,10116.0,Intermediate,1,,A,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,,BAO_0000218,N,,1,,CHEMBL628501,
14564,,,22224,,Autocuration,1,,A,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,,BAO_0000019,U,,0,,CHEMBL628502,
14565,,,22224,,Autocuration,1,,A,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,,BAO_0000019,U,,0,,CHEMBL628503,
14566,,,22224,,Autocuration,1,,A,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,,BAO_0000019,U,,0,,CHEMBL628504,
14567,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,BAO_0000019,U,,0,,CHEMBL628505,
14568,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,,BAO_0000019,U,,0,,CHEMBL874452,
14569,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,,BAO_0000019,U,,0,,CHEMBL628506,
14570,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,,BAO_0000019,U,,0,,CHEMBL628507,
14571,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,,BAO_0000019,U,,0,,CHEMBL628508,
14572,,,22224,,Autocuration,1,,A,,Michaelis constant (KM) was evaluated,,,BAO_0000019,U,,0,,CHEMBL628509,
14573,,,22224,,Autocuration,1,,A,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,,BAO_0000019,U,,0,,CHEMBL628510,
14574,,,22224,,Autocuration,1,,B,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,,BAO_0000019,U,,0,,CHEMBL628511,
14575,,,22224,,Autocuration,1,,B,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,,BAO_0000019,U,,0,,CHEMBL628512,
14576,,,22224,,Autocuration,1,,B,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,,BAO_0000019,U,,0,,CHEMBL628513,
14577,,,22224,,Autocuration,1,,B,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,,BAO_0000019,U,,0,,CHEMBL628514,
14578,,,22224,,Autocuration,1,,A,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,,BAO_0000019,U,,0,,CHEMBL628515,
14579,,,22224,,Autocuration,1,,A,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,,BAO_0000019,U,,0,,CHEMBL628516,
14580,,,22224,,Autocuration,1,,A,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,BAO_0000019,U,,0,,CHEMBL628517,
14581,,,22224,,Autocuration,1,,A,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,,BAO_0000019,U,,0,,CHEMBL628518,
14582,,,22224,,Autocuration,1,,A,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,,BAO_0000019,U,,0,,CHEMBL628519,
14583,,,22224,,Autocuration,1,,A,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,,BAO_0000019,U,,0,,CHEMBL628520,
14584,,,22224,,Autocuration,1,,A,,Binding constant was determined,,,BAO_0000019,U,,0,,CHEMBL628521,
14585,,,22224,,Autocuration,1,,A,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,,BAO_0000019,U,,0,,CHEMBL630443,
14586,,,22224,,Autocuration,1,,A,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,,BAO_0000019,U,,0,,CHEMBL630444,
14587,,,22224,,Autocuration,1,,A,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,,BAO_0000019,U,,0,,CHEMBL857732,
14588,,,22224,,Autocuration,1,,P,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,,BAO_0000100,U,,0,,CHEMBL630445,
14589,,,22224,,Autocuration,1,,A,,Catalytic rate constant of the compound,,,BAO_0000019,U,,0,,CHEMBL630446,
14590,,,22224,,Autocuration,1,,B,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,,BAO_0000019,U,,0,,CHEMBL630447,
14591,,,22224,,Autocuration,1,,A,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,,BAO_0000019,U,,0,,CHEMBL630448,
14592,,,22224,,Autocuration,1,,A,,Catalytic rate constant against phospholipase A2 was determined,,,BAO_0000019,U,,0,,CHEMBL630449,
14593,,,22224,,Autocuration,1,,A,,"Compound was evaluated for catalytic constant, Kcat",,,BAO_0000019,U,,0,,CHEMBL630450,
14594,,,22224,,Autocuration,1,,A,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,,BAO_0000019,U,,0,,CHEMBL630451,
14595,,,22224,,Autocuration,1,,A,,Kcat calculated from 0.693/T1/2,,,BAO_0000019,U,,0,,CHEMBL630452,
14596,,,22224,,Autocuration,1,,A,,Kcat was determined,,,BAO_0000019,U,,0,,CHEMBL630453,
14597,,,22224,,Autocuration,1,,A,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,,BAO_0000019,U,,0,,CHEMBL630454,
14598,,,22224,,Autocuration,1,,A,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,,BAO_0000019,U,,0,,CHEMBL630455,
14599,,,22224,,Autocuration,1,,A,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,,BAO_0000019,U,,0,,CHEMBL631487,
14600,,,22224,,Autocuration,1,,A,,Kcat value was determined,,,BAO_0000019,U,,0,,CHEMBL631488,
14601,,,22224,,Autocuration,1,,A,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,,BAO_0000019,U,,0,,CHEMBL876440,
14602,,,22224,,Autocuration,1,,A,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,,BAO_0000019,U,,0,,CHEMBL631489,
14603,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,BAO_0000019,U,,0,,CHEMBL857742,
14604,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,BAO_0000019,U,,0,,CHEMBL631490,
14605,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,,BAO_0000019,U,,0,,CHEMBL631491,
14606,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,,BAO_0000019,U,,0,,CHEMBL631492,
14607,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,,BAO_0000019,U,,0,,CHEMBL631493,
14608,,,22224,,Autocuration,1,,A,,Kinetic parameter for rate of conversion to PABA was determined,,,BAO_0000019,U,,0,,CHEMBL631494,
14609,,,22224,,Autocuration,1,,A,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,BAO_0000019,U,,0,,CHEMBL631495,
14610,,1988.0,50597,10116.0,Intermediate,1,Feces,A,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,,BAO_0000218,N,,1,,CHEMBL631496,
14611,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,,BAO_0000218,N,,1,,CHEMBL631497,
14612,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,,BAO_0000218,N,,1,,CHEMBL631498,
14613,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,,BAO_0000218,N,,1,,CHEMBL629776,
14614,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,,BAO_0000218,N,,1,,CHEMBL629777,
14615,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,,BAO_0000218,N,,1,,CHEMBL629778,
14616,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630456,
14617,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630457,
14618,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630458,
14619,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630459,
14620,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630460,
14621,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,,BAO_0000218,N,,1,,CHEMBL876550,
14622,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630461,
14623,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630462,
14624,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630463,
14625,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630464,
14626,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630465,
14627,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630466,
14628,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630467,
14629,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630633,
14630,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630634,
14631,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630635,
14632,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630636,
14633,,,50597,10116.0,Intermediate,1,,A,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,,BAO_0000218,N,,1,,CHEMBL630637,
14634,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,,BAO_0000218,N,,1,,CHEMBL630638,
14635,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,,BAO_0000218,N,,1,,CHEMBL630639,
14636,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,,BAO_0000218,N,,1,,CHEMBL630640,
14637,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,,BAO_0000218,N,,1,,CHEMBL876551,
14638,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,,BAO_0000218,N,,1,,CHEMBL630641,
14639,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,,BAO_0000218,N,,1,,CHEMBL630642,
14640,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,,BAO_0000218,N,,1,,CHEMBL630643,
14641,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,,BAO_0000218,N,,1,,CHEMBL630644,
14642,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,,BAO_0000218,N,,1,,CHEMBL630645,
14643,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,,BAO_0000218,N,,1,,CHEMBL625599,
14644,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,,BAO_0000218,N,,1,,CHEMBL625600,
14645,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,,BAO_0000218,N,,1,,CHEMBL625601,
14646,,1988.0,50592,9986.0,Intermediate,1,Feces,A,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,,BAO_0000218,N,,1,,CHEMBL625602,
14647,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,,BAO_0000218,N,,1,,CHEMBL627470,
14648,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,,BAO_0000218,N,,1,,CHEMBL627471,
14649,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,,BAO_0000218,N,,1,,CHEMBL627472,
14650,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,,BAO_0000218,N,,1,,CHEMBL627473,
14651,,1088.0,50592,9986.0,Intermediate,1,Urine,A,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,,BAO_0000218,N,,1,,CHEMBL627474,
14652,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL627475,
14653,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL627476,
14654,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627477,
14655,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627478,
14656,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627479,
14657,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627480,
14658,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627481,
14659,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627482,
14660,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL627483,
14661,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL875636,
14662,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625764,
14663,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625765,
14664,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625766,
14665,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625767,
14666,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625768,
14667,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625769,
14668,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625770,
14669,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625771,
14670,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625772,
14671,,1088.0,50588,9615.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625773,
14672,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625774,
14673,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625775,
14674,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625776,
14675,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625777,
14676,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625778,
14677,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625779,
14678,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625780,
14679,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL625781,
14680,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL875637,
14681,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626473,
14682,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626474,
14683,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626475,
14684,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626476,
14685,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL634397,
14686,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL626477,
14687,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631069,
14688,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631070,
14689,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631071,
14690,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631072,
14691,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631073,
14692,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631074,
14693,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631075,
14694,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631725,
14695,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631726,
14696,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631727,
14697,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631728,
14698,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631729,
14699,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631730,
14700,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631731,
14701,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631910,
14702,In vivo,10000000.0,50597,10116.0,Intermediate,1,Hippocampus,A,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,,BAO_0000218,N,,1,,CHEMBL631911,
14703,In vivo,1898.0,50597,10116.0,Intermediate,1,Hypothalamus,A,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,,BAO_0000218,N,,1,,CHEMBL631912,
14704,In vivo,1898.0,50597,10116.0,Intermediate,1,Hypothalamus,A,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,,BAO_0000218,N,,1,,CHEMBL631913,
14705,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631914,
14706,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631915,
14707,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL875778,
14708,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631916,
14709,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631917,
14710,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631918,
14711,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631919,
14712,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL631920,
14713,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631921,
14714,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631922,
14715,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL631923,
14716,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631924,
14717,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630234,
14718,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL630235,
14719,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630236,
14720,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630237,
14721,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630238,
14722,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630239,
14723,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL630303,
14724,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630304,
14725,In vivo,,50597,10116.0,Intermediate,1,,A,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630305,
14726,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630306,
14727,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630307,
14728,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL630308,
14729,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630309,
14730,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL629309,
14731,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL629993,
14732,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL629994,
14733,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL629995,
14734,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631993,
14735,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631994,
14736,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631995,
14737,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL631996,
14738,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631997,
14739,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631998,
14740,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631999,
14741,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL632000,
14742,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL632001,
14743,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL874424,
14744,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL632002,
14745,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL632003,
14746,,,22224,,Autocuration,1,,A,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,,BAO_0000019,U,,0,,CHEMBL632004,
14747,,,22224,,Autocuration,1,,A,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,,BAO_0000019,U,,0,,CHEMBL632005,
14748,,,22224,,Autocuration,1,,A,,Compound was tested for amidase rate in the presence of N62C screen enzyme,,,BAO_0000019,U,,0,,CHEMBL632006,
14749,,,22224,,Autocuration,1,,A,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,,BAO_0000019,U,,0,,CHEMBL632007,
14750,,,22224,,Autocuration,1,,A,,Compound was tested for amidase rate in the presence of S166C screen enzyme,,,BAO_0000019,U,,0,,CHEMBL632008,
14751,,,22224,,Autocuration,1,,A,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,,BAO_0000019,U,,0,,CHEMBL632009,
14752,,,22224,,Autocuration,1,,A,,Compound was tested for esterase rate in the presence of N62C screen enzyme,,,BAO_0000019,U,,0,,CHEMBL632010,
14753,,,22224,,Autocuration,1,,A,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,,BAO_0000019,U,,0,,CHEMBL857750,
14754,,,22224,,Autocuration,1,,A,,Compound was tested for esterase rate in the presence of S166C screen enzyme,,,BAO_0000019,U,,0,,CHEMBL632011,
14755,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,BAO_0000019,U,,0,,CHEMBL632012,
14756,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,BAO_0000019,U,,0,,CHEMBL632013,
14757,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,,BAO_0000019,U,,0,,CHEMBL632014,
14758,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,BAO_0000019,U,,0,,CHEMBL629622,
14759,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,,BAO_0000019,U,,0,,CHEMBL629623,
14760,,,22224,,Autocuration,1,,A,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,,BAO_0000019,U,,0,,CHEMBL629624,
14761,,,22224,,Autocuration,1,,A,,Ratio of Kcat to that of Km was determined,,,BAO_0000019,U,,0,,CHEMBL629625,
14762,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,BAO_0000019,U,,0,,CHEMBL629626,
14763,,,22224,,Autocuration,1,,A,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,,BAO_0000019,U,,0,,CHEMBL629627,
14764,,,22224,,Autocuration,1,,A,,"Compound was evaluated for constant, Kd",,,BAO_0000019,U,,0,,CHEMBL629628,
14765,,,22224,,Autocuration,1,,A,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,,BAO_0000019,U,,0,,CHEMBL629629,
14766,,,22224,,Autocuration,1,,A,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,,BAO_0000019,U,,0,,CHEMBL629630,
14767,,,22224,,Autocuration,1,,A,,Dissociation Constant of compound determined,,,BAO_0000019,U,,0,,CHEMBL856030,
14768,,,22224,,Autocuration,1,,B,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,,BAO_0000019,U,,0,,CHEMBL629631,
14769,,,22224,,Autocuration,1,,B,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,,BAO_0000019,U,,0,,CHEMBL629632,
14770,,,22224,,Autocuration,1,,P,,Dissociation constant of compound with Fructose was determined,,,BAO_0000100,U,,0,,CHEMBL629633,
14771,,,22224,,Autocuration,1,,P,,Dissociation constant of compound with Fructose was determined; Not determined,,,BAO_0000100,U,,0,,CHEMBL629634,
14772,,,22224,,Autocuration,1,,P,,Dissociation constant of compound with Lactulose was determined,,,BAO_0000100,U,,0,,CHEMBL629635,
14773,,,22224,,Autocuration,1,,P,,Dissociation constant of compound with Lactulose was determined; Not determined,,,BAO_0000100,U,,0,,CHEMBL629636,
14774,,,22224,,Autocuration,1,,P,,Dissociation constant of the Compound,,,BAO_0000100,U,,0,,CHEMBL629637,
14775,,,22224,,Autocuration,1,,P,,Dissociation constant by non-linear regression analysis,,,BAO_0000100,U,,0,,CHEMBL629638,
14776,,,22224,,Autocuration,1,,P,,Dissociation constant was determined,,,BAO_0000100,U,,0,,CHEMBL629639,
14777,,,22224,,Autocuration,1,,P,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,,BAO_0000100,U,,0,,CHEMBL629640,
14778,,,22224,,Autocuration,1,,P,,Dissociation constant was determined,,,BAO_0000100,U,,0,,CHEMBL629641,
14779,,,22224,,Autocuration,1,,P,,Dissociation constant was determined,,,BAO_0000100,U,,0,,CHEMBL631344,
14780,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,,BAO_0000218,N,,1,,CHEMBL631345,
14781,,,22224,,Autocuration,1,,A,,The dissociation constant determined by fluorescence displacement assay,,,BAO_0000019,U,,0,,CHEMBL631346,
14782,,,22224,,Autocuration,1,,A,,kd value surface plasmon resonance (SPR) method,,,BAO_0000019,U,,0,,CHEMBL631524,
14783,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,,BAO_0000218,N,,1,,CHEMBL631525,
14784,,,22224,,Autocuration,1,,F,,First dissociation constant of the binding of compound to V30M TTR,,,BAO_0000019,U,,0,,CHEMBL631526,
14785,,,22224,,Autocuration,1,,F,,Second dissociation constant of the binding of compound to V30M TTR,,,BAO_0000019,U,,0,,CHEMBL631527,
14786,,,22224,,Autocuration,1,,A,,"Compound was evaluated for equilibrium constant, Ke",,,BAO_0000019,U,,0,,CHEMBL631528,
14787,,1898.0,22224,,Autocuration,1,Hypothalamus,A,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,,BAO_0000019,U,,0,,CHEMBL631529,
14788,,1898.0,22224,,Autocuration,1,Hypothalamus,A,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,,BAO_0000019,U,,0,,CHEMBL631530,
14789,,,22224,,Autocuration,1,,A,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,,BAO_0000019,U,,0,,CHEMBL631531,
14790,,,22224,,Autocuration,1,,A,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,,BAO_0000019,U,,0,,CHEMBL631532,
14791,,,22224,,Autocuration,1,,A,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,,BAO_0000019,U,,0,,CHEMBL631533,
14792,,,50594,10090.0,Intermediate,1,,A,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,BAO_0000218,N,,1,,CHEMBL876552,
14793,,,50594,10090.0,Intermediate,1,,A,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,BAO_0000218,N,,1,,CHEMBL631534,
14794,,,50594,10090.0,Intermediate,1,,A,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,BAO_0000218,N,,1,,CHEMBL631535,
14795,,,50594,10090.0,Intermediate,1,,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,BAO_0000218,N,,1,,CHEMBL631536,
14796,,,50594,10090.0,Intermediate,1,,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,,BAO_0000218,N,,1,,CHEMBL631537,
14797,,,50594,10090.0,Intermediate,1,,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,,BAO_0000218,N,,1,,CHEMBL631538,
14798,,,50594,10090.0,Intermediate,1,,A,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,,BAO_0000218,N,,1,,CHEMBL631539,
14799,,,50594,10090.0,Intermediate,1,,A,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,,BAO_0000218,N,,1,,CHEMBL631540,
14800,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,N,,1,,CHEMBL625637,
14801,,,50597,10116.0,Intermediate,1,,A,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,,BAO_0000218,N,,1,,CHEMBL625638,
14802,,,50597,10116.0,Intermediate,1,,A,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,,BAO_0000218,N,,1,,CHEMBL625639,
14803,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625640,
14804,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625641,
14805,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625642,
14806,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625643,
14807,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625644,
14808,In vivo,2113.0,50597,10116.0,Intermediate,1,Kidney,A,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625645,
14809,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625646,
14810,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625647,
14811,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625648,
14812,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625649,
14813,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625650,
14814,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625651,
14815,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625652,
14816,In vivo,14.0,50597,10116.0,Intermediate,1,Zone of skin,A,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625653,
14817,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625654,
14818,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,,BAO_0000218,N,,1,,CHEMBL625655,
14819,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of Compound in rat blood after 15 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL625656,
14820,In vivo,178.0,50597,10116.0,Intermediate,1,Blood,A,,Biodistribution of Compound in rat blood after 2 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL625657,
14821,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of Compound in rat brain after 15 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL625658,
14822,In vivo,955.0,50597,10116.0,Intermediate,1,Brain,A,,Biodistribution of Compound in rat brain after 2 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL625659,
14823,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of Compound in rat heart after 15 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL625660,
14824,In vivo,948.0,50597,10116.0,Intermediate,1,Heart,A,,Biodistribution of Compound in rat heart after 2 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL625661,
14825,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of Compound in rat liver after 15 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL625662,
14826,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution of Compound in rat liver after 2 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL625663,
14827,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of Compound in rat lung after 15 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL875621,
14828,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution of Compound in rat lung after 2 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL628382,
14829,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of Compound in rat muscle after 15 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL628383,
14830,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution of Compound in rat muscle after 2 minutes of administration,,,BAO_0000218,N,,1,,CHEMBL628384,
14831,,,50597,10116.0,Intermediate,1,,A,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,,BAO_0000218,N,,1,,CHEMBL628385,
14832,,,50597,10116.0,Intermediate,1,,A,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,,BAO_0000218,N,,1,,CHEMBL875753,
14833,,,50597,10116.0,Intermediate,1,,A,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,,BAO_0000218,N,,1,,CHEMBL628386,
14834,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat blood 2 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL628387,
14835,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat blood 2 hr after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL628388,
14836,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat blood 30 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL628389,
14837,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat blood 30 min after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL632756,
14838,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat brain 2 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL628390,
14839,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat brain 2 hr after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631811,
14840,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat brain 30 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631812,
14841,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat heart 2 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631813,
14842,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat heart 2 hr after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631814,
14843,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat heart 30 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631815,
14844,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat kidney 2 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631816,
14845,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat kidney 2 hr after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL875758,
14846,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat kidney 30 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631817,
14847,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Organ distribution in rat liver 2 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631818,
14848,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Organ distribution in rat liver 2 hr after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631819,
14849,,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Organ distribution in rat liver 30 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631820,
14850,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat lung 2 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631821,
14851,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat lung 2 hr after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631822,
14852,,,50597,10116.0,Intermediate,1,,A,,Organ distribution in rat lung 30 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631823,
14853,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Organ distribution in rat muscle 2 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631824,
14854,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Organ distribution in rat muscle 2 hr after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631825,
14855,,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Organ distribution in rat muscle 30 minutes after intravenous injection,,,BAO_0000218,N,,1,,CHEMBL631826,
14856,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,,BAO_0000218,N,,1,,CHEMBL631827,
14857,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,,BAO_0000218,N,,1,,CHEMBL631828,
14858,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,,BAO_0000218,N,,1,,CHEMBL631829,
14859,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL875759,
14860,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631830,
14861,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631831,
14862,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631832,
14863,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631833,
14864,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631834,
14865,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631835,
14866,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631836,
14867,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631837,
14868,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631838,
14869,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631839,
14870,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631840,
14871,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631841,
14872,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631842,
14873,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631843,
14874,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631844,
14875,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631845,
14876,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631846,
14877,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL875760,
14878,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL632199,
14879,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631847,
14880,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL631848,
14881,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628707,
14882,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628708,
14883,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628709,
14884,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628710,
14885,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628711,
14886,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628712,
14887,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628713,
14888,,1088.0,50597,10116.0,Intermediate,1,Urine,A,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,,BAO_0000218,N,,1,,CHEMBL628714,
14889,,,50597,10116.0,Intermediate,1,,A,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,,BAO_0000218,N,,1,,CHEMBL628715,
14890,,,22224,,Autocuration,1,,A,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,,BAO_0000019,U,,0,,CHEMBL629179,
14891,,,22224,,Autocuration,1,,A,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,,BAO_0000019,U,,0,,CHEMBL629180,
14892,,,22224,,Autocuration,1,,A,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,,BAO_0000019,U,,0,,CHEMBL875108,
14893,,1235.0,22224,,Autocuration,1,Adrenal cortex,A,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629181,
14894,,1235.0,22224,,Autocuration,1,Adrenal cortex,A,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629182,
14895,,,22224,,Autocuration,1,,A,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629183,
14896,,,22224,,Autocuration,1,,A,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629184,
14897,,1235.0,22224,,Autocuration,1,Adrenal cortex,A,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629185,
14898,,1235.0,22224,,Autocuration,1,Adrenal cortex,A,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629186,
14899,,,22224,,Autocuration,1,,A,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629187,
14900,,,22224,,Autocuration,1,,A,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629887,
14901,,,22224,,Autocuration,1,,A,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629888,
14902,,,22224,,Autocuration,1,,A,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629889,
14903,,1235.0,22224,,Autocuration,1,Adrenal cortex,A,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629890,
14904,,,22224,,Autocuration,1,,A,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629891,
14905,,,22224,,Autocuration,1,,A,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629892,
14906,,1235.0,22224,,Autocuration,1,Adrenal cortex,A,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629893,
14907,,,22224,,Autocuration,1,,A,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629894,
14908,,,22224,,Autocuration,1,,A,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,,BAO_0000019,U,,0,,CHEMBL629895,
14909,In vivo,,22224,9615.0,Autocuration,1,,A,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,,BAO_0000218,U,,0,,CHEMBL875109,
14910,In vivo,,22224,9541.0,Autocuration,1,,A,,Absolute bioavailability in male cynomolgus monkeys,,,BAO_0000218,U,,0,,CHEMBL629896,
14911,In vivo,,22224,10116.0,Autocuration,1,,A,,Absolute bioavailability in maleSprague-Dawley rats,,,BAO_0000218,U,,0,,CHEMBL629897,
14912,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL629898,
14913,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630057,
14914,In vivo,2107.0,50597,10116.0,Intermediate,1,Liver,A,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630058,
14915,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630059,
14916,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630060,
14917,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL630061,
14918,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630062,
14919,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630063,
14920,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630064,
14921,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630065,
14922,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL630066,
14923,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630067,
14924,In vivo,2048.0,50597,10116.0,Intermediate,1,Lung,A,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630068,
14925,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631113,
14926,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631114,
14927,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL631115,
14928,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL631116,
14929,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630528,
14930,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630529,
14931,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630530,
14932,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL630531,
14933,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630532,
14934,In vivo,2385.0,50597,10116.0,Intermediate,1,Muscle tissue,A,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630533,
14935,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution in normal mice blood after 120 hr,,,BAO_0000218,N,,1,,CHEMBL630534,
14936,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution in normal mice blood after 24 hr,,,BAO_0000218,N,,1,,CHEMBL630535,
14937,In vivo,178.0,50594,10090.0,Intermediate,1,Blood,A,,Biodistribution in normal mice blood after 4 hr,,,BAO_0000218,N,,1,,CHEMBL630536,
14938,In vivo,10000001.0,50594,10090.0,Intermediate,1,Bone,A,,Biodistribution in normal mice bone after 120 hr,,,BAO_0000218,N,,1,,CHEMBL630537,
14939,In vivo,10000001.0,50594,10090.0,Intermediate,1,Bone,A,,Biodistribution in normal mice bone after 24 hr,,,BAO_0000218,N,,1,,CHEMBL630538,
14940,In vivo,10000001.0,50594,10090.0,Intermediate,1,Bone,A,,Biodistribution in normal mice bone after 4 hr,,,BAO_0000218,N,,1,,CHEMBL630539,
14941,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,Biodistribution in normal mice heart after 120 hr,,,BAO_0000218,N,,1,,CHEMBL630540,
14942,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,Biodistribution in normal mice heart after 24 hr,,,BAO_0000218,N,,1,,CHEMBL630541,
14943,In vivo,948.0,50594,10090.0,Intermediate,1,Heart,A,,Biodistribution in normal mice heart after 4 hr,,,BAO_0000218,N,,1,,CHEMBL630542,
14944,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Biodistribution in normal mice kidney after 120 hr,,,BAO_0000218,N,,1,,CHEMBL630543,
14945,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Biodistribution in normal mice kidney after 24 hr,,,BAO_0000218,N,,1,,CHEMBL630544,
14946,In vivo,2113.0,50594,10090.0,Intermediate,1,Kidney,A,,Biodistribution in normal mice kidney after 4 hr,,,BAO_0000218,N,,1,,CHEMBL630545,
14947,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution in normal mice liver after 120 hr,,,BAO_0000218,N,,1,,CHEMBL630546,
14948,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution in normal mice liver after 24 hr,,,BAO_0000218,N,,1,,CHEMBL630547,
14949,In vivo,2107.0,50594,10090.0,Intermediate,1,Liver,A,,Biodistribution in normal mice liver after 4 hr,,,BAO_0000218,N,,1,,CHEMBL630548,
14950,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Biodistribution in normal mice spleen after 120 hr,,,BAO_0000218,N,,1,,CHEMBL630549,
14951,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Biodistribution in normal mice spleen after 24 hr,,,BAO_0000218,N,,1,,CHEMBL630550,
14952,In vivo,2106.0,50594,10090.0,Intermediate,1,Spleen,A,,Biodistribution in normal mice spleen after 4 hr,,,BAO_0000218,N,,1,,CHEMBL876426,
14953,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630551,
14954,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630552,
14955,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL630553,
14956,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630554,
14957,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630555,
14958,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630556,
14959,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630557,
14960,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,,BAO_0000218,N,,1,,CHEMBL630558,
14961,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630559,
14962,In vivo,2106.0,50597,10116.0,Intermediate,1,Spleen,A,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL630560,
14963,In vivo,2046.0,50597,10116.0,Intermediate,1,Thyroid gland,A,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,,BAO_0000218,N,,1,,CHEMBL876427,
14964,,,50597,10116.0,Intermediate,1,,A,,The Kel values in female wistar rats.,,,BAO_0000218,N,,1,,CHEMBL630561,
14965,,,22224,,Autocuration,1,,A,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,,BAO_0000019,U,,0,,CHEMBL630562,
14966,,,22224,,Autocuration,1,,A,,Hydrolysis rate constant of the compound,,,BAO_0000019,U,,0,,CHEMBL630563,
14967,,,22229,,Autocuration,1,,P,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,,BAO_0000100,U,,0,,CHEMBL629673,
14968,,,22224,,Autocuration,1,,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,,BAO_0000019,U,,0,,CHEMBL629674,
14969,,,22224,,Autocuration,1,,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,,BAO_0000019,U,,0,,CHEMBL629675,
14970,,,22224,,Autocuration,1,,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,,BAO_0000019,U,,0,,CHEMBL629676,
14971,,,22224,,Autocuration,1,,A,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,,BAO_0000019,U,,0,,CHEMBL629677,
14972,,,22224,,Autocuration,1,,A,,Apparent inactivation rate constant was evaluated,,,BAO_0000019,U,,0,,CHEMBL629678,
14973,,,22224,,Autocuration,1,,A,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,,BAO_0000019,U,,0,,CHEMBL629679,
14974,,,22224,,Autocuration,1,,A,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,,BAO_0000019,U,,0,,CHEMBL629680,
14975,,,22224,,Autocuration,1,,A,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,,BAO_0000019,U,,0,,CHEMBL629681,
14976,,,22224,,Autocuration,1,,A,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,,BAO_0000019,U,,0,,CHEMBL629682,
14977,,,22224,,Autocuration,1,,A,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,,BAO_0000019,U,,0,,CHEMBL629683,
14978,,,22224,,Autocuration,1,,F,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,,BAO_0000019,U,,0,,CHEMBL629684,
14979,,,22224,,Autocuration,1,,P,,Dissociation constant was determined,,,BAO_0000100,U,,0,,CHEMBL629685,
14980,,,22224,,Autocuration,1,,P,,Dissociation constant was determined,,,BAO_0000100,U,,0,,CHEMBL629686,
14981,,,22224,,Autocuration,1,,P,,Dissociation constant at pH 7.4,,,BAO_0000100,U,,0,,CHEMBL872932,
14982,,,22224,,Autocuration,1,,P,,Dissociation constant in presence of 1 mM dithiothreitol,,,BAO_0000100,U,,0,,CHEMBL629687,
14983,,,22224,,Autocuration,1,,A,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,BAO_0000019,U,,0,,CHEMBL872931,
14984,,,22224,,Autocuration,1,,A,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,,BAO_0000019,U,,0,,CHEMBL628151,
14985,,,22224,,Autocuration,1,,A,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,BAO_0000019,U,,0,,CHEMBL628152,
14986,,,22224,,Autocuration,1,,A,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,,BAO_0000019,U,,0,,CHEMBL628153,
14987,,,22224,,Autocuration,1,,A,,Kinetic constant for aromatization of androstenedione,,,BAO_0000019,U,,0,,CHEMBL628154,
14988,,,22224,,Autocuration,1,,A,,Kinetic constant for aromatization of testosterone,,,BAO_0000019,U,,0,,CHEMBL628155,
14989,,,22224,,Autocuration,1,,A,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,,BAO_0000019,U,,0,,CHEMBL628156,
14990,,,22224,,Autocuration,1,,A,,Local inhibition constant was determined,,,BAO_0000019,U,,0,,CHEMBL628157,
14991,,,50347,4932.0,Intermediate,1,,A,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,,BAO_0000218,N,,1,,CHEMBL857533,
14992,,,22224,,Autocuration,1,,P,,Dissociation constant value of the compound,,,BAO_0000100,U,,0,,CHEMBL628158,
14993,,964.0,22224,,Autocuration,1,Cornea,A,,In vitro permeability through cornea without epithelium,,,BAO_0000019,U,,0,,CHEMBL628159,
14994,,964.0,22224,,Autocuration,1,Cornea,A,,In vitro permeability through intact cornea,,,BAO_0000019,U,,0,,CHEMBL875616,
14995,,964.0,50592,9986.0,Intermediate,1,Cornea,A,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,,BAO_0000218,N,,1,,CHEMBL628160,
14996,,,22224,,Autocuration,1,,A,,Rate of enzyme inactivation for the compound was determined,,,BAO_0000019,U,,0,,CHEMBL628161,
14997,,964.0,22224,,Autocuration,1,Cornea,A,,In vitro permeability through cornea without epithelium,,,BAO_0000019,U,,0,,CHEMBL628162,
14998,,964.0,22224,,Autocuration,1,Cornea,A,,In vitro permeability through intact cornea,,,BAO_0000019,U,,0,,CHEMBL628163,
14999,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628164,
15000,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628165,
15001,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628166,
15002,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628167,
15003,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628168,
15004,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628169,
15005,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628170,
15006,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628171,
15007,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL627434,
15008,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL627435,
15009,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628110,
15010,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628111,
15011,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628112,
15012,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628260,
15013,,,22224,,Autocuration,1,,A,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,,BAO_0000019,U,,0,,CHEMBL628261,
15014,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,,BAO_0000218,N,,1,,CHEMBL628262,
15015,In vivo,,50587,9606.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,,BAO_0000218,N,,1,,CHEMBL628263,
15016,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,,BAO_0000218,N,,1,,CHEMBL628264,
15017,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,,BAO_0000218,N,,1,,CHEMBL628265,
15018,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,,BAO_0000218,N,,1,,CHEMBL628266,
15019,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,,BAO_0000218,N,,1,,CHEMBL628267,
15020,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,,BAO_0000218,N,,1,,CHEMBL628268,
15021,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,,BAO_0000218,N,,1,,CHEMBL628269,
15022,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,,BAO_0000218,N,,1,,CHEMBL628270,
15023,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,,BAO_0000218,N,,1,,CHEMBL628271,
15024,In vivo,,50594,10090.0,Intermediate,1,,A,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,,BAO_0000218,N,,1,,CHEMBL628272,
